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ABSTRACT 
A programme of research was carried out to attempt the molecular characterisation of the human and 
animal pathogen, Burkholderia pseudomallei, the causative agent of melioidosis and the newly 
described avirulent species, B.thailandensis for comparative purposes. Melioidosis is still little 
understood, and so the clinical approach to the prevention and control of melioidosis must ultimately 
rest upon the basic understanding of the causative organism, particularly the pathogenic properties of 
B.pseudomallei. 
A range of B.pseudomallei and B.thailandensis isolates were cultured and the extracellular products 
were isolated and concentrated and an initial study conducted to identify potential target molecules for 
cloning. Those isolates tested were shown to have somewhat differing ECP profiles when analysed 
with SOS-PAGE and antigenk profiles when subject to irnmunoblotting using convalescent human 
serum although isolates within and between species shared a number of common bands. The ECPs 
were also tested for a range of activities and it was established that both species had proteolytic and 
phospholipase activities neither had a haemolytic activity and only isolates of B.pseudomallei had a 
hexosaminidase activity a putative pathogenicity determinant. 
Genomic DNA of B.pseudomallei was used to construct genomic libraries in a range of E.coli host 
vector systems. A A.GTII genomic library was screened with antisera for the presence of 
B.pseudomallei antigens and a number of natural and synthetic substrates for the presence of 
haemolytic and proteolytic components. Screening yielded one stable immunopositive clone with a 
novel positive reaction in the form of a "halo" of reaction around the plaque. The 5 kbp cloned 
fragment was subcloned into a plasmid vector, and the resulting recombinant molecule, pBPGT2 was 
DNA sequenced and found to contain a putative pilin gene. Attempts were made to determine the size 
of the recombinant antigen and to further express the pilin gene product all of which were 
unsuccessful. A southern blot procedure confirmed the fidelity of the cloning procedure proving that 
the fragment was from the host organism, B.pseudomallei. A further southern blot procedure tested for 
the presence of the pi! in sequence in a range of B.pseudomallei and B.thailandensis isolates proving 
the presence of the gene in only isolates of B.pseudomallei. 
PCR primers were designed to amplify the DNA encoding the active site of the ADP-ribosylating 
toxin (ET A) of Pseudomonas aeruginosa and a PCR reaction was carried out on a number of 
B.pseudomallei and B.thailandensis isolates. The reaction yielded a 500 bp product in only 
B.pseudomallei isolates and DNA sequencing of the product revealed no obvious homology to ET A of 
P.aeruginosa but was used as a probe to isolate a larger fragment of DNA which was found to encode 
a number of interesting putative genes. These included one with homology to a porin similar to that of 
the pathogen Neisseria gonorrhoea, with a role in virulence. 
During attempts to digest the genomic DNA of B.pseudomallei isolate 4845 with the restriction 
enzyme Sau3A two 12 kbp bands of DNA were resistant to the endonuclease activity. Attempts were 
made to clone these bands into a range of plasmid vectors with two clones containing deleted products. 
DNA sequencing proved inadequate with only a small amount of sequence information obtained. 
However, towards the final stages of the research project sequence infonnation from the 
B.pseudomallei genome sequencing project facilitated the recognition of a 38 kbp fragment containing 
the sequence information from one of the clones, which encodes an alkaline protease and a putative 
haemagglutinin and is postulated to be a Pathogenicity Island encoding secreted virulence factors. 
The sequencing project also facilitated the isolation of two putative hexosaminidase genes postulated 
to be responsible for the activities observed when testing the B.pseudomallei isolates concentrated 
ECPs. Future studies for the putative genes identified and other components of B.pseudomallei are 
discussed. 
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CHAPTER! 
INTRODUCTION 
1.1 IDSTORY OF MELIOIDOSIS AND THE CAUSATIVE AGENT, 
Burkholderia pseudomallei. 
1.1.1 The First Descriptions of Melioidosis. 
Me I ioidosis was first reported in Apri I 191 1 by a British pathologist, Captain A. Whitmore 
working in Rangoon General Hospital, Burma (Whitmore and Krishnaswamy, 1912). While 
carrying out a post-mortem on a 40-year-old " morphia" addict, Whitmore discovered a 
glanders-like infectious disease and cultures grown yielded an organism the same size and 
shape as "Bacillus mallei", the name used at the time for the causative agent of glanders. 
Hence the organism was originally named "Bacillus pseudomallei'' due to this resemblance. 
Over the next 6 years in Rangoon, Knapp and Krishnaswamy described further cases of the 
disease based on Whitmore' s initial observations (Dance, 1991 ). [n fact, the disease proved to 
be surprisingly common, being identified in approximately 5% of post-mortem reports in 
Rangoon General Hospital (Krishnaswamy, 1917). 
The disease was again recognised later by Stanton and Fletcher ( 1921) working in Kuala 
Lumpur, who were responsible for naming the disease melioidosis, which was derived from 
the Greek term for a variety of conditions resembling glanders. Stanton and Fletcher ( 1932) 
predicted that the disease would prove to be far more prevalent than appreciated at that time; a 
claim that has been substantiated in the past twenty years or so, as melioidosis has gained 
greater recognition, particularly in the tropics. In the same report, the authors developed the 
concept that the wild rat was the natural reservoir of infection and that humans contracted the 
disease through ingestion of food or water contaminated with rat excreta. Several years later, 
French workers in lndo-China made a number of observations of the disease and its causative 
agent, which has led to current understanding of the ecology of B.pseudomallei (Dance, 
2000c). The French workers noted that infections in humans and animals often followed 
exposure to mud and water and that the disease was very rarely observed in wild rodents 
(Dance, 2000c). Chambon ( 1955) isolated the organjsm from mud and water of ponds and rice 
paddies in southern Vietnam and thus it became apparent that the organism was actually an 
environmental saprophyte, and that disease in man and animals ensued as a consequence of 
exposure to the organism in soil and surface water (Dance, 2000c). 
The first confirmed indigenous case of melioidosis in Thailand was reported in 1955 (Chittivej 
et al. 1955), despite previous descriptions of an imported case in 1928 and cases of 
melioidosis in two prisoners of war in 1947 (Dance, 1991). [n Australia, melioidosis was first 
identified in sheep in Queensland in 1949 (Dance, 1990) and the first human case was 
described by Rimmgton ( 1962) in a 32-year-old diabetic man. Cases of melioidosis were then 
described in many areas of the tropics and by 1957 more than 300 human cases of melioidosis 
had been documented worldwide (Smith et al. 1987). 
1.1.2 Military Experience of Melioidosis. 
A high incidence of melioidosis has been reported in army personnel who have participated in 
military campaigns taken place throughout history in Southeast Asia (Smith et al. , 1987), 
which has consequently led to an increased recognition of the disease worldwide. During the 
Civil War in Vietnam, there was a notable increase in the number of infections occurring in 
troops (Rubin et al. , 1963). However, melioidosis first gained recognition in the Western 
world during the French-lndochina War, dating from 1948 to 1954, where at least I 00 cases 
were reported in French forces (Dance, 1990). Some years later, melioidosis again provoked 
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interest when 343 American military personnel on active duty in Vietnam from 1965 to 1971 
were treated for overt disease (Chodimella et al. , 1997). Clayton et al. (1973) postulated that 
some of the American military personnel who had been exposed to B.pseudomallei during the 
conflict may go on to develop the disease at a later date, due to its long latency period. indeed 
there have now been a number of reports of Vietnam veterans developing melioidosis more 
than 20 years after the conflict (Chodimella et al. , 1997). 
More recently in a report by Embi et al. ( 1992) the incidence of antibody to exotoxin was over 
40% and 30% for military personnel in the age group 26 to 32 years serving in Sarawak and 
Sabah, Malaysia, respectively. Also in a recent study in Singapore between 1987 and 1994, 23 
cases of melioidosis were diagnosed in persons serving in the Singapore Armed Forces (Lim, 
1997). Melioidosis therefore poses a significant health threat to military personnel serving in 
endemic areas, particularly if they sustain injury during this period. 
1.1.3 Recent History of Melioidosis. 
Little further progress was made with the disease until the mid 1970's (Dance, 2000b). In 1975 
at the meeting of the [nfectious Disease Group of Thai land, Punyagupta et al. ( 1976) reported 
on I 0 culture proven cases of melioidosis. The first national workshop on melioidosis was 
then held I 0 years later, compiling more than 700 reported cases that led to research activities 
on various aspects of the disease (Leelarasamee, 2000). Melioidosis now qualifies as an 
emerging infection, since it has been recognised with increased frequency over the past two 
decades both within established endemic areas and elsewhere (Dance, 2000b). Increasing 
recognition of the disease has partly been due to an increased awareness on the part of the 
clinicians and microbiologists, especially as diagnostic facilities have improved greatly, 
allowing the identification of more cases of melioidosis. However, Dance (2000b) suggested 
that there could actually have been a genuine increase in the disease in recent times, perhaps 
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due to changing environmental factors and farming practices. 
Enthusiasm and interest for this disease reached the point that an International Symposium on 
"Melioidosis: Prevailing Problem and Future Direction" was organised in 1994 (Leelarasamee, 
2000), and more recently an International Congress on Melioidosis was held in Bangkok in 
November, 1998 where researchers from all over the world discussed significant progress in 
different aspects of the disease. 
1.1.4 Taxonomy of The Genus, Burkholderia and Burkholderia pseudomallei. 
Under current nomenclature, the agent of melioidosis is known as Burkholderia pseudo mallei. 
However, the same organism has been known as Bacillus pseudomallei, Pfeifferella whitmori, 
Bacillus whitmore, Flavobacterium pseudomallei, Actinobacillus pseudomallei, Loejjlerella 
and Malleomyces pseudomallei (Tan et al. , 1997). Furthermore, based on assessment of 
nutritional and biochemical characteristics, Haynes (1957) reassigned the organism to the 
genus Pseudomonas. More recently, investigations based on 16S ribosomal RNA (rRNA) 
sequences, DNA-DNA homology values, cellular lipid and fatty acid composition, and 
phenotypic characteristics, led Yabuuchi et al. (1992) to propose a new genus, Burkholderia, 
for the RNA homology group 11 of the genus Pseudomonas, which included P.pseudomallei. 
Seven species in this group were transferred to the new genus Burkholderia at the time, those 
being B.cepacia, B.mallei, B.pseudomallei, B.caryophylli, B.gladioli, B.pickettii and 
B.solanacearum. Further work on internal transcribed spacer (ITS) sequence homology by 
Tyler et al. (1995) supported the transfer of these former Pseudomonads to a new genus, as 
well as work by Li and Hayward ( 1994) comparing whole cell protein profiles. The genus was 
named Burkholderia, after W.H.Burkholder, the American bacteriologist who first discovered 
the etiologic agent of rotten onion (Burkholder, 1950), now known as Burkholderia cepacia. 
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Since the initial transfer, other species have been added and conversely removed from 
Burkholderia. B.solanacearum and B.pickettii were found to belong to a separate RNA 
subgroup establishing another genus, Ralstonia (Yabuuchi et al. , 1995). Other species that 
have now been transferred to the genus Burkholderia include B.plantarii, B.glumae, B. vandii 
(Urakami et al. , 1994), B.pyrrocinia (Viallard et al., 1998) and B.vietamensis (Gillis et al. , 
1995). Recently, new species have been identified and deemed members of the genus 
Burkholderia. One, B.caribensis was isolated on the island of Martinique in the French West 
£ndies by Achouak et al. ( 1999) and another, B.graminis identified by Viallard et al. (1998). 
However, of this genus at present, only B.mallei, B.pseudomallei, B.cepacia and B.gladioli are 
pathogenic for humans or animals, whereas the other members are mostly found in, or on, 
plants (Otterbein et al., 1998). 
1.1.5 Bacteriology. 
B. pseudomallei is an oxidase positive, gram-negative rod, which is motile by means of a polar 
tuft of 2 to 4 flagella and able to use a wide range of substrates as carbon sources (Redfearn et 
al., 1966; Dance, 1990; Sanford, 1995; DeShazer et al. , 1997). It is obligately aerobic and non 
spore-forming (Leelarasamee and Bovomkitti, 1989), and when stained with methylene blue, 
Wayson or Wright stain, marked irregularities with a bipolar "safety pin" pattern are observed 
(San ford, 1995). Growth of the organism is accompanied by a distinctive sweet, earthy smell 
(Dance, 1990) and it is readily identified by its growth and characteristic morphology on 
Ashdown' s selective medium (Chaowagul, 1996). The bacterium appears as cream to yellow-
coloured colonies, 2 to 3 mm in diameter with a reported metallic sheen over areas of 
confluent growth (Smith et al. , 1987; Dance et al., 1989b). On Blood agar, colonies are opaque 
white and after 48 hours a narrow zone of beta haemolysis becomes visible around each colony 
(Jesudason et al. , 1997). Colonies can vary from smooth to rough in appearance and often 
become wrinkled after a few days of incubation (Leelarasamee and Bovomkitti, 1989). The 
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respective virulence of these colonial types has been studied by Veljanov and Najdenski 
( 1993), who observed that bacteria from smooth colonies survived and multiplied more 
actively in macrophages than the alternative, rough colonial bacteria. Other characteristic 
properties of B.pseudomallei include the reduction of nitrates, the ability to accumulate poly-13-
hydroxybutyrate, and arginine dihydrolase and gelatinase activity (Dance, 1990). Plasmids 
have not been identified in the bacterium (Dance, 1990), but 32 B.pseudomallei bacteriophages 
have been isolated (Manzenyuk et al. , 1 994). 
The guanine +cytosine (G+C) content of the DNA of B.pseudomallei is 69% (Redfearn et al. , 
1966). Recent work by Songsivilai and Dharakul (2000) has shown that two large replicons 
constitute the genome of B.pseudomallei, which appear to be chromosomes as each one 
contains rRNA sequences. The combined genome size of B.pseudomallei estimated from 
pulsed field gel electrophoresis (PFGE) separation of undigested chromosomal DNA was 
calculated to be approximately 6.54 megabase pairs (Mbp), which makes it one of the largest 
bacterial genomes (Songsivilai and Dharakul, 2000). Songsivilai and Dharakul (2000) suggest 
the average gene size as being about I 03 I bp and that the genome is gene rich, with about 89% 
of the potential coding capacity being used as coding sequences 
1.1.6 Burkholderia mallei. 
When first describing B.pseudomallei in 1911 , Whitmore thought it bore a striking 
resemblance to B.mallei, the causative agent of glanders. Glanders is primarily an infectious 
disease of equine animals, for example the horse, mule or donkey (Sanford, 1995), but it is 
also infectious for humans and is characterised by a high mortality rate. Melioidosis does 
indeed bear a remarkable resemblance to glanders both clinically and pathologically, but it is 
epidemiologically dissimilar (Sanford, 1995). Once found worldwide, glanders has now been 
eliminated in Western Europe and Northern America through the use of the mallein test, but 
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recently Arun et al. (1999) confirmed that equine glanders is still endemic in Turkey. Glanders 
was recognised as early as 400BC and it has been postulated that B.pseudoma/lei may have 
unwittingly been the etiological agent of many past cases of "glanders" in man and animals 
before its own recognition (Rubin et al., 1963). 
The organism, B.mallei is a non-moti le, gram-negative bacillus (Sanford, 1995) and so differs 
from B.pseudomallei with respect to motility. The two organisms have very similar antibiotic 
susceptibility profiles (Kenny et al., 1999) and although biochemical testing distinguishes 
between B. mallei and B.pseudomallei, it creates a high risk of infection through working with 
live cultures. For this reason, a polymerase chain reaction (PCR) procedure has been 
developed to discriminate between B.mallei and B.pseudomallei, detecting a nucleotide 
difference in the 23S rRNA sequences at position 2143 (Bauemfeind et al. , 1998). 
1.1.7 Burkholderia thailandensis. 
Wuthiekanun et al. ( 1996) investigated an observed discrepancy between the distribution of 
the disease and the distribution of the organism in the environment, which compared the 
biochemical and antigenjc features, and antibiotic susceptibilities of clinical and 
environmental isolates of B.pseudomallei. Results showed that a lthough clinical and 
environmental isolates of B.pseudomallei were morphologically similar and antigenically 
indistinguishable, all clinical isolates of B.pseudomallei failed to utilise the carbohydrate, L-
arabinose (Ara-), whereas some soil isolates from areas of endemic infection could utilise this 
carbohydrate (Aral. The Ara+ biotype was also shown by Wuthiekanun et al. (1996) to differ 
from the Ara- isolates by its positive reaction for adonitol , 5-keto-gluconate and xylose and by 
its failure to assimilate dulcitol , erythritol and trehalose. To determine whether the varieties of 
B.pseudomallei were genomically related or were sufficiently different to warrant further 
investigation of species identity, the variation in rRNA gene loci of isolates with both 
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phenotypes was examined by Trakulosomboon et al. ( 1997). At the species level, these 
sequences are sufficiently conserved that differences within them often reflect intra-species 
variation or types (Trakulosomboon et al. , 1997). Results showed that approximately half of 
the isolates from soil specimens were of ribotypes similar to those from patients with 
melioidosis, but were markedly different from other environmental isolates, which is 
inconsistent with the single species concept (Trakulosomboon et al., 1997). lnvestigations by 
Dharakul et al. (1999) on the 16S rRNA-encoding genes showed that there were differences 
between the Ara +and Ara- isolates, although the difference observed was smaller than amongst 
the other species of the genus Burkholderia. Further supportive evidence for the Ara + isolates 
being a different species was shown by Brett et al. (1998), using 16S rDNA-based 
phylogenetic analysis, and the new species name suggested for this organism was 
Burkholderia thailandensis (Brett et al., 1998). 
Perhaps the most significant difference associated with the Ara + isolates was discovered in an 
investigation by Brett et al. ( 1997), which showed that these isolates had a markedly decreased 
virulence in the Syrian golden hamster model; in fact demonstrating more than a I 05 -fold 
decrease in virulence relative to the clinical Ara- isolates. At present there has only been one 
reported case of "melioidosis" having been caused by an Ara +isolate, but it was suggested that 
this was due to an unusually heavy inoculation at the time of the accident responsible for the 
infection (Lertpatanasuwan et al., 1999). 
Further work has now been carried out investigating other differences between the two species. 
Work by Winstanley et al. (1998) on conservation amongst flagellin genes, showed high levels 
of conservation amongst the Ara- clinical isolates (over 99%) which contrasted with less than a 
90% similarity on comparison with an Ara+ isolate. A conserved deletion of 5 amino acids in 
the flagellin gene sequence within 41 Ara+ isolates has been demonstrated by Wajanarogana et 
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al. (1999), thus providing one fonn of differentiation between Ara + and Ara- isolates. Another 
recent finding is that Ara· and Ara + isolates have different macrorestriction patterns on PFGE 
(Chaiyaroj et al., 1999), and investigations by Winstanley and Hart (2000) have shown that 
type Ill secretion genes were absent from most of the Ara + isolates tested but present in all Ara-
isolates. Further differences will inevitably be highlighted between the two species, especially 
with respect to virulence detenninants and the genes that encode them, and so the newly 
discovered species B.thailandensis will prove an invaluable tool for investigating the 
pathogenicity of B.pseudomallei. 
1.1.8 Burkho/deria uboniae. 
Recently, Yabuuchi et al. (2000) have identified another new species, which was originally 
identified as B.thailandensis, and although able to assimilate L-arabinose, revealed a DNA-
DNA reassociation rate of 36.7% under stringent conditions with the type strain of 
B.thailandensis. The authors noted that this strain differed from the B.thailandensis type strain 
by its physiological, biochemical and nutritional characteristics without any significant 
difference in cellular fatty acid and lipid composition, and has named the new species 
Burkholderia uboniae. 
1.2 ECOLOGY OF B.pseudomallei. 
1.2.1 Geographical Distribution of Melioidosis Cases and of B.pseudomallei. 
The majority of cases of melioidosis reported in the world literature have arisen in Southeast 
Asia and Northern Australia, with most cases in general tending to occur between the latitudes 
20"N and 20°S (Leelarasamme and Bovomkitti, 1989; Dance 1991 ). Fig. 1.1 shows the 
worldwide distribution of B.pseudomallei and B.pseudomallei-like isolates (Dance, 1991 ). 
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Fig.l.l The worldwide distribution of B.pseudomallei and B.pseudomal/ei-like isolates (Dance, 1991). Shaded areas represent the main endemic 
areas and hatched areas and asterisks represent sporadic isolates. 
Considering that there are still limited microbiological facilities in some areas of the tropics, 
coupled with a lack of awareness on the part of some clinicians, melioidosis may actually be 
under-diagnosed in many rural areas of the tropics and so the overall picture has yet to be fully 
elucidated. Melioidosis, however, is rarely encountered in Europe but as worldwide travel 
becomes easier and more frequent, particularly with regard to the transportation of animals, it 
is likely that the disease could spread from endemic areas to those areas not presently believed 
to be at threat from melioidosis. Infected animals may excrete B.pseudomal/ei in sputum, pus, 
urine and faeces, which may then contaminate their new environment, providing it is suitable 
(Dance, 2000b). There have been many cases where travel to endemic areas has caused 
melioidosis, which becomes apparent on return to the Western world (Dance, 1990). Ofthe 15 
human cases diagnosed in the UK between 1988 and 1998, five originated from Bangladesh 
and one each from India and Pakistan (Dance et al., 1999). A similar problem has also been 
shown to occur in Australia, where imported melioidosis cases are seen in southern hospitals, 
normally from tourists returning from the Northern Territory of Australia as well as Southeast 
Asia. There have also been documented cases of melioidosis occurring as a result of animal 
transportation from endemic areas. This occurred in France during the mid 1970s, after an 
imported panda donated by Mao-Tse-Tung probably caused an outbreak of melioidosis 
(Mollaret, 1988). There have also been cases of melioidosis in imported primates in Britain 
originating from Indonesia and the Philippines (Trakulsomboon et al., 1994). In temperate 
Southwest Australia between 1966 and 1991, melioidosis occurred in a farmer and his 
livestock, which was investigated by Currie et al. ( 1994). In this investigation molecular 
typing supported the theory of clonal introduction of B.pseudomallei into the non-endemic 
region, local dissemination and persistence for over 25 years (Currie et al., 1994). 
Geographical distribution of the causative organism itself has not been studied in any great 
detail worldwide. Studies carried out by Vuddhakul et al. (1999) investigating the distribution 
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of B.pseudomallei in the soil collected from four regions in Thailand (Table 1.1), showed that 
the organism was far more prevalent in the Northeast region, which correlated with a higher 
incidence of melioidosis. 
Table 1.1 Isolation rate of Burkho/deria pseudomallei from soil samples m Thailand 
(Vuddhakul eta/., 1999). 
Region Number of soil Number of positive Number of Number of positive 
samples samples collection sites sites 
North 720 32 (4.4%) 180 25 (13.8%) 
Central 196 12(6.1%) 49 12 (24.5%) 
Northeast 1428 291 (20.4%) 357 179 (50.1%) 
South 1241 73 (5.9%) 310 57 (18.4%) 
Overall 3585 408 (11.4%) 896 273 (30.5%) 
1.2.2 Soil Ecology. 
In nature, members of the genus Burkho/deria multiply in the rhizosphere, defined as the 
region of soil modified as a result of the uptake and deposition of substances growing in the 
plant root, where the bacteria grow in close association with root nodules and assist in the 
fixation of nitrogen and promote uptake of minerals, particularly phosphate by the plant (Pitt et 
al., 2000). A specific plant host has yet to be described for B.pseudoma/lei but it is considered 
plausible that the species may play a similar role to B.cepacia in the rice paddy field (Pitt et 
al., 2000). The distribution and behaviour of B.pseudomallei within the soil environment is a 
significant factor in the epidemiology of the disease, and in determining pathways of 
melioidosis transmission (Brook et al., 1997). A number of factors that may influence the 
distribution of B.pseudomallei in soil have been investigated, including climatic factors such 
as rainfall, temperature and sunlight. However, Dance (2000c) stressed recently that any 
environmental surveys using artificial media pre-1997 may not discriminate between 
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B.pseudomallei (Ara) and B.thailandensis (Ara), and so the isolation of B.pseudomallei in 
some of these cases may not indicate endemicity for pathogenic B.pseudomallei, since only 
Ara· isolates cause infection. 
1.2.2.1 Temperature. 
Considering that melioidosis is predominantly a disease of tropical and subtropical climates, it 
is probable that environmental temperature contributes to the distribution of the organism and 
disease (Dance, 2000c). B.pseudomal/ei-positive areas investigated by Tong et al. ( 1996) were 
usually places where the atmospheric temperatures in January, the coldest month in the South, 
were above I2°C. The study also showed that the optimum temperature for growth of the 
organism in vitro was between 24°C and 32°C (Tong et al., 1996). Indeed, most workers find 
the organism unable to grow at temperatures below 21°C (Dance, 2000c). Further 
investigations have shown the organism to be very susceptible to heat, as well as the cold, as 
exposure for I 0 minutes at 50°C, and at 4°C for 2 to 3 weeks were equally lethal, which may 
explain the restriction of the free-living organism to tropical regions (Smith et al., 1987). 
However, if climatic conditions continue to change, with the threat of global warming, it may 
eventually mean that the organism will not be as environmentally restricted as it currently is. 
Persistence of B.pseudomallei within the environment has been studied and the organism has 
been shown to remain viable and to retain its virulence even after 27 days of being kept 
desiccated, mixed with garden soil at 27°C (Smith et al., 1987). Wuthiekanun et al. (1995b) 
monitored the successful survival of B.pseudomallei in sterile triple-distilled water at tropical 
room temperature, without any additional nutrients for more than three years, showing that the 
bacterium has a remarkable capacity to survive in a nutrient-free medium. 
1.2.2.2 Rainfall and Moisture Content of the Soil. 
Most cases of melioidosis present during the rainy season months in endemic areas and in the 
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case of Thailand, this is presumably as a result of direct infection during rice farming in wet 
paddy fields (White, 1994). However, the possibility of other seasonal factors, for example, 
dietary changes, stress, or concomitant viral infection that may precipitate relapse of latent 
melioidosis cannot be excluded (Dance, 2000c). It is thought that during periods of high 
rainfall, B.pseudomallei is physically leached from its normal environmental habitat of soil and 
surface water, temporarily creating a more widespread distribution (Leakey et al., 1998). Tong 
et al. ( 1996) showed that soil with water contents of below I 0% were highly detrimental to 
B.pseudomallei, but increasing water content up to 40% increased survival. Studies by 
Wuthiekanun et al. (1995a) on recovering B.pseudomallei from soil has similarly shown it to 
be dependent on moisture content; as no strain was isolated from the soil surface in the dry 
season. The association between isolation rate and soil depth may partly be related to the 
killing of B.pseudomallei by sunlight, which has been investigated by Tong et al. (1996) who 
found that the organism was more easily killed by UV light in vitro than the "permanent soil 
bacteria" (Tong et al., 1996). 
1.2.2.3 Other Factors Affecting Soil Distribution of B.pseudomallei. 
Studies carried out by Tong et al. (1996) on the correlation between a variety of soil conditions 
and the survival of B.pseudomallei showed that pH values below 4 and above 8 were 
detrimental to the organism. The pH of soil in the rice field is usually between 5 and 6.8 and so 
is well within the range that B.pseudomallei can tolerate (Tong et al., 1996). Extensive 
investigations into soil type have not been carried out, but in a study in Australia by Thomas et 
al. ( 1981 ), it was found that the isolation rate of the organism was higher in clay soils as 
opposed to sandy; possibly attributed to the greater water retention of clay. It has also been 
shown that cultivated areas and wet rice fields provided higher isolation rates of 
B.pseudomallei than forested areas (Straus et al., 1969), and considering that B.pseudomallei 
is able to reduce nitrate in order to grow in an anaerobic environment, the use of nitrate 
14 
fertilisers may actually contribute to its proliferation in agricultural land (Dance, 2000c). 
Further investigations are obviously needed, but it is clear that temperature, water content and 
soil pH are major ecological conditions governing the environmental distribution of 
B.pseudomallei. 
1.3 EPIDEMIOLOGY OF MELIOIDOSIS. 
1.3.1 Incidence of Melioidosis. 
Melioidosis is especially prevalent m Northeast Thailand where approximately 20% of 
community-acquired septicaemia can be attributed to this bacterial pathogen (Chaowagul et 
al., 1989). In Thailand, it has been estimated that between 2000-5000 cases of melioidosis 
occur each year (Dharakul et al., 1996). The disease is also prevalent in Northern Australia and 
in a period between October 1989, and February 1997, 170 cases of melioidosis were 
diagnosed in the Northern Territory of Australia (Edmond et al., 1998). Findings over a 9-year 
period carried out in the top end of the Northern Territory of Australia by Currie et al. (2000b) 
showed that the average annual incidence of melioidosis was 16.5/100,000 population, and the 
overall mortality was 21%. This compares to an annual incidence of 4.4/ I 00,000 population in 
Ubon Ratchathani, in Northeast Thailand (Suputtamongkol et al., 1994). The higher incidence 
rate reported in Australia has been suggested by Currie et al. (2000b) to be a reflection of a 
possible underassessment in the study in Thailand, where less severely ill patients are treated 
in different hospitals and not referred to the larger central hospital and so missed. An 
interesting observation in the study by Currie et al. (2000b) was that although Aboriginal 
Australians account for just 24% of the population of the region, they represented 50% of the 
melioidosis cases reported. Surprisingly, in Singapore between 1989 and 1996, the incidence 
of melioidosis was relatively high, 1.71100,000 population, despite the highly urbanised 
environment with 88% of the population living in high-rise flats (Heng et al., 1998). In a 
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recent study carried out by Vuddhakul et al. (1999) it showed that of in-patients observed in 
Northeast Thailand, 137.9/100,000 admitted had melioidosis compared with 13.41100,000 in 
Central Thailand, 181100,000 in the North and 14.41100,000 in the South, which reflects the 
authors findings that the organism has a much higher isolation rate in the Northeast region 
(Table 1.1 ). 
The male to female ratio of melioidosis cases in Thailand is approximately 3:2 respectively, a 
fact that has previously been attributed to work-related exposure, although many women in 
rural Thailand participate actively in rice farming (Dance, 1990). However, Currie et al. 
(2000b) found in Australia that 74% of the cases observed were in males. Melioidosis may 
present at any age, although the disease is very rarely observed in neonates (Halder et al., 
1998).1n Northeast Thailand the mean age ofpresentation is in the fifth decade (White, 1994). 
1.3.2 Inoculating Events and Mode of Transmission. 
B.pseudomallei is a free-living bacterium found widely in soil and surface water of rice 
paddies, fields newly planted with oil palm, monsoon drains, gardens and playgrounds in 
endemic areas (Leelarasamee and Bovornkitti, 1989). In humans, it is thought that melioidosis 
is mainly acquired by contact with infectious soil and water through a pre-existing skin 
abrasion or ulcer, but infection is possible through ingestion, or inhalation of infectious dust 
particles (Leelarasamee and Bovornkitti, 1989). Melioidosis is found more frequently amongst 
the rice farming community in Thailand as rice farmers often plough and plant seedlings 
without any protective clothing, therefore minor skin trauma is very common (Wuthiekanun et 
al., 1995a). However, in 15% of cases there is no obvious focus of primary infection 
(Chaowagul et al., 1989). In fact, relatively few patients can identify a specific incident before 
they become ill, probably because rice farmers, for example, are continually exposed to 
infection and because of the variable incubation period of the disease, which may remain latent 
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for weeks, months or years (Dance, 2000a). In a study by Currie et al. (2000b) only 25% of 
cases had likely inoculating events, those being situations of exposure to soil or muddy water 
speci tically recalled. 
Recently, an outbreak of melioidosis in Northwest Australia was investigated by lnglis et al. 
(2000) where the source of contamination was tracked-down to a potable water supply and the 
aerator was identified as the probable source. This is concerning as many remote communities 
in Australia have similar water supplies and so should be considered in future as possible 
sources of infection. Infection due to inhalation of contaminated dust or soil particles became 
apparent during the Vietnam conflict, where a disproportionately high number of helicopter 
crewman developed melioidosis in comparison to other soldiers, and it was proposed that the 
rotors of the helicopter disturbed infectious dust particles facilitating pulmonary infection 
(Sanford, 1990). 
Human-to-human transmission 1s rare and only one sexually transmitted case has been 
described in a man who had chronic prostatitis and his wife subsequently had a raised 
haemagglutination titre (McCormick et al., 1975). A case described by Kunakorn et al. 
( 1991 a) involved a man with melioidosis who was believed to have passed it on to his sister 
who had cared for him during his illness, and the isolates were later shown to be 
indistinguishable by PFGE (Dance, personal communication). In a recent report, a goat with 
melioidosis from the Darwin rural region aborted twins and died shortly afterwards and 
B.pseudomallei was isolated from the goat's uterus and from the spleen of one of the aborted 
twins, confirming transplacental infection in animals (Choy et al., 2000). 
1.3.3 Host Risk Factors. 
Cellular immunity is postulated to play important roles in immunity to melioidosis that may 
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influence the severity and clinical outcome of the disease (Dharakul et al., 1998). The majority 
of adult cases have an underlying predisposition to infection; for example, diabetes mellitus 
and chronic renal disease are the two most common predisposing conditions (White, 1994). 
Other pre-existing circumstances such as steroid or cytotoxic drug therapy, leukaemia, 
tuberculosis, alcoholism, malignancy, connective tissue diseases and cirrhosis can also 
predispose individuals (Dance, 1990; Chaowagul, 1996; Dance, 2000c). Recently, Currie et al. 
(2000b) reported that in a 9-year study, 36% of cases observed were in diabetics, 37% were 
heavy alcohol consumers, 24% had chronic lung disease and 11% had chronic renal failure. A 
study by Ahmed et al. (1999) revealed that B.pseudomallei has low attachment ability to 
pharyngeal epithelial cells, which may partly explain why melioidosis mainly affects 
malnourished and immunodeficient hosts. Perhaps surprisingly, Thummakul et al. (1999) 
reported that melioidosis was not an important opportunistic infection in acquired immune 
deficiency syndrome (AIDS) patients in endemic regions. 
Genetic factors, including human leukocyte antigen (HLA) polymorphism, play important 
parts in the cellular immunity against infectious diseases (Dharakul et al., 1998). Work by 
Dharakul et al. ( 1998) has showed evidence of the association of certain HLA Class 11 alleles 
in particular groups of melioidosis patients, especially those with severe clinical disease and 
relapse cases. As there is a very strong association of melioidosis with diabetes, investigations 
into the interaction of B.pseudomallei and insulin was carried out by Woods et al. ( 1993), who 
found that insulin apparently inhibited the growth of B.pseudomallei. However, Simpson and 
Wuthiekanun (2000) showed that B.pseudomallei growth was in fact inhibited by m-cresol, a 
preservative found in the insulin preparations, whereas growth of the bacterium was not 
inhibited by pure insulin. Thus the findings of Woods et al. ( 1993) may have been due to the 
preservative rather than the insulin. Currie ( 1995) also stated that most diabetic patients with 
melioidosis, in their experience, did not actually have the insulin-dependent type I diabetes and 
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that many diabetics are probably hyperinsulinemic due to control over diet and drug therapies. 
Woods et al. (1993) provided the first evidence for the presence of a specific insulin receptor 
on B.pseudomallei, through radiolabelled insulin binding studies. Studies by Kanai et al. 
( 1996) showed that B.pseudomallei and B.cepacia stained positively with tluorescently 
labelled insulin, whereas Pseudomonas aeruginosa did not, and reported findings that insulin 
exposure reduced phospholipase C and acid phosphatase activities in B.pseudomallei. The 
findings by Kanai et al. (1996) thus support those of Woods et al. (1993), concluding that 
B.pseudomal/ei may possess insulin receptors which could be associated with a signal transfer 
system involving phospholipase and protein tyrosine phosphatase. 
1.3.4 Molecular Epidemiology of B.pseudomallei. 
Epidemiological studies of B.pseudomallei have been hampered in the past by the lack of 
discriminatory typing methods (Lew and Desmarchelier, 1993). Ribotyping is now a common 
method as an epidemiological tool in the study of a number of bacterial pathogens, whereby 
patterns of restriction fragment length polymorphisms (RFLPs) in rRNA genes from different 
isolates are compared. Lew and Desmarchelier (1993) carried out BamHl restriction enzyme 
digests of I 00 isolates of B.pseudomallei from a number of sources, and on the basis of the 
patterns observed, the strains were classified into 22 different groups. However, this was 
before the discovery of B.thai/andensis and so some of the ribotype groups represented this 
species rather than B.pseudomal/ei. Interestingly, Lew and Desmarchelier ( 1993) found that 
some of the ribotypes were restricted to a particular host species, geographical area or period 
of isolation, as all of the earliest strains were represented as a single clone, whereas strains 
from 1940 onwards belong to increasingly divergent ribotype patterns. This typing method was 
later utilised by Trakulsomboon et al. (1997) to investigate differences between clinical and 
environmental strains, showing that the ribotype patterns fell into two groups which are now 
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clearly identified as B.pseudomallei (Group I) and B.thailandensis isolates (Group 11). Pitt et 
al. (2000) have also carried out ribotyping on 350 isolates and discovered 44 ribotypes, 
whereby types I and 3 are the most common, accounting for half of the collection and 
prevalent worldwide. 
Norton et al. (1998) applied random amplification of polymorphic DNA (RAPD) and 
multilocus enzyme electrophoresis (MEE) to investigate whether disease presentation was 
clonally related in 18 cases of melioidosis observed in four geographically separate 
communities in North Queensland, Australia. The authors found that isolates segregated into 
two groups that actually correlated with disease presentation rather than geographical location, 
· with the first group including patients mainly with respiratory disease and the second, from 
patients with abscesses in viscera other than the lung or brain and those with bone or joint 
disease. Norton et al. ( 1998) suggested that different strains of B.pseudomallei might carry 
genetic regions capable of influencing tissue tropism of the infecting strain, although a study 
using a larger group of clinical isolates would be required to develop this clonal hypothesis. 
Koonpaew et al. (2000), however, found no significant association between clinical 
manifestations of melioidosis and the level of relatedness of B.pseudomallei isolates, whose 
DNA had been digested with a restriction enzyme, Ncol and then subjected to PFGE. 
1.4 MELIOIDOSIS. 
1.4.1 Clinical Manifestations. 
When humans and animals encounter B.pseudomallei in the environment one of the following 
outcomes are possible; firstly there may be no effect, secondly, asymptomatic seroconversion 
may occur and thirdly, a clinical infection becomes apparent (Dance, 2000a). Melioidosis has 
actually been termed "the great imitator" of every infectious disease, as virtually every organ 
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can be affected (Leelarasamee and Bovomkitti, 1989). Attempts have been made to classify 
"subtypes" of the disease, but none of these are entirely satisfactory (Dance, 1990). Some 
descriptions tend to classify the illness manifesting as an acute, subacute, or chronic process 
(San ford, 1995). The acute form is the most severe, with a rapid onset (24 to 48 hours) of non-
specific symptoms (Leakey el al., 1998) that may result in death within 72 hours (Smith el al., 
1987). Acute disease may involve one or a combination of several different types of disease: 
septicaemia, pneumonia, emphysema, localised abscess or wound infection, urinary tract 
infection, septic arthritis and visceral abscess formation (Walsh and Wuthiekanun, 1996). The 
lung is the most common organ involved, either as a primary focus of infection, or secondary 
to metastatic spread from bloodstream infection (White, 1994), and the severity of infection 
can range from a mild bronchitis to a disseminated bronchopneumonia (Dance, 1990). The 
subacute and chronic types take the form of a prolonged febrile illness associated with the 
formation of multiple abscesses with death ensuing in a few weeks or months (Smith el al., 
1987). 
Around 60% of melioidosis patients are bacteraemic, with most of these presenting with 
community-acquired sepsis syndrome and evidence of multi focal metastatic infection, with the 
remaining 40% having localised infections usually abscesses or granulomata (Dance, 2000a). 
Abscesses in the lungs, liver and spleen are common and 5% of patients also have superficial 
skin abscesses (Chaowagul, 1996). There have also been cases of abscesses occurring in the 
brain (Lee and Chua, 1986; Lath el al., 1998; Padiglione el al., 1998), but it is thought that the 
blood-brain barrier is breached only in overwhelming widespread infection in a debilitated 
host. Many patients require over one month's hospitalisation and the overall mortality of 
melioidosis is approximately 40% (Chaowagul, 1996). Subclinical infections, defined by the 
detection of haemagglutinating antibody in people residing in areas of endemicity, are very 
common (Anuntagool el al., 1998). However with the recent recognition of B.lhailandensis, a 
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proportion of these may represent asymptomatic infection with the newly described species, 
rather than B.pseudomallei. 
Other manifestations have been observed, such as neurological melioidosis, which has been 
described in a number of cases (Woods et al., 1992; Howe et al., 1997; Maguire et al., 1998). 
Clinical features of this initially manifest as a headache and in some cases stiffness in the neck 
is observed, but eventually the brainstem, cerebellum and spinal cord are all affected. Currie et 
al. (2000a) found in a 9-year study that 5% of melioidosis cases were neurological and that the 
mortality rate was 25% in those cases. 
1.4.2 Acute Suppurative Parotitis. 
Acute suppurative parotitis accounts for nearly 7% of the disease in Ubon Ratchatani, and 
almost exclusively affects children, manifesting normally as a unilateral parotitis, presenting 
with painful facial swelling and fever (Dance, 1990). Parotitis constitutes 38% of melioidosis 
cases in children in Northeast Thailand (Dance et al., 1989a). The underlying reasons for this 
are unclear, since children are usually previously healthy, but presumably reflects oral 
contamination with soil or water during play (Dance, 1990). Dance et al. (1989a) postulated 
that superinfection with B.pseudomallei may follow mumps parotitis, as a small number of 
children suffering with this had previously had mumps, but further investigation is needed to 
prove this theory. Reports bY Edmond et al. ( 1998) show that cases of parotid abscesses were 
not shown in children in the Northern Territory of Australia between 1989 and 1997, and 
suggest that a comparison of behaviour patterns and perhaps dietary habits of the children in 
Australia and Thailand is needed to explain such a finding. Acute suppurative parotitis may 
represent primary infection, but there is a good prognosis provided there is early incision, 
drainage and appropriate antibiotic therapy (Chaowagul, 1996). 
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1.4.3 Latency and Relapse of Melioidosis. 
Failure of antimicrobial therapy resulting in acute deterioration and death, the appearance of 
new abscesses whilst patients are on treatment, or relapse of the infection after completing a 
course of antimicrobial treatment are all common (Chaowagul, 1996). Relapse of melioidosis 
occurs especially in hosts who are immunocompromised or who have an associated condition 
such as diabetes mellitus, cirrhosis of the liver, chronic pyelonephritis and alcoholism 
(Leelarasamee and Bovornkitti, 1989), or in patients with large abscesses and a multi-organ 
involvement (Thummakul et al., 1999). Moreover, improvement in acute treatment has 
resulted in a greater number of successfully treated patients who survive and leave hospital, 
but eventually relapse (Chaowagul et al., 1993). In a study carried out by Chaowagul et al. 
( 1993) the overall relapse rate was found to be around 15.3% per year of follow up; but this 
figure may be inaccurate as large numbers were lost to follow up. The same study showed that 
the median time to relapse was 21 weeks and the longest period between recovery and relapse 
was five and a half years. RAPD typing and RFLP analysis has confirmed that the majority of 
relapse cases of melioidosis are in fact a re-emergence of the initial infecting strain, and that 
relapsed melioidosis is almost always associated with failure to complete maintenance therapy 
(Desmarchelier et al., 1993; Haase et al., 1995; Vadivelu et al., 1998). However, Vadivelu et 
al. ( 1998) discovered that in one case, two distinct strains were isolated from a patient with a 
single episode of melioidosis, suggesting that some patients may be infected with more than 
one strain of B.pseudomallei. The antimicrobial susceptibility patterns of the relapse isolate are 
usually unchanged, although a simultaneous resistance to chloramphenicol, doxycycline, and 
trimethoprim-sulfamethoxizole is occasionally recognised (Chaowagul, 1996). Thus, 
Chaowagul (1996) suggests that all relapse isolates should be reanalysed for their 
antimicrobial susceptibility patterns. 
B.pseudomallei may remain dormant m asymptomatic individuals only to recrudesce, if 
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conditions are favourable, and in many cases years after initial exposure, as an acute 
exacerbation (Ashdown and Koehler, 1990). The longest period of latency, described by 
Chodimella el al. ( 1997), is in a Vietnam veteran who developed melioidosis after an 
inapparent infection 29 years earlier in an endemic area. 
1.4.4 Disease in Animals. 
The disease occurs naturally in rats, rabbits, birds, pandas, kangaroos, guinea pigs, cats, dogs, 
sheep, goats, swine, horses, squirrels, crocodiles, koalas and seals, and occasional isolates have 
been reported from cows (Smith el al., 1987; Veljanov and Najdenski, 1993; Sanford, 1995; 
Markova el al., 1998). Melioidosis has also been identified in a camel in the United Arab 
Emirates (Wemey el al., 1997). Vedros el al. ( 1988) reported cases of melioidosis in captive 
cetaceans kept at Ocean Park in Hong Kong, where the highest mortality occurs during the 
rainy season. During this period considerable amounts of soil contaminated with 
B.pseudomallei are washed down from the mountains into bays that used as a source of water 
for the Ocean Park cetacean pools, hence causing infection (Vedros e/ al., 1988). Arthropod-
borne infection has never been known to occur naturally, although experimental transmission 
has been accomplished in guinea pigs, from the bite of the mosquito and of the rat flea 
(Sanford, 1995). 
Infected animals may play a role in the dissemination of the organism to new environments 
(Dance, 1990), but apparently do not represent a major reservoir for human disease (Sanford, 
1995). Treatment of animals suffering with melioidosis can become an expensive, prolonged 
and often unsuccessful venture, and in the case of farming it is dealt with by prevention and 
control rather than treatment (Choy e1 al., 2000). 
24 
1.5 DIAGNOSIS AND TREATMENT OF MELIOIDOSIS. 
1.5.1 Diagnosis of Melioidosis. 
In acute cases of melioidosis rapid diagnosis is urgent so that effective chemotherapy can be 
instituted as early as possible, as most patients will die within 2 to 3 days if they are not 
properly diagnosed and treated (Pongsunk et al., 1999). Melioidosis is confirmed by growth of 
the organism from blood or body fluids, such as purulent exudates, sputum, spinal fluid, urine 
or faeces (Smith et al., 1987; Chaowagul, 1996). This approach is time-consuming and 
consequently it is often too late to administer effective therapy (Rattanathongkom et al., 1997). 
Problems are also encountered with specimens such as sputum and throat swabs, as they are 
likely to be heavily contaminated (Walsh et al., 1994), a factor additionally complicated by the 
relative slow growth of B.pseudomallei in comparison with other flora. Walsh and 
Wuthiekanun ( 1996) suggested that on admission to hospital a patient suspected of suffering 
with melioidosis should have the following performed: 3 blood cultures (ISm I of blood), 
tracheal or sputum aspirate, throat swab and urine sample as well as a sample of any other 
fluid, pus or wound exudates that may be present. 
Identification of B.pseudomallei can be achieved by using the commercial APt 20NE 
biochemical kit (Dance et al., 1989b). Dance et al. (1989b) found the APt 20NE to be 
extremely reliable, identifying over 97% of strains on the first testing and over 99% on the 
second. One disadvantage is that the cost of the kit is quite high per test, and may not be 
economically acceptable in many areas where melioidosis is endemic (Dance, 1989b). lnglis et 
al. (1998) found that the APt 20NE test would sometimes mistakenly identify B.pseudomallei 
as Chromobacterium violacieum and found it more economically viable to use the Microbat 
24E system. 
Serological diagnosis however IS fraught by the high background seroconversion m the 
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population and therefore it lacks specificity. However, there have been significant 
improvements in recent years as enzyme-linked immunosorbant assay (ELISA) tests based on 
specific antigens have been developed (Chaowagul, 1996). Examples include an ELISA 
developed by Petkanjanapong et al. ( 1992) with endotoxin preparations of B.pseudomallei as 
the antigen, which gave satisfactory results for sensitivity and specificity (95.7% and 94.2% 
respectively), but is still at an experimental level. Anuntagool et al. (1996) have developed a 
simple antigen detection test based on the use of a specific monoclonal antibody (mAb) in a 
sandwich ELISA, and an ELISA using a tluorescein isothiocyanate (FITC)-anti-FITC 
amplification system has been developed by Desakorn et al. (1994) to detect B.pseudomallei 
antigen in urine. However, these methods require either expensive equipment or reagents, 
making them difficult to set up in poor areas where infection is endemic (Anuntagool et al., 
1996). 
Pongsunk et al. ( 1999) have developed a monoclonal antibody specific to the 30 kilodalton 
(kDa) protein of B.pseudomallei that can be used to identify the bacterium in blood culture, 
shortening the time for results by at least two days with the added advantage of not identifying 
B.thailandensis. Recently, a latex agglutination test based on an exopolysaccharide-specific 
antibody has been developed by Steinmetz et al. ( 1999) to which B.pseudomallei-like 
organisms did not react and which can be used to identify B.pseudomallei from different 
geographical locations. 
Alternative methods of detection being developed include a PCR devised by Rattanathongkom 
et al. (1997), indirect immunofluorescence microscopy (Naigowit et al., 1993) and a gold blot 
to detect immunoglobulin M (I gM) specific antibodies (Kunakorn et al., 1991 b). However, 
microbiological isolation and identification of B.pseudomallei is still used as conclusive 
evidence for the diagnosis of melioidosis. 
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1.5.2 Antibiotic Susceptibility of B.pseudomalleL 
B.pseudomallei has an unusual antibiotic susceptibility pattern, as it is susceptible to co-
amoxyclav, ceftazidime, the carbapenems, chloramphemicol, doxycycline and co-trimoxazole, 
but intrinsically resistant to many other antibiotics, including most early [3-lactams, for 
t:l<l!mP.lt: l!ffiPi~illiJ1, tht: ml!~roli~(!S, amin~glycosides, and most cephalosporins (Walsh and 
Wuthiekariun, 1996; Dance, 2000a). A multidrug effiux system has been identified in 
B.pseudomallei by Moore et al. ( 1999), which is active for both aminoglycoside and macrolide 
antibiotics and hence accounts for the organism's resistance to these antibiotics. 
Recently, investigations have been carried out by Haussler et al. ( 1999) on slow growing 
"small colony variants" (SCVs), which are isolated after exposure to ceftazidime, 
ciprofloxacin and gentamicin. The SCVs isolated show a significant increase in the minimal 
inhibitory concentrations of various unrelated classes of antimicrobial agent and this 
phenotype was stable throughout numerous passages on antimicrobial-free media, although 
interestingly, revertants to the parental phenotype did occur, and these revertants led to rapid 
overgrowth in liqUid media (Haussler et al., 1999). Thus, an in vivo selection 6f SCVs under 
antibiotic treatment would be difficult to detect in clinical specimens and so further 
investigations are needed to assess whether SCV revertants contribute to the frequently 
observed relapses of melioidosis. 
1.5.3 Treatment of Melioidosis. 
Prior to the use of antimicrobials, the case fatality rate from apparent B.pseudomallei 
infections was 95%, and French experience in lndochina indicated that with chloramphenicol 
therapy the mortality was still 20% (Woods et al., 1999). Traditional treatment of melioidosis 
with a combination of chloramphenicol, doxycycline and trimethoprim-sulphamethoxazole is 
still of value in the maintenance treatment of the infection, but was replaced by ceftazidime for 
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acute treatment of severe melioidosis as it was shown to halve the mortality of severe 
melioidosis in a trial carried out by White et al. ( 1989). Since then, Thamprajamchit et al. 
( 1998) have found that cefoperazone/sulbactam plus co-trimoxazole was of potential use as an 
alternative treatment for severe melioidosis, giving similar results to ceftazidime. Furthermore, 
Simpson et al. (1999) showed imipenem to be a safe and effective treatment for severe 
melioidosis and suggested its use as an alternative to ceftazidime, if necessary. Recently, in 
one case of me I ioidosis reported by Minassian et al. (1999) imipenem had to be used as the 
patient did not respond to ceftazidime. Investigations by Chaowagul et al. ( 1997) using oral 
tluoroquinolones yielded poor results and it was suggested that they could only be used as a 
third-line drug for those patients who are either intolerant of the other available antibiotics, or 
who have organisms that are resistant to them. More recently, Vorachit et al. (2000) have 
suggested, based on initial experiments that the following agents are successful in the 
treatment of acute melioidosis and should be used in clinical trials: imipenem, meropenem, 
and imipenem plus azithromycin. 
Parenteral antimicrobial therapy should be given for at least I 0 to 14 days and continued until 
there is clear evidence of symptomatic improvement, with maintenance treatment given for at 
least 18 weeks (Chaowagul, 1996). The cost of effective treatment is therefore considerable, 
and would substantially exceed annual per-capita health expenditure in the majority of the 
tropical countries (White, 1994). 
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1.6 PATHOGENESIS. 
1.6.1 Immunology of Burkholderia pseudomallei. 
The features of melioidosis suggest that there may be unique microbial virulence factors that 
not only promote tissue invasion and destruction, but also permit evasion from the normal 
humoral and cell-mediated immunity (Egan and Gordon, 1996). B.pseudomallei was shown by 
Pruksachartvuthi et al. ( 1990) to remain undigested and able to multiply within human 
phagocytes. Jones et al. ( 1996) have similarly shown that B.pseudomal/ei is capable of 
invading non-professional phagocytes and has the ability to survive intracellularly m 
professional phagocytic cells, and postulate that resistance to defensins may contribute towards 
intracellular survival. The ability of B.pseudomal/ei to survive and multiply in both 
professional and non-professional phagocytes may provide an explanation for both the 
occurrence of latent infections, and the relapses of infection that result from reactivation of a 
persistent endogenous source of infection (Jones et al., 1996). Harley et al. ( 1994) showed that 
uptake of B.pseudomal/ei appeared to be by conventional phagocytosis, but the organism 
would then escape from vacuoles, postulated to be as a result of damage to the vacuolar 
membrane. Jones et al. ( 1996) reached a similar conclusion, but further work is required to 
fully elucidate the mechanisms of intracellular survival of B.pseudomallei. 
1.6.2 lmmunopathogenesis of melioidosis. 
The immunopathogenesis of melioidosis, particuhirly with respect to the development of acute 
versus chronic infection, is poorly understood (Uiett et al., 1998). However, regarding the 
mechanisms responsible for the acute and chronic clinical presentations of B.pseudomal/ei 
infection, it is possible that the balance between T helper I (Th I) I T helper 2 (Th2) responses 
determines the clinical course of infection in humans (Uiett et al., 1998). 
Cytokines are critical immunoregulatory determinants of the pathway of disease pathogenesis 
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and progression (Ulett et al., 2000). Investigations carried out by Friedland et al. ( 1992) 
showed that elevated interleukin 6 (IL-6) concentration was the best predictor of mortality in 
B.pseudomal/ei sepsis and that 50% of patients with detectable IL-8 levels died, but found that 
plasma tumour necrosis factor (TNF) bioactivity did not relate to outcome. In a recent study by 
Ulett et al. (2000) it was demonstrated that high levels of TNF -a, IL-113 and IL-6 contribute 
towards disease pathogenesis and progression in B.pseudomal/ei infection, hence showing that 
proinflammatory cytokine responses are important in the immunopathogenesis of melioidosis 
(Uiett et al., 2000). 
1.6.3 Endotoxin (Lipopolysaccharide) and Serum Sensitivity. 
Endotoxin is a lipopolysaccharide (LPS) that is an integral component of the outer membrane 
of gram-negative bacteria (Salyers and Whitt, 1994). Matsuura et al. (1996) suggested that 
because B.pseudomal/ei is a gram-negative bacterium, it is likely that endotoxin plays a role as 
a virulence factor, similar to that of Enterobacteriaceae. Results by Anuntagool et al. (1998) 
showed that LPS from clinical Ara- isolates and Ara- soil isolates were indistinguishable and 
were identical to the LPS of Ara + isolates with regards to sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) profiles and immunoreactivities with 
melioidosis sera. Due to the antigenic similarity between pathogenic Ara- isolates and non-
pathogenic Ara + isolates, Anuntagool et al. (1998) suggested that this provides an explanation 
to the observed discrepancy between seroprevalence and disease prevalence in melioidosis. 
This then poses the question of whether LPS has a role in virulence. Studies carried out by 
Matsuura et al. ( 1996) showed that the LPS of B.pseudomal/ei clinical isolates appeared to be 
less toxic than those from other gram-negative pathogens. The endotoxic activities of the LPS 
of B.pseudomallei (BP-LPS), such as pyrogenic activity in rabbits and lethal toxicity in 
Galactosamine (GaiN)-sensitised mice, were shown to be some 10 to 100 times weaker than 
those of the reference, Salmonella abortus equi (SEA-LPS) in an investigation by Matsuura et 
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al. ( 1996). Similarly, in macrophage activation experiments, BP-LPS exhibited activities I 0 
times weaker than SEA-LPS (Matsuura et al., 1996). 
Anuntagool et al. (2000) recently proposed the possibility that B.pseudomallei may release 
higher amounts of LPS into the surrounding tissues during growth in patients. Investigations 
carried out by Anuntagool et al. (2000) showed that the shedding pattern and quantity of LPS 
found in the culture of fluid during growth of Ara· and Ara+ isolates were similar, but the Ara-
isolates contained a previously described 200 kDa antigen (Sirisinha et al., 1998) in large 
quantities during the early phase of growth. 
B.pseudomallei has been found to produce two S-type LPSs, differing in the chemical 
structures of their 0-polysaccharide (0-PS) components and termed, 0-PS I, and 0-PS 11 
(Perry et al., 1995). Many gram-negative bacteria are susceptible to the serum bactericidal 
system, but some pathogens possess mechanisms to evade killing by this system (Woods et al., 
1999). Initial work by Egan and Gordon (1996) revealed that B.pseudomallei rapidly activated, 
and then consumed complement and that the organism was resistant to killing by 
polymorphonuclear leukocytes. Recently, DeShazer and Woods (1999) using Tn5-0TI82 
mutagenesis revealed that serum-sensitive mutants were deficient in the type 11 0-antigenic 
polysaccharide moiety of LPS and discovered a cluster of 15 genes required for the 
biosynthesis of type 11 0-PS and serum resistance. Thus concluding that the type 11 0-PS 
moiety of LPS is essential for B.pseudomallei serum resistance and virulence (DeShazer and 
Woods, 1999). 
1.6.4 The Capsular Polysaccharide of B.pseudomal/ei. 
Some bacterial pathogens are able to combat the bactericidal activity of complement and 
phagocytes by encapsulation with structurally diverse polysaccharides and so only late into ~9 
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infection, when anticapsular antibodies are produced by the host, can the protective 
encapsulation activity be overcome (Masoud et al., 1997). Little is known about the capsular 
polysaccharide (CPS) of B.pseudomal/ei. In a study carried out by Vorachit et al. ( 1995) it was 
shown that cells of B.pseudomal/ei tend to produce exopolysaccharide materials that constitute 
a highly hydrated glycocalyx. When cells were grown in liquid media or in animal tissues, the 
production of the fibrous glycocalyces facilitated the formation of microcolonies or "sister" 
cells that adhered readily and non-specifically to available surfaces, showing that in infected 
tissue the organism actually grows in glycocalyx-enclosed biofilms (Vorachit et al., 1995). 
Structural analysis of the CPS by Masoud et al. ( 1997) revealed it to be an unbranched 
polymer of repeating tetrasaccharide units composed of D-galactose and 3-deoxy-D-manno-
octulosonic acid (KDO), containing an 0-acetyl substituent. The authors also found that sera 
from patients with me I ioidosis contained high titres of antibodies to the CPS, but sera from the 
controls did not, which suggests that the CPS functions as an immunogen and thus has 
potential use in serological diagnosis as well as vaccine development (Masoud et al., 1997). 
1.6.5 Exotoxin of B.pseudomallei. 
Nigg et al. (1955) first described the presence of a thermolabile, lethal toxin in culture 
supematants of B.pseudomallei. Later, Heckly and Nigg (1958) described the presence of two 
thermolabile toxins, one that produced necrotic lesions and the other, which was non-
necrotising, but still lethal for mice and hamsters. A thermolabile toxin produced as a 36 kDa 
polypeptide chain by B.pseudomallei is postulated to inhibit intracellular protein synthesis by 
the same mechanism as diphtheria toxin (DT) of Corynebacterium diphtheriae and the 
exotoxin A (ETA) of P.aeruginosa (Ism ail et al., 1991 ). The mode of action of these exotoxins 
is the catalysis of adenosine-5-diphosphate ribose from oxidised nicotinamide adenine 
dinucleotide (NAD) to elongation factor 2 (EF2), and such toxins are termed ADP-ribosylating 
toxins (Mohamed et al., 1989). Investigations by Mohamed et al. (1989) showed that a lag 
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period was not required before toxic activity was expressed in B.pseudomallei, and so it would 
seem that the toxin was not of the membrane-damaging class of bacterial protein toxins, but 
that it acted on an intracellular mechanism, such as protein synthesis, supporting the theory 
that the toxin could indeed be an ADP-ribosylating toxin. This theory was further supported in 
the same study, whereby the toxin produced by B.pseudomallei was found to inhibit both DNA 
and protein synthesis in macrophages (Mohamed et al., 1989). 
The extent to which the toxic product of B.pseudomallei is involved in human and animal 
infections remains unclear (lsmail et al., 1987), but the discovery that antibodies to the toxin 
are produced in individuals during infection implies that the toxin is elaborated in vivo during 
the course of the disease (Smith et al., 1991). The uncertainty concerning the role of the 
exotoxin in the pathogenesis of melioidosis stems in part from the lack of a simple, precise and 
highly sensitive test (lsmail et al., 1987). lsmail et al. ( 1987) developed a competitive ELlS A 
procedure for exotoxin measurement over 16 ng/ml, and found that exotoxin production was 
higher at 37°C than at room temperature, using Brain Heart Infusion Broth (BHIB), 
supplemented with glycerol at 2%. Interestingly, supplementing with glycerol has also been 
shown to increase production of ET A in P.aeruginosa (Liu, 1973). 
An exotoxin lethal to cells in culture has been identified in culture filtrates of B.pseudomallei 
by Haase et al. ( 1997). The cytolethal toxin (CL T) was able to pass through a 10 kDa cut-off 
ultrafilter, and may represent the second thermolabile toxin previously reported by Heckly and 
Nigg ( 1958). In the investigation carried out by Haase et al. ( 1997), during the process of 
ultrafiltration, the upper chamber retained a cell-elongating activity (CEA), which was 
concentrated to one-tenth of the initial volume and wlien incubated with McCoy cells DNA 
synthesis was shown to be inhibited by 50% and protein synthesis by 25% (Haase et al., 1997). 
The CL T was shown to be produced at different amounts by different strains, which appeared 
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to be correlated with their respective virulence. In the light of recent investigations, this may 
now actually correspond to some strains having been the avirulent species, B.thailandensis. 
However, in the study all soil isolates tested did produce the CL T at low amounts, including 
therefore any B.thailandensis isolates. Further investigations are required to elucidate the role 
of the CL T and the CEA in the pathogenic processes of melioidosis and if they are different 
from other known toxins. 
1.6.6 Motility of B.pseudomalleL 
Flagellin proteins from several different strains of B.pseudomal/ei have been isolated and 
purified by Brett et al. ( 1994), and analysis on SOS-PAGE revealed that flagellin monomer 
protein bands were around 43,400 Da in size. A number of genes involved in the synthesis and 
operation of the flagellar apparatus in B.pseudomallei have now been identified by DeShazer 
and Woods (1999) using Tn5-0T182 mutagenesis. The flagellin structural gene,jliC, has been 
cloned and characterised by DeShazer et al. ( 1997) and investigations carried out by DeShazer 
and Woods ( 1999) usingjliC mutants showed that no significance difference in virulence was 
observed in mutants of the flagellar structural gene. They concluded that the flagellum is 
probably not a virulence determinant, but is postulated to serve as a protective immunogen 
against B.pseudomallei infection (DeShazer et al., 1997). 
1.6.7 Secretion Products of B.pseudomalleL 
Ashdown and Koehler (1990) tested the extracellular products from a number of clinical 
isolates and found that most strains of B.pseudomallei produced a lecithinase, lipase and 
protease, however none tested positive for elastase. The authors also discovered that most 
strains produced a haemolysin that was weakly cytolytic and another, which although it 
occurred infrequently, was found to be far more cytolytic. Haussler et al. (1998) also identified 
an extracellular product from B.pseudomallei that was both cytotoxic and haemolytic, from 
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culture supematants of B.pseudomallei and this has been identified as a rhamnolipid. The 
rhamnolipid is believed to be the extracellular product responsible for producing the heat-
stable haemolytic activity first identified by Liu ( 1957) (Haussler et al., 1998). However, 
further studies are needed to fully elucidate the role of the acidic rhamnolipid as a virulence 
determinant in the pathogenesis of melioidosis. 
Sexton and Jones, ( 1994) confirmed the presence of a 36 kDa antigen associated with 
proteolytic activity in B.pseudomallei culture supematants, and later Percheron et al. (1995) 
characterised a 42 kDa protease produced by most B.pseudomallei strains. However, it has 
been shown by Gauthier et al. (2000) that the expression of a high proteolytic activity by 
strains of B.pseudomallei was neither sufficient nor necessary for virulence when bacteria were 
injected via the intraperitoneal route. 
DeShazer and Woods (1999) used transposon mutagenesis with Tn5-0T182 to obtain mutants 
unable to secrete protease, lipase or lecthinase and a number of these mutants were mapped to 
a genetic locus spanning 12 kb. This region encoded proteins with a high degree of homology 
to the general secretory, or type 11 secretion pathway proteins, and others to an unlinked gene 
encoding a protein with homology to type IV prepilin peptidases. Thus indicating that 
protease, lipase and lecthinase are secreted by a type 11 secretion pathway (DeShazer and 
Woods, 1999). The relative virulence of secretion mutants was then studied but allegedly these 
mutants were not seriously attenuated in their ability to cause fulminating illness (Brett and 
Woods, 2000). 
1.6.8 Adherence of B.pseudomallei. 
Woods et al. (1999) claim that B.pseudomallei possesses at least two types of pili and that they 
have cloned genes with strong homology to pi/B, pi/C and pi/D of P. aeruginosa for type IV 
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pili and a 15 kDa pilin structural protein, FimC, a chaperone protein, and an outer membrane 
usher protein FimD, all for type I pili. Vorachit et al. ( 1995) observed that strains which 
produced pili had a much reduced capacity for glycocalyx formation, tending not to form 
microcolonies in fluid media but adhering to available surfaces as dispersed individual cells 
rather than as coherent biofilms. 
1.6.9 Other Potential Virulence Factors of B.pseudomallei. 
A phosphatidylcholine-hydrolysing phospholipase C (PC-PLC) gene has been cloned and 
characterised by Korbsrisate et al. ( 1999). The PC-PLC was demonstrated to be non-
haemolytic and the authors suggested that it might have a role in the intracellular survival of 
the organism and cell-to-cell spread, although further studies are needed to prove this theory. 
A siderophore was identified by Yang et al. ( 1991 ), which was found to belong to the 
hydroxymate class of siderophores, and was termed malleobactin. Further investigations by 
Yang et al. (1993) demonstrated that the siderophore (malleobactin) was capable of 
scavenging iron from both lactoferrin and transferrin in vitro. Additionally, malleobactin was 
shown to enhance the growth of B.pseudomallei and thought to contribute towards virulence 
by allowing the organism to multiply in host tissue or survive in the bloodstream (Yang et al., 
1991). 
Recently, Brett and Woods (2000) claim to have isolated a mutant devoid of acid phosphatase 
activity and that the translated product of the gene involved was highly homologous to an acid 
phosphatase expressed by Francisella tularensis. 
1.6.10 Vaccine Development. 
There is currently no available licensed vaccine for use against B.pseudomallei. However, 
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B.pseudomal/ei produces several surface-associated molecules that have been proposed for use 
as vaccine components (DeShazer et al., 1998), which include LPS and flagella. Woods et al. 
(1999) believe, in light of their studies with B.pseudomal/ei, that the strongest and most 
promising vaccine candidates are the flagellin protein and the 0-polysaccharide (PS) moieties 
derived from endotoxin. In a study by Brett and Woods ( 1996) it was shown that when the 0-
polysaccharide moiety was covalently linked to flagellin protein it elicited a high titre IgG 
response, which was then capable of protecting diabetic rats from challenge with 
B.pseudomal/ei. Similar findings have been shown by Charuchaimontri et al. (1999), where a 
high level of anti-LPS 11 was a significant factor protective against fatal melioidosis and 
postulate it to be a potentially useful component of a vaccine. Steinmetz et al. (2000) have 
attempted passive immunisation using a specific monoclonal antibody with specificity for the 
tetrasaccharide repeating unit of the capsular polysaccharide of B.pseudomallei and their 
results indicate that it may be a promising candidate for use as a protective antigen in active 
immunisation experiments. Experimental vaccines have been used in animals with some 
degree of success. Vedros et al. ( 1988) prepared an experimental vaccine consisting of a 
protein-polysaccharide mixture given to captive cetaceans and claim to have observed a 
reduced mortality over a 5-year period from 45% to less than I%. 
1.7 MOLECULAR BIOLOGY: APPLICATIONS IN THE STUDY OF 
BACTERIAL PATHOGENS. 
Molecular biology has become an essential analytical tool in all fields of biology and has led to 
current understanding of the molecular basis of life. The field of molecular biology is 
extensive and encompasses not only the study of DNA, but also the biochemical basis of gene 
expression and its regulation, as well as the characterisation and manipulation of the protein 
products encoded. Thus, molecular biology involves not only recombinant DNA 
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techniques but biochemical, immunological and protein analysis techniques. It is gene cloning 
though, perhaps more than any other factor that has made the biggest impact on biological 
research and so its origins and development with respect to the study of bacterial pathogens is 
discussed next. 
1. 7.1 The Origins and Development of Gene Cloning. 
Modem recombinant DNA technology has mainly developed over the past thirty years or so 
from the early experiments carried out. Molecular biology arose from Oswald Avery's initial 
observations on bacterial transformation in the 1940's (Shostak, 1998), which in turn led to 
other attempts to investigate the way in which bacteria can acquire new genetic information. 
Thus, three main methods of gene transfer in bacteria were discovered: 
I) Transformation, whereby bacteria can take up and express exogenous DNA (Mandel and 
Higa, 1970) 
2) Conjugation, where DNA is transferred directly from one bacterium to another (Williams 
and Skurray, 1980). 
3) Bacteriophage-mediated transduction, where genetic material is transferred from one 
bacterium to another via a bacteriophage particle (Singer and Berg, 1991 ). 
Whilst characterisation of these processes was in progress, attempts were made at introducing 
foreign DNA into prokaryotic and eukaryotic host cells. These attempts were fairly 
unsuccessful, which was due to a number of reasons. Firstly, there was the problem that 
bacteria possess host restriction and modification systems and so any DNA introduced into the 
host bacterial cells was degraded. Secondly, and most importantly, even assuming that the 
foreign DNA could be taken up by recipient cells, it could not be maintained because it could 
not replicate in the new host, and so would become lost during successive rounds of 
multiplication of the host cells. In addition to the problems of replication, if subsequent 
detection of DNA uptake was dependent on gene expression, failure could be due to lack of 
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accurate transcription and translation or failure of any post-translational modification. 
Research thus focused on overcoming such fundamental problems that eventually led to a 
number of solutions that form the basis of modem gene cloning technology. For example, 
when genes specifying host controlled restriction and modification were identified, this 
facilitated the production of restrictionless bacteria for cloning purposes, and there now exists 
a number of strains of Escherichia coli with various restriction/modification phenotypes. Also, 
in order to ensure the replication of foreign DNA, it needed to be linked to an origin of 
replication, or replicon, and in bacteria there is only one per genome. However, due to the size 
of the bacterial genome, it would not be possible to manipulate it in an intact form. Therefore, 
smaller rep I icons were sought, and as a consequence of the huge amount of microbial genetic 
studies performed with bacterial species such as E.coli, the discovery of more suitable 
rep I icons in the form of small plasmids and bacteriophage DNA was achieved. These are now 
known in gene cloning as vectors, and it is derivatives of the wild types discovered that are 
now widely used, as well as man-made cosmid vectors. These make suitable cloning vectors 
because their maintenance is not dependent on integration into the host's genome and it is 
possible to isolate their DNA in an intact form. So, not only do these vectors provide the 
replicon function, but they also permit the easy bulk preparation of foreign DNA sequence, 
free from host cell DNA (Old and Primrose, 1989). Molecules in which foreign DNA has been 
inserted into a vector molecule are known as recombinant molecules, and the process has been 
termed molecular cloning or gene cloning because it facilitates the propagation of a line of 
genetically identical organisms, all of which contain the same inserted foreign DNA fragment. 
Hence amplifying not only the composite molecule but any gene product whose synthesis it 
directs. 
The basic procedure of in vitro gene cloning in prokaryotes was also facilitated by the 
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simultaneous development of the following techniques. I. Cutting and joining DNA molecules 
as a result of the discovery of restriction endonucleases and DNA ligases (Gefter et al., 1967; 
Zimmerman et al., 1967; Smith and Wilcox, 1970 and Mertz and Davis, 1972). 2. Monitoring 
the cutting and joining of molecules through the development of agarose gel electrophoresis 
(Sharp et al., 1973; Helling et al., 1974). 3. Introducing recombinant DNA into the host cell 
through a number of experiments on transforming E. coli. Cohen et al., ( 1972) showed that 
CaCh treated £.coli were effective recipients for plasmid DNA. All these techniques were 
developed in the late 1960's and early 1970's and facilitated the first cloning experiments 
carried out by Jackson et al. ( 1972) and Lob ban and Kaiser ( 1973). 
1.7.2 Plasmids as Cloning Vectors. 
The development of plasmids to serve as vectors for recombinant DNA cloning was essential 
and it was Cohen and Chang who developed the first plasmid for use as a cloning vector, 
pSCIOI, in the 1970's (Cohen et al., 1973 and Cohen and Chang, 1977). Plasmids are usually 
covalently-closed circles (CCC) of double-stranded DNA and have been detected in a wide 
range of bacterial genera that are stably inherited in an extrachromosomal state. 
The desirable properties of plasmid cloning vectors are as follows: 
I) A low molecular weight, 
2) An ability to confer readily selectable phenotypic traits on host bacteria, 
3) Single sites for a number of restriction endonucleases, preferably in genes with a 
readily scorable phenotype (Old and Primrose, 1989). 
The ideal plasmid cloning vector should be within the s1ze range of 2 to I 0 kb, as 
transformation efficiency decreases steeply with increasing plasmid size and as a consequence 
it is desirable to limit the amount of foreign DNA to be cloned accordingly. 
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Additionally, high molecular weight plasmids are more likely to be physically damaged when 
handled in gene cloning experiments. Whereas the low molecular weight plasmid is often 
present in multiple copies, which not only facilitates it own isolation but means that, via a gene 
dosage effect, it can direct the synthesis of high levels of cloned gene products. In some cases 
though, certain genes cannot be cloned on high copy number plasmids because their presence 
seriously disrupts the normal physiology of the host and so the strategy here may be to use a 
low copy number plasmid instead. 
1.7.3 Bacteriophage A as a Cloning Vector. 
Bacteriophage A vectors have been used extensively in recombinant DNA cloning (Murray, 
1991 ). The DNA of bacteriophage A is a linear duplex molecule of about 48.5 kbp and at the 
ends are short, single stranded 5' projections of 12 nucleotides, which are complementary in 
sequence (known as the cos site), whereby the DNA adopts a circular structure once injected 
into a host cell (Old and Primrose, 1989). Genes located in the central region of the DNA 
sequence are concerned with recombination and lysogenisation and therefore non-essential for 
lytic growth of the phage, and so can be deleted or replaced with little adverse effect on the 
propagation of the phage. This region is known as the "stutTer" fragment. Viable phage 
particles can only be produced if the total DNA is between 37-52 kbp in length this is due to a 
physical requirement for that amount of DNA by the packaging protein for production of the 
phage particle. Bacteriophage A has been the focus of extensive study over the years and so a 
myriad of derivatives have been developed which can be categorised as either insertional 
vectors, whereby there exists a single target site where foreign DNA may be inserted or 
alternatively, replacement vectors where a pair of sites define a fragment that can be removed 
and replaced by foreign DNA. 
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1.7.4 Cosmids as Cloning Vectors. 
Cosmids are plasmids that contain the cohesive end sites (cos) of bacteriophage A., where the 
cos region is essential for the packaging of A. DNA into its capsid. So, providing that the cos 
regions are located in parallel in the DNA and are 37 to 52 kb apart, these vectors can be 
incorporated into and propagated as complete A. particles (Collins and Hohn, 1978). Cosmids 
are therefore useful cloning vectors as they facilitate the study of large genetic regions. They 
also contain a plasmid origin of replication, at least one selectable marker, and useful 
restriction endonuclease sites. Packaged DNA is transfected into A.-sensitive E.coli by means 
of the normal A. infection process and then once introduced into the E. coli cell, it circularises 
via the cos sites and replicates as a plasmid. An advantage of using cosmids is that because 
only DNAs that have the cos sites the correct distance apart are packaged into phage heads, 
only recombinant cosmids will be transduced. 
1.7.5 Benefits of Gene Cloning. 
lt is accepted that gene cloning is carried out routinely in the study of bacterial pathogens but it 
is important to address the fundamental reasons for carrying out such a procedure. Why clone 
DNA? Basically, DNA is cloned to obtain a specific fragment of DNA in large enough 
amounts to analyse. In the case of bacterial pathogens, as it is virulence factors that are directly 
involved in the mechanisms of pathogenicity, their genes represent targets for gene cloning 
procedures to analyse their potential contribution to pathogenicity. The subsequent 
identification of such genes is central to understanding how bacterial pathogens circumvent the 
immune system and cause disease. Gene cloning has made possible numerous types of detailed 
analyses of DNA, which will be discussed along with the main benefits of cloning genes with 
respect to the study of bacterial pathogens. The techniques applied to characterise cloned 
virulence genes and their products is too vast and complex to be fully covered in this review, 
but the reader can gain suitable knowledge from a number of excellent publications, for 
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example, Harb and A buK waik ( 1999) and Pel icic et al. ( 1998). 
1.7.5.1 Moving Genes from Organism-to-Organism. 
Perhaps the most important advantage of cloning genetic material from bacterial pathogens 
comes from the ability to move genes encoding putative virulence factors into a host cell in 
which their structure, function and regulation may then be readily studied (Singer and Berg, 
1991). This enables gene(s) of interest to be separated, subsequently propagated and possibly 
expressed away from the confusing and often interfering molecular mechanisms of the 
organism from which the gene was isolated. The hosts most widely used for prokaryotic gene 
cloning are based upon E.coli strain Kl2, which has been aptly named as the "workhorse" of 
molecular biologists and has contributed majorly to modem knowledge of elementary 
molecular biological mechanisms and the genetic basis of life (Kunhert et al., 2000). This is 
one example and there exists in practice a range of host/vector systems, but their ultimate 
function is still the same. 
1.7.5.2 Investigations into the Structure of a Gene. 
Gene cloning has made analysis of nucleotide sequence possible through methods developed, 
for example, by Sanger et al. ( 1977). Sequence information is a prerequisite for planning any 
substantial manipulation of the DNA, and the deduced nucleotide sequence may then be 
processed in a number of ways. It is possible to search for all known restriction endonuclease 
target sites to produce a comprehensive physical map that facilitates procedures such as 
subcloning. Features such as tandem repeats, inverted repeats and potential promoters may be 
searched for. Analyses are assisted by computer software that allows the nucleotide sequence 
to be translated into six possible polypeptides, using all three reading frames on both strands 
so that "open" reading frames (ORFs), which are sequences that do not contain premature 
terminating codons may be identified that could indicate a polypeptide coding region. It is now 
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possible to ascertain or confirm a possible function to a sequence by comparing it with other 
sequences already deposited in DNA databases from other organisms. This can be done at the 
nucleotide level as well as the amino-acid level, however, due to the degeneracy of the code, 
similarities may be found between two polypeptide sequences, which may not be so apparent if 
carried out at the DNA level. Therefore, if sequence similarity is identified this can be an 
indication of similar function. The intemet is now an essential tool in this process as it allows 
rapid homology searches such as Web-based BLAST searches (Aitschul et al., 1997). 
1.7.5.3 Investigating the Control of a Gene. 
A common aspect of the many strategies adopted by pathogenic bacteria is the ability to vary 
the expression of the molecules and structures involved in virulence by either the induction or 
repression of gene expression in response to environmental stimuli. Hence the expression of a 
number of virulence genes in a closely co-ordinated manner is one of the main factors in 
determining the success of a pathogen, and so it must recognise signals from the host and 
express key virulence determinants accordingly to ensure rapid growth and/or survival in a 
host environment. Virulence gene expression can be followed indirectly by the use of reporter 
gene fusion technologies in which the regulatory sequences of virulence genes direct the 
expression of a readily assayable product such as 13-galactosidase, alkaline phosphatase, 
chloramphenicol acetyl transferase, or the green fluorescent protein (Harb and AbuKwaik, 
1999). 13-galactosidase (lacZ) gene fusions have been used to detect the expression of genes in 
response to laboratory conditions that are thought to mimic the intracellular environment that a 
pathogen encounters, such as low pH or changes in temperature, upon entry to the host. 
Leimeister-Wachter et al. (1992) studied the virulence genes of Listeria monocytogenes and 
through gene fusions, showed the virulence genes to be thermoregulated, suggesting that the 
virulence of the organism is triggered on entry to the host. 
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1.7.6 Other Techniques Used in the Study of Bacterial Pathogenesis. 
1.7.6.1 Creating Mutants. 
Mutants are an essential pre-requisite for any genetic study and no more so than in the study of 
gene structure and function relationships (Old and Primrose, 1989). With the development of 
gene cloning it is possible to precisely modify DNA sequences in vitro, prior to studies carried 
out either in vivo or in vitro on the genetic function of the modified DNA. A variety of 
strategies for mutant construction have been developed and the method of choice for a given 
DNA sequence depends not only on the questions being asked, but on the information already 
available on the DNA sequence. Once a gene has been cloned and sequenced it is possible to 
determine whether that particular bacterial gene is involved in pathogenicity by creating a 
mutant through allelic exchange mutagenesis (Pelicic et al., 1998). However, there are other 
techniques that can be performed without the prior knowledge of the nucleotide sequence of 
the gene, such as transposon mutagenesis. These two methods will be discussed in turn: allelic 
exchange mutagenesis and transposon mutagenesis. 
1.7.6.1.1 Allelic Exchange Mutagenesis. 
It is possible to use allelic exchange mutagenesis, whereby the gene under scrutiny is disrupted 
by exploiting the homologous recombination properties of the cell: the functional allele is 
thereby replaced with an inactivated copy and the virulence of the mutant is compared with 
that of the parental strain (Pelicic et al., 1998). Mutations can be generated by introducing a 
point mutation via site-directed mutagenesis as well as null mutations caused by insertions of 
large fragments of DNA, typically carrying a drug resistance marker. Site-directed mutagenesis 
is a highly specific predetermined change and the simplest method employed is the single 
primer method (Gillam et al., 1980; Zoller and Smith, 1983). This method involves priming in 
vitro DNA synthesis with a chemically synthesised oligonucleotide, around 7 to 20 nucleotides 
in length that carries a base mismatch with the complementary sequence. The synthetic 
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oligonucleotide primes DNA synthesis and is itself incorporated into the resulting 
heteroduplex molecule. After transfonnation of the host E. coli, this heteroduplex gives rise to 
homoduplexes whose sequences are either that of the wild type DNA or that of the mutant, 
which can be identified by screening by nucleic acid hybridisation with a 32P-Iabelled 
oligonucleotide as the probe. 
1.7.6.1.2 Transposon Mutagenesis. 
Another approach is to make mutations at random in the genome of a particular pathogen 
using a transposon, and to screen the mutants generated by this process to ascertain whether 
there has been a loss of virulence, hence indicating that the mutant is lacking gene(s) required 
for virulence. A transposon is a genetic entity that promotes its own movement or 
transposition. They are otherwise known as mobile genetic elements and can insert as a 
discrete segment of DNA at random into plasmids or the bacterial chromosome (Karcher, 
1995). The subsequent insertion of the transposon disrupts the nucleotide sequence and thus a 
mutant is generated. The transposon contains a genetic marker, often an antibiotic resistance 
gene so that selection of cells that contain transposons is easily conducted. Transposon 
mutagenesis has been the most commonly used tool for the identification of virulence genes 
(Valdivia and Falkow, 1998). Early experiments using this method were applied to Salmonella 
typhimurium, whereby genes essential for intracellular survival were identified (Miller et al., 
1989). Here, mutants were screened in a macrophage infection model and this led to the 
identification of a 2-component regulatory system (PhoP!PhoQ) required for intracellular 
survival (Groisman et al., 1989; Miller et al., 1989). 
1.7.6.2 Polymerase Chain Reaction. 
The polymerase chain reaction (PCR) has proved to be an invaluable tool in molecular 
biology. Fundamentally the method involves the in vitro enzymatic amplification of a specific 
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DNA fragment. Various techniques utilising PCR have been developed for identifying 
differentially transcribed genes, such as RNA subtractive hybridisation (RSH) and differential 
display PCR (DD-PCR) (Harb and AbuKwaik, 1999). RSH relies on the hybridisation of 
cDNAs from bacterial populations exposed to different conditions, the cDNAs found under 
both conditions are subtracted, and unique cDNAs are studied further (Straus and Ausubel, 
1990; Timblin et al., 1990). RSH was used by Plum and Clark-Curtiss ( 1994) to identify a 
macrophage-induced gene (mig) that is transcribed between one and five days postinfection, 
but its role in virulence has yet to be fully established. 
1.7.6.3/n Vivo Expression Technology. 
Recently, there has been the development of in vivo expression technology (IVET), which has 
the advantage over classical gene fusion technologies of positively selecting bacterial genes 
that are induced within their host (Mahan et al., 1993). IVET requires a strain with a mutation 
in a biosynthetic gene that greatly attenuates its growth in vivo. A library of DNA fragments 
are fused to an operon formed of the same promoter-less gene and a reporter gene is 
constructed and introduced into the auxotrophic mutant (Pelicic et al., 1998). Clones that show 
expression of the reporter activity are discarded, and the remaining recombinants are used to 
infect the host, so that only clones with the DNA fragments that can complement the 
auxotrophic mutant growth, which correspond to promoters of in vivo up-regulated genes, are 
recovered. Several variations of the I YET method have been used successfully to detect genes 
that are expressed preferentially during infection (Camilli et al., 1994; Mahan et al., 1995). 
Some of the genes identified by !VET are involved in general biosynthetic processes or 
transcriptional regulation, and whilst mutations in some of the in vivo induced (ivi) genes led 
to a decrease in virulence, the role of many of these genes remains unclear (Valdivia and 
Falkow, 1998). Thus, I VET methodology is still being developed and refined. 
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1.7.6.4 Signature Tagged Mutagenesis. 
A new approach has been developed that is less labour-intensive than transposon mutagenesis, 
which is signature tagged mutagenesis (STM), developed by David Holden and eo-workers 
working on S.typhimurium (Hensel et al., 1995). STM combines mutational analysis with the 
ability to follow the fate of a large number of different mutants within a single animal. It 
allows the identification of genes that are required for the infective process, but excludes all 
genes required for survival on laboratory media (Pelicic et al., 1998). Each transposon is 
engineered to contain a unique, short DNA tag that allows mutants to be distinguished from 
each other, therefore it is possible to determine which tag from a bacterial input pool used to 
infect a host is not retrieved in the pools recovered from various organs, hence possible to 
identify avirulent mutants, unable to persist in animals (Pelicic et al., 1998). The application of 
STM to the study of S.typhimurium resulted in the identification of 19 new virulence genes, 
most of which were located on a new Pathogenicity Island (SP 12) on the Salmonella 
chromosome (Hensel et al., 1995; Shea et al., 1996). 
1.8 VIRULENCE FACTORS OF BACTERIAL PATHOGENS. 
Virulence factors can be loosely classified into two categories: those factors that cause damage 
to the host, and those factors that promote colonisation and invasion of the host (Salyers and 
Whitt, 1994). A myriad of virulence fa,c,to_rs exist in bacterial pathogens and it is beyond the 
scope of this study to review all the mechanisms of microbial pathogenesis, but there are 
comprehensive reviews available such as Salyers and Whitt (1994) and Patrick and Lark in 
(1995). 
1.8.1 Virulence Factors that Damage the Host. 
At a chemical level there are two types of bacterial toxins, firstly, lipopolysaccharides (LPS), 
which are associated with the cell walls of gram-negative bacteria (endotoxin), and secondly, 
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proteins which may be released into the extracellular environment of pathogenic bacteria 
(exotoxin). 
1.8.1.1 Exotoxins. 
There are different types of exotoxins, grouped together on the basis of their modes of action. 
One type of exotoxin are the membrane-disrupting, of which there are two types. Firstly, there 
are those that form channels, or pores in the host cell membrane, which leads to lysis of the 
host cell, for example, the a-toxin of Staphylococcus aureus and streptolysin 0 produced by 
Streptococcus pyogenes. The second are enzymes known as phospholipases that destabilise the 
membrane by removing the charged head group from the lipid portion of phospholipids 
(Salyers and Whitt, 1994). An example is the phospholipase C or a-toxin of Clostridium 
perfringens, which causes damage to the membrane of leukocytes, fibroblasts and muscle 
cells, and causes platelets to aggregate and lyse (Patrick and Larkin, 1995). Lysis of host 
bacterial cells can be an advantage to the invading pathogen, as it is a way of releasing 
nutrients not otherwise available to the bacterium and facilitates the spread of the bacterium 
through host tissues (Patrick and Larkin, 1995). 
A different type of bacterial exotoxin are those that have an intracellular target and have a 
bifunctional AB structure; where the A component contains the enzymatically active domain, 
and the B component mediates the binding to the membrane and translocation to the cytosol 
(Balfanz et al., 1996). Examples are transferases that basically function to inhibit protein 
synthesis of target cells. This involves the transfer of the ADP-ribosyl moiety ofNAD to GTP-
binding proteins, examples of these are cholera toxin (Vibrio cholerae), diphtheria toxin (DT) 
of C.diphtheriae, the Exotoxin A (ETA) and Exoenzyme S (EXOS) of P.aeruginosa, the C2 
toxin of Clostridium botulinum and the iota toxin of C.perfringens (Kruger and Barbieri, 
1995). P.aeruginosa, for example produces two ADP-ribosyltransferases that differ in their 
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biochemical properties as ETA ADP-ribosylates elongation factor 2 (lglewski et al., 1977), 
while EXOS ADP-ribosylates several different eukaryotic proteins including vimentin and low 
molecular weight GTP-binding proteins, in vitro (Cobum et al., 1989). The overall effect of 
these toxins is to kill the cell by stopping protein synthesis. 
A final type of exotoxin are those involved with the modulation of physiological receptors of 
cells, which have an affect on intracellular reaction cascades (Balfanz et al., 1996). An 
example is the heat stable group of toxins (ST) of enterotoxigenic E. coli that stimulate cyclic-
GMP synthesis in the intestinal brush border, producing an overall effect of fluid loss and lack 
of fluid adsorption (Patrick and Lark in, 1995). 
1.8.1.2 Endotoxins. 
The biological, immunological and serologic properties of endotoxin, or LPS, is determined by 
its structure, and so a full elucidation of such structures is therefore an essential element in 
establishing a role in virulence at the molecular level. The lipid portion of LPS, which is the 
toxic portion, is embedded in the outer membrane and exerts its effect on lysis of the bacterial 
cell, as released LPS is thought to play a major role in the development of the septic-shock that 
accompanies gram-negative caused infectious diseases (Giauser et al., 1991). Functionally, 
LPS provides a barrier to heavy metals, lipid-disrupting agents, and larger molecules such as 
lytic enzymes. It also contains a highly variable carbohydrate (0-antigen) that functions to 
reduce complement binding and presents the host with multiple antigenic structures in various 
strains, thus rendering the organisms more resistant to serum-mediated host defences (Proctor 
et al., 1995). 
1.8.1.3 Enzymes that Degrade the Host Extracellular Matrix. 
Some pathogenic bacteria produce enzymes that degrade the extracellular matrix in host 
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tissues, which functions to hold tissues together to give them their physical structure, and is 
composed of a network of fibrous proteins such as collagen, elastin and fibronectin embedded 
in a hydrated polysaccharide gel (Patrick and Larkin, 1995). Elastin accounts for nearly 30% of 
the protein in lung tissue and is responsible for the elasticity of other tissues such as blood 
vessels and skin. P.aeruginosa has elastolytic activity that appears to be due to the activity of 
two enzymes: LasA and LasB (Salyers and Whitt, 1994). The elastase activity is thought to be 
involved in the damage that the organism causes to the lungs, particularly common in people 
with cystic fibrosis. Collagenases are also produced by some pathogens, for example 
Clostridium histolyticum expresses at least two collagenases that cause severe tissue damage 
and are lethal if injected intravenously into animals where they cause pulmonary damage 
(Patrick and Larkin, 1995). 
1.8.2 Virulence Factors that Promote Colonisation. 
1.8.2.1 Pili (Fimbriae). 
Adherence to host tissues is required for successful colonisation and subsequent infection by 
most bacterial pathogens and so to achieve this many pathogenic bacteria possess filamentous 
surface structures termed pili or fimbriae, of which two major types will be described, Type I 
and Type IV. It is the tip of the pilus that mediates adherence of bacteria, by attaching to a 
molecule on the host cell surface, commonly carbohydrate residues of glycoproteins or 
glycolipids (Salyers and Whitt, 1994). Type I pili are found on the majority of E.coli, and 
Salmonella species as well as Klebsiella pneumonia and are thin, 7 nm wide and 
approximately l11m long surface polymers that bind to D-mannose residues on eukaryotic cells 
(Ciegg and Gerlach, 1987). Type I pilin structures have been implicated in the role of E.coli 
colonisation of the urinary tract and the large bowel during infection (Finlay and Falkow, 
1989). 
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Type IV pili are found in Pseudomonas (Pasloske et al., 1985), Neisseria (Meyer et al., 1984), 
Moraxella (Marrs et al., 1985), Bacteriodes (EIIeman et al., 1986) and Vibrio (Taylor et al., 
1987). Type IV pili have been grouped together on the basis of amino acid sequence 
similarities among the major pilin component, where homology is highest at the amino-
terminus (Femandez and Berenguer, 2000). The second conserved characteristic is the 
occurrence of N-methylated amino acids (phenylalanine or methionine) as the first amino acid 
of the mature pilin structural subunit (Strom and Lowry, 1993). In P.aeruginosa it was shown 
that piliated organisms were I 0 times more virulent than non-piliated strains in a burned 
mouse model (Strom and Lowry, 1993). Type IV pili are thought to have other possible 
functions in pathogenesis, such as twitching motility, which allows bacteria to spread in 
infected tissue, as seen in P.aeruginosa. 
Bacteria also possess proteins on the surface of the cell that aid adherence, but are clearly not 
assembled as pili and are often referred to as afimbrial adhesins and are thought to be proteins 
that mediate the tighter binding of bacteria to host cells that follows initial binding via pili 
(Salyers and Whin, 1994). 
1.8.2.2 Flagella. 
Motility in non-filamentous bacteria is generally provided by flagella, which are helical surface 
structures that rotate from membrane-bound "motors", which push bacteria like boat propellers 
by anticlockwise rotation (Femandez and Berenguer, 2000). Potential benefits include 
increased efficiency of nutrient acquisition, avoidance of toxic substances, the ability to 
translocate to preferred hosts and access optimal colonisation sites within them, and dispersal 
in the environment during the course oftransmission (Ottemann and Miller, I997). In the case 
of Campylobacter jejuni and Helicobacter pylori the flagellum is essential for pathogenesis, as 
these organisms have adapted to survival in the gastrointestinal mucus, where colonisation is 
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imperative in the avoidance of removal by the flow of intestinal chyme, and for negotiating 
mucus that covers the epithelial surface ofthe gut (Ottemann and Miller, 1997). 
1.8.2.3 Capsule. 
A capsule is a loose network of polymers, mostly composed ofpolysaccharides, that covers the 
surface of a bacterium (Salyers and Whitt, 1994). The capsule is an important structure, aiding 
the colonisation of pathogenic bacteria by preventing phagocytosis and protecting the bacteria 
against complement activation as part of the host's inflammatory response. For example, the 
capsule of Streptococcus pneumoniae has long been recognised as its major virulence factor 
(AlonsoDeVelasco et al., 1995). 
1.8.2.4 Iron Acquisition. 
A prerequisite for bacterial colonisation of any environment is the biochemical machinery 
necessary to obtain adequate nutrition (Patrick and Larkin, 1995). For example, iron is 
essential for bacterial growth, and in a host such as the human body, the concentration of free 
iron is low because lactoferrin, transferrin, ferritin, and haemin bind most of the available iron 
(Salyers and Whitt, 1994). Thus, bacteria have developed mechanisms to acquire iron by 
producing low-molecular weight structures with a high affinity for Fe3+, known as 
siderophores. A notable example is that the majority of enterobacteria produce an 
enterochelin-phenocatechol siderophore, termed enterobactin (Siegfried and Kmetova, 1997). 
1.8.2.5 slgA Proteases. 
Mucus layers in the human body contain secretory lgA, whereby its Fe tail attaches to mucin 
and traps bacteria in the mucus layer. However, some pathogenic bacteria attempting to 
colonise mucosal surfaces possess a slgA proteases that break down secretory lgA allowing 
these bacteria to avoid being trapped in the mucin layer (Salyers and Whitt, 1994). 
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1.9 AIMS OF THE RESEARCH PROJECT. 
In this research project, the techniques of molecular biology are used to study the bacterial 
pathogen, B.pseudomallei and for comparative purposes, the newly discovered avirulent 
species, B.thailandensis the overall aims of which are: 
I. To use genomic DNA from B.pseudomallei to construct various genomic libraries 
in a number of E. coli host/vector systems. 
2. To screen constructed genomic libraries for recombinant bacterial and viral clones 
producing antigens, enzymes or other components of B.pseudomallei. 
3. To isolate and characterise any cloned B.pseudomallei antigens of interest and to 
determine their gene sequences and presence in other isolates of B.pseudoma/lei 
and B.thai/andensis to elucidate a role in the pathogenicity of B.pseudomallei. 
4. To use sequences encoding extracellular virulence factors available from other 
bacterial pathogens to construct PCR primers to test for the presence of 
homologous sequences in B.pseudomallei and B.thailandensis. 
5. To directly compare the ECPs of B.pseudomallei and B.thailandensis to elucidate 
differences that may reflect virulence factors and targets of any future cloning 
strategies. 
In attempting these aims it is hoped that the molecular characterisation of B.pseudoma/lei will 
elucidate virulence factors and hence the pathogenic processes involved with melioidosis, 
which has been previously little understood in the hope that a vaccine may be produced. 
Initially experiments proceeded using donated B.pseudomallei and B.thailandensis DNA 
kindly supplied by collaborators. Towards the end of the project, a Containment Level 3 
facility, necessary for the safe handling of category 3 pathogens, such as B.pseudomallei 
became available in the department. Subsequently, some work with B.pseudomal/ei cultures 
was possible. Consequently, the order in which experimental chapters appear in the thesis do 
not reflect the chronological order in which experimental work was carried out. 
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CHAPTER2 
MATERIALS AND METHODS 
2.1 REAGENTS AND MEDIA. 
Details of formulation and preparation of laboratory reagents and growth media (including 
antibiotics) are given in Appendix I. 
2.2 BACTERIOLOGY. 
2.2.1 Bacterial Strains. 
Isolates of B.pseudomallei and B.thailandensis used in this study are listed in Table 2.1 and 
bacterial species closely related to B.pseudomallei, which were used as controls and for 
comparative purposes in certain investigations, are listed in Table 2.2. 
Strains of E. coli K 12 used in gene cloning experiments, together with their genotypes are 
given in Table 2.3. 
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Table 2.1 Isolates of B.pseudoma//ei and B.lhai/andensis Used in Experiments in this 
Research Project (Provided by Dr. D.A.B. Dance PHLS, Derriford Hospital, Plymouth, Dr. T. 
Pitt, CPHL, Colindale, London and Dr. R. Titball, Porton Down, Salisbury). 
STRAIN SOURCE SITE GEOGRAPHICAL DATE ARA 
ORIGIN UTILISATION 
19 Environment Soil Singapore 1991 -
22 Environment Soil Burkinafaso 1973 -
25 Environment Soil Madagascar 1977 -
33 Environment Manure France 1976 -
46 Human Blood NE Thailand 1988 -
53 Human Urine NE Thailand 1987 -
97 Environment Soil Australia 
- -
98 Environment Soil Australia - -
102 Environment Soil Australia 
- -
112 Human Multiple NE Thailand 1992 -
212 Environment Soil NE Thailand 1990 -
216 Environment Soil NE Thailand 1990 -
217 Environment Soil (wet) NE Thailand 1990 -
392 Human Pus NE Thailand 1989 -
426 Environment Soil Vietnam - -
448 Environment Soil Vietnam - -
E254 Environment Soil Thailand - + 
E255 Environment Soil Thailand - + 
E256 Environment Soil Thailand - + 
E260 Environment Soil Thailand 
-
+ 
441398 Human Blood Abergavenny (ex- 1999 -
Malaysia) 
E8 Environment Soil Thailand 
- -
E25 Environment Soil Thailand 
-
-
E27 Environment Soil Thailand - + 
E82 Environment Soil Thailand - + 
204 Human Blood Thailand - -
576 Human Blood Thailand - -
Hainan I Human Pus Hainan Island 1996 • 
Hainan 2 Human Pus Hainan Island 1996 • 
Hainan 4 Human Blood Hainan Island 1996 • 
Hainan 55 Human Blood Hainan Island 1996 -
Hainan 706 Human Pus Hainan Island 1996 -
Hainan 106 Human Blood Hainan Island 1996 -
Hainan 93 Human Blood Hainan Island 1996 -
Jie 187 Human Blood China - -
Zhan I Human Pus China - • 
4845 Monkey Blood Unknown 1936 -
MAL6 Unknown - - - -
*These isolates are claimed by Prof. Song Yang, Hainan Peoples Hospital, China, to be Ara+s 
which were all isolated from clinical cases (Dance, personal communication), but their 
arabinose utilisation has not yet been confirmed by either Dr. D.A.B. Dance or Dr. T. Pitt 
through the API 20NE biochemical testing kit. 
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Table 2.2 Other Strains of the Genus Burkho/deria Used in Experiments in this Research 
Project (Provided by Dr T Pitt. CPHL, Colindale London). 
SPECIES GENOMOV AR or STRAIN SOURCE 
B.cepacia I Non-epidemic, Cystic Fibrosis 
(sputum) 
B.cepacia 11 Non-epidemic, Cystic Fibrosis 
(sputum) 
B.cepacia Ilia epi Epidemic from New-Zealand, 
Cystic Fibrosis (sputum) 
B.cepacia fila non-epi Non-epidemic, Cystic Fibrosis 
(sputum) 
B.cepacia lllb Non-epidemic, Cystic Fibrosis 
(sputum) 
B.cepacia lllc Asaccharolytic epidemic, Cystic 
Fibrosis (sputum) 
B.cepacia IV Non-epidemic, Cystic Fibrosis 
(sputum) 
B.cocovenans LMG 11626 
B.p/antarii LMG 10908 
B. vietnamensis LMG 6998 
B. vietnamensis LMG 6999 
B. vietnamensis LMG 10926 
B.vandii LMG 10620 
B. gladioli NCTC 12378 
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Table 2.3 Strains of E. coli K 12 Used in Gene Cloning Experiments in this Study. (All strains 
were obtained from the Department of Biological Sciences, University of Plymouth culture 
collection). 
STRAIN GENOTYPE USE 
JMI09 recA I supE44 end A I hsdR 17 A recombinant-deficient lac· 
gyrA96 re/A I thi ll (lac-proAB) strain for use with vectors 
carrying the ~-galactosidase 
system. 
DHI supE44 hsdR17 recAI endAI A recombinant deficient strain 
gyrA96 thi-1 re/A I used for routine plating and 
growth of plasmids and 
cosmids. 
DH5a F-end A I hsdR 17 [rK- mK +] A recombinant deficient strain 
supE44 thi-1 recA I gyrA96 used as a host in plasmid gene 
re/A I ~80d/acll.M 15 cloning. 
ll[/acZY A-argF] U 169 
LE392 FhsdS20 [rK.mKl/acYI ga/K2 A strain used for propagation of 
metB I trpR55 supE44 supF58 A.GEMII. 
~c· 
C600 supE44 hsdR thi-l thr-1 leuB6 A suppresser strain used in 
lacYitonA21 transfection experiments. 
YI088 ll (/acU 169) supE supF hsdR Used for the construction of 
(r- m+) metB trpR tonA21 gene libraries in A.GT 11. 
proC::Tn 5 (pMC 9) 
YI089 araD139lllacUI69 proA+ lllon Used for gene cloning in 
rpsL hj/AI50 [chr::TniO(tet')] A.GTII, deficient in the Ion 
pMC9 protease, which may allow 
increased stability of foreign 
proteins. 
YI090 supF hsdR araD 139 ll/on Used for screening expression 
lllacU 169 rpsL libraries and propagation of 
trpC22::TniO(tet') pMC9 A.GTII. 
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2.2.2 Laboratory Culture and Storage of Bacteria. 
2.2.2.1 Strains of E.co/L 
Strains of E. coli K 12 were routinely cultured using Luria-Bertani (LB) medium. Those strains 
that bore plasmids were cultured using LB supplemented with the appropriate antibiotic(s). 
Bacterial strains were streaked onto LB agar, and subsequently single colonies for broth 
culture were used to inoculate a given volume of LB media. Bacterial cultures were incubated 
aerobically at 37°C unless otherwise stated. Stock cultures were maintained in 50% glycerol 
(which served as a cryoprotectant), in I ml volumes stored in polypropylene microcentrifuge 
tubes (MCC tubes) kept at -20°C. Some strains were flash frozen in liquid nitrogen and stored 
at -70°C. Petri dishes containing agar cultures of E. coli in regular use were stored, inverted at 
4°C and subcultured every 4 to 6 weeks. 
2.2.2.2 Strains of B.pseudomallei, B.thailandensis and other Burkholderia species. 
B.pseudomallei is classified by the Advisory Committee on Dangerous Pathogens (ACDP) as a 
category 3 pathogen and thus requires special containment facilities. All strains of 
B.pseudomallei and B.thailandensis were cultured in a Containment Level 3 (CL 3) laboratory 
unit either by Dr. D.A.B. Dance at the PHLS, Derriford Hospital, Plymouth or by Dr. M.L. 
Gilpin in 401A, Davy Building, University of Plymouth. Isolates of B.pseudomallei, 
B.thailandensis and other Burkholderia species used were initially streaked onto LB media 
whereby single colonies were used to inoculate I 0 ml of LB broth in sterile polypropylene 
Universal bottles. Cultures were incubated statically at 37°C for 48 h. 
2.2.3 Characterisation of Bacterial Cultures. 
Cultures of B.pseudomallei supplied by Dr. D.A.B. Dance from PHLS, Derriford hospital, 
Plymouth, and cultures of other Burkholderia species supplied by Dr. T. Pitt, CPHL, 
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Colindale, London had been previously identified by means of the API 20NE biochemical 
testing kit. 
2.3 BACTERIOPHAGE 'A. 
2.3.1 Titration of Bacteriophage A Suspensions. 
This procedure enabled the titre (the number of plaque forming units per ml) of a 
bacteriophage A suspension to be determined. A I 0 ml culture of the appropriate E. coli host 
strain was incubated overnight at 37°C in NZCYM broth supplemented with 0.2% (w/v) 
maltose. Bacteria grown in the presence of maltose adsorb bacteriophage A more efficiently as 
it induces the maltose operon, which contains the gene (lamB) encoding the bacteriophage A. 
receptor. Hence, incubation with maltose functions to increase the number of bacteriophage 
receptors (Sambrook et al., 1989). A set of serial, I 0-fold dilutions were set up (of the order 
I o·' to 10-7) of the phage suspension using SM buffer as the diluent. A 0.1 ml volume of phage 
dilution was placed into a sterile, thick-walled Universal tube to which 0.2 ml of the 
appropriate E.coli host strain was added. The contents were mixed gently and incubated at 
37°C for 15-20 min. to allow the phage to absorb to the bacteria, after which a 5 ml volume of 
molten soft NZCYM agar was added. The tube was mixed gently, so as not to introduce any 
air bubbles, and overlayed onto NZCYM agar plates. Plates were left for a few minutes to set 
and then incubated, inverted at 37°C for 18-24 h. 
2.3.2 Preparation of Bacteriophage A Stocks. 
2.3.2.1 Bacteriophage A Stock from a Single Plaque. 
A small-scale stock of phage could be made from just one plaque and this stock was stable 
stored at 4°C for long periods of time. A sterile Pasteur pipette with a rubber bulb attached was 
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stabbed through a chosen plaque, and by applying mild suction the plaque and underlay was 
drawn up into the pipette. Well-separated plaques were preferentially picked, as bacteriophage 
f... is able to diffuse considerable distances through the top layer of soft agar (Sambrook et al., 
1989). The agar plug was placed into I ml of SM buffer, held in a sterile MCC tube and one 
drop of chloroform was added to inactivate any remaining bacteria. The tube was left for at 
least 1-2 h. to enable phage to diffuse out ofthe agar plug. 
2.3.2.2 Bacteriophage f... Stock from Confluent Lysis Plates. 
Larger stocks of phage were prepared from whole plate lysates. Dilutions of the appropriate 
phage were plated out as in 2.3.1, and those plates exhibiting near confluent lysis were chosen. 
Approximately 20 plates were used and after incubation each plate was flooded with a 3 ml 
volume of SM buffer and placed at 4°C for 1-2 h. to soften the agar overlay. Afterwards, the 
soft agar overlay was macerated using a sterile spreader to ensure good recovery of the phage. 
The preparation was transferred into MCC tubes and centrifuged at 13,000 x g for I 0 min. to 
pellet the soft agar, and the resulting supematant was collected into fresh MCC tubes to which 
3 drops of chloroform from a Pasteur pipette was added. 
2.3.2.3 Bacteriophage f... Stock From Liquid Cultures. 
This method yielded a high titre stock of phage that could be used for DNA extraction and 
subsequent use in gene cloning experiments. This procedure involved large volumes of 
cultures, initially containing a low concentration of phage and a known number of host 
bacterial cells, which were incubated so that uninfected bacterial cells would continue to 
divide for several hours. The ratio of phage to host bacterial cells, or multiplicity of exposure 
(MOE) was calculated in each experiment. A MOE of I was a I: I ratio of phage to bacterial 
cells. MOE's ranging from 0.01 to 100 were used in experiments and calculated by firstly 
enumerating the number of bacterial cells in an overnight culture using a haemocytometer, and 
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using the phage titre which was previously obtained by performing an assay as detailed in 
2.3.1. Flasks (2 litres) containing 500 ml of Phage Propagation Media were incubated with a 
known number of phage particles and bacterial cells for 16-18 h. at 3 7°C with shaking. During 
this time, successive rounds of infection led to the production of increasing quantities of phage 
until complete lysis of the culture occurred. This was easily visualised as the culture would be 
clear in colour with strings of cell debris at the bottom of the flask. 
A 0.25 ml volume of chloroform was added to flasks showing evidence of complete lysis and 
left shaking at 37°C for I 0 min. Afterwards, the culture was centrifuged at 5000 x g for I 0 
min. to remove cell debris. The volume of supernatant was measured before transferring to a 
sterile flask and NaCI was added to 0.5M and polyethylene glycol (PEG) 6000 to I 0% (w/v). 
The contents were shaken to dissolve the PEG 6000 and allowed to incubate overnight, on ice 
to precipitate the phage. Precipitated phage was pelletted by centrifugation at 15,000 x g for 15 
min. at 4°C before resuspending in 35 ml of SM buffer. Once resuspended, the contents were 
transferred to a 40 ml Beckman Quickseal tube and heat-sealed. This was ultracentrifuged for 
12 h. at 27,000 x g at 20°C. The bacteriophage particles appeared as a glassy pellet at the 
bottom of the tube. The supernatant was carefully discarded and the pellet resuspended in a 
500jll volume ofSM buffer. 
2.3.3 Extraction of Bacteriophage A DNA. 
A high titre stock of phage (as produced in 2.3.2.3) was aliquoted in I 00 jll volumes into 
sterile MCC tubes. Next, a I 0 J.ll volume of 2 M Tris-HCI and 0.2 M Na2EDT A (pH 8.5) 
solution was added and mixed thoroughly. An equal volume ( 110 jll) of formamide was added 
and the preparation was incubated at room temperature for 1-2 h. Afterwards, an equal volume 
(220 J.ll) of sterile analar water was added and the phage DNA was precipitated with ethanol 
(2.4.1 ). The phage DNA was pelletted by centrifugation at 13,000 x g for I 0 min., the 
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supematant was removed and the DNA pellet washed with 70% ethanol, allowed to dry and 
resuspended in TE buffer. The DNA was further purified by extraction with phenol (2.4.3.2). 
2.3.3.1 Wizard Lambda Prep-DNA Purification System (Promega). 
Alternatively, phage DNA was isolated from lysates (prepared as in 2.3.2.2) usmg a 
commercial kit as follows. To a I 0 ml volume of phage lysate, 40 Ill of resuspended Nuclease 
Mixture was added and the tube incubated for 15 min. at 37°C. A 4 ml volume of Phage 
Precipitant Solution was added, the contents mixed gently and left on ice for 30 min. Next, the 
contents were centrifuged at I 0,000 x g for I 0 min. The resulting supematant was discarded 
and the pellet resuspended in 500 Jll of Phage Buffer Solution and transferred to a sterile MCC 
tube. Any insoluble particles were removed by centrifuging for I 0 sec. at I 0,000 x g and the 
resulting supernatant transferred to a fresh MCC tube, where I ml of thoroughly resuspended 
Purification Resin was added and mixed by inverting the tube. The phage DNA was recovered 
using Wizard minicolumns attached to a vacuum manifold. The columns were prepared by 
attaching a syringe barrel to the Luer-lok extension of each column. The resin/lysate mixture 
was loaded into the syringe barrel and a vacuum applied to draw this mixture through the 
column. The column was washed using 2 ml of 80% isopropanol (propan-2-ol), drawn through 
the column and the resin was dried by drawing a vacuum for an additional 30 sec. after the 
isopropanol had been pulled through the column. The column was removed, placed into a 1.5 
ml MCC tube and centrifuged at 10,000 x g for 2 min. to remove any remaining isopropanol. 
The column was then placed into a fresh MCC tube and a I 00 Jll volume of sterile analar 
water, or TE buffer pre-heated to 80°C was added and the column immediately centrifuged for 
20 sec. at I 0,000 x g to elute the DNA. A second elution was carried out using a 50 jll volume 
of water or TE buffer, to ensure maximal recovery. 
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2.4 DNA ISOLATION AND PURIFICATION METHODS. 
2.4.1 Concentrating DNA solutions. 
DNA solutions were concentrated by either ethanol or isopropanol precipitation. Firstly, the 
DNA solution was measured into a sterile MCC tube and a 0.1 volume of 3 M sodium acetate 
was added and mixed gently. To this either a 0.6 volume of isopropanol or 2.5 volumes of ice-
cold analytical grade ethanol was added. To facilitate precipitation, DNA precipitated with 
ethanol was incubated at -80°C for 15 min. and DNA precipitated with isopropanol was 
incubated at room temperature for up to 2 h. Resulting precipitated DNA was pelletted by 
centrifugation in a microcentrifuge at 13,000 x g for I 0 min. Once pelletted the supernatant 
was removed and the DNA pellet was washed with 70% (v/v) ethanol and centrifuged again at 
13,000 x g for 5 min. The DNA pellet was dried and resuspended in TE buffer or sterile analar 
water and stored at 4°C. 
2.4.2 Plasmid DNA Isolation. 
2.4.2.1 Miniprep Method. 
A variation on the alkaline lysis method of Birnboim and Doly (1979) was used to produce 
plasmid DNA of a sufficient quality to enable restriction enzyme digestion and transformation. 
A 1.5 ml volume of an overnight bacterial culture was transferred into a MCC tube and 
centrifuged at 13,000 x g for 30 sec. to pellet the bacterial cells. The supernatant was discarded 
and the cell pellet was resuspended in I 00 Jll of B&D Solution I and incubated at room 
temperature for 5 min. Next, 150 Jll of B&D Solution 11 was added and the contents mixed 
gently by inverting the tube several times. At this stage the solution appeared clear and viscous 
and was incubated on ice for 5 min., after which time 150 Jll of ice-cold B&D Solution Ill was 
added, mixed gently and the preparation incubated on ice for a further 5 min. A white 
flocculent precipitate formed which was pelletted by centrifugation at 13,000 x g for 5 min. to 
yield a clear supernatant of approximately 400 Jll, which was transferred to a fresh MCC tube. 
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To this I ml of ethanol (-20°C) was added to precipitate the plasmid DNA, and after mixing 
the tube was incubated on ice for 10 min. followed by centrifugation at 13,000 x g for 10 min. 
The pellet of plasmid DNA was washed with 70% ethanol, centrifuged at 13,000 x g for 2 min. 
and the pellet was dried before resuspending in either TE buffer or sterile analar water. Often 
RNA was present in the preparation and therefore I 111 of RNase (I jlg/jll) would be added and 
the contents incubated at 37°C for 1-2 h. The RNase and any residual proteins were then 
removed by extraction with phenol (2.4.3.2) and the plasmid DNA finally precipitated with 
ethanol and resuspended as before. 
2.4.2.2 Maxiprep Method. 
The maxi prep method was used if processing larger cultures from 500 ml up to 2 litres and is 
again a variation of Bimboim and Doly ( 1979). Bacterial cells were harvested by 
centrifugation at 5000 x g for 15 min. at room temperature and resuspended in 16 ml of B&D 
Solution I, which was supplemented with 0.8 ml of lysozyme at 20 mg/ml, to weaken the cell 
walls of the bacteria. Next, 16 ml of B&D 11 was added and mixed gently by swirling the tube, 
the solution appeared clear and viscous at this stage. The solution was left on ice for I 0 min., 
after which 12 ml of ice-cold B&D Ill was added and the contents mixed gently to form a 
white tlocculent precipitate and left on ice for a further I 0 min. The precipitate was pelletted 
by centrifugation at 5000 x g for 15 min. at 4°C and the resulting supernatant was removed and 
allowed to warm to room temperature before adding a 0.6 volume of room temperature 
isopropanol. The contents were left for 2-3 h. at room temperature to precipitate the plasmid 
DNA. Afterwards, the plasmid DNA was pelletted by centrifugation at I 0,000 x g for 15 min. 
and resuspended in 2.5 ml ofTE buffer ready for Caesium Chloride-Ethidium Bromide (CsCI-
EtBr) density centrifugation to purify the plasmid DNA. 
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2.4.2.3 DNA Wizard Plus Maxiprep DNA Purification System (Promega) 
This commercial kit was used to isolate plasmids from bacterial cultures that were 100-500 ml 
in size as an alternative method of isolating plasmid DNA of a quality for restriction enzyme 
analysis and ligation. The culture was pelletted by centrifugation at 5000 x g for I 0 min. at 
20°C and resuspended in 15 ml of Cell Resuspension Solution. Next, 15 ml of Cell Lysis 
Solution was added and mixed gently by inverting the centrifuge tubes. The solution became 
clear and viscous once cell lysis was completed (approximately 20 min.). To this 15 ml of 
Neutralisation Solution was added and mixed immediately by gently inverting the centrifuge 
tubes. The solution was then centrifuged at 14,000 x g for 15 min. The cleared supematant was 
filtered through miracloth, the volume measured and transferred to a clean centrifuge bottle. A 
0.5 volume of room-temperature isopropanol was added and mixed in order to precipitate the 
plasmid DNA. The solution was centrifuged at 14,000 x g for 15 min. to pellet the plasmid 
DNA. The supematant was discarded and the DNA pellet resuspended in 2 ml ofTE buffer. 
A 10 ml volume of DNA Purification Resin was added to the solution and mixed. One Wizard 
maxicolumn was used for each extraction and inserted into a vacuum manifold port. The 
DNA/resin mix was transferred into the maxicolumn and to this 25 ml of Column Wash 
Solution was added and a vacuum was applied. A 5 ml volume of 80% ethanol was added to 
the column and a vacuum applied once again until the ethanol had passed through. The 
maxicolumn was removed and inserted into a 50 ml Falcon tube and centrifuged in a Denley 
bench top centrifuge at I ,300 x g for 5 min. after which both the Falcon tube and contents were 
discarded. The maxicolumn was replaced back onto the vacuum source and the resin allowed 
to dry to completion by drawing a vacuum for 5 min. before placing into a provided tube to 
which 1.5 ml of pre-heated (65-70°C) TE buffer was added, and after waiting for one minute 
the plasmid DNA eluted by centrifuging at 1300 x g for 5 min. To eliminate any resin fines 
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that may have been present, the DNA solution was passed through a 0.2 Jlm filter with the aid 
of a syringe. The resulting plasmid DNA was stored at 4°C. 
2.4.2.4 Qiagen Plasmid Isolation (Minikit). 
Qiagen kits were often used as an alternative to the CsCI/EtBr density centrifugation method 
(2.4.3.1) as a quick method of isolating plasmid DNA of a sufficient quality for DNA 
sequencing. A 3 ml volume of an overnight culture was centrifuged at 13,000 x g, for I min. to 
pellet the bacterial cells, the supematant was discarded and the cells were resuspended in 0.3 
ml of Buffer PI. To this 0.3 ml of Buffer P2 was added, mixed gently and incubated at room 
temperature for 5 min. Afterwards, 0.3 ml of ice-cold Buffer P3 was added and mixed 
immediately, before incubating on ice for a further 5 min. The preparation was centrifuged at 
13,000 x g for 10 min. and the supematant was discarded. A Qiagen-tip 20 column was 
allowed to equilibrate by applying I ml of Buffer QBT and allowing the column to empty by 
gravity flow. Afterwards, the column was washed with I ml of Buffer QC, which was repeated 
for a total of 4 washes. The plasmid DNA was eluted from the column with 0.8 ml of Buffer 
QF into a sterile MCC tube and precipitated with a 0. 7 volume of isopropanol. The plasmid 
DNA was pelletted by centrifugation at 13,000 x g for I 0 min., the supematant was removed 
and after washing the pellet with I ml of 70% ethanol, the plasmid DNA was dried and 
resuspended in 20 Jll ofTE buffer or sterile analar water. 
2.4.3 Plasmid DNA Purification Methods. 
2.4.3.1 Caesium chloride/Ethidium bromide density ultracentrifugation. 
This process allowed the isolation of higher and purer concentrations of plasmid DNA, free of 
contaminating molecules such as chromosomal DNA, high molecular weight RNA and 
protein, which was important for successfulligation reactions and for DNA sequencing. 
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To resuspended plasmid DNA in a volume of 2.5 ml of TE buffer, 2.6 g of CsCI was added, 
and the contents warmed slightly to aid solution of the salt. Next, 0.25 ml of ethidium bromide 
solution (I 0 mg/ml) was added and the tube was left in the dark for around 2 h. to allow 
proteins to complex with the ethidium bromide. The tube was spun briefly to pellet the 
unwanted protein material and the supematant was loaded into a 3.5 ml Beckman Quickseal 
tube and heat-sealed before ultracentrifuging at 80,000 x g for 24 h. at 20°C. After this time, 
two distinct bands of DNA were visible using UV light. The top band, which contained less 
material, represented any remaining chromosomal DNA and nicked plasmid DNA, whereas 
the lower band represented the closed circular plasmid DNA. Any RNA in the preparation was 
pelletted at the bottom of the tube. A hypodermic needle was inserted into the top of the tube 
to allow air to enter. A fresh needle attached to a syringe was inserted into the side of the tube, 
bevelled side up and positioned just below the lower plasmid band. The contents of the band 
were drawn into the syringe carefully so as not to remove any ofthe upper chromosomal DNA. 
The volume of resuspended plasmid DNA recovered from the CsCI!EtBr density 
centrifugation procedure was measured and to this an equal volume of isopropanol, previously 
saturated with water and CsCI was added and mixed gently. Two distinct layers formed, of 
which the upper, containing the isopropanol and ethidium bromide was removed carefully with 
a pipette and discarded. This process was repeated until the lower aqueous layer containing the 
plasmid DNA was clear in colour, indicating that the ethidium bromide had been removed. 
The plasmid DNA and CsCI were precipitated with ethanol after adding a 0.1 volume of 3 M 
sodium acetate, and the resulting pellet was washed with I ml of 70% ethanol, which 
functioned to dissolve the CsCI. The tube was then centrifuged at 13,000 x g for 5 min. to 
pellet plasmid DNA and any undissolved CsCI. The supematant was discarded and another I 
ml of 70% ethanol was added to fully dissolve all of the remaining salt. The tube was 
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centrifuged again at 13,000 x g for 5 min. to pellet the plasmid DNA, which was resuspended 
in TE buffer or analar water. 
2.4.3.2 Phenol Extraction of DNA. 
Extraction of DNA with liquefied phenol facilitates the removal of proteins from DNA 
solutions, which is often necessary to improve the quality of DNA for techniques such as 
restriction analysis or ligations. An equal volume of phenol solution was added to a DNA 
solution of known volume in a MCC tube, mixed thoroughly until an emulsion formed. The 
mixture was centrifuged at I 0,000 x g for 2 min. in a microcentrifuge to separate into 2 layers. 
The upper aqueous layer of DNA solution was removed carefully with a pipette so as not to 
disturb the band of proteinaceous material that had formed at the interface, and was transferred 
to a new MCC tube. To this an equal volume of a phenol solution previously mixed with 
chloroform plus isoamylalcohol (IAA) in the ratio: 24:24: I was added, mixed to form an 
emulsion and separated by centrifugation at I 0,000 x g for 2 min. Again, the top aqueous layer 
containing the DNA was removed and transferred to a new MCC tube. This step was repeated 
until no band of proteinaceous material was visible at the interface. Finally, an equal volume 
of a water-saturated solution of chloroform plus IAA was added to the DNA solution, mixed 
and centrifuged at I 0,000 x g for 2 min. The upper aqueous layer was removed and transferred 
to a new MCC tube. This was repeated twice to ensure that no phenol remained in the DNA 
solution, which might interfere with subsequent processes such as restriction digestion and 
ligation reactions. 
2.4.4 Chromosomal DNA Isolation Procedures. 
2.4.4.1 Rapid Prep™ Genomic DNA Isolation Kit (Pharmacia Biotech) 
This commercial kit was used to isolate chromosomal DNA from Burkholderia species that 
did not require Containment level 3 facilities and any E.coli strains used as negative controls 
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in Southern blots. The kit was also used to further purify genomic DNA isolated from 
B.pseudomal/ei and B.thailandensis in 2.4.4.2. 
A volume of culture that contained 2 xI 09 bacterial cells was centrifuged at 13,000 x g for one 
minute in a 1.5 ml MCC tube and the supematant was discarded. A 50 J.ll volume of Modified 
Extraction Buffer was added to the sedimented cells and vortexed until a homogeneous 
suspension formed, and the preparation was incubated at 55°C for 30 min. Afterwards, 800 111 
of Application Buffer was added and mixed by inverting the tube several times, followed by 
incubation at room temperature for 5 min. 
Microspin columns were prepared by inverting several times to resuspend the resin. The 
bottom closure was snapped off, the top cap removed and the column placed into a MCC tube 
and centrifuged at 735 x g for I min. The MCC tube was discarded and the bottom closure 
replaced on the column. A 400 111 volume of the bacterial preparation was added to the column 
and inverted several times before leaving for I min. to allow the resin to settle. The top cap 
and bottom closure were again removed and the microcolumn centrifuged in a clean MCC 
tube at 735 x g for 2 min. The support tube was emptied and the remaining 400 111 of the 
preparation was added to the same pre-spun column, again resuspending the resin before 
centrifuging at 735 x g for 2 min. A 400 111 volume of Wash Buffer was added to the top of the 
resin bed and the microspin column centrifuged at 735 x g for 2 min. The support tube was 
emptied and this process repeated once for a total of 2 washes. The support tube was replaced 
with a clean MCC tube and 200 111 of Elution Buffer was added to the column and centrifuged 
at 735 x g for 2 min., which was repeated for a total of two elutions. The genomic DNA was 
precipitated by adding 320 111 of isopropanol and incubating at room temperature for I 0 min. 
The genomic DNA was pelletted by centrifugation for I 0 min. at 13,000 x g, and resuspended 
in 10 J.ll ofTE buffer. 
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2.4.4.2 Chromosomal DNA Isolation Procedures for B.pseudomallei and B.thailandensis 
Cultures. 
These procedures were carried out either by Dr. D.A.B. Dance or Dr. M.L. Gilpin. 
2.4.4.2.1 Miniprep Method (10 ml Cultures). 
This method was used for small cultures of B.pseudomallei and B.thailandensis to produce 
DNA of a quality for PCR reactions. To a I 0 ml culture of B. pseudo mallei 5 ml of Solution A 
was added, mixed and left at room temperature for 5 min. Next, I ml of Solution 8 was added 
and the preparation was left at room temperature for a further 5 min. After which time a 4 ml 
volume of Solution C was added and mixed, followed by 2 ml of Solution D. The preparation 
was placed at 80°C with occasional mixing for 1-2 h. From this solution, 0.2 ml aliquots were 
removed and spread onto Nutrient agar plates to check for viability. Plates were incubated at 
37°C for 72 h., while the remaining lysate was stored at 4°C until viability checks were 
completed to a satisfactory conclusion. This ensured lysates were free of the pathogen before 
being released from the CL 3 laboratory for use elsewhere. These preparations were sometimes 
subjected to further purification (2.4.4.1 ). 
2.4.4.2.2 Maxiprep Method (200 ml Cultures) 
To a 200 ml culture of B.pseudoma/lei or B.thailandensis. 100 ml of Solution A was added, 
mixed and left for 5 min. at room temperature. A 20 ml volume of solution B was added, the 
contents mixed and left at room temperature for a further 5 min. After which time 80 ml of 
Solution C was added, followed by 40 ml of Solution D, the tube contents mixed and left at 
80°C with occasional mixing for 1-2 h. Next, 0.2 ml volumes were removed from the 
preparation and spread onto Nutrient agar plates to check for viability. Plates were for 
incubated for 48 h. at 37°C and the lysate was stored at 4°C until viability checks were 
complete (as in 2.4.4.2.1 ). 
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2.4.5 Agarose Gel Electrophoresis. 
2.4.5.1 Determination of DNA Concentration. 
The amount of DNA in a given solution was determined using ethidium bromide .fluorescent 
quantification, which utilises the ultraviolet fluorescence emitted by ethidium bromide 
molecules intercalated into the DNA (Sambrook, et al., 1989). This was achieved by 
subjecting the DNA sample to electrophoresis in agarose gels containing ethidium bromide at 
a concentration of 0.5 ~g/ml. Whereby DNA samples to be checked were run alongside DNA 
standards of known concentration. Bacteriophage A DNA was used, whereby 4 ~I of the A 
standard DNA was equivalent to 0.5 ~g of DNA. A variety of amounts of the standard were 
used on an agarose gel and the unknown was compared against these on the basis of the 
amount of fluorescence emitted when exposed to UV light (31 On m) on a UV transilluminator 
(UV Products inc., California USA). 
2.4.5.2 Preparation of an Agarose Gel. 
In order to analyse, identify and purify DNA fragments, electrophoresis through an agarose gel 
was the standard method used. DNA's from 200 bp up to approximately 50 kbp in length can 
be separated in agarose gels of various concentrations (Sambrook et al., 1989). Gels of either 
0.8% (w/v) or I% (w/v) were used in most cases. This was achieved by adding the desired 
percentage of agarose to either 30 ml or 60 ml of Tris-Borate EDTA (TBE) buffer in a conical 
flask. TBE buffer was prepared at I 0 X strength and diluted with distilled water accordingly. 
The agarose and TBE preparation was heated in a microwave oven for approximately 3 to 4 
min. until all of the agarose had melted. Molten agarose was placed in a waterbath at 45°C 
until equilibrated. Once cooled, ethidium bromide was added, 5 ~I (at a concentration of I 0 
mg/ml) per I 00 ml of agarose gel solution to give an overall concentration of 0.5 ~g/ml. The 
molten agarose was poured into a taped UV-transparent gel mould into which a comb was 
inserted to create subsequently, wells in which to load the DNA samples. 
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2.4.5.3 Agarose Gel Electrophoresis. 
Once an agarose gel had been made and allowed to set, DNA samples were prepared by 
mixing them with a Ficoll DNA loading buffer. The taped ends of the tray mould containing 
the agarose gel were removed and the tray was placed into a Pharmacia GNA I 00 
electrophoresis tank, filled with 350 ml of TBE buffer (X I) so that it was submerged by the 
buffer, before loading the DNA samples into the wells. The gel was run at a constant 120 V 
after which the DNA bands were visualised using a UV transilluminator and photographed 
using a Polaroid CU 5 camera system with a type 665 film, or by using a UVI pro 
documentation system. 
2.4.6 Recovery of DNA from Agarose Gels. 
2.4.6.1 Electroelution into Dialysis Tubing. 
Dialysis tubing was prepared by boiling in 100 ml of TBE buffer (XI) for 3 min. in a 
microwave and allowing it to cool. Once a DNA sample had been run on an agarose gel, the 
DNA band of interest was located on the transilluminator and by using a clean, sterile razor 
blade, a slice of agarose was excised containing the desired DNA band. This was placed into 
dialysis tubing with a knot at one end. The tubing was filled with I X TBE buffer and another 
knot was placed in the opposite end to seal the contents, care was taken not to introduce any 
air bubbles into the tubing. The tubing was immersed in I X TBE buffer in an electrophoresis 
tank and an electric current applied to electroelute the DNA out of the gel and onto the inner 
wall of the bag. A constant 120 V was applied for 30 min. to ensure that all the DNA was 
eluted out of the agarose gel. The polarity of the current was reversed for I min. to release the 
DNA from the inner wall of the tubing back into the TBE buffer and the DNA solution was 
removed and placed into a MCC tube. The tubing was washed out with a small amount ofTBE 
buffer to enhance DNA retrieval and the DNA recovered was purified using the 810-RAD, 
Prep-A-Gene DNA Purification System (2.4.6.2). 
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2.4.6.2 DNA Isolation from Agarose Slices Using the 810-RAD Prep-A -Gene Kit. 
This method was sometimes used as a quicker alternative to isolating DNA from agarose gels 
as described in 2.4.6.1. The Prep-A-Gene kit was also adapted to purifY DNA fragments as an 
alternative to phenol extraction. 
The desired DNA band was excised from an agarose gel using a sterile razor blade as in 
2.4.6.1 and placed into a MCC tube. The amount of DNA in the band was estimated by 
comparing the fluorescence to that of the standards prior to excision. The gel slice was 
centrifuged for several seconds so that it was situated on bottom of the tube and the volume of 
the gel slice was estimated. The amount of Prep-A-Gene Matrix to be used was calculated, 
given that I Jll of Matrix binds 0.2 Jlg of DNA. Hence, based on the estimated volume of the 
gel slice and the calculated amount of Matrix needed to bind all of the DNA, 3 volumes of this 
combined amount of DNA purification kit Binding Buffer was added to the gel slice and the 
tube agitated gently so that it fully dissolved. After which, the predetermined amount of Matrix 
was added and the tube mixed gently at room temperature for 10 min. The Matrix was 
pelletted by centrifuging 13,000 x g for 30 sec. and the supernatant was discarded. The pellet 
was resuspended in an amount of purification kit Binding Buffer equivalent to 25 X the Matrix 
volume. The tube was centrifuged again at 13,000 x g for 30 sec., the supernatant disposed of 
and the pellet washed with a 25 X Matrix volume of Wash Buffer for a total of 2 washes, 
whereupon after the second wash, all traces of liquid were carefully removed by centrifuging 
twice. The DNA was eluted by resuspending the pellet in at least I pellet volume of Elution 
Buffer and incubated between 37-50°C for 5 min., which was repeated for a total of 2 elutions. 
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2.5 DNA MANIPULATION METHODS. 
2.5.1 Transformation of Calcium Chloride Treated E. coli with Plasmid DNA. 
Plasmid DNA was introduced into E.coli by the process of transformation, whereupon 
treatment of bacterial cells with divalent cations makes the bacteria temporarily permeable to 
small DNA molecules, such as plasmids. A 1.5 ml volume of appropriate bacteria, grown to an 
OD of 0.6 (As9o) was centrifuged at 5,000 x g for I minute in a sterile MCC tube. The 
supernatant was discarded and the bacterial cell pellet resuspended in 200 !J.I of ice-cold CaCI2 
solution (75 mM). Once resuspended, the bacteria were left at 4°C for 40 min. and re-pelletted 
by centrifugation at 5,000 x g for I min. The supernatant was again discarded and the bacterial 
cell pellet resuspended in I 00 !J.I of ice-cold CaCb (75 mM). Plasmid DNA was added to the 
bacteria, mixed gently and the preparation left on ice for I 0 min., before placing at room 
temperature for a further I 0 min. and finally returning to ice for 30 min. Unless otherwise 
stated, 50 ng of plasm id DNA was added in a volume no greater than I 0 !J.I to be transformed. 
Next, the bacteria were heat-shocked by placing at 42°C for 2 min. and a 0.9 ml volume of LB 
broth was added, mixed gently and the transformation mix was placed at 37°C for 90 min. 
After this time, samples were spread onto LB plates supplemented with the appropriate 
antibiotic required for selection of successful transformants. Plates were incubated at 37°C for 
24-36 h. although longer periods of incubation were used if more than one antibiotic was being 
selected for, or alternatively, if lower incubation temperatures were being used in certain gene 
cloning experiments. 
2.5.2 Blue/White Screening to Detect Recombinant Plasmids in E.coli Kl2 Hosts that 
Contain the lac Genes. 
To check for recombinants, isolation plates would often be supplemented with 5-bromo-4-
chloro-3-indolyi-13-D-galactoside (X-gal) and isopropylthio-13-D-galactosidase (IPTG) if the 
vector contained the lacZ gene, which codes for 13-galactosidase. Recombinants disrupt the 
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/acZ gene, as foreign DNA is ligated into it, and so a non-active form of 13-galactosidase is 
produced. Recombinants appear white as opposed to non-recombinants, which appeared blue-
green in colour. When 13-galactosidase is assayed with X-gal, which is nonnally colourless, it 
cleaves off the galactose moiety from X-gal, forming a blue colour. However, if there is a 
disruption of the lacZ gene so that an inactive fonn of 13-galactosidase is fonned, the reaction 
cannot happen and so the galactose moiety remains on X-gal, hence the recombinant colonies 
are white. To screen recombinants in this way, LB agar containing the appropriate antibiotic 
was prepared and the plates dried at 45°C for I 0-15 min. The plates were overlayed with 5 ml 
of LB agar supplemented with the same antibiotic, as well as X-gal solution (at 40 j.tg/ml) and 
IPTG solution (at 120 Jlg/ml). The overlay was allowed to set before the transformation 
mixture was spread plated onto the plates, which were incubated for 24 h. at 37°C, unless 
otherwise stated, and examined for presence of blue (lac+, non-recombinant), and white (lac·, 
recombinant) colonies. 
2.5.3 Preparation of Transformation Competent E. coli K12 Cells. 
2.5.3.1 Preparation of Frozen Competent E. coli Cells. 
A procedure for making competent cells was carried out, which had been developed by 
Viesturs Simanis, Imperial College, London, previously developed from a procedure by 
Hanahan ( 1985). The bacterial strain used was DH5u, of which a 400 ml culture was 
incubated at 37°C with shaking until an OD of0.6 (A600). The culture was chilled on ice for 15 
min. before centrifugation at I ,000 x g, 15 min. at 4°C to pellet the bacterial cells. The 
supematant was discarded and the bacteria were resuspended in one-third of the initial culture 
volume of RF I (Appendix I) and kept on ice for 15 min. before centrifuging at I ,000 x g for 
15 min. at 4°C. The bacteria were resuspended in 1/12.5 ofthe initial culture volume ofRF2 
(Appendix 1). Competent cells were aliquoted into 200 j.tl volumes in MCC tubes and flash 
frozen in liquid nitrogen for storage at -70°C until needed. 
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2.5.3.2 Transformation of Frozen Competent E. coli Cells. 
A 200 J.LI volume of frozen competent DH5a bacteria was removed from -70°C and allowed to 
thaw on ice. The bacteria were mixed gently by flicking the tube and to this the plasmid DNA 
was added. A maximum of 50 ng of DNA was added in a volume no greater than I 0 J.LI per I 00 
J.LI of competent cells. After gently mixing, the transformation mixture was left on ice for 20-
40 min. Next, the bacteria were heat shocked at 42°C for 2 min. before placing on ice for a 
remaining 2 min. An 800 J.LI volume of cold (4°C) LB media was added to the bacteria and the 
tube incubated at 37°C for 90 min. before plating out onto fresh LB media containing 
appropriate antibiotics. 
2.5.4 Restriction Endonuclease Digestion. 
Restriction endonucleases are enzymes that cleave both strands of double stranded DNA at 
specific nucleotide sequences. The digestion reaction was carried out using an excess of 
restriction enzyme in the supplier's recommended buffer system. The amount of restriction 
enzyme required is calculated in units, whereby I unit of enzyme cuts I J.Lg of A. DNA in I h. at 
3 7°C in a volume of 50 J.LI. Typically a reaction contained the following solutions: 
DNA solution (typically I J.Lg of DNA) I J.LI 
Restriction enzyme buffer (xI 0) I J.LI 
Analytical grade H20 7 J.LI 
Restriction enzyme I J.LI 
The components of the reaction were added in the above order into a MCC tube, the contents 
mixed thoroughly, centrifuged briefly and incubated at 37°C for 3-18 h. If larger quantities of 
DNA were digested the reaction could be scaled up, ensuring that the restriction enzyme buffer 
was present at a 1/10 overall concentration. Double enzyme digests were carried out using a 
suitable buffer, deemed by the supplier's guide, to provide suitable conditions for both 
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enzymes and the quantity of each restriction enzyme added was halved. Products of restriction 
enzyme digests were visualised using agarose gel electrophoresis and compared with the 
migration of DNA molecular size markers. 
2.5.5 Alkaline phosphatase treatment of plasmid DNA. 
Calf-intestinal alkaline phosphatase (ClAP) was used in this procedure, which functioned to 
remove the 5'-phosphate groups from linear DNAs. This process prevented the 
recircularization of plasmid DNA in gene cloning experiments. Cleaved plasmid DNA was 
ethanol precipitated and resuspended in 44 j!l of analar water in a sterile MCC tube, to which 5 
j.ll of ClAP buffer (X I 0) and I j!l of CIA P was added. The contents of the tube were incubated 
at 37°C for 30 min. After the incubation time, a further I j.ll of ClAP was added to the tube and 
incubated for 30 min. at 37°C. The ClAP was inactivated by heating the contents of the tube to 
75°C for 10 min. A phenol extraction was carried out to remove the alkaline phosphatase. 
2.5.6 Ligation of Foreign DNA into Plasmid Vectors. 
Plasmid DNA that has been cleaved with a restriction enzyme can be joined in vitro to foreign 
DNA in a ligation reaction. Successfulligation depended on the compatibility of the termini of 
the foreign DNA fragment and the restriction sites in the plasmid vector. Additionally, the 
relative concentration of plasmid and foreign DNA in the reaction was calculated based upon 
their relative nucleotide sizes. Unless otherwise stated, the ratio of plasmid DNA to foreign 
DNA was 2:1 respectively. The reaction was performed using T4 DNA ligase in the supplier's 
recommended buffer system. Ligations, unless otherwise stated were incubated at I5°C for 18 
h. in an overall volume of 50 j!l. Agarose gel electrophoresis comparing ligated DNA with 
unligated DNA solutions was used to confirm successfulligations. 
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In a reaction with blunt-ended termini, where both plasmid and vector in the ligation reaction 
have blunt ends with no overhanging bases, the efficiency of ligation tends to be reduced and 
so higher concentrations of DNA and ligase were used. 
2.5.7 SURECLONETM Ligation Kit (Pbarmacia Biotecb). 
This commercial kit was used as an alternative method to clone PCR products quickly for 
DNA sequencing. The first step of the method involved blunt-ending the PCR product, which 
was carried out in a reaction as follows: 
PCR Product 
Klenow fragment 
Buffer (IOX) 
Polynucleotide kinase 
Analar HzO 
I Jlg 
I 111 
2 Jll 
I Jll 
15 Jll added to give a total volume of 20 Jll. 
The components were added into a sterile MCC tube, mixed gently and centrifuged briefly and 
incubated at 37°C for 30 min. After which the product was purified using the BIO-RAD Prep-
A-Gene Kit (2.4.6.2) and resuspended in I 0 Jll of sterile analar water. The following ligation 
reaction was then set up: 
DNA (PCR product) 2 Ill 
Vector (pUCI8) I Jll 
2 X Ligation Buffer 10 Jll 
OTT I Jll 
T4 Ligase I Jll 
Sterile Analar Water 5 Jll 
This gave an overall total of 20 Jll and the preparation was incubated at 15°C for 90 min. 
before using in a transformation procedure (2.5.1) using blue/white screening (2.5.2). 
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2.6 PROTEIN ANALYSIS METHODS. 
2.6.1 SOS-PAGE. 
Proteins were electrophoretically separated for analysis by SDS-PAGE using a discontinuous 
buffer system. The electrophoretic equipment used in this study was either the Mini-Protean 11 
system (810-RAD, Herts., UK) or the Biometra system. The SDS-PAGE gel consisted of two 
gels; a main, separating gel and an upper stacking gel formed between two glass slides. 
Polymerisation of gels was carried out using the ammonium persulphate (APS)/TEMED 
system. Details of gel formulation and reagents used can be found in Appendix I. 
2.6.1.1 Formation of SOS-PAGE Gels. 
The two glass slides that formed the sandwich support for the formation of the SDS-PAGE gel 
were cleaned with 70% IMS, dried and assembled. The main gel was made at the desired 
concentration with the APS and TEMED added lastly. This mixture was pipetted into the 
space between the plates using a glass pipette and filled to about two-thirds the height of the 
largest glass plate. Once filled to the desired level, a small volume of water-saturated 
isobutanol was added, forming a layer on top of the main gel to exclude air, hence promoting 
gel polymerisation. A period of 30 min. was allowed for polymerisation of the main gel to 
occur. After this time, the water-saturated isobutanol was poured off and the top of the gel was 
washed with sterile analar water before the second, stacking gel was added. The stacking gel 
was made to the desired concentration, as with the main gel by adding APS and TEMED lastly 
and was pipetted onto the set, main gel. A comb was placed into the stacking gel prior to 
polymerisation so that the protein samples could be added to the wells formed by the comb. A 
further 30 min. was allowed for polymerisation of the stacking gel. 
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2.6.1.2 Electrophoresis of SDS-PAGE Gels. 
Once set, the whole gel was transferred to the electrophoresis tank. Electrophoresis buffer was 
poured into the tank and the comb was removed. Any air bubbles at the bottom of the gel were 
removed carefully with a syringe. Protein samples were mixed with SOS-PAGE loading buffer 
and boiled for 5 min. before loading onto the gel. A maximum of 20 Jll of sample could be 
loaded into each well. Coloured molecular weight markers (Sigma) were also boiled and 
loaded onto the gel. The gel was then run at around 120 V for approximately I h., or until the 
dye front had run off the bottom ofthe gel. 
2.6.1.3 Staining of SDS-PAGE Gels. 
Gels were stained with coomassie blue to visualise protein bands, or used in a Western blotting 
procedure for immunological detection of proteins. The gel was first removed from the 
electrophoresis tank and carefully separated from the glass slides and placed in coomassie blue 
staining solution for around 40 min. with gentle agitation before destaining. The gel was left in 
destaining solution with gentle agitation, whereby the destaining solution was changed several 
times over a period of 3-18 h. 
2.6.2 Western Blotting. 
Proteins on an SOS-PAGE gel could be transferred onto nitrocellulose for the purpose of 
immunological detection, which was carried out using the 810-RAO Transblot system. A 
piece of nitrocellulose was cut to the size of the gel, along with 3 pieces of blotting paper and 
left in transfer buffer for I 0 min. along with two foam pads. These were then arranged so that 
the foam pads were on the outside, a piece of blotting paper was placed onto one of the foam 
pads and the gel was carefully placed onto this followed by the nitrocellulose and a couple of 
pieces of blotting paper and the second foam pad. Any air bubbles on the nitrocellulose were 
rolled out using a clean glass rod. The gel was then electroblotted overnight at 30 m A at 4°C. 
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Once electroblotting was complete, the nitrocellulose membrane was washed in PBS for 5 
min. to remove any methanol left from the transfer buffer, and incubated with blocking 
solution for I h. After this time, the nitrocellulose was removed and incubated with the desired 
concentration of primary antibody for 2 h. followed by washing in 50 ml of PBS for a total of 
3 washes. Afterwards, the nitrocellulose was left incubating for 2 h. with the secondary 
antibody conjugate at the appropriate concentration to label bound antibody, which was, unless 
otherwise stated, peroxidase-conjugated swine anti-rabbit immunoglobulins, before finally 
washing with PBS 3 times. Labelled antibody was visualised by development using the 3'3' 
diaminobenzidine tetrahydrochlorate (DAB) system with nickel enhancement (Harlow and 
Lane, 1988), where a positive reaction was indicated by a purple/brown colour. 
2.7 SOUTHERN BLOTTING. 
Southern blotting allows the detection of homologous DNA sequences (Southern, 1975) that 
have been transferred from an agarose gel to a membrane support, through capillary action 
and, using a nucleic acid probe that hybridises to the transferred DNA, and depending on the 
type of label, hybridisation bands of interest can then be detected. Sodium saline citrate (SSC) 
buffer is used, in which nucleic acids are highly soluble, and it is drawn up through the gel 
taking with it single stranded DNA which becomes trapped in the membrane. 
2.7.1 Digoxigenin Non-radioactive Labelling of DNA. 
Southern blotting was carried out using a non-radioactive nucleic acid detection system, as 
opposed to the alternative, radioactively labelled DNA detection system. The system used was 
the digoxigenin-anti-digoxigenin system, which uses DIG (digoxigenin) (Boehringer 
Mannheim), a cardenolide steroid isolated from Digitalis plants (Martin et al., 1990). A 
nucleotide triphosphate analogue containing the digoxigenin moiety (DIG-UTP) is 
incorporated into DNA through random primer labelling in a PCR reaction. The DIG-labelled 
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probe is then detected using an enzyme-linked immunoassay using an antibody to digoxigenin 
(anti-DIG), to which alkaline phosphatase has been conjugated. A chromogenic substrate for 
alkaline phosphatase was used to detect the DIG-labelled probe, the 5-bromo-4-chloro-3-
indolyl phosphate (BCIP) with nitroblue tetraazolium chloride (NBT) system. Unless 
otherwise stated a 5 !JI volume of DIG-UTP was incorporated into the standard PCR reaction 
designed for the probe. 
2.7.2 Southern Blotting Procedure. 
The DNA samples to be used were firstly digested with the appropriate restriction enzymes 
(2.5.4) and separated by agarose gel electrophoresis. Specific markers were run on the gel, 
which were composed of a size standard of A. DNA cut with Hindlll (Gibco/BRL). Once 
· agarose gel electrophoresis of the DNA samples was complete and a photograph was taken, 
the wells were removed and the gel was placed into 0.2 M HCI for I 0 min. as a depurination 
step. The gel was removed and placed in a separate container along with I 00 ml of 
Denaturation Solution and left to soak for 20 min. Finally, the gel was placed into a 200 ml of 
Neutralisation Solution. A piece of nylon membrane was cut to the size of the agarose gel 
along with 2-3 pieces of filter paper. Numerous paper towels were also cut to this size for use 
in the blotting procedure. The blotting unit was prepared by firstly washing with water. The 
unit was then left to soak in sterile water before priming the wick by adding 25-50 ml of I OX 
SSC solution over the surface, and 450 ml of IOX SSC was added to the blotting base. The gel 
was placed, facedown, onto the centre of the wick and cling film was used to cover the 
remaining surface of the wick not covered by the gel to prevent a "short-circuit" during 
transfer. The membrane and filter paper were soaked in water for 2-3 min. followed by I OX 
SSC for 5 min. Next, the membrane was placed onto the gel, followed by the filter paper and a 
stack of paper towels were placed on top of the filter paper high enough so that the lid would 
sit above the blotting base. This was left overnight to facilitate the transfer of DNA onto the 
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nylon membrane. After this time, the towels and filter paper were removed and the membrane 
was washed by immersion in 5X SSC for 1-5 min. to remove any residual agarose and left to 
air dry for around 30 min. before binding the nucleotides to the membrane by UV crosslinking. 
This was achieved by placing the membrane on a transilluminator and subjecting it to UV light 
of 254 nm for two and a half min. The membrane was removed and prehybridised with 30 ml 
of Prehybridisation Solution at 68°C for 2 h. During this time, the probe was denatured by 
boiling for I 0 min. in a waterbath before placing directly onto ice. The Prehybidisation 
Solution was replaced with Hybridisation Solution containing around I 00 ng of the freshly 
denatured probe, and was left to hybridise overnight. Next, the membrane was washed twice 
with 50 ml of Wash Buffer I for 5 min. at room temperature and a further 2 times with 50 ml 
of Wash buffer 11 for 15 min. at 68°C. The detection procedure was started by washing the 
membrane for I min. in Detection Buffer I, followed by 50 ml of Detection Buffer 11 for 30 
min. and finally the membrane was washed again in 50 ml of Detection Buffer I for 2 min. The 
antibody conjugate (Anti-Digoxigenin-AP) was diluted to 150 mU/ml, a I in 5000 dilution. 
Thus, 5 Jll of the conjugate was added to 25 ml of Detection Buffer I and the membrane was 
incubated in this before adding the Coloured Detection Solution. The reaction was stopped by 
adding Detection Buffer Ill. 
2.8 POLYMERASE CHAIN REACTION (PCR). 
PCR is the in vitro amplification of specific sequences of nucleic acid. lt allows an exponential 
increase in the amount of any given DNA template by the simultaneous primer extension of 
the two complementary strands of DNA. This is achieved by the use of synthetic 
oligonucleotides, termed primers that are complementary to sequences within the target DNA 
and flank the piece of DNA to be amplified. DNA polymerase then carries out the synthesis of 
a complementary strand of DNA. 
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2.8.1 Primer Design. 
One primer is designed to be complementary to the 3' end of the antisense strand of DNA 
(forward primer) and the other is designed to be complementary to the 3' end of the sense 
strand of DNA (reverse primer). Generally, PCR generates shorter DNA sequences (200-400 
nucleotides in length) more reliably than longer sequences, and this was taken into account 
when designing primers to the target DNA. Ideally, primers were designed so that they had a 
50% G+C content, or a G+C content similar to the fragment to be amplified, and so that they 
would not contain extensive secondary structure nor be complementary to each other. Design 
of PCR primers was carried out using the DNasis computer program (Hitachi) and the 
resulting choices of primers were checked by the computer program Amplify to identify the 
best suited forward and reverse primers. Primers were synthesised by Sigma-Genosys Ltd. 
(Cambridgeshire, UK). 
2.8.2 Storage of Primers. 
Primers were received lyophilised, and resuspended in 500 J.d of I X TE buffer, boiled in a 
waterbath for I 0 min. and placed directly onto ice to ensure that the primers were fully 
denatured. The concentrations of the primers were calculated, and the primer solutions were 
further diluted with sterile analar water to give stock concentrations of around 20 pmoi/J.d. The 
primer stocks were stored in sterile, thin-walled PCR tubes in 50 Jll aliquots at -80°C. 
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2.8.3 The PCR Reaction. 
The basic steps of the PCR were as follows, although the time and temperature of the 
annealing step sometimes differed, depending on the melting point of the primers and often it 
was necessary to carry out a number of PCRs to ascertain the ideal reaction conditions: 
I. Denaturation oftemplated DNA 9S°C, I min. 
2. Annealing primers to templated DNA 4S-6S°C, 1-2 min. 
3. Extension of primers by DNA polymerase 72°C, 2 min. 
Steps 1-3 were repeated 30 times, unless otherwise stated, followed by I 0 min. at 72°C to 
allow filling-in of the fragments. The reaction conditions were programmed into the 
thermocycler, which was, unless otherwise stated, a Perk in El mer TC I. 
The overall volume of the PCR reaction was SO 1.11 and the reaction components generally 
consisted of the following, although exact quantities differed slightly: 
Reaction Buffer (xI 0) 
Forward primer 
Reverse primer 
dNTPs 
Taq DNA polymerase 
Template DNA 
Analar H20 
Mineral oil 
s Jll 
10-100 pmol 
10-100 pmol 
2mM 
2 units 
2-SO ng 
Added to bring the final volume of the reaction to SO Jll. 
so )ll 
Components were added into 0.5 ml thin-walled PCR tubes and throughout the procedure all 
components and tubes were kept on ice. Mineral oil was the final component to be added to 
form a layer above the reaction mixture to minimise any evaporation during the heating and 
cooling cycles. The tubes were then placed into the thermocycler, previously programmed to 
carry out the desired steps of the PCR cycle automatically. 
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The purity of DNA was crucial, as any DNA contaminants would be amplified if the primers 
were able to anneal to a part of the sequence. Therefore, to avoid nuclease contamination, 
gloves were worn throughout the procedure, which was carried out in a specialised PCR 
cabinet where all equipment was first sterilised under UV light prior to use. In addition to 
these precautions, micropipettors were used with tips that contained a filter to prevent 
contamination, and all solutions and equipment used for PCR were kept separate from other 
laboratory uses. In most cases, once the PCR reaction was complete, a one-tenth volume of the 
reaction mixture was run on a I% agarose gel to examine the products produced and to 
estimate their relative sizes. 
2.9 DNA SEQUENCING. 
DNA sequencing in this project was carried out either by Dr. R. Titball at DERA, Porton 
Down, Salisbury or commercially by MWG Biotech Ltd. 
2.9.1 Sequencing Methods. 
The sequencing method utilised in both cases are variations on the chain terminator, or 
dideoxy procedure, which is now favoured for large-scale DNA sequence determination and 
considered to be more simple, rapid and accurate. The chain terminator DNA sequence 
procedure was developed by Sanger et al. ( 1977) and basically involves the synthesis of a 
DNA strand by a DNA polymerase in vitro using a single-stranded template, which capitalises 
on two properties of DNA polymerase: 
I. Its ability to synthesise faithfully a complementary copy of a single stranded 
DNA template. 
2. Its ability to use 2'3'-dideoxynucleoside triphosphates (ddNTP) as substrates 
(Old and Primrose, 1989). 
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Dideoxynucleotides lack the 3' hydroxyl group necessary for the formation of the next 
phosphodiester bond during chain elongation, and so is therefore terminated whenever a 
dideoxynucleotide is incorporated into the strand. Initiation of DNA synthesis requires a 
primer and usually this is a chemically synthesised oligonucleotide. DNA synthesis is then 
carried out in the presence of the four dideoxynucleoside triphosphates (ddNTPs) and 
deoxynucleotides (dNTPs) in four separate incubation mixes containing a low concentration of 
one of the ddNTP analogues so that a ddNTP is incorporated into the growing chain rather 
than a dNTP. This means that in each reaction there is a population of partially synthesised 
DNA molecules, each having a common 5' end, but each varying in length to a base specific 3' 
end. The Klenow fragment of DNA polymerase I lacks the 5 '~3' exonuclease activity of the 
intact enzyme, and was therefore used in the original protocol to synthesise a complementary 
copy of the single-stranded target sequence, and keeps the 5' end of the primer intact. 
Sequencing methods now make use of thermostable DNA polymerases, which, unlike the 
previous DNA polymerases allows the template DNA to be used many times in a single 
reaction. The four different reaction mixtures are separated by size on a polyacrylamide gel 
and the sequence is determined by correlating the order of the bands on the gel with the 
dideoxynucleotide used to generate each band. Labels, which can be radiolabels or dyes, are 
used for the detection of the DNA synthesised in a sequencing reaction and can be 
incorporated into the primer, the deoxynucleotides or dideoxynucleotides. 
2.9.2 Automated Sequencing. 
The development of instruments for automated sequencing has dramatically increased the 
throughput of individual laboratories. Unlike manual sequencing, which generally uses a 
radioactive label and visualisation of the banding pattern is by autoradiography the sequencing 
carried out in this project was by an automated sequencer. Automated sequencers use a 
scanning laser to detect DNA fragments labelled with fluorescent dyes. The health risks and 
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inconvenience of radioisotope disposal are sufficient incentive for many laboratories to 
automate much or all of their DNA sequence analysis. The fluorescent dyes can be linked to 
the primer (dye primer), the deoxynucleotides (internal labelling) or the dideoxynucleotides 
(dye terminator). The products are loaded onto a sequencing gel and separated according to 
size. A laser beam continuously scans across the lower portion of the gel, which functions to 
excite the fluorescent dyes attached to the fragments, and they emit light at a specific 
wavelength for each dye. The light is collected and separated according to wavelength by a 
spectrograph, where data collection software collects the light intensities and stores them as 
electrical signals for eventual processing. 
2.9.3 Template Preparation for DNA Sequencing by MWG-BIOTECH Ltd. 
To achieve optimum results, DNA cloned into a plasmid to be sent for sequencing, was 
cultivated in an endA E. coli strain and in the case of this research project, this was always 
carried out in DH5a. The DNA purification methods used to prepare all DNA samples was 
either the CsCI-EtBr density centrifugation or by using a Qiagen plasmid kit. The following 
amounts were sent according to the size of the insert to be sequenced and the service required: 
Single sequencing reaction 
Complete double strand: Insert length <5 kbp 
<10 kbp 
>10 kbp 
10 1-lg 
30 1-lg 
50 llg 
I 00 1-1g 
All samples were sent as a freeze-dried pellet of the appropriate quantity of DNA. 
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CHAPTER3 
COMPARISON OF THE EXTRACELLULAR PRODUCTS OF 
B.pseudomallei AND B.thailandensis. 
3.1 INTRODUCTION. 
Many bacterial pathogens produce extracellular products that are essential for pathogenicity. 
This may also be true of B.pseudomal/ei, as its virulence appears to be partly reliant on the 
production of a number of extracellular products during the course of infection. For example, 
of those already identified, there exists a thermolabile exotoxin (Nigg et al., 1955), a cytolethal 
toxin (Haase et al., 1997) a lecthinase, lipase, protease (Ashdown and Koehler, 1990), a 
haemolytic product (Liu, 1957) and a phospholipase (Korbsrisate et al., 1999). However, there 
is little evidence in current literature to show that an extensive study on all of the extracellular 
products (ECPs) produced by B.pseudomallei has been carried out. Therefore, it was decided 
to investigate the ECPs produced by a range of isolates of the bacterium. In addition to this, in 
light of the recent identification of the species B.thailandensis, there has not yet been a direct 
comparison of the ECPs produced by the two different species. Considering that the two 
species are antigenically indistinguishable and share the same LPS profile, but differ with 
respect to their virulence, there may exist certain factor(s) produced by B.pseudomallei 
responsible for this, of which some may be extracellularly produced. Thus, any differences 
observed between their respective ECP profiles could be representative of potential virulence 
factors in B.pseudomal/ei. There is also the possibility of variation between isolates of 
B.pseudomallei obtained from infected humans and isolates obtained from the environment, 
which again have not been compared with respect to the ECPs produced. Any differences 
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observed between such isolates may indicate virulence factors that are elicited or essential 
during the course of infection. 
In addition to ECP SOS-PAGE profiles, there is little published work concerning direct testing 
of B.pseudomallei isolates, in particular the ECPs, for a range of activities, such as haemolysis. 
Therefore, microtitre plate assays to detect a range of activities were performed on 
B.pseudomal/ei and B.thailandensis isolates. It was hoped that this would highlight activities 
of B.pseudomallei that had yet to be discovered and represent potential targets for any future 
gene cloning work with the pathogen. 
3.2 Isolation and Concentration of Extracellular Products. 
3.2.1 Bacterial Strains. 
The isolates of B.pseudomallei and B.thailandensis used in this study are shown in Chapter 2 
(Table 2.1 ). Other Burkholderia species were also used for comparative purposes in this study 
(Table 2.2). 
3.2.2 Isolation and Concentration of ECPs. 
Ten ml volumes of cultures were centrifuged at 4,400 x g in an IEC centrifuge at 4°C for 20 
min. The resulting supematant was aliquoted into MCC tubes and centrifuged at 15, 000 x gat 
4°C for I 0 min. The supematants were carefully removed and subjected to concentration in 
AMICON MINICON mini-plus units to X 250. For most isolates, 15 1-11 of concentrated 
supematant was added to 15 1-11 of SOS-PAGE loading buffer. Exceptions, due to less bacterial 
growth, were as follows; B.cepacia genomovars lllb, 11 and Ill non-epi, and B. vietnamensis 
LMG 6998, 30 1-11 of concentrated supematant was added to 30 1-11 of loading buffer and for 
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B.cepacia genomovars lllc, Ilia epi and IV, and B. vietnamensis LMG 6999, 40 )ll of 
concentrated supematant was added to 40 )ll of loading buffer. Samples were boiled in the 
CL3 laboratory for 10 min. and stored at -70°C until use. Viability checks were carried out 
before use outside the CL3 laboratory. 
3.3 SDS-PAGE ANALYSIS. 
3.3.1 SOS-PAGE Analysis to Test the Concentration of the Isolated ECPs. 
A representative group of isolates were chosen to test on SDS-PAGE (2.6.1) to ascertain the 
respective concentrations of the ECPs isolated. The isolates tested were B.pseudoma/lei 19, 
B.thailandensis E82, B.cepacia 11 and B. vietnamensis LMG 6999. A range of volumes were 
used as follows: 0.25 fll, 0.5 fll, I fll, 2 Ill and 5 Ill of concentrated supematant mixed with 
more loading buffer to bring the final volume up to 20 fll. Samples were placed in a boiling 
waterbath for S min. and subjected to electrophoresis in 13% polyacrylamide gels and the 
resulting protein bands were visualised with coomassie blue staining. The results showed that 
there was a very low concentration of ECPs isolated and even when using the largest volume 
of concentrated supematant (Sill), protein bands were just visible (results not shown). 
3.3.2 SOS-PAGE Analysis of Concentrated ECPs Isolated from B.pseudomallei and 
B.thailandensis Isolates. 
Profiles of the ECPs from all the isolates of B.pseudomallei and B.thailandensis were obtained 
using SDS-PAGE analysis (2.6.1). The volume of concentrated supematant used was 
detennined by the test perfonned (3.3.1 ), but as the concentration of the proteins was found to 
be very low, a maximum IS )ll of concentrated supematant was mixed with 5 )ll of loading 
buffer and boiled for I 0 min. Samples were subjected to electrophoresis in 13% · 
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polyacrylamide gels in conjunction with coloured molecular weight markers (Sigma). Protein 
bands were visualised by staining with coomassie blue. 
The results of all the SOS-PAGE gels can be seen in Appendix Ill (Gels 1- 6), as some ofthe 
concentrations of ECPs were so low that protein profiles could not be distinguished. In 
addition to this, some samples were difficult to load, probably due to high carbohydrate 
content. Therefore, a representative group of B.pseudoma/lei and B.thailandensis ECP profiles 
can be seen in Fig.3.1. Relative molecular weights of the protein bands were calculated by 
measuring the running distance of the molecular weight markers from the top of the gel and 
plotting the logged values against their respective logged molecular weights, which was 
carried out for each individual gel. Protein bands from the samples were measured from the 
same point as the markers and the logged value used to calculate the relative molecular weight 
graphically. Results of this can be seen in Table 3.1. 
An example of a SOS-PAGE gel showing whole-cell profiles of B.pseudomallei isolates, 
carried out by Mr M. Mahfouz, has been included in Fig.3.2 for comparative purposes and to 
determine whether any of the ECP samples had been inadvertently contaminated with whole-
cell proteins. lt seemed unlikely that an overspill of whole-cell proteins had occurred, as the 
pattern of protein bands observed from whole-cells were not evident in the ECP protein 
profiles. 
3.4 WESTERN BLOTTING OF ECPs. 
The ECPs of a representative number of isolates from both B.pseudoma/lei (53, H706, E8, 
448, 576 and 217) and B. thailandensis (E255 and E260) were analysed by immunoblotting. 
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The B.pseudomallei isolates chosen represented both clinical and environmental isolates. The 
ECPs were separated by SDS-P AGE (2.6.1) before being electrotransferred onto a 
nitrocellulose membrane. lmmunoblotting was carried out using convalescent human serum as 
the primary antibody (2.6.2). This was kindly donated by Dr. T. Pitt, CPHL, Colindale. Little 
background information was available concerning the human sera, including its relative 
concentration and so it was used experimentally at a concentration of I :200. Goat anti-human 
immunoglobulins (Sigma) with peroxide conjugate were used as the secondary at a 
concentration of I :400. Resulting bound antibody was visualised using DAB/NiCh colour 
development. The results of the immunoblotting can be seen in Fig.3.3. The ECPs are 
somewhat overshadowed by the immune response to what is considered to be polysaccharide 
or LPS, which is represented by the darker coloured "ladder" of bands in each lane, which 
were equally as strong in both species. The exceptions to this were B.pseudoma/lei strains 576 
and 217 where there was no evidence of the ladder in the lanes and so major protein bands 
were easily observed. However, with the use of a light box, major ECPs could be identified in 
the other isolates and their relative sizes estimated as with the SOS-PAGE gels (3.3.2). This 
was carried out firstly for B.pseudomallei 576 as these bands were the clearest and the other 
isolates were compared to this. 
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Fig. 3.1Concentrated ECPs from a Representative Group of B.pseudomallei and B.thailandensis Isolates. LANE 1: Coloured Molecular 
Weight Markers (Sigma) (from top to bottom): 205 kDa, 125 kDa, 78 kDa, 51 kDa, 30 kDa, 23 kDa, 16.5 kDa. LANE 2:448 (Gel 3). LANE 3: 
576 (Gel 3). LANE 4: 217 (Gel 3). LANE 5: 25 (Gel 1). LANE 6:46 (Gel 1). LANE 7: 53 (Gel 1). LANE 8: E27 (Gel4). LANE 9: JIE187 (Gel 
4). LANE 10: H706 (Gel 4). LANE 11: E260 (Gel 5). LANE 12: E256 (Gel 5). LANE 13: E255 (Gel 5). LANE 14: Coloured 
MolecularWeightMarkers (Sigma). LANE 15: E8 (Gel2). LANE 16: Coloured Molecular Weight Markers (Sigma). 
Table 3.1 Relative Molecular Weights Calculated for Protein Bands of B.pseudomallei and B.thailandensis Isolates Visualised by SOS-PAGE 
A I . nalysJs. 
SPECIES/ISOLATE LOG DISTANCE (mm) LOG MWt (kDa) RELATIVE MWt (kDa) 
B.pseudoma//ei 448 (Gel3) 1.04 1.18 1.29 1.48 1.53 1.56 1.57 1.61 2.18 2.15 2.02 1.84 1.78 1.76 1.75 1.7 151.4 141.3 104.7 69.2 60.3 57.5 56.2 
1.63 1.66 1.69 1.7 1.74 1.78 1.79 1.8 1.68 1.65 1.6 1.59 1.56 1.48 1.47 50.2 47.9 44.7 39.8 38.9 36.3 30.2 
1.81 1.83 1.46 1.44 1.41 29.5 28.8 27.5 25.7 
B.pseudomal/ei 576 (Gel 3) 1.39 1.43 1.46 1.48 1.51 1.53 1.56 1.57 1.92 1.89 1.86 1.84 1.8 1.78 1.76 83.2 77.6 72.4 69.2 63.8 60.3 57.5 
1.63 1.66 1.69 1.7 1.74 1.77 1.79 1.8 1.75 1.68 1.65 1.6 1.59 1.56 1.5 56.2 47.9 44.7 39.8 38.9 36.3 31.6 
1.81 1.83 1.47 1.46 1.44 1.41 29.5 28.8 27.5 25.7 
B.pseudoma//ei E8 (Gel 3) 1.28 1.31 1.34 1.43 1.48 1.51 1.52 1.56 2.2 1.99 1.97 1.89 1.84 1.805 1.795 158.5 98.9 93.3 77.6 69.2 63.8 62.4 
1·.59 1.62 1.64 1.66 1.67 1.68 1.69 1.71 1.76 1.72 1.68 1.66 1.65 1.63 1.62 57.5 52.5 47.9 45.7 44.7 42.7 41.7 
1.72 1.74 1.75 1.78 1.79 1.81 1.82 1.6 1.58 1.57 1.54 1.53 1.48 1.47 39.8 38.0 37.2 34.7 33.9 30.2 29.5 
1.4451.42 27.9 26.3 
B.pseudomallei 25 (Gel I) 1.34 1.39 1.42 1.43 1.47 1.5 1.51 1.525 1.94 1.87 1.85 1.84 1.86 1.78 1.77 87.1 74.1 70.8 69.2 63.2 60.3 58.9 
1.57 1.58 1.59 1.63 1.65 1.66 1.67 1.69 1.75 1.705 1.695 1.68 1.65 1.62 1.6 56.2 50.7 49.5 47.9 44.7 41.7 39.8 
1.7 1.78 1.79 1.8 1.81 1.59 1.56 1.55 1.42 1.41 1.38 1.36 36.3 35.5 26.3 25.7 24.0 22.9 
B~pseudomallei 46 (Gel I) 1.13 1.23 1.34 1.39 1.43 1.48 1.5 1.51 2.1 2.02 1.94 1.87 1.84 1.795 1.78 125.9104.7 87.1 74.1 69.2 62.4 60.3 
1.54 1.55 1.57 1.59 1.62 1.64 1.66 1.67 1.77 1.74 1.73 1.705 1.68 1.65 1.63 58.9 55.0 53.7 50.7 47.9 44.7 42.7 
1.69 1.7 1.71 1.75 1.78 1.79 1.8 1.81 1.6 1.59 1.56 1.55 1.54 1.48 1.42 39.8 38.9 36.3 35.5 34.7 30.2 26.3 
1.41 1.38 1.36 25.7 24.0 22.9 
B.pseudomallei 53 (Gel I) 0.7 0.93 1.08 1.13 1.23 1.27 1.32 1.34 2.25 2.195 2.12 2.1 2.02 1.98 1.945 177.8 156.7 131.8 125.9 104.7 95.5 88.1 
1.37 1.39 1.43 1.47 1.48 1.5 1.51 1.525 1.94 1.905 1.87 1.84 1.805 1.795 1.78 87.1 80.4 74.1 69.2 63.8 62.4 60.3 
1.54 1.57 1.59 1.61 1.63 1.65 1.67 1.69 1.77 1.75 1.74 1.705 1.68 1.66 1.65 58.9 56.2 55.0 50.7 47.9 45.7 44.7 
1.7 1.71 1.72 1.74 1.75 1.76 1.78 1.79 1.62 1.59 1.56 1.55 1.54 1.52 1.49 41.7 38.9 36.3 35.5 34.7 33.1 30.9 
1.8 1.81 1.48 1.46 1.42 1.41 1.38 1.36 30.2 28.8 26.3 25.7 24.0 22.9 
B.t/1ailandensis E27 (Gel 4) 1.5 1.57 1.62 1.71 1.87 1.8 1.74 1.62 74.1 63.1 55.0 41.7 
B.pseudomallei JIEI87 (Gel 4) 1.4 1.45 1.56 1.57 1.6 1.61 1.63 1.65 1.96 1.905 1.805 1.8 1.77 1.76 1.74 91.2 80.4 63.8 63.1 58.9 57.5 55.0 
1.66 1.69 1.695 1.7 1.74 1.7 1.695 1.65 1.64 1.635 1.58 50.7 49.5 44.7 43.7 43.2 38.0 
B.pseudomallei H706 (Gel4) 1.4 1.45 1.5 1.56 1.57 1.6 1.61 1.63 1.96 1.905 1.87 1.805 1.8 1.77 1.76 1.74 91.2 80.4 74.1 63.8 63.1 58.9 57.5 
1.65 1.66 1.69 1.695 1.7 1.76 1.8 1.7051.695 1.65 1.64 1.635 1.55 1.48 55.0 50.7 49.5 44.7 43.7 43.2 35.5 30.2 
B.thai/andensis E260 (Gel 5) 1.15 1.23 1.32 I .42 1.49 1.52 1.56 1.57 2.03 2.005 1.945 1.87 1.805 1.78 1.74 107.2 101.2 88.1 74.1 63.4 60.3 55.0 
1.61 1.63 1.65 I .66 1.68 1.69 1.72 1.74 1.72 1.68 1.65 1.62 1.61 1.58 1.56 52.5 47.9 44.7 41.7 40.7 38.0 36.3 
1.76 1.765 1.52 1.48 1.43 1.42 33.1 30.2 26.9 26.3 
B.tlwila11densis E256 (Gel 5) 1.57 1.65 1.69 1.72 1.62 1.56 52.5 41.7 36.3 
B.thailandensis E255 (Gel 5) 1.23 1.32 1.42 1.48 1.49 1.57 1.61 1.65 2.005 1.945 1.87 1.82 1.805 1.72 1.68 101.2 88.1 74.1 66.1 63.4 52.5 47.9 
1.69 1.72 1.62 1.56 1.52 41.7 36.3 33.1 
B.pseudomal/ei 2 I 7 (Gel 2) 1.5 1.57 1.63 1.65 1.69 1.71 1.75 1.785 1.78 1.7 1.65 1.62 1.56 1.54 1.48 60.3 50.2 44.7 41.7 36.3 34.7 30.2 
1.79 1.42 1.41 26.3 25.7 
205 kDa ..,.. 
125 kDa ..,.. 
78kDa 
51 kDa 
30kDa 
23kDa 
16.5 kDa ..,.. 
1 2 3 4 5 6 7 8 9 10 
Fig.3.2 SDS-PAGE Analysis of Whole-Cell Proteins from Isolates of B.pseudomallei and 
B.thailandensis. LANE I: Coloured Molecular Weight Markers (Sigma). LANE 2: E8. LANE 
3: 19. LANE 4: 22. LANE 5: 25. LANE 6: E25. LANE 7: 35. LANE 8: 46. LANE 9: 
Coloured Molecular Weight Markers (Sigma). LANE 10: E260. 
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The relative molecular weights calculated from the individual gels were analysed for protein 
bands common to the two different species. The general pattern appeared to be that although 
isolates of both species shared a number of common bands, there were differences in the SOS-
PAGE ECP profiles between species, with the B.thailandensis isolates generally having fewer 
protein bands than B.pseudomallei isolates. B.thailandensis isolates E260, E256 and E255 
were run on the same gel and obvious similarities can be seen. Similar protein bands were then 
looked for in the B.thailandensis isolate E27 and all the molecular weight values calculated for 
each B.thailandensis isolate were compared to E260, which had the clearest, and most 
resolved protein bands present. The results of which can be seen in Table 3.2. 
Table 3.2 Protein Bands Common to B.thailandensis Isolates E260, E256, E255 and E27. 
Protein Bands E256 E255 E27 
of E260 (kDa) 
107.2 
101.2 • 
88.1 • 
74.1 • • 
63.4 • (63.1) 
60.3 
55.0 • 
52.5 • • 
47.9 * 
44.7 
41.7 • • • 
40.7 
38.0 
36.3 • • 
33.1 • 
30.2 
26.9 
26.3 
"'Asterisks denote identical molecular weight values. 
From Table 3.2, the isolates from this species clearly share a number of common protein 
bands, and those bands common to two or more of the B.thailandensis isolates tested are as 
follows: I 0 1.2, 88.1, 74.1, 63.4 (63.1 ), 55.0, 52.5, 47.9, 41.7, 36.3 and 33.1 kDa. 
98 
The B.pseudomal/ei isolates similarly share a number of common protein bands. Although 
isolates were run on different gels all molecular weight values calculated for the 
B.pseudomallei isolates were compared to B.pseudomallei 53 (Table 3.3), which contained the 
clearest and most resolved protein profile. 
Table 3.3 Protein Bands Common to B.pseudomallei Isolates 53, JIE187, H706, 576,46, 448, 
25, E8 and 217. 
Clinical Soil 
Protein JlE187 H706 576 46 448 25 E8 217 
Bands of 
53 (kDa) 
177.8 
156.7 
131.8 
125.9 • 
104.7 • • 
95.5 
88.1 
87.1 • • 
80.4 • • 
74.1 • • • 
69.2 • • • • • 
63.8 • • • (63.22 • 
62.4 • • 
60.3 • • • • • 
58.9 • • • • 
56.2 • • • 
55.0 • • • 
50.7 • • • (50.2) • (50.2_2_ 
47.9 • • • • • 
45.7 • 
44.7 • • • • • • • • 
41.7 • • • 
38.9 (38.0) • • • (38.0) 
36.3 • • • • • 
35.5 • • • 
34.7 • • • 
33.1 1_33.9_2_ 
30.9 
30.2 • • • • • 
28.8 • • 
26.3 • • • • 
25.7 • • • • • 
24.0 • • 
22.9 • • 
*Asterisks denote identical molecular weight values. 
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Those bands common to two or more isolates of B.pseudoma/lei include the. following: 125.9, 
I 04.7, 87.1, 80.4, 74.1, 69.2, 63.8 (63.2), 62.4 (63.1 ), 60.3, 58.9, 56.2, 55.0, 56.7, 47.9, 45. 7, 
44.7, 41.7, 38.9 (38.0), 36.3, 35.5, 34.7, 30.2, 28.8, 26.5, 25.7, 24.0 and 22.9 kDa. Those 
values in brackets are of a similar molecular weight and common to a number of isolates. In 
addition to these, a number of other bands are found in more than one of the B.pseudoma/lei 
isolates but not found in 53, which are 39.8 and 57.5 kDa. The following common protein 
bands are found in both species: 88.1, 74.1, 55.0, 47.9, 41.7, 36.3 and 33.1 kDa. Virtually all 
of the protein bands that are common to the B.thailandensis isolates tested are also found in 
B.pseudoma/lei isolates. However, there are many other differing bands both between species 
and within species. 
Dividing the B.pseudomallei isolates into clinical and environmental, or soil isolates facilitated 
the discovery of other similarities, as the protein bands of 125.9 and 80.4 kDa were found only 
in clinical isolates and so may represent virulence factors elicited on infection. 
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Fig 3.3 Western Blot of ECPs Isolated from B.pseudomallei and B.thailandensis. LANE I: 
Coloured Molecular Weight Markers (Sigma). LANE 2: 53. LAN E 3: H706. LANE 4: 448. 
LANE 5: 576. LANE 6: 2 17. LANE 7: E8. LANE 8: E255. LANE 9: Coloured Molecular 
Weight Markers (S igma). LAN E I 0: E26. 
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Table 3.4 Relative Molecular Weights of Extracellular Protein Bands from a number of B.pseudomal/ei and B.thai/andensis Isolates Visualised by 
Western Blotting. 
Species/Isolate Log Distance (mm) Log M Wt. (kDa) Relative M Wt. (kDa) 
B.pseudomallei 53 0.6 0.7 0.78 0.81 0.85 0.93 0.95 0.98 1.02 2.22 2.2 2.18 2.17 2.15 2.12 2.1 2.06 166.0 158.5 151.4 147.9 141.3 131.8 125.9 
1.08 1.1 I 1.19 1.31 1.62 1.65 1.69 1.74 2.08 2.03 2.005 1.96 1.87 1.52 1.47 1.38 120.2 114.8 107.2 101.2 91.2 74.1 33.1 
1.2 29.5 24.0 15.9 
B.pseudomallei H706 1.02 1.19 1.23 1.27 1.31 1.38 1.41 1.45 1.53 2.06 1.96 1.93 1.895 1.87 1.86 1.8 1.76 114.8 91.2 85.1 78.5 74.1 72.4 63.1 
1.5 1.705 1.68 1.65 57.5 50.7 44.7 45.7 
B.pseudomallei 448 1.08 1.29 1.31 1.35 1.38 1.45 2.03 1.88 1.87 1.82 1.8 1.705 107.2 75.9 74.1 66.1 63.1 50.7 
B.pseudomallei 576 0.95 0.98 1.02 1.08 1.11 1.15 1.16 1.19 1.23 2.1 2.08 2.06 2.03 2.005 1.99 1.98 1.96 125.9 120.2 114.8 107.2 101.2 97.7 95.5 
1.31 1.32 1.35 1.38 1.41 1.45 1.50 1.53 1.55 1.93 1.87 1.86 1.82 1.80 1.76 1.70 1.68 91.2 85.1 74.1 72.4 66.1 63.1 57.5 
1.60 1.62 1.65 1.69 1.71 1.65 1.62 1.56 1.52 1.47 1.38 1.305 50.7 45.7 44.7 41.7 36.3 33.1 29.5 
24.0 20.2 
B.pseudomallei 217 1.02 1.11 1.15 1.19 1.23 1.27 1.31 1.41 1.45 2.06 2.0051.99 1.96 1.93 1.895 1.87 1.76 114.8 101.2 97.7 91.2 85.1 78.5 74.1 
1.5 1.705 1.68 57.5 50.7 45.7 
B.tllailande11sis E255 0.6 0.81 0.93 1.02 1.06 1.1 1.15 1.16 1.19 2.22 2.18 2.12 2.06 2.04 2.02 1.99 1.98 166.0 151.4 131.8 114.8 109.6 104.7 97.7 
1.22 1.31 1.35 1.4 1.45 1.51 1.56 1.65 1.96 1.94 1.87 1.82 1.77 1.72 1.67 1.605 95.5 91.2 87.1 74.1 66.1 58.9 52.5 
1.47 46.8 40.3 29.5 
B.tllaila11densis E260 0.6 0.93 1.02 1.1 1.15 1.31 1.65 2.22 2.12 2.06 2.02 1.99 1.87 1.47 166.0 131.8 114.8 104.7 97.7 74.1 29.5 
The molecular weight values calculated for the ECPs in the Western blot were then analysed 
for bands of similar molecular weight in the different isolates. As B.pseudomallei isolate 576 
had no ' LPS' like reaction, the bands were clearer and so the other isolates were compared 
against this (Table 3.5). 
Table 3.5 Isolates of B.pseudomallei and B.thailandensis that Share Common Protein Bands 
with B.pseudomallei Isolate 576 as Visualised by Western Blotting. 
B.pseudomallei B.tlwilandensis 
Protein 53 H706 448 217 E255 E260 
Bands of (Clinical) (Clinical) (Soil) (Soil) 
576 (kDa) 
125.9 * 
120.2 * 
] 14.8 * * * * * 
107.2 * * 
101.2 * * 
97.7 * * * 
95.5 * 
91.2 * * * * 
85.1 * • 
74.1 * * * * * * 
72.4 * 
66.1 * * 
63.1 * * 
57.5 * * 
50.7 * * * 
45.7 * * 
44.7 * 
41.7 
36.3 
33.1 * 
29.5 * * * 
24.0 * 
20.2 
*Asterisks denote identical molecular weight values. 
Table 3.5 reveals that there are a number of extracellular protein products common to both 
species. Those include proteins at a molecular weight of 114.8, 101.2, 97.7, 95.5, 91.2, 85.1 , 
74.1, 66.1, 57.5, 50.7, 45.7 and 29.5 kDa. 
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In addition to these, bands of 166.0, 151.4 and 131.8 kDa were visualised in B.pseudomallei 
isolate 53 and in B.thailandensis E255, and so too could be considered common to both 
species. Interestingly, all isolates tested contained a protein band of 74.1 kDa. Those protein 
products found only in B.thailandensis isolates were bands of 109.6, 104.7, 87.1, 58.9, 52.5, 
46.8 and 40.3 kDa. However, only five B.pseudomallei isolates were tested and so other 
isolates of B.pseudomallei not tested may contain these bands. Of the B.pseudomallei isolates, 
these were further divided into clinical and soil isolates, which revealed a number of bands 
found in clinical isolates, not found in those from the soil. These included bands at 125.9, 
120.2, 72.4, 44.7, 41.7, 36.3, 33.1, 24.0 and 20.2 kDa. It is possible that these may represent 
virulence factors elicited during the course of an infection. 
3.5 Microtitre Plate Assays. 
In each assay IJ.Ll of the concentrated ECP isolated was mixed with 2.5 Jll of the appropriate 
substrate in a microtitre plate well. Stock solutions of substrates (I mg/ml) were made in 
dimethyl formamide (DMF) and tests were carried out according to the manufacturers (Sigma) 
instructions. In each case, 21.5 f.ll of PBS was added to the ECP-substrate mixture and left at 
37°C for 1310 h. and. This was carried out, unless otherwise stated, with a panel of 4 
representative isolates which were as follows: B.pseudomallei 204, B.pseudomallei 576, 
B.pseudomallei 448 and B.thailandensis 82. The microtitre tests carried out and results can be 
found in Table 3.6. 
104 
0 
Vl 
Table 3.6 Microtitre Plate Assays to Test ECPs from Isolates of B.pseudomallei and B.thailandensis for Various Activities. 
SUBSTRATE ACTIVITY ISOLATES RESULTS 
TESTED B.pseudomal/ei 
Sheep red blood cells Haemolysis, 30 Ara· 6Ara+ -
p-nitrophenylphosphoryl-choline Phospholipase C 30 Ara· 6Ara+ + 
N-trinitrophenylphosphatidyl ethanolamine (chromogenic) Phospholipase A2 PANEL -
5-bromo-4-chloro-3-indolyl phosphate (chromogenic) Phosphatase PANEL -
(+ 576 only) 
AZO-COLL (chromo11.enic) General Protease PANEL + 
BANA (chromogenic) Trypsin PANEL -
BAPNA (chromogenic) Chymotrypsin PANEL -
AZO-CASEINE (chromogenic) Protease PANEL + 
AZO-ALBUM!N Protease PANEL + 
4-phenylazobenyloxycarbonyi-PRO-LEU-GL Y -PRO-ARG (chromogenic) Peptidase PANEL -
N-CB2-GLYGL Y-PRO-LEU-GL Y-PRO (chromogenic) Elastase PANEL -
N-CB2-PRO-ALA-GL Y -PR0-4-methoxy-~-naphthylamide (_chromogenic) Collagenase PANEL -
MU-acetyl-neuramide (fluorogenic) Neuraminidase PANEL -
MU-diacetyl-chitobioside Hexosaminidase PANEL + 
MU-N-acetyl-galactosaminidine (fluorogenic) Hexosaminidase PANEL + 
MUTMAC (fluorogenic) Chymotrypsin PANEL -
MU-N-acetyl-glucosaminidine (fluorogenic) Hexosaminidase PANEL + 
MU-mannopyranoside (fluorogenic) Mannosidase PANEL -
MU-guanidinobenzoate (fluorogenic) Trypsin PANEL -
MU-fucoside (fluor11.enic) Fucosidase PANEL -
N-t-Boc-LEU-GLY-ARG 7-amido 4 methyl coumarin (fluoro11.enic) C5 peptidase PANEL -
MU-oleate (fluorogenic) Lipase PANEL + 
RESULTS 
B.tllailandensis 
-
+ 
-
-
+ 
-
-
+ 
+ 
-
-
-
-
-
-
-
-
-
-
-
-
+ 
The results from the microtitre plate assays revealed that in the ECPs of B.pseudoma/lei and 
B.thailandensis there is phospholipase C activity, protease activity and lipase activity, which 
have all been previously described for B.pseudoma/lei but not confirmed in any isolates of 
B.thailandensis. No haemolytic activity, trypsin or chymotrypsin activity was found in either 
species. However, in only the B.pseudomallei isolates there was a hexosaminidase activity, 
which has previously been undescribed for the pathogen. Activity was found when screening 
with all of the following substrates: MU-diacetyl-chitobioside, MU-N-acetyl-
galactosaminidine and MU-N-acetyl-glucosaminidine. lt may be that B.pseudoma/lei possesses 
three separate enzymes or a single hexosaminidase enzyme responsible for the activities 
observed. 
3.6 DISCUSSION. 
The SDS-PAGE ECP profiles revealed that there were differences between the true 
B.pseudoma/lei isolates and isolates of the proposed species, B.thailandensis. However, there 
were also differences between isolates of the same species. In the case of the B.thailandensis 
isolates it may be possible that some of these may unknowingly be members of the very newly 
recognised species, B.uboniae (Yabuuchi et a/, 2000). The results of the immunoblotting 
highlighted some interesting findings. Firstly, in that the strains 576 and 217 had no ladder of 
what was considered to be LPS reacting with the convalescent human serum. Isolate 576 
reportedly has an atypical LPS pattern, shared with 5% of B.pseudomallei isolates (Dr. T. Pitt, 
personal communication). Therefore it is possible that the sera contained antibodies raised to 
the typical LPS, which is found in 95% of B.pseudomal/ei isolates and indeed B.thailandensis 
isolates. It was also observed that both species had the same ladder of LPS reaction, which is 
in keeping with the findings that LPS is immunologically indistinct from the two species 
(Anuntagool et al., 1998). 
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The results of the SOS-PAGE analysis and the Western blot revealed that of the isolates tested, 
the two species shared a number of common protein bands, although obviously it is possible 
that the two species may share protein bands of exact size but that they may not actually be 
related proteins. However, it may be relevant as many asymptomatic infections are believed to 
be due to B.thailandensis, which reacts similarly to B.pseudomallei in the older tests first 
developed for melioidosis, which have now been superseded by more discriminating tests 
(Pongsunk et al., 1999; Steinmetz et al., 1999). This is most likely due to LPS, but a false 
positive as a result of similar ECPs possessed by the two species cannot be ruled out. 
Additionally, there were differences observed between the clinical and environmental isolates 
of B.pseudomallei tested. It may be the case therefore that these differences represent virulence 
factors elicited on infection. Unfortunately, the reaction to LPS was so strong in some of the 
isolates that they could not be analysed between particular molecular weights, which may 
affect conclusions regarding the presence of certain bands in particular isolates, or between the 
species. This reaction however has shown the overwhelming response in infections to LPS and 
indicates the sheer mass of this material that must surround bacterial cells, which may be the 
reason that some samples were found to float out of the wells during SOS-PAGE. 
Comprehensive literature regarding such investigations is not available and so only tentative 
explanations regarding the likely character of these proteins can be attempted by analysing 
published literature. A phosphatidylcholine-hydrolysing phospholipase C (PC-PLC) has been 
characterised by Korbsrisate et al. ( 1999), which was revealed to be produced as a 73 kOa 
mature protein. lt was not established in which isolates of B.pseudomallei this was produced 
nor if the avirulant species, B.thailandensis also produced the PC-PLC. Results from the 
Western blot indicated that all isolates tested, including B.thailandensis, produced a protein at 
around 74.1 kDa. In addition to this, from the microtitre plate assays it was shown that all 
isolates of both species produced phopholipase C activity and so the 74.1 kOa band may 
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represent the PC-PLC, allowing for any error involved with manually calculating an 
approximate value for the molecular weight. In Listeria monocytogenes a similar 
phospholipase has been shown to be involved in intracellular survival and cell-to-cell spread 
(Korbsrisate et al., 1999), a factor perhaps common to both species of Burkholderia. 
Perhaps most importantly regarding potential extracellular virulence factors, it has been 
reported that B.pseudomallei produces a 36 kDa exotoxin (Nigg et al., 1955; lsmail et al., 
1991 ). Again, no extensive investigations have yet been carried out to establish which isolates 
produce the toxin or whether the newly defined species, B.thailandensis also produces this 
toxin. On analysing the protein bands on SOS-PAGE gels, many isolates produce a band 
around 36 kDa, including B.thailandensis isolates. However, on analysis of the Western blot it 
was only 576, a clinical B.pseudomallei isolate that contained a protein band of 36.3 kDa. 
Obviously it has not been proven that this band represents the toxin but it was the only band 
produced of such size and moreover, in a clinical isolate. As there was such a strong reaction 
to LPS in the clinical isolate 53 it was not possible to establish whether this too possessed a 
similarly sized band. 
Among other extracellular products that have been reported is a protease produced by 94% of 
clinical isolates tested by Gauthier et al. (2000) at a molecular weight of 42 kDa (Percheron et 
al., 1995). However, the report by Gauthier et al. (2000) did not state whether the protease was 
produced in environmental isolates or in isolates of B.thailandensis. Korbsrisate et al. ( 1999) 
similarly described the presence of a protease in isolates of B.pseudomallei but again did not 
mention if the protease was found in B.thailandensis isolates. SOS-PAGE profiles indicated 
that all of the B.thailandensis isolates tested and B.pseudomallei 53 produced a band of around 
42kDa, which may represent the protease described by Percheron et al. ( 1995). However, in 
the Western blot only B.pseudomallei 576 produced a band near to this value of42 kDa (41.7 
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kDa). The protease may be common to both species, as tests by Gauthier et al. (2000) showed 
the protease was not necessary for virulence. Indeed, the microtitre tests in 3.5 revealed that 
proteolytic activity was present in both B.pseudomallei and B.thailandensis isolates and so it is 
possible that both species may possess the same protease. Obviously further testing of 
B.thailandensis isolates for the protease is required to prove this. However the gene(s) 
encoding the protease have yet to be cloned and characterised in B.pseudomallei and so the 
protease may still represent a potential candidate for future gene cloning studies. 
The microtitre plate assays (3.5) revealed no haemolytic activity in any of the B.pseudomallei 
or B.thailandensis isolates. Ash down and Koehler (1990) found that of I 00 clinical isolates 
tested, 93 produced a haemolysin but they only found the activity around very heavy growth on 
saline-washed sheep erythrocyte brain heart infusion agar and failed to observe this around 
individual colonies or in broth culture filtrate. In current literature very little has been 
investigated concerning culture supematants and extracellular products but it must be stressed 
that different groups have all used different media to culture B.pseudomallei in such 
experiments. Both Heckly and Nigg ( 1958) and Coiling et al. ( 1958) when assaying for a toxic 
product used media containing 4% glycerin beef extract to enhance expression. Further studies 
are therefore needed assaying isolates on a range of media to test for enhanced expression of 
certain activities. 
Additionally, the microtitre plate assays revealed the presence of a potential hexosaminidase 
only in the B.pseudomallei isolates, which has not been described for this pathogen and 
therefore represents an ideal target for future cloning work with the pathogen. The microtitre 
tests also showed that activities already described for B.pseudoma/lei such as the 
phospholipase C, protease and lipase activities were also present in isolates of B.thailandensis 
and may not, therefore, have an essential role in virulence. 
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CHAPTER4 
CONSTRUCTION AND SCREENING OF B.pseudomallei 
GENOMIC LIBRARIES IN E.coli K12 HOST/VECTOR 
SYSTEMS. 
4.1 INTRODUCTION. 
Creating a genomic library enables the study of the complete genome of a bacterium, through 
fragmenting its DNA and randomly cloning the resulting fragments into a vector such as a 
plasmid, cosmid or a bacteriophage. The resulting pool of recombinant molecules is then 
introduced into a suitable bacterial host (usually E.co/i) and the mixture of recombinant 
bacterial colonies, or phage plaques obtained represent a genomic library or gene bank. This 
process is also referred to as shotgun cloning and in theory, given enough clones it is possible 
to find every gene possessed by the organism under investigation. 
In the case of this research, that is applying the techniques of molecular biology to the study of 
B.pseudomallei, the work progressed as in the manner of other studies with such pathogens, 
with the process of creating genomic libraries. This allowed random fragments of 
B.pseudomallei genomic DNA to be transferred into E.coli to facilitate the isolation and 
subsequent characterisation of genes encoding proteins of interest from B.pseudomallei. Thus 
enabling the identification of gene sequences and their products, with the potential aim of 
elucidating a role for them in the pathogenesis of melioidosis. 
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In order to create a genomic library the initial step is to fragment the genome of the bacterium 
to produce appropriately sized, random DNA fragments for subsequent ligation into the 
cloning vector of choice. The most suitable method for achieving this is by using restriction 
enzymes. It is possible to create a genomic library with a single restriction enzyme, such as 
EcoRI, with a six-base recognition site and so fragments will be on average several kilobases 
long. The disadvantage with the use of this is that there is the chance that a gene of interest 
may well have a recognition site within it and so will not be cloned intact. Or conversely, it 
could be surrounded by a region of DNA containing no EcoRI sites and so the resulting 
fragment will be so large that it will be cloned with a reduced efficiency in certain vectors, 
notably plasmids. However by using an enzyme with a four-base recognition site, such as 
Sau3A, the randomness of the library can be improved. This can be achieved by partial 
digestion of the genomic DNA with the enzyme, because allowing complete digestion of the 
DNA will yield fragments too small to be of use, but a partial digest will yield fragments of 
differing sizes. Thus, if a gene of interest is cut in one fragment the chance is that there will be 
several others where it is intact. The disadvantage to using such a frequently cutting enzyme is 
that multiple inserts could be cloned due to the re-ligation of fragments, which although may 
not prevent detection of a specific DNA sequence, may cause considerable confusion when 
characterising the cloned fragment and its relationship to adjacent regions of the bacterial 
DNA. Alternatively, to generate a completely random library it is possible to subject the 
genomic DNA to mechanical shearing such as sonication. However, this will generate 
fragments of which there is no knowledge of their termini, which may well prove incompatible 
to those on the cloning vector. 
The choice of vector for use in a genomic library is based on the construction of a conveniently 
sized library so that only a relatively small number of individual recombinant bacterial or 
phage clones need to be screened to ensure a high probability of obtaining the gene sequence 
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of interest. Additionally, individual vectors have a specific capacity for foreign DNA inserts 
and as the genome its_elf is of a finite size it is often useful to have some idea of the number of 
independent recombinant clones that are required in the library for screening purposes. This is 
so that the number of clones used is representative of the genome so to be reasonably confident 
of finding the gene of interest. This can be calculated by the following formula devised by 
Clarke and Carbon ( 1976): 
where: 
N = log Cl - P) 
log (I - x/y) 
N =the number of clones needed; P =the probability of a specific gene being present; x =the 
size of the foreign DNA insert (bp) and y =the size of the genome (haploid) in bp. 
Thus, for example, for a genomic library of E.coli (4 x 106 bp) ifthe average insert size was 4 
kbp the number of clones needed for a 99% probability (P = 0.99) is about 4600, but if inserts 
are larger, a smaller number of corresponding clones are needed. However, this figure assumes_ 
a random distribution of clones with no sequences being under or over-represented and so was 
used only as a token guide to the minimum number of bacterial colonies or phage plaques to 
be screened. Thus, in practice far more recombinants were screened than the equation 
predicted necessary. 
The genomic library constructed can be screened immediately (an unamplified genomic 
library) by using selective media or overlays or by transferring the colonies or plaques to a 
membrane such as nylon or nitrocellulose that can be tested for the presence of the gene of 
interest. Positive clones can then be picked, purified, checked and confirmed. Alternatively, 
clones can be harvested and stored as a mixture for future plating out and screening; this 
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constitutes an amplified genomic library. There are three main ways of screening genomic 
libraries which make use of two detectable and unique properties of the clone of interest, one 
being the nucleotide sequence of the foreign DNA and the other any product of expression of 
the cloned gene. The former is through the use of gene probes and the latter is through 
immunological or enzymatic activity, respectively. 
In order to generate a gene probe, some information regarding the likely sequence of the gene 
in question is required. If the corresponding gene from a closely related organism has already 
been cloned, it is possible to use the sequence information available from various databases, 
particularly if the organisms are very closely related, because the likelihood is that the 
sequence homology will be high. Alternatively, if the protein product of the gene has been 
purified, then determination ·of a short region of the amino acid sequence at the amino-
terminus (N-terminus) allows prediction of the DNA sequence of the corresponding portion of 
the gene, although there will be some mis-match owing to the degeneracy of the universal code 
(Grange et al., 1991 ). Probes can then be generated through a PCR reaction or a custom-made 
oligonucleotide and either radiolabelled or labelled with a non-radioactive chromogenic 
system, such as DIG. 
An alternative to the use of gene probes is the use of indirect methods of screening that are 
based on the selection of a given phenotype. In the case of this study there were no available 
probes for the direct screening of recombinants. Thus, indirect methods of screening were 
utilised whereby the target gene product is in fact an enzyme whose activity can be detected, or 
a protein that can be detected immunologically. With both of these procedures the gene of 
interest must be expressed, or at least that part containing the epitope to be detected, and so 
this too has an important influence over the choice of vector. A gene may not be transcribed in 
a foreign host, or the gene product may be degraded, especially if only one part of the protein 
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is produced. This is why expression vectors such as pUC I 8 and A.GTI I are used but the 
resulting product may still be subject to proteolytic degradation. This chapter describes the 
construction of gene libraries in plasmid, cosmid and bacteriophage cloning vectors and their 
subsequent screening with both enzymatic and immunological detection methods for the 
expression of haemolytic or proteolytic activity, or the expression of B.pseudomallei antigens 
recognised by polyclonal rabbit antiserum raised against whole cells and formalised cells of 
the bacterium. 
4.2 SOURCE OF B.pseudomallei DNA AND ANTISERUM. 
The B.pseudomallei DNA used in constructing all of the genomic libraries prepared in this 
study was kindly donated by Dr. R.Titball, DERA, Porton Down. The DNA had been prepared 
by a cell lysis procedure, followed by purification with repeated phenol extractions. The DNA 
used was obtained from isolates 204 and 576 (Table 2.1 ). These isolates were used, as they 
were representative examples of each of the two LPS profiles found in this bacterium. 
Antiserum used in screening gene libraries was kindly donated by Dr. T Pitt, CPHL, Colindale, 
London, which was generated in rabbits against two isolates of B.pseudomallei, 204 heat-
killed whole cells and 576 formalised cells. 
4.3 ATTEMPTS TO CONSTRUCT B.pseudomallei GENOMIC 
LIBRARIES IN PLASMID AND COSMID VECTORS. 
As B.pseudomallei probably has a number of genes encoding toxic products, a range of 
plasmids were used to attempt the construction of genomic libraries, those being the high copy 
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number expression plasmid, pUC18, the low copy number expression plasmid pGD103 and a 
medium copy number plasmid, pBR328. Genomic libraries using pUCI8 were attempted with 
576 B.pseudoma/lei DNA digested with EcoRV, Hpal and Seal. With the cloning vector, 
pGDI03 a genomic library was attempted using 204 B.pseudomallei DNA digested with 
Sau3A and with pBR328 attempts were made with both 204 and 576 B.pseudomallei DNA 
with the following enzymes: BamHl, EcoRl and EcoRV. Ligation reactions were often 
unsuccessful and the number of recombinants obtained when successful genomic libraries 
were transformed was not of a number high enough to represent the entire genome of 
B.pseudomallei. Hence none of these gene banks was used for screening. 
A cosmid genomic library was attempted using pHC79 ligated to Sau3A digested 
B.pseudomallei 204 genomic DNA. However, this too was unsuccessful. 
4.4 CONSTRUCTION OF A B.pseudomallei GENOMIC LIBRARY IN A 
BACTERIOPHAGE LAMBDA VECTOR. 
4.4.1 Bacteriophage A.GTll. 
The bacteriophage cloning vector, A.GTll (Fig.4.1) is a A.-derived insertional vector that is 
capable of cloning foreign DNA of up to 7.2 kbp into a unique EcoRl site within a lacZ gene. 
As the insertion site for foreign DNA is within the j3-galactosidase gene, under appropriate 
conditions, the foreign DNA is expressed as part of a fusion protein with [3-galactosidase. 
However, as it makes use of an inducible promoter, expression of a fusion protein will only 
occur if an inducing agent is added, such as IPTG. Without the addition of an inducing agent 
host cells produce large quantities of lac operon repressor (encoded by the lacl gene) which 
functions to prevent P-/acZ-directed expression of a fusion protein during the initial hours of 
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plaque formation, which is advantageous if the foreign protein is toxic to the host cells, as 
insufficient amounts of the antigen will be produced for detection. IPTG functions to 
inactivate the lacl repressor protein hence /acZ-directed expression occurs. Additionally, a Ion· 
strain is used as a host to increase the stability of foreign proteins that may be expressed 
because E. coli produce Ion protease as one of a number of proteases responsible for lowering 
the stability of foreign or abnormal proteins that are not normally produced in the cell. Foreign 
protein may also be expressed without being fused to J3-galactosidase as a result of 
transcription and translation of the foreign DNA sequence by means of promoter regions 
within the DNA insert (lac independent) or alternatively the expression may be as a result of 
the lacZ promoter (lac dependent). It is also possible to use antibodies as probes to screen the 
genomic library constructed in A.GTII for recombinants producing proteins that may be of 
interest. The phage vector produces a temperature-sensitive repressor (cl857), which is 
activated at 42°C and carries an amber mutation (SI 00) that renders it lysis-defective in hosts 
lacking the amber repressor (supF) (Huynh et al., 1985). 
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BamHI Kpnl EcoRI Sacl Xbal BamHl Xhol BamHl HindiTl Hindlll 
I I I I I I 11 l /acZ cl857 SI 00 43.7 kbp 
3' ... CTI AAG GCG ... 5' 
A.GTll 43.7 kbp (Huynh et al., 1985) 
Figure 4.1 Bacteriophage cloning vector A.GTll. 
Restriction enzyme cleavage sites are shown, including the unique EcoRI site for the insertion of foreign DNA into the lacZ gene for the 
expression of foreign DNA as fusion proteins. Also shown is the cl857 temperature-sensitive repressor region and the SI 00 amber 
mutation. 
4.4.2 Construction of a /..GT11/B.pseudomallei!EcoRI Genomic Library. 
Approximately 2 jlg of B.pseudomal/ei 204 genomic DNA was digested with the restriction 
enzyme, EcoRl (2.5.4) and afterwards a sample of the digest was checked on a 0.8% agarose 
gel (2.4.5) to ensure complete digestion had occurred. EcoRI-cleaved A.GTII was obtained in 
the form of alkaline phosphatase phosphorylated vector arms (Stratagene, La Jolla, CA., 
USA). A ligation reaction (2.5.6) was set up using the vector arms obtained and the 
B.pseudomallei 204 EcoRI-cleaved genomic DNA and incubated at I5°C for 18 h. and stored 
at 4°C. A sample of the ligation reaction was checked on an agarose gel to confirm successful 
ligation. Ligated DNA was packaged using a commercial In Vitro packaging kit (Boheringer 
Manneheim). A ten-fold dilution series of the packaged bacteriophage particles was made in 
SM buffer and samples were plated with the E. coli host strain, Y I 088 in an overlay on 
NZCYM plates. The resulting phage, which represented a B.pseudomallei//..GTll genomic 
library were recovered from the soft agar overlay (as in 2.3.2.2), treated with a drop of 
chloroform and titrated (2.3.1) using NZCYM plates containing X-gal and IPTG to ascertain 
the number of recombinant phage. The number of non-recombinants was calculated, appearing 
as blue plaques, and the recombinant frequency was calculated as being approximately 99%. 
The genomic library was stored at 4°C until needed. 
4.5 IMMUNOLOGICAL SCREENING OF A t..GT111B.pseudomallei!EcoRI 
GENE LIBRARY. 
The B.pseudomallei gene library constructed in the /..GTJI expression vector (4.4.2) was 
screened immunologically as recombinant phage plaques on a lawn of E. coli K 12 host 
bacteria. Proteins released by the lysis of the cells within the plaques were immobilised on 
nitrocellulose membranes placed over the lawn. Protein bound to the nitrocellulose was 
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screened with the two different types of antisera donated (4.2). Antisera was preadsorbed 
overnight with Acetone powders (made by Dr. A. Evenden) to pre-adsorb any anti-E.coli 
antibodies that may have been present in the antiserum. The genomic library was plated out so 
that it gave rise to the formation of approximately I 000 plaques per plate. The actual number 
of individual plaques needed to constitute a A.GTIIIB.pseudomallei/EcoRI genomic library 
was estimated by using the formula described in 4.1, using a probability value of 0.99 and 
taking an average insert size of 4 kbp and the size of the B.pseudomallei genome as 6.54 x I 06 
bp (Songsivilai and Dharakul, 2000), which gave a number of phage particles to be screened as 
7527. However, the actual number of phage particles screened was far higher and of the order 
of 20,000 plaques. The A.GTII genomic library was plated out onto NZCYM plates, 
supplemented with 0.2% lactose, with an overnight culture of E. coli Y I 090. Once the plates 
were set they were incubated, inverted at 37°C for 18 h. After incubation, plates were 
overlayed with gridded, 82mm nitrocellulose filters (BA 85/23 Schleicher and Schuell, Dassel, 
Germany). The nitrocellulose filters were numbered and marked with a ball-point pen in the 
centre with a cross and a line was marked at the centre of the top of the grid vertically down to 
indicate the top of the nitrocellulose and smaller lines were marked at the centre of the other 
three outer edges. The nitrocellulose was then transferred, wearing surgical gloves and using 
forceps so as not to contaminate the plates, gridded side down, onto the plates. This was done 
carefully and the filter was folded slightly so that the middle of the filter touched the plate first 
so as not to introduce any air bubbles. The bottom of the petri dish was marked in the same 
fashion as the filter so that the orientation of the filter and plate could be easily aligned after 
screening. The filters were left to absorb for 30 min. at 37°C before carefully removing with 
forceps and washed for 5 min. in a 50 ml volume of PBS with gentle agitation before 
removing the PBS and replacing it with 200 ml of PBS containing 1% (w/v) casein as a 
membrane-blocking reagent. Blocking was carried with gentle agitation for I h. after which the 
blocking reagent was replaced, and primary antibody was added at a concentration of I :200 
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and incubated for 90 min. at room temperature. The filters were then washed with 200 ml of 
PBS for 5 min. at room temperature for a total of three washes. Next, 200 ml of blocking 
solution was added and to this the secondary antibody, swine anti-rabbit immunoglobulins 
(P217, Dako Ltd., High Wycombe, UK) at a concentration of I :500. Filters were left 
incubating with the secondary antibody for 90 min. followed by three washes with 200 ml of 
PBS for 5 min. at room temperature. After washing, antibody binding was visualised using 
DAB/NiCb colour development. The A.GTll/B.pseudomallei/EcoRl genomic library was 
screened in this manner on four occasions, twice where the primary antibody was rabbit 
antisera raised against B.pseudomallei 204 heat-killed whole cells and twice against rabbit 
antisera raised against B.pseudomallei 576 formalised cells. Therefore, of 80 filters each 
containing approximately 1000 plaques, two were found to contain one immunopositive 
plaque each, of which an example can be seen in Fig. 4.2, both of which were the result of 
screening with antisera to 576 formalised cells. Both immunopositives were identified as a 
"halo" of colour that developed around the plaque. 
4.6 PURIFICATION OF AN IMMUNOPOSITIVE RECOMBINANT 
A.GTll BACTERIOPHAGE. 
The immunopositive plaques, designated A.BPGTI and A.BPGT2 were identified on their 
respective plates using the grids on the filters and picked with a sterile Pasteur pipette (as in 
2.3.2.1) along with several negative plaques. A wire loopful of the resulting phage suspensions 
were streaked out onto NZCY M plates and overlayed with soft agar continuing Y I 090 host 
cells, supplemented with 0.2% lactose and incubated at 37°C for 18 h. Afterwards, areas with 
well separated plaques were overlayed with nitrocellulose, including several negative controls 
and subsequently probed with antiserum as before (4.5). The recombinant phage, A.BPGTI 
remained immunopositive and was retained for further analysis, whereas A.BPGT2 did not. 
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lmmunopositive plaque 
Fig.4.2. Nitrocellulose Filter Containing an Immunopositive Plaque-Lift from a 
'J...GTll/B.pseudomallei/EcoRI. Genomic Library. The immunopositive plaque is arrowed 
and appears as a "halo" of colour around the plaque. The filter shown was probed with rabbit 
anti-B.pseudomallei 576 formalised cell serum as the primary antibody using the method in 
4.5. 
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4.7 SCREENING OF A A.GTiliB.pseudomallei/EcoRT GENOMIC 
LIBRARY. 
In addition to the immunological screening of the A.GTII library, the library was also screened 
for enzymatic activity in a number of ways. As previously calculated (4.5), around 7527 
plaques were required to screen the entire A.GTII genomic library and around 10,000 
recombinant plaques were screened for each substrate used. Recombinant phage plates were 
set up as in 4.5. 
4.7.1 Screening of a A.GTIIIB.pseudomallei/EcoRJ Genomic Library for Haemolytic 
Activity. 
While ECPs of B.pseudomallei showed no detectable haemolytic activity (3.5), blood agar 
plates of the bacterium did show some haemolysis and so recombinants were screened with 
blood for this reason. Plates of recombinant A.GTII plaques and a control were screened for 
haemolytic activity using an erythrocyte/agarose overlay. This was essentially a modification 
of Kehoe et al. ( 1983) where erythrocyte/agarose overlays were used to detect genes coding for 
the a-haemolysin from Saureus in "-47.1. The genomic library was screened using sheep 
erythrocytes, carried out as follows. A 5 ml volume of overlay which consisted of I 0% sheep 
erythrocytes suspended in a PBS/agarose (45°C) was carefully poured onto the recombinant 
A.GT 11 plaques and allowed to set. The overlayed plates were then incubated either at room 
temperature for 24h., or at 37"C for 4 h. and then placed room temperature. Recombinants 
were analysed for any exhibiting zones of haemolytic activity around the plaques. However, no 
zones of haemolytic activity were observed in any of the overlayed plates. 
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4.7.2 Screening of a f...GTll!B.pseudomallei/EcoRl Genomic Library for Proteolytic 
Activity. 
The recombinant f...GT 11 phage plaques were also screened for the presence of proteolytic 
activity. Plates were screened along with vector phage controls and each plate was overlayed 
with molten agarose/PBS containing a protease substrate, allowed to set and incubated for 24h. 
prior to examination. 
4.7.2.1 Natural Protease Substrates. 
Recombinant f...GTII clones were screened with two natural protease substrates, casein and 
gelatin. Both substrates were incorporated into 5 ml of agarose/PBS overlay solution at a 
concentration of I% (w/v), overlayed onto the phage-containing plates and incubated at either 
room temperature or 37°C. Plates containing casein as a substrate were examined by flooding 
the surface with 3% (v/v) acetic acid solution, whilst gelatin-containing plates were flooded 
with 5% (w/v) tannic acid solution. Both acetic acid and tannic acid function to precipitate the 
protein substrate so that any clones producing a proteolytic activity may be identified by a zone 
of proteolysis. No proteolytic activity was detected in the overlayed plates. 
4.7.2.2 Synthetic Protease Substrates. 
Recombinant f...GTII clones were also screened with synthetic protease substrates, which 
included chromogenic azocollagen (azocoll), Na-benzoyi-DL-arginine-p-nitroamide (BAPNA) 
and Na-benzoyi-DL-arginine 13-napthylamide (BANA) and fluorogenic 4-methylumbelliferyl 
p-guanidinobenzoate (MUGB). The library and controls were overlayed with 5 ml of 
agarose/PBS solution containing 0.5% (w/v) azocoll and 0.1% (w/v) BAPNA, BANA and 
MUGS. All followed incubation either at room temperature or 37°C. Plates containing the 
azocoll overlay were examined for the release of red/purple chromagen in areas of proteolysis 
and those containing BAPNA and BANA were examined for an orange-red colour. Plates 
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containing the tluorogenic substrate (MUGB) were examined under UV light for a blue-white 
fluorescence. However, no proteolytic activity was observed. 
4.7.3 Other Substrates. 
Recombinant A.GTII plaques were also screened with MU-N-acetyl-glucosaminidine a 
tluorogenic substrate to screen clones for any producing hexosaminidase activity. Microtitre 
plate testing revealed that all isolates of B.pseudomallei tested had a hexosaminidase activity 
(3.5). However, no clones with hexosaminidase activity were observed. 
4.8 DISCUSSION. 
Attempts to create plasmid genomic libraries were unsuccessful; mainly due to problems in 
ligating B.pseudomallei DNA with plasmid vector DNA, hence not producing sufficient clones 
when transformed to warrant screening. That is, enough to represent the entire genome of 
B.pseudomallei. The B.pseudomal/ei DNA used in the attempts to create plasmid genomic 
libraries was donated, and the case would seem that this DNA was not of a quality for 
successful ligation. It was suspected that the B.pseudomallei genomic DNA was contaminated 
with a fair amount of complex carbohydrates not removed during the cell lysis procedure. 
Moreover, as the DNA was purified with phenol extractions, which functions to dissociate 
DNA from protein, the contaminating carbohydrate would still be present. Additionally, only 
small quantities of B.pseudomallei DNA were received and so it was not feasible to further 
purifY the DNA, for example thorough a CsCI/EtBr density ultracentrifugation procedure. 
Only one of the B.pseudomallei genomic libraries created was successful, that being the 
A.GTll/B.pseudomallei/EcoRl genomic library. However, the screening procedures then used 
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with this genomic library yielded little in the way of results, and only two immunopositive 
clones were identified using rabbit antiserum to B.pseudomallei 576 formalised cells and only 
one of these retained its immunopositivity. In retrospect, it was perhaps not surprising that 
antiserum to whole cells yielded no positives when considering the previous chapter's results 
when ECPs isolated from B.pseudomallei isolates were immunoblotted using convalescent 
human sera (3.4); as the main immune response was to LPS. Therefore, the antiserum to whole 
cells and probably that to formalised cells as well, was likely to be mainly against LPS. 
Additionally, when generating antiserum to both whole cells and formalised cells it was likely 
that many of the ECPs were lost in a washing procedure and so there would therefore be little 
in the way of results. 
In addition to this, the general lack of success of screening was probably due to a number of 
other factors that influence the outcome of any gene screening procedure. Firstly, those 
resulting from the construction of the genomic library; secondly, inadequacies in the screening 
procedure itself and thirdly, and probably most fundamentally with respect to the present 
study, is the expression of the gene sequences contained in the genomic library. lt was 
unlikely, with respect to the A.GTII genomic library, to be a result of a deficiency in the 
construction of the gene bank. Each stage of its construction was carefully monitored and the 
proportion of recombinants was calculated at being 99%, hence the library being composed of 
a high proportion of vector-only ligations was not the case. In addition, each screening 
procedure involved considerably more recombinants than the number predicted by Clarke's 
formula. 
The screening procedures employed were based on published reports that the bacterium had 
haemolytic activity and although no activity was observed with the ECPs in this study, blood 
agar plates of the bacterium did yield some haemolysis. Also, that B.pseudomal/ei produces 
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proteolytic activity, although the exact nature of the protease has yet to be elucidated and so a 
range of proteolytic substrates were used for screening. Microtitre plate assays of ECPs from 
B.pseudomallei isolates also revealed a hexosaminidase activity (3.5) but screening the A.GTII 
genomic library with one of the substrates used to detect hexosaminidase activity yielded 
nothing. Two temperature ranges were also employed in screening as some components may 
only be expressed at specific temperatures, for example on entering the human body, at 37°C, 
but neither revealed any results. 
The construction of the A.GTll/B.pseudomallei/EcoRl gene library was a fairly straightforward 
process, however the successful expression of the sequences cloned is a somewhat more 
difficult procedure. Although steps were taken to encourage expression by using the 
expression vector A.GT 11 and inducing the fusion of 13-galactosidase with any foreign proteins 
in frame by the addition of an inducing agent, the lack of expression of B.pseudomallei genes 
in the E. coli K 12 host/vector system was probably one of the biggest problems, in addition to 
the antisera, which led to the lack of success experienced in screening the library. There was 
limited published information on cloning B.pseudomallei DNA into E. coli K 12 host/vector 
systems and so it was not known how successful the expression of B.pseudomallei genes in 
these systems would be, although it was assumed that considering such a large number of 
genes from a wide range of bacterial taxa have been successfully cloned and expressed in these 
systems that it would be possible to do the same with B.pseudomallei. However, although 
B.pseudomallei is a gram-negative bacterium it is still possible that incompatibilities between 
the machinery of gene expression exist, despite the fact that steps were taken by using a 
cloning vector where lac-gene fusions could occur. 
The immunopositive clones were identified as a "halo" of colour that formed around the 
plaques. This was unusual in that most immunopositives screened in this way are identified as 
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a complete colour development over the entire plaque. It was not known what exactly this 
represented, but it could be as a result of a breakdown of the protein responsible for the 
immunopositivity, or perhaps representative of export of the protein or it may represen-t the 
relative solubility of the protein. As this was the only positive result from the construction and 
screening of the genomic libraries and the fact it was continually and strongly immunopositive 
compared to negative controls, and of the interesting nature of the colour development, it was 
decided to pursue this clone. 
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CHAPTERS 
MANIPULATION AND STRUCTURAL ANALYSIS OF THE 
IMMUNOPOSTIVE CLONE A.BPGTl. 
5.1 INTRODUCTION. 
Once a clone exhibiting a desired genetic property is selected from a genomic library, analysis 
can begin on the recombinant. In the case of the immunopositive clone, A.BPGTI obtained 
(Chapter 4), attempts to determine the size and level of expression of the immunoreactive 
antigen(s) was investigated without any knowledge of the function of the genes responsible. 
This may be achieved most simply on an SOS-PAGE gel, by comparing the protein profiles of 
the immunopositive against a negative control in order to identiry the synthesis of any novel 
proteins in cells carrying the recombinant molecules. However, normal E.coli proteins may 
mask the detection of recombinant gene products, in which case Western blotting may be 
applied. Other methods exist which allow the detection of novel proteins without the often 
confusing concurrent expression of the host genome, of which there are three main methods, 
two of which are in vivo: 
I. Minicells for the expression of plasmid-borne genes (Frazer and Curtiss, 1975), 
2. Maxicells also applicable to genes cloned in A. vectors (Sancar et al., 1979; Newman et al., 
1979), and 
3. In vitro transcription and translation systems. 
Bacterial cell-free systems for coupled transcription and translation of in vitro genes contained 
on bacterial plasmids or bacteriophage genomes are available commercially and rely on the 
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presence of all the biochemical components of protein synthesis extracted from certain cell 
types, but without a functional genome. These systems have advantages over the in-vivo 
methods with respect to their sensitivity, as they allow higher expression levels of proteins that 
are normally expressed at low levels in vivo due to the action of host-encoded repressors. An 
additional advantage is that results can be visualised after just a few hours. The system used in 
this project to attempt to detect proteins expressed in the immunopositive clone not present in 
E.coli controls was the E.coli S30 Extract System for Circular DNA that incorporates the 
Transcend™ Non-Radioactive Translation Detection System (Promega). This particular 
system allows the non-radioactive detection of proteins synthesised in vitro, as biotinylated 
lysine residues are incorporated into nascent proteins during translation, thus eliminating the 
need for labelling with e5S] methionine. The biotinylated lysine is added to the translation 
reaction as a precharged E-labelled biotinylated lysine-tRNA complex rather than a free amino 
acid. After subjecting the reaction products to SDS-PAGE and electroblotting, the biotinylated 
proteins can be visualised by binding Streptavidin-Aikaline Phosphatase (AP) or Steptavidin-
Horse Radish Peroxidase (HRP), followed by either colorimetric or chemiluminescent 
detection. Typically, 0.5 to 5 ng of protein can be detected within 3 to 4 hours after gel 
electrophoresis and so the sensitivity of this non-radioactive detection system is equivalent to 
that achieved with e5s] methionine incorporation and autoradiographic detection, 6 to 12 
hours after gel electrophoresis. The system thus confers the advantage of not only eliminating 
the need for radioisotope handling, storage and disposal but also that the biotin tag is stable for 
12 months unlike 35S-Iabelled proteins, whose label decays over time. 
Once the gene product of interest has been detected, the characterisation process can begin. To 
aid characterisation of a DNA sequence it is often necessary to subclone the fragment into a 
more appropriate vector, for example from a f... vector to a plasmid, so that restriction mapping 
can be facilitated. Restriction mapping itself is usually one of the first steps in the 
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characterisation of a cloned DNA fragment and is a prerequisite for planning a sequencing 
strategy and selecting appropriate fragments for further subcloning. Restriction maps 
themselves can be determined either directly using partial digestion techniques, or by indirect 
approaches such as those based on the analysis of fragments created by single and double 
digests with a set of restriction enzymes (Brown, 1993). The latter, indirect method eventually 
arrives at a map compatible with the measured fragment sizes by a process of exclusion, which 
is relatively straightforward, providing the number of sites for each enzyme is small. To start 
the map, the DNA is digested with a series of single restriction enzymes and the fragments 
produced are analysed by agarose gel electrophoresis, and their sizes estimated against a ladder 
of known molecular weights. Once achieved, commonly the DNA is then digested with 
combinations of restriction enzymes whose single profiles have been characterised and the 
results are used to create a restriction map. 
5.2 ATTEMPTS TO DETECT IMMUNOREACTIVE ANTIGENS IN 
A.BPGTl. 
The initial stage in the characterisation of the immunopositive clone involved the detection of 
the antigen(s) responsible for the immunogenicity of the clone, A.BPGTI. To aid the detection 
of the unknown antigen(s), negative controls of Y I 088 cells infected with A.GTII phage were 
used. 
5.2.1 Preparation of a Concentrated Lysate of A.BPGTl. 
Phage lysate stocks of A.BPGTI and two negative controls were made from plates 
supplemented with 0.2% (w/v) lactose that exhibited confluent lysis (2.3.2.2). The resulting 
stock of phage was titrated (2.3.1) and stored at 4°C until use. 
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5.2.2 SOS-PAGE and Western Blotting of A.BPGTI. 
The concentrated phage lysates (5.2.1) were subjected to SOS-PAGE analysis (2.6.1) and a 
Western blotting procedure (2.6.2) using antisera to B.pseudomallei 576 formalised cells. No 
difference was observed in the protein profiles between the immunopositive and the negative 
controls in either technique. 
5.3 SUB-CLONING OF A.BPGTl INTO A PLASMID VECTOR. 
1t was decided to isolate the DNA insert contained within A.BPGTI to ascertain its size and to 
subclone the fragment into a plasmid vector to aid manipulation and further analysis of the 
clone. 
5.3.1 Isolation ofA.BPGT I DNA. 
A high titre stock of the recombinant phage, A.BPGTI was obtained from liqiud cultures 
(2.3.2.3). The recombinant phage DNA was extracted with Formamide (2.3.3) and a sample 
checked on an agarose gel. 
5.3.2 Determination ofthe Insert Size for A.BPGTI. 
There exists one EcoR I cleavage site in A.GT I I, which was used to create the 
A.GTIIIB.pseudomallei!EcoRI genomic library (4.4.2) hence digesting the DNA of 
recombinants with EcoRI releases the foreign fragment. Approximately 0.5 11g of A.BPGTI 
DNA was used in a restriction enzyme digest (2.5.4) with EcoRI and the products were 
visualised on agarose gel electrophoresis (Fig 5.1 ), which shows clearly an insert of 
approximately 5 kbp. 
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5.3.3 Subcloning the 5 kbp Fragment into the Plasmid Vector, pUC18. 
5.3.3.1 The Plasmid Vector, pUC18. 
The plasmid vector, pUC 18 (Appendix 11) is a small vector of 2. 7 kbp, carrying the selectable 
phenotype of resistance to ampicillin. The vector also contains the lacZa region of E.coli, 
which renders recombinants lac·, facilitating their selection via lac gene complementation 
(blue-white screening) in E.co/i hosts deleted for lacZa. Additionally, due to the strong 
inducible lac promoter, coupled with a potentially high copy number of up to 700 plasmids per 
cell, cloning into pUC 18 facilitates the increased production of any foreign proteins. 
5.3.3.2 The Subcloning Procedure. 
Approximately I J.lg of A.BPGTI DNA and 2 J.lg of pUC 18 DNA were digested with EcoRl. 
Products of digestion were checked on an agarose gel and the digested A.BPGT I DNA was 
purified by extraction with phenol (2.4.3.2). Linearised pUC 18 DNA was treated with alkaline 
phosphatase (2.5.5) before purification by phenol extraction. A standard ligation reaction was 
set up (2.5.6) and incubated at I5°C for 18 h. Ligation products were checked on an agarose 
gel before carrying out a transformation using DH5a competent cells (2.5.3.2). The 
transformation mix was plated out onto LB media supplemented with ampicillin and an 
overlay of X-gal and IPTG facilitating blue/white screening (2.5.2). Plates were incubated at 
37°C for 18 h. A number of resulting white colonies were cultured in I 0 ml of LB broth 
supplemented with ampicillin and incubated at 37°C for 18 h. with shaking. Small-scale 
plasmid extractions (2.4.2.1) were performed on six subclones (pBPGT 1-6). Plasmid DNA 
isolated was digested with EcoRl and subjected to agarose gel electrophoresis to check for the 
presence of an appropriately sized DNA insert (Fig.5.2). All recombinant plasmids pBPGTI-6 
contained an insert of approximately 5kbp. 
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5.4 COLONY BLOTS. 
Subclones pBPGT2, 3, 4, and 6 grew successfully on LB media supplemented with ampicillin 
and 0.2% lactose and were used in a colony blot to determine whether they were 
immunopositive. Nitrocellulose filters were layered over well-spaced recombinant colonies 
and a comparative control of DH5a recently transformed with pUC 18. Filters were left on the 
plates for 2 min. before carefully removing with forceps and placing onto filter paper saturated 
with 0.1% SDS for 15 min. to lyse the bacterial cells. Afterwards, the filters were suspended in 
a tank filled with chloroform for 20 min. before placing into Blocking Solution for 18 h. 
Screening and developing after this time was carried out using the same procedure used to 
screen the A.GT 11 I B.pseudomallei/ EcoRI genomic library ( 4.5), with the exception that the 
primary antibody was used at a concentration of I: I 00. The subclones did develop earlier and 
slightly darker than the control, especially pBPGT2 which was chosen for further analysis but 
the recombinants did not develop the "halo" effect as observed with the immunopositive phage 
clone, A.BPGTI. However, after 20 min. of developing time, there was little difference 
between the recombinants and the control. 
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1 2 3 4 
12 kbp ..... 
3 kbp ..... 
1.6 kbp ..... 
Fig.S.l Agarose Gel Electrophoresis of EcoRI and BamHl Cleaved DNA from a 
t..GTll/B.pseudomallei/EcoRI Immunopositive Clone, A.BPGTJ. LANE I : I kpb ladders 
(from top to bottom) 12 kbp, 11 kbp, I 0 kbp, 9 kbp, 8 kbp, 7 kbp, 6 kbp, 5 kbp, 4 kbp, 3 kbp, 2 
kbp and 1.6 kbp. LANE 2: t..BPGTI/EcoRl DNA. LANE 3: A.BPGTl /BamHI DNA. 
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3 kbp 
1.6 kbp 
1 kbp 
1 2 3 4 5 6 7 8 9 10 11 
Fig.5.2 Agarose Gel Electrophoresis of Recombinant Plasmid Subclooes (pBPGTl-6) 
Digested with EcoRI. LANE 1: I kbp ladders. LANE 2: pUCI8/EcoRI. LANE 3: pBPGT2. 
LANE 4: pBPGT2/EcoRJ. LANE 5: pBPGT3. LANE 6: pBPGT3/EcoRJ. LANE 7: 
pBPGT4/EcoRl. LANE 8: pBPGT5/EcoRI. LANE 9: pBPGT6. LANE 10: pBPGT6/EcoRI. 
LANE 11 : I kbp ladders. 
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5.5 RESTRICTION ENZYME MAPPING OF pBPGT2. 
5.5.1 Single Restriction Enzyme Digests. 
Single restriction enzyme digests were set up with approximately 0.5 J.lg of pBPGT2 DNA to 
determine if there were any sites for these enzymes on the cloned insert and their relative value 
for use in double enzyme digests. Restriction enzymes chosen were those known to cleave the 
vector once or twice or not at all. The results of which were analysed on agarose gel 
electrophoresis (Fig.5.3) and the resulting fragment sizes were assessed by comparison to I 
kbp ladders. Cleavage with £coR V and Xhol, for example, produced two fragments and these 
enzymes are known not to cleave the vector and so it can be inferred from this that there are 
two sites on the cloned insert for each of these enzymes. 
5.5.2 Double Enzyme Digests. 
Using information that the single enzyme digests provided double enzyme digests were 
performed, whereby two restriction enzymes were used in combination. These were mainly 
carried out using both a "primary" enzyme, known to cleave the insert in p8PGT2, and a 
"secondary" enzyme whose cleavage site was undetermined and far enough from the insert to 
produce fragments easily visible after agarose gel electrophoresis. The double enzyme digests 
were set up (2.5.4) and as with single enzyme digests the results were analysed by agarose gel 
electrophoresis (Fig.5.4). Using the results from single and double enzyme digests (Fig.5.3 and 
5.4), i.e. the number of bands produced and their relative sizes and relating this information to 
sites that exist on the vector and those that can be deduced on the insert, a map of restriction 
sites on the foreign 5 kbp fragment was produced (Fig.5.5). 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
12 kbp ..... 
3 kbp ..... 
1 kbp ..... 
0.5 kbp ..... 
Lane Enzyme No. of No. of Cleavage No. of Cleavage Size of fragments Total 
Fraements Sites on VECTOR Sites on INSERT (kbp) 
I Markers - - - - -
2 Uncut - - - - -
pBPGTI 
3 EcoRI 2 I 0 2.7, 5.0 7.7 
4 BamHI I I 0 7.7 7.7 
5 Sail - I - - -
6 Markers - - - - -
7 HindiTI I I 0 7.7 7.7 
8 Hincfl - I 
- - -
9 EcoRV 2 0 2 7.5, 0.2 7.7 
10 Seal I I 0 7.7 7.7 
I I Markers - - - - -
12 Xhol 2 0 2 6.0, 1.7 7.7 
13 Smal 2 I I 6.3, 1.4 7.7 
14 PvuiT 2 2 0 5.1, 2.3 7.4 
15 Xbal I I 0 7.7 7.7 
16 Pstl 2 I I 7.0, 0.7 7.7 
17 Markers - - - - -
18 Hpal 0 0 0 - -
19 Bell 0 0 0 - -
20 Bgm 2 0 2 6.2, 1.5 7.7 
2 1 Ncol I 0 I 7.7 7.7 
22 Markers - - - - -
Fig.5.3. Agarose Gel Electrophoresis of Single Enzyme Digests of the Recombinaot Plasmid, 
pBPGT2. 
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12 kbp ~ 
1.6 kbp ~ 
1 kbp ~ 
0.5 kbp ~ 
Lane 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Restriction Enzymes Sizes of Fragments Total 
Produced (kbp) 
Markers - -
Uncut pBPGTl - -
XbaVNcol 5.7, 2.0 7.7 
Xbai/Bscl 7.7 7.7 
XbaVEcoRV 7.0, 0.5, 0.2 7.7 
Xbai!Xhol 3.5, 2.2, 2.0 7.7 
Markers - -
Xbal/BJ(lll 6.4, 1.5, 0.6 8.5 
Aval 3.2, I .6, 1.4, 0.9, 0.3, 0.2 7.7 
Smai!Ncoi 7.0, 1.9, 0.4, 0.3 9.6 
Markers 
-
-
Markers - -
Smai!Bscl - -
Smai!EcoRV 6.0, 1.2, 0.6 7.8 
Smai!Xhol 3.4, 2.0, 1.8, 0.5 7.7 
Smai!BglU - -
Markers - -
Fig.5.4. Agarose Gel Electrophoresis of Double Restriction Enzyme Digests of the 
Recombinant Plasmid, pBPGT2. 
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5.6 FURTHER SUBCLONING OF THE RECOMBINANT PLASMID 
pBPGT2. 
Once a restriction map had been obtained for pBPGT2 (Fig.5.5) it was decided to further 
subclone the 5 kbp insert into smaller clones for attempts to aid expression of the immunoreactive 
antigen(s) and to facilitate sequencing. 
5.6.1 Cloning Strategy. 
The cloning strategy is shown in Fig.5.5 whereby the 5 kbp fragment was digested with 
predetermined restriction enzymes, sites for which were previously mapped, to create specific 
DNA fragments that were to be cloned into a suitable vector thus creating the five desired 
subclones pCD 1-5, as indicated in Table 5.1. 
Table 5.1 Strategy Used for Further Subcloning of the 5 kbp Fragment into Plasmid Vectors. 
Restriction Enzymes Expected Size of tbe Plasmid Vector Recombinant 
fragment (kbp) 
EcoRI/Pstl 1.0 pGD103 pCDI 
Pstl/Smal 0.7 pUCIS pCD2 
Smal!Xhol 0.9 pUCIS pCD3 
Xhol 1.8 pUCIS pCD4 
Xhol/EcoRl 0.6 pUCIS pCDS 
5.6.2 Isolation of DNA Fragments for Further Subcloning. 
Approximately 3 11g of pBPGT2 was digested with each combination of restriction enzymes as 
indicted in Table 5.1 and the products were analysed on agarose gel electrophoresis. The desired 
band was identified by size in each case, excised from the agarose gel and the DNA electroeluted 
(2.4.6.1) and purified with the 810-RAD Prep-A-Gene kit (2.4.6.2). 
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5.6.3 Subcloning Procedure. 
The DNA fragments isolated for cloning into pUC 18 (Table 5.1) were ligated using the Sureclone 
Kit (2.5.7). The EcoRI!Pstl fragment was cloned into the plasmid vector pGDI03 (Appendix 11), 
which carries the selectable phenotype of kanamycin resistance. Approximately 0.5 ~g of 
pGD I 03 DNA was digested with the restriction enzymes EcoRl and Pstl, and after checking the 
digest on an agarose gel the linearised plasmid was treated with alkaline phosphatase (2.5.5), 
purified by extraction with phenol (2.4.3.2) and used in a ligation reaction with the EcoRll Pstl 
fragment at a ratio of 5: I respectively. All ligations were used in a transformation procedure with 
DH5a competent cells (2.5.3.2) and the transformation mix was spread onto LB media containing 
the appropraite antibiotics and incubated at 37°C for 18 h. Recombinants were identified using 
blue/white screening and recombinant white colonies were cultured in I 0 ml LB broths 
supplemented with the appropriate antibiotics. Small-scale plasmid extractions were carried out 
on cultures (2.4.2.1). All plasmid DNA was digested with the restriction enzymes EcoRl and Pstl 
to ensure that they contained a correctly sized insert. Subclones containing the desired size insert 
were identified, results of which can be seen in Fig.5.6. 
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EcoRl Pstl Smal Ncol Bglli Xhol Xhol EcoRl Sacl 
0 1 2 3 4 5 
The 5 kbp fragment was digested using the restriction enzymes indicated (in red) to create fragments for further subcloning into plasmid vectors: 
EcoRIIPstl 
(pCDl) 
PstVSmal 
(pCD2) 
SmaVXhol 
(pCD3) 
Xhol 
(pCD4) 
Xhol/EcoRJ 
(pCDS) 
Fig.5.5 Restriction Map of the 5 kbp foreign B.pseudomallei DNA fragment and Further Subcloning Strategy. The restriction map 
shows all tested restriction sites within the fragment and shows those restriction enzymes used for further subcloning of the 5 kbp fragment 
into other plasmid vectors (pCDl-5). 
1 2 3 4 5 6 7 8 9 10 1112 13 14 
12 kbp .... 
3 kbp .... 
0.5 kbp .... 
Fig.5.6 Agarose Gel Electrophoresis of Subclones (pCDl-5) Digested witb tbe Restriction 
Enzymes EcoRIIPstl to Release a Foreign Insert. LANE I: I kpb ladders. LANE 2: A. 
Standard (0.125 J..Lg) LANE 3: pCDl. LANE 4: pCD1 /EcoRr/Pstl. LANE 5: pCD3. LANE 6: 
pCD3/EcoRVPstl. LANE 7: pCD4. LANE 8: pCD4/EcoRl/Pstl. LANE 9: I kbp ladders. 
LANE 10: A. Standard (0.125 J..Lg) LANE 11 : pCD2. LANE 12: pCD2/EcoRl!Pstl. LANE 13: I 
kbp ladders LANE 14: pCD5/EcoR1/Pstl. 
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5. 7 ATTEMPTS TO USE AN In Vitro TRANSCRIPTION AND 
TRANSLATION KIT TO IDENTIFY NOVEL PROTEINS PRODUCED 
BY THE SUBCLONE, pBPGT2. 
No protein product(s) could be identified from the immunopositive clone A.BPGT I. For this 
reason, the E.coli S30 Extract System for Circular DNA that incorporates the Transcend™ 
Non-Radioactive Translation Detection System (Promega) was used to try to identify any 
novel proteins produced by the subclone, pBPGT2 and further subclones of the fragment, 
pCD 1-5. In this way the gene(s) responsible for the immunopositivity observed may have 
become separated away from other, interfering sequences contained on the fragment. 
5. 7.1 Standard Protocol. 
For each DNA sample used the following basic reaction was set up: 
DNA template 
Amino acid mixture (complete) 
S30 Premix without amino acids 
S30 extract, Circular 
Nuclease-free water to a final volume of 
:::;4 ~g 
1 ~I 
20 ~I 
15 ~I 
49 ~I 
The components were added into a MCC tube, vortexed gently and centrifuged for a few sec. 
to bring the reaction mixture to the bottom. A 1 ~I volume of Transcend™ tRNA was added to 
the translation reaction and immediately incubated at 37°C for 2 h. The reaction was 
terminated by placing the tubes into an ice bath for 5 min. A provided positive control was set 
up in each experiment which was the plasmid, pBEST/uc™ which synthesises firefly 
luciferase which migrates to 60 kDa and it also contains the gene for ampicillin resistance, 
which can appear as a faint band migrating to 31.5 kDa. A negative control was also used 
which consisted of the same reaction components as the positive control with the omission of 
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the plasmid DNA. Once the S30 extract reaction was complete, a 5 Ill aliquot was removed 
and added to 20 111 of acetone in a MCC tube and placed on ice for 15 min. The unused portion 
of the reaction was stored at -20°C. The sample was then centrifuged at 12,000 x g for 5 min. 
The supernatant was removed and the pellet was dried for 15 min. under vacuum. Afterwards, 
201-11 ofSDS-PAGE Loading buffer was added and heated to 100°C for 2-5 min. A sample of 
this was then analysed by SOS-PAGE (2.6.1) using a 13% gel and staining with coomassie 
blue or used in a Western blotting procedure (2.6.2). Western blotting was carried out using 
Tris-buffered saline (TBS) with 0.5% Tween® 20 (TBST) as a blocking buffer. Biotinylated 
proteins were visualised by binding Streptavidin-Aikaline Phosphatase, followed by 
colorimetric detection with Western Blue® Stabilised Substrate for Alkaline Phosphatase. 
5.7.2 Application of the In Vitro Transcription and Translation Kit. 
The following DNA templates were set up as in 5.7.1 a positive control (pBEST/ucTM), 
pBPGT2, pUC 18 and pCD 1-5 and once the reaction was complete these were subject to SOS-
PAGE and Western blotting. The positive control developed the expected protein bands of 
luciferase (60.7 kDa) and 13-lactamase (31.5 kDa). However, no novel protein bands were 
observed in any of the recombinant subclones. This was repeated for a total of three times per 
sample altering the reaction conditions slightly each time, but the results remained unchanged. 
5.8 DISCUSSION. 
The method used in this Chapter (5.2) to identify any recombinant novel protein(s) produced 
by the immunopositive, A.BPGT I was unsuccessful. The technique used would have given an 
indication of the size of the protein but could not in itself detect low levels of protein 
expression, or determine whether the protein was in its native form. The immunopositive 
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clone, A.BPGTI was initially identified as having a "halo" of positive reaction around the 
plaque and the possible explanations for such an observation were discussed in Chapter 4. It is 
possible that no protein bands were visualised, as there was a very low level of expression of 
the cloned product, hence making the immunopositive protein barely detectable with the 
antisera used, producing just a "halo" of positive reaction. Alternatively, the production of an 
insoluble protein from A.BPGT I would also be responsible for the lack of a protein band on an 
SOS-PAGE gel and in Western blotting. As previously discussed (4.7) the "halo" effect 
observed may have been indicative of degradation of the protein, and indeed if this were 
occurring, there would be no products observed. For any given protein a variety of factors 
singly, or in combination may modulate its half-life in vivo. Among such factors are the 
flexibility, accessibility and sequence of the N- and C- termini, the presence of chemically 
blocking amino-terminal groups such as the acetyl group, and the exposure on the surface of 
the folded protein of protease cleavage sites (Old and Primrose, 1989). It has been shown that 
in yeast, for example that proteins derived from 13-galactosidase have a half-life that varies 
from just 3 minutes to 20 hours, depending on the amino acid at theN-terminus (Bachmair et 
al., 1986). lt is not known whether a similar phenomenon occurs in E. coli but if it does it may 
explain the great variation observed in the stability of different proteins that have been made 
from similar gene constructs. 
To facilitate further analysis of the immunopositive clone the foreign fragment was subcloned 
into a plasmid vector. This facilitated restriction mapping of the fragment. Some digests were 
inconclusive and occasionally the sizes of the fragments yielded did not add exactly to the 
estimated size, in some cases due to partial digestion products and in others due to "star" 
activity. Star activity was observed with single digests using Sail and Hincll (Fig.5.3) and is a 
phenomenon exhibited by a number of restriction enzymes under non-optimal conditions, and 
is the loss of sequence specificity (Kessler and Holtke, 1986). In the case of partial digests, 
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bands appear too light and the addition of all the fragments yields a value too large. Problems 
with restriction digests are encountered if the G+C content of the fragment is high, which 
could well have been the case with B.pseudomallei DNA, as the genome has a G+C content 
around 69% (Redfearn et al., 1966). High G+C fragments tend to migrate faster than 
fragments with lower G+C contents and the problem is particularly common with short DNA 
fragments. However, subcloning the fragment presented no problems and further subcloning 
into five smaller fragments was carried out. lt was hoped that the gene(s) responsible for the 
initial immunopositive reaction would be contained within one of the subclones, which would 
facilitate its expression by isolating the sequence away from other, potentially interfering 
sequences. 
The colony blot carried out with recombinant plasmid subclones was inconclusive as 
eventually little difference was observed between the reaction of the recombinants to that of 
the E.coli control. However, it was observed that the recombinants developed quicker and 
slightly darker than the control. lt could be possible that there existed a high background 
reaction from E.coli proteins not adsorbed by the acetone powders used and such a level of 
background reaction did not exist when using the phage clones. 
Again, attempts to detect novel proteins produced by the plasmid subclones were unsuccessful, 
even with the use of the in vitro transcription and translation kit. A number of factors again 
could be responsible for this. Firstly, if the protein were unstable or insoluble it would still be 
undetectable on an SOS-PAGE gel and in Western blotting even with the use of the kit. If the 
protein is normally produced at very low levels, which was an explanation to why it was 
initially undetectable in experiments carried out with A.BPGT I, the in vitro transcription and 
translation system should overcome this problem as it increases the level of expression of very 
such proteins. It could be possible that the imrnunopositive antigen was in fact a 
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B.pseudomallei protein produced in-frame with the 13-galactosidase system in A.GT 11 and 
through subcloning the ffagment, such expression has been lost or that a deletion event may 
have occurred whereby even the loss of one base would disrupt the reading frame of the 
protein and hence expression would be lost. As no proteins were visualised with the subclones 
pCD 1-5 it is possible that the gene(s) had been disrupted through the subcloning procedure 
and so expression of the full product did not occur. 
As this was the only clone identified from screening with antisera, despite the problems 
encountered with the identification of any novel protein(s) it was decided to continue work 
with the immunopositive clone and to sequence the DNA. The lack of expression may have 
been due to the myriad of reasons discussed and considering that little work has been carried 
out with cloning and expression of B.pseudomallei DNA and proteins in E.coli systems there 
was little information to compare. Sequencing the fragment may provide answer to the 
problems encountered, as more information regarding the nature of the genes encoded may 
allude to whether the product is insoluble, easily degraded or perhaps requires post-
translational modifications. 
147 
CHAPTER6 
ANALYSIS OF THE NUCLEOTIDE SEQUENCE OF AN 
IMMUNOPOSTIVE CLONE FROM B.oseudomallei. 
6.1 INTRODUCTION. 
Once a fragment of DNA has been cloned that is thought to encode gene(s) responsible for an 
observed activity, the next step is to sequence the DNA, which gives essential information 
regarding the structure, function and evolutionary history of the gene(s) encoded. Knowledge 
of a DNA sequence may often be an end in its own right but the information that DNA 
sequencing provides can be processed by comparing the nucleotide sequence itself or the 
deduced polypeptide sequence with a data bank of other sequences. Any similarities 
highlighted can, in principle arise by two routes: either by convergent evolution, or through 
their being related by descent from a common ancestral sequence (Old and Primrose, 1989). 
Convergent evolution implies the two sequences have not descended from a common ancestral 
sequence, but have instead arisen as a consequence of selection for a particular function. The 
alternative implies that the two sequences have remained similar in evolutionary time due to a 
selection pressure, which has limited any scope for divergence. Whatever the route has been, 
the implication here is that any sequence similarity can be taken to be indicative of similar 
function. It must also be stressed that selection pressure per se does not necessarily act on the 
protein as a whole but that certain coding regions fulfil in themselves a distinct function, such 
as DNA binding and so these conserved domains are often the subjects of intense selection 
pressure. The overall rationale therefore is that when evolution has developed a successful idea 
it tends to stick with it, which can be paralleled to virulence gene in pathogens. The sequence 
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data banks are rapidly growing and are at present more than an adequate size to search for 
similarities in any newly discovered sequence. 
The base sequence can also be analysed for structural and physical features such as restriction 
enzyme sites, base composition and open reading frames, through computer programs. The 
importance of this infonnation allows additional sequences to be searched for, such as the 
"machinery of gene expression", this includes ribosome binding sites, promoter and tenninator 
regions. Efficient translation requires that the mRNA bears a ribosome binding site, or Shine 
and Dalgarno sequence (SD) that varies in length from three to nine bases and precedes the 
translational start codon by three to nine bases (Steitz, 1979). In addition to this, the 
transcription of a given coding DNA sequence is initiated by the formation of a stable complex 
between the RNA polymerase enzyme and a characteristic control sequence, called the 
promoter. Extensive analysis of these (Hawley and McClure, 1983) has identified two regions 
that are consistently similar. One of these contains 6 or 7 bases and occurs about I 0 bases 
upstream of the nucleotide at which transcription commences (+I) and is often tenned the -I 0 
sequence or "Pribnow Box". The second is 9 nucleotides long and clustered about 35 
nucleotides upstream of the of the RNA initiation site, known as the -35 sequence. A 
consensus sequence for the -35 site has been deemed, 5'-TTGACA, and for the -10 Pribnow 
Box, 5'-TATAAT. In addition to the transcriptional initiation regions, DNA sequences may 
also possess transcriptional tenninators, consisting of inverted extended repeat sequences 
distal to the translation termination codon. These sequences induce the 3' ends of RNA 
transcripts to form "stem-loop" structures which are believed to interfere with RNA 
polymerase activity and facilitate the disassociation of the synthesised m RNA chain from the 
template (Adhya and Gottesmann, 1978). 
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Once a putative gene has been identified it is then possible to analyse the structure and 
composition of the protein molecule encoded by the gene of interest. Amino acid regions of 
secondary structure such as disulphide bridges and alpha helices can be detected as well as 
conserved motifs such as signal peptides and DNA binding regions, and functional properties 
such as hydrophobicity and antigenicity. 
6.2 SEQUENCING OF pBPGT2. 
Approximately 30 J.lg ofpBPGT2 DNA was isolated using the Qiagen kit (2.4.2.4), and sent to 
MWG-BIOTECH as a dried pellet. The fragment was sequenced using the primer-walking 
service. The complete nucleotide sequence of the EcoRI-generated fragment was found to be 
4969 nucleotides in length and can be found in Appendix Ill. 
6.3 NUCLEOTIDE SEQUENCE ANALYSIS OF THE 5 kbp FRAGMENT. 
The complete 5 kbp sequence received was entered into the DNasis program (Hitachi) 
installed on a personal computer which consists of a number of programs for the analysis of 
nucleotide or amino acid sequences. 
6.3.1 Restriction Endonuclease Cleavage Site Analysis. 
The first analysis carried out on the nucleotide sequence of the 5 kbp fragment was the 
production of a more detailed restriction enzyme cleavage map than the one previously 
produced (Fig.5.5) so that further manipulations of the fragment may be more readily 
performed. The following restriction site table (Table 6.1) was compiled using DNasis 
software for sequence analysis. 
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Table 6.1 Computer-prepared Restriction Site Analysis of the 5 kbp £eaRl-generated 
B.pseudomallei DNA Fragment. 
ENZYME SEQUENCE COUNT CUTTING POSITION 
Aatll GACGT.!.C 3 800,2734,3564 
Ajlll cl.TfAAG I 297 
A pal GGGCdC I 917 
Aspl GACN.!.NNGTC I 3477 
Avill TGC.!.GCA 4 1503, 1979, 3823, 4292 
Ben T.!.GATCA I 843 
Bfri dTIAAG I 297 
Bgnt A.!.GATCT 2 6I9, 1813 
BseAI T.!.CCGGA 3 280, I436,40IO 
Bs1WI C.!.GTACG 2 2662,3954 
Bsml G.!.CATTC I 4669 
Drall RGWNCCY 3 913, 914,972 
Eeo471ll AGdGCT I 3916 
EeoRl G.!.ATTC 2 53,5016 
EeoRV GAT.!.ATC 2 517,592 
Mlul A.!.CGCGT 4 2253,3236,4021,4825 
Munl c.!.AATTG I 2522 
Ncol CkATGG I 1897 
Nhel G.!.CTAGC I 1983 
Nsil ATGCA.!.T 3 36I2,3848,4552 
Pstl CTGCA.!.G 2 18, 1062 
Real TkATGA I 981 
Rsrll CG.!.GWCCG 4 IOI~3068,3935,4244 
Sa cl GAGCT.!.C 3 51,87,I705 
Sfol TT.!.CGAA I 396I 
SgrAI CR.!.CCGGYG 2 2485,4679 
Smal ccc.!.GGG 2 39, 1617 
SnaBl TAC.!.GTA I I209 
Sty I c.!.CWWGG I 1897 
Tru91 T.!.TAA 2 298,2391 
Van911 CCANNNN.!.NTGG I 4530 
Xhol C.!.TCGAG 2 2405,4I96 
Xholl R.!.GATCY 4 32, 6 I 9, 1813, 3638 
In the restriction enzyme recognition sequences a Y represents a pyrimidine base (C or T), R 
represents a purine base (G or A) and N represents any base. The values for the EcoRl 
cleavage sites in Table 6.1 (in blue) represents the position of the foreign DNA insert within 
the sequence, therefore positions in red represent cleavage sites on the vector DNA. 
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6.3.2 Open Reading Frame (ORF) Analysis. 
Following restriction enzyme analysis, the next part of the analysis involved a search for open 
reading frames of nucleotide bases that when transcribed into m RNA may act as a template for 
a protein that could be responsible for the immunopositivity previously observed with the 
clone A.BPGTI. The DNasis computer program used translates the nucleotide sequence of 
interest into all six possible reading frames of base triplets. The program then searches for the 
translation initiation sequence A TG, followed by a search "in frame" for the presence of one of 
three possible termination sequences, T AA, TAG and TGA. This· is then presented to the user 
in the format as seen in Fig.6.1, which shows the open reading frame analysis on the 5 kbp 
fragment carried out with this program. 
Prior to nucleotide sequencing, attempts to determine a protein produced by both A.BPGT I and 
pBPGT2 in which the 5 kbp fragment was cloned were unsuccessful, therefore there were no 
indications as to the size of protein produced therefore an estimate of the possible ORF size 
could not be deduced. Thus the strategy used next was to use all putative open reading frames 
in Web-based BLAST searches to identify possible homologies with other proteins, and to 
analyse these. 
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Forward Translation: 
1 1004 2007 3010 4013 5020 
Reverse Translation: 
1 1004 2007 3010 4013 5020 
Fig.6.1. Open Reading Frame Analysis of pBPGT2 Forward and Reverse Translations in 
all Three Reading Frames. The lines represent stop codons and the triangles represent start 
codons (TAA, TAG, TGA). The red arrow represents an ORF not identified by DNasis. 
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6.3.3 Web-Based BLAST Searches of Putative Open Reading Frames. 
From the ORF analysis carried out (6.3.2) all ORFs identified by DNasis (Fig.6.1) were used 
in Web-based BLAST searches (Altschul et al., 1997) to identify any homologies with similar 
sequences with known functions. A number ofORFs identified within the 5 kbp fragment had 
homologies with proteins from a range of other bacteria and in some cases with other 
prokaryotes and eukaryotes. 
All BLAST results were analysed and eventually four ORFs encoding putative genes, over the 
whole 5 kbp fragment were identified, the results of this can be seen in Fig.6.2. These four 
ORFs cover the first 2.5 kbp of the fragment. In the latter 2.5 kbp ORFs did not yield any 
homologies with proteins from BLAST searches in any of the reading frames. This does not 
necessarily mean that the sequence contains no coding regions but that perhaps the ORFs code 
for proteins not yet identified in any other organisms. One of the ORF's identified (ORF I), did 
not have a termination codon as the sequence was probably disrupted by the EcoRI site used to 
generate the genomic library in Chapter 4 and so the rest of the sequence is probably contained 
on an adjacent EcoRI fragment. 
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Vl 
Vl 
ORF2 ORF3 
... 
ORFI ORF4 
0 1 2 3 4 5 
(kbp) 
Fig.6.2 Map of the 5 kbp B.pseudomallei Fragment Indicating Putative ORFs Encoding Sequences with Homology to Other 
Bacterial Protein Sequences Deposited in BLAST Databases. Those putative ORFs above the sequence (2 and 3) are in the normal, 
forward translation, those beneath the sequence (I and 4) are the reverse complementary. 
6.4 ANALYSIS OF ORFs IDENTIFIED ON THE 5 kbp EcoRI-
GENERATED FRAGMENT FROM B.pseudomallei. 
6.4.1 Proteins Identified in the BLAST-P Database Having Homology to the ORF 
Sequences Identified. 
The following tables show proteins with homology to the ORFs identified (Fig.6.2) and are 
given along with their Accession numbers and brief titles describing their function. 
Table 6.2 Web-Based BLAST-P Matches for ORF I. 
Acession Matcb Sequence Title Percentage Homology 
Number (Positives)* 
AF075709 /-;!'A Pseudomonas outida 96 
090905 Rehvdrin Svnechocvstis so. 82 
014662 Human Antioxidant Protein 2 (24 Kda) Homo sapiens 87 
AF004670 Mouse Antioxidant Protein 2 Mus musculus 85 
AF093852 1-Cys peroxiredoxin Mus musculus 85 
AF014009 Thiol-specific antioxidant protein Rattus norvegicus 83 
AL033396 Rehydrin-like protein Candida albicans 74 
Yl2089 Peroxiredoxin Arabidopsis thai/ana 67 
U40818 Rehvdrin Tortula ruralis 66 
AE000711 AlkYl Hvdrooeroxide Reductase A.aeo/icus 63 
U31052 Thiol-Soecific Antioxidant Onchocerca volvulus 73 
Y08256 Probable Peroxiredoxin Sulfolobus solfataricus 59 
X74264 Probable Peroxiredoxin Methanobacterium thermoautotroohicum 62 
U67520 Probable Peroxiredoxin Methanococcusjannaschii 59 
APOOOOOS AlkYl Hydroperoxids Reductase Pyrococcus horikoshii 59 
AF007757 Probable Peroxiredoxin 2 Su/folobus metallicus 59 
L46863 Alkvlhydrogenperoxide Reductase LeJ{ionel/a pnuemophi/a 62 
AJ222857 vkuU Protein Bacillus subtilis 58 
AFOI6233 Alkvlhvdrogenperoxide Reductase Enterococcus{aecalis 52 
ABOI0689 AhoC Pseudomonas outida 60 
M60116 20 KDa Protein in Rubredoxin Ooeron Clostridium pasteurianum 54 
U65510 AlkYl Hydroperoxide Reductase Rhodosoirillum rubrum 60 
AL031798 Thioredoxin Peroxidase Schizocaccaromvces oombe 57 
* This represents the percentage similanty of the putative ammo ac1d sequence with those 
deposited in the BLAST-P database. 
The amino acid sequence of ORF I had a very high homology to lsfA of P.putida (96% 
positivity) and with other peroxidases from other bacteria and so could potentially have a 
peroxidase function in B.pseudomallei. 
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Table 6.3 Web-Based BLAST-P Matches for ORF 2. 
Accession 
Number 
Ul8997 
U58768 
AE000352 
AF073461 
X04465 
U40566 
Match Sequence Title 
47 
43 
51 
54 
46 
Z99708 Putative Protein A.thaliana 49 
* This represents the percentage similarity of the putative amino acid sequence with those 
deposited in the BLAST-P database. 
Table 6.4 Web-Based BLAST-P Matches for ORF 3. 
Accession 
Number 
AE000392 
Ul8997 
U75930 
Match Sequence Title 
Hypothetical 15.1 kDa Protein in EXUR-TDCC lntergenic region 
E. coli 
ORF ol57 £.coli 
Hypothetical Protein 25.6 kDa Orgyia pseudotsugata nuclear 
ol hedrosis virus 
44 
43 
* This represents the percentage similarity of the putative amino acid sequence with those 
deposited in the BLAST "P database. 
ORF 2 is immediately followed by ORF 3 in the 5 kbp nucleotide sequence and both are in the 
same reading frame. Both sequences have homology to a range of putative proteins from other 
bacteria, most notably from E.coli. Interestingly, both have homology to small, intergenic 
putative proteins from the same region, the EXUR-TDCC in E.coli. 
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Table 6.5 Web-Based BLAST-P Matches for ORF 4. 
Accession Match Sequence Title Percentage Homology 
Number (Positives) • 
AF027189 Comf Acinetobacter ca/coaceticus 40 
U02552 PilE P.aeruf!;inosa (involved in Tvoe IV oilin biogenesis). 36 
Z69262 PilE Neisseria f!:Onorrhoeae 40 
L32968 Preoilin Moraxella bovis 35 
AF027189 ComE Acinetobacter ca/coaceticus 43 
U32715 Prepilin peptidase dependent protein D Haemophilus influenzae 40 
Ml1323 Pi I in protein precursor P.aeruf!;inosa 37 
Mll435 Beta pilin M.bovis 38 
M32345 Q pi fin M.bovis 38 
M59712 Pilin subunit M. bovis 38 
AFI09904 PiiA Vibrio cholera 35 
Ml4849 Pilin protein P.aeruf!;inosa 46 
K02080 Pilus protein precursor N.gonorrhoeae 38 
868101 Pilin P.aeruginosa 44 
831105 Pi fin protein precursor P.aeruJZinosa 37 
SI5265 Pi fin protein precursor Dicelobacter nodosus 35 
Ul6742 Pilin Monomer N.f!:onorrhoeae 38 
* Th1s represents the percentage Similarity of the putative amino acid sequence with those 
deposited in the BLAST-P database. 
Perhaps the most interesting homology was identified to this particular ORF, ORF 4, as it has 
homology to pilin genes from a range of other bacterial pathogens. 
6.4.2 Nucleotide Sequences of the ORFs Identified. 
The next part of the analysis was to identify possible transcriptional and translational control 
regions on the ORFs. Analysis of possible -I 0 and -35 sequences was carried out using a range 
of E.coli promoters and those from similar species. Unfortunately, very little information 
regarding possible -I 0 and -35 sequences for different B.pseudomallei genes exists. In addition 
to this possible ribosome binding sites (SD regions) and termination loops were searched for. 
The results of these can be seen in Figs.6.3, 6.4 and 6.5. 
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-35 13 bases -10 5 bases +I 
... ~ ~ ~ 
383 GAlTGTCAAA TCGCACCCGG CAAGAATGAT AAAA.AGGCAT GAATATCTGA 
333 CGGAATAATC GlTCGCGCCG GCCGCAGGAT CGClTAAGCT AAAAAClTGT 
so 
283 CCGGATGCGC GATGCGTCCG GGCACCCAAC CCATGCAAGT TCAAGGAGCT 
START 
233 GTAACATGAG TCTACGTClT GGCGACATCG CGCCGGATlT CGAGCAGGAT 
183 TCGAGCCTCG GCCGCATCAA ATlTCACGAA TGGCTCGGCA ATAGlTGGGG 
133 CGTCCTGlTC TCGCATCCGG CCGACTACAC GCCCGTCTGC ACGACGGAGC 
83 TCGGCTIGAC CGCGAAGCTC AAGGGAGAAT TCGAGCTCGG TACCCGGGGA 
33 TCCTCTAGAG TCGACCTGCA GGCATGCAAG 
Fig.6.3 Partial Nucleotide Sequence of a Putative Gene Encoded by ORF 1. The open 
reading frame has been extended to include putative -35 and -I 0 regions, which have been 
highlighted on the sequence. A putative ribosome binding site (SO) has also been found and 
the initiation codon ATG is also highlighted in red. Those sequences in green represent vector 
DNA as the sequence has probably been disrupted by the EcoRl site used to clone the fragment 
into A.GTII. 
159 
ORF2 -35 12 bases -10 6 bases +I 
... ... ... ... 
411 TCTCfATTGT ~CGGCAAGT CGTTTACCAT GCTGTTCAAG CGCGATCTTG 
461 CGCCACCfGC GCGCCGTGCC CGCGCGCCCG CGGCCAGGCA CGGGTTTCGC 
so START 
511 TACGATATCC GTAGCACAAC CCGCTTCGGC AAGAAGGGAG TCGCAATGTC 
561 TGAAGTCAAC AAGGAGAAAC TGATGTCGGA TATCAAAACT GTTCTCGCGG 
611 ACGCGGAAGA TCTGCTGAAG CAGGCCGCGA GCAGCACGGG CGACCGTGCG 
661 ACCGAGCfGC GCGAGAAGGC GCTCGCACGC CTGAAACAGG CGAAGGAGAA 
711 GGCGACCGAT GTCCAGGTGG TCGTGGTCGA AAAAGGCAAG AAGGCGGCGC 
761 GCGCCACCGA CGACTACGTG CACGAGCATC CGTGGACGTC GATCGGCATC 
STOP 
811 GCGGCCGGCG TCGGCGTATT GATCGGCCTG CTGATCAACC GCAAGTA_~CG 
ORF3 
861 CGGCACGCCC CCGCGAGAGA CAGCCCCCGG CTCGCCGCCG CGTGACGGCC 
911 GGGGCCCTGC GCTCCGGCCC GCCGCGCCCA GTTGCGACGC CGGCCGTTCT 
START 
961 CCGCGCGCAA CCTCTTTCAT QACGACAGAA ACCTCATCGC ACCAGTCCGG 
1011 GCACGGACCG CTGCGCCGCC TGCTCGGCTC GGTGCTCGCG CTCCTGCAGA 
1061 CCCGGCTCGA ACTCGTCGGC ATCGAACTCG CCGAGGAGAA GGAACGCCTG 
Ill I ATGGGCGTAC TCTTTGTCGG GCTCGCCGCG ATGATGCTCG CGACGATGGC 
1161 GCTCATCAGC CTGACGGTGC TCATTGCGAT CGCGTTCTGG GATACGTACC 
1211 GCTGGCAATC GCTCGCCGTC GTCACCGCGC TCTACGCGCT CGGCGCACTC 
1261 GCCTGCTGGC TGAAGGCGCG CTCGGGACTG CGCGACGCGC CCAGCGTGTT 
1311 CGAGGCGACG CfGAACGAAC TCGAAAAGGA CCGCGAGCTG TTCCGCGGCA 
STOP 
1361 AGCCGTGA 
Fig.6.4 The Complete Nucleotide Sequences of Putative Genes Encoded by ORFs 2 and 3. 
These genes have been included together due to their proximity, but on closer analysis putative 
-35 and -1 0 promoters were identified by extending ORF 2, but no clear promoters could be 
identified for ORF 3, nor a ribosome binding site close to the transcriptional start codon, ATG. 
A putative SD sequence was identified at position 875. lt may be that the two putative proteins 
are transcribed together especially considering that they are in the same reading frame. 
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2604 CCGGCGCGCC CCGACGTGCG CGCCTTCCTC GTAACCGCGC GCGGCGTGGG 
-35 -10 +l 
2554 CGCATCGAAC GATACGGCCG AGTGGCTGCA ATTGCAGGAT GCGCTCGACG 
2504 GCGGGCGCGT CGAGCCCCGG TGGCGTCGGG TCGTGGGACG GCCGGCATAG 
so START 
2454 GCAACGGGAG QCATGAGCGA IQCCATGTAC GGGGCGCAAT TCGCCCTCGA 
2404 GAGGCTTCAC CTTAATCGAG GTGGTCGTCG CGATCGCGAT CGTGGCGGTG 
2354 CTCGCGGCGT TTGCCGTGCC GTCGTATCGC AGTTATGTCG AACGGGTGAA 
2304 CCGATTGACC GCGGTTGCCG CGCTCTATCG CGCCGCGCAA TACGTGGACG 
2254 CGTTCGGCGA CGCGCCGCCC ACCGCGTTGC CGGAAGGGGT GAACAGGGCG 
2204 CCCGAATCCG GCAAGCTCGT CTATGTGCTG CGGATCATGT TCGACGACGC 
2154 GCGCGGCGGA TACGCACTGG AGGCGCGTCC CGCCGCCGAT GGTGCAATGC 
2104 GGGACGACAG ATGCGGCGTC TACGTGCTGC ATGCGGACGG CACGAGCGAG 
2054 AATCGCGTGG CCGGAGGCGT CGCGCTCGAT GGCGGTGCGG CGGAGGGCGA 
STOP TERMINATION LOOP 
2004 TGCCTGCTGG CGAACAGGCT AQCTGCGCAG CGCCGGGCGT GTCGATCTCC 
1954 CCQGCGCCGG CAGCCGGCCG GCGCGGTCGG CGCGCCGGCT CGGTCGACGG 
Fig.6.5 Tbe Complete Nucleotide Sequence of an Open Reading Frame (ORF 4) 
Encoding a Putative Pilin Gene in B.pseudomallei. The putative reading frame has been 
extended to include a putative -10 and -35 sequences. Also shown is the transcriptional start 
nucleotide (+I) the putative Shine-Dalgarno sequence (SO) and a possible transcription 
termination loop (LOOP). 
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6.5 THE PRIMARY AMINO ACID SEQUENCES OF THE PUTATIVE 
PROTEINS. 
6.5.1 ORF 1 Putative Peroxidase. 
MSLRLGDIAPDFEQDSSLGRIKFHEWLGNSWGVLFSHP ADYTPVCTT 
ELGLTAKLKGEF (stop codon not found, the reading frame goes beyond the available 
sequence). 
6.5.2 ORF 2 Putative Protein. 
MSEVNKEKLMSDU(TVLADAEDLLKQAASSTGDRATELREKALARL 
KQAKEKA TDVQVVVVEKGKKAARA TDDYVHEHPWTSIGIAAGVGV 
LIGLLINRK. 
6.5.3 ORF 3 Putative Protein. 
MTTETSSHQSGHGPLRRLGSVLALLQTRLELVGIELAEEKERLMGV 
LFVGLAAMMLATMALISLTVLIAIAFWDTYRWQSLA VVT AL Y ALGA 
LACWLKARSGLRDAPSVFEATLNELEKDRELFRGKP. 
6.5.4 ORF 4 Putative Pilin Gene. 
MPCTGRNSPSRGFTLIEVVV AlA V A VLAAF A VPSYRSYVERVNRL TA 
VAALYRAAQYVDAFGDAPPTALPEGVNRAPESGKLVYVLRIMFDDA 
RGGYALEARPAADGAMRDDRCGVYVLHADGTRENRAGGVALDGG 
AAEGDACWRTG. 
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Table 6 6 Codon Usage of the Putative Genes Identified in the 5 kbo EcoRl Generated Fragment . 
CO DON AMINO USAGE o/o USAGE % USAGE o/o USAGE o/o TOTAL o/o 
ACID ORFI ORF2 ORF3 ORF4 USAGE 
GCA A - - I 1.0 - - 2 1.33 3 0.7 
GCC A I 1.69 3 3.0 5 4.17 7 4.67 16 3.7 
GCG A 2 3.39 10 10.0 9 7.5 18 12.0 39 9.07 
GCT A - - - - - - - - - -
AGA R - - - - - - 2 1.33 2 0.47 
AGG R - - - - - - I 0.67 I 0.23 
CGA R - - - - - - 2 1.33 2 0.47 
CGC R I 1.69 4 4.0 6 5.0 6 4.0 17 3.95 
CGG R -
- - -
I 0.83 3 2.0 4 0.93 
CGT R I 1.69 I 1.0 - - I 0.67 3 0.7 
AAC N 
- -
2 2.0 I 0.83 2 1.33 5 1.16 
AAT N I 1.69 - - - - 2 1.33 3 0.7 
GAC D 2 3.39 4 4.0 2 1.67 7 4.67 15 3.49 
GAT D 2 3.39 3 3.0 I 0.83 3 2.0 9 2.09 
TGC c I 1.69 - - - - 2 1.33 3 0.7 
TGT c -
- - - - -
I 0.67 I 0.23 
CAA Q 
- - - - I 0.83 I 0.67 2 0.47 
CAG Q I 1.69 3 3.0 2 1.67 - - 6 1.4 
GAA E 2 3.39 3 3.0 4 3.33 3 2.0 12 3.95 
GAG E 2 3.39 5 5.0 3 2.5 4 2.67 14 4.4 
GGA G I 1.69 - - I 0.83 2 1.33 4 0.93 
GGC G 5 8.48 6 6.0 7 5.83 10 6.67 28 6.5 
GGG G - - - - 2 1.67 2 1.33 4 0.93 
GGT G - - - - - - 2 1.33 2 0.47 
CAC H I 1.69 I 1.0 3 2.5 - - 5 1.16 
CAT H I 1.69 I 1.0 I 0.83 I 0.67 4 0.93 
ATA I - - - - - - - - - -
ATC 1 2 3.39 5 5.0 7 5.83 4 2.67 18 4.19 
ATT I - - - - I 0.83 - - I 0.23 
CTA L I 1.69 - - - - - - I 0.23 
CTC L 4 6.78 2 2.0 12 10.0 4 2.67 22 5.12 
CTG L I 1.69 7 7.0 7 5.83 3 2.0 18 4.19 
CTT L I 1.69 
- -
- - -
-
I 0.23 
TTA L - - - - - - I 0.67 I 0.23 
TTG L I 1.69 I 1.0 I 0.83 2 1.33 5 1.16 
AAA K I 1.69 4 4.0 - - - - 5 1.16 
AAG K 2 3.39 8 8.0 2 1.67 I 0.67 13 3.0 
ATG M I 1.69 2 2.0 5 4.17 3 2.0 11 2.56 
TIC F 3 5.01 - - I 0.83 3 2.0 7 1.63 
TTT F l 1.69 - - I 0.83 I 0.67 3 0.7 
CCA p 
- - - - -
- I 0.67 I 0.23 
ccc p I 1.69 - - - - 4 2.67 5 1.16 
CCG p 2 3.39 I 1.0 2 1.67 3 2.0 8 1.86 
CCT p - - - - - - - - - -
AGC s I 1.69 2 2.0 I 0.83 - - 4 0.93 
AGT s 2 3.39 - - - - I 0.67 3 0.7 
TCA s - - - - I 0.83 - - I 0.23 
TCC s - - - - I 0.83 l 0.67 2 0.47 
TCG s 2 3.39 2 2.0 4 3.33 3 2.0 11 2.56 
TCT s - - I 1.0 - - - - I 0.23 
ACA T 
- - - -
I 0.83 I 0.67 2 0.47 
ACC T I 1.69 3 3.0 4 3.33 3 2.0 I I 2.56 
ACG T 3 5.01 2 2.0 5 4. 17 I 0.67 I I 2.56 
ACT T 
- -
I 1.0 - - - - I 0.23 
TAC y I 1.69 I 1.0 2 1.67 4 2.67 8 1.86 
TAT y - - - - - - 4 2.67 4 0.93 
GTA V 
- -
I 1.0 2 1.67 - - 3 0.7 
GTC V 2 3.39 4 4.0 5 4. 17 6 4.0 17 3.95 
GTG V - - 4 4.0 3 2.5 10 6.67 17 3.95 
GTT V - - I 1.0 - - I 0.67 2 0.47 
TGG w 2 3.39 I 1.0 3 2.5 1 0.67 7 1.63 
TOTAL 59 100 120 150 429 
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6.6 MULTIPLE SEQUENCE ALIGNMENTS. 
Once proteins with similar homology have been identified from the Web-based BLAST searches, 
those regions exhibiting homology can be further analysed by aligning the protein sequences. 
This can be carried out by most relevant Web-based protein analysis sites. In the case of this 
project multiple sequence alignments were carried out using the Web-based Network Protein 
Sequence @nalysis at Pole Blo-lnformatique Lyonnais. The program used was CLUST AL W 
multiple sequence alignment (Thompson et al., 1994). This program functions to align proteins 
through sequence weighting, position-specific gap penalties and weight matrix choice (Thompson 
et al., 1994). For each of the putative genes identified those proteins bearing the greatest 
homology were used in a sequence alignments. Complete amino acid sequences for the proteins 
from other bacterial species were derived from searching the BLAST database by their Accession 
numbers. Multiple alignments can be found in Figs.6.6, 6.7, 6.8 and 6.9. 
lt was decided to analyse the putative pilin gene in more detail as the other putative genes, 
although interesting, are not relevant to the aims of the project. That is to clone and characterise 
putative virulence genes from B.pseudomallei. 
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Fig.6.6 Alignment of Similar Sequences with the Putative Peroxidase from B.pseudomallei. 1. B.pseudomallei putative Peroxidase (59 
amino acids available). 2. LsfA P.putida (total sequence 212 amino acids). 3. Rehydrin Synecocytis sp. (total sequence 211 amino acids). 
* Asterisks denote identical amino acids; : denotes similar amino acids. 
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Fig.6.7 Sequence Alignment of the Putative Protein (ORF 2) and a Hypothetical Protein in E.coli (Accession AE000352). 1. Putative Protein 
from B.pseudomallei (ORF 2); 2. Hypothetical Protein E. coli. * Asterisks denote identical amino acids; :denotes simjlar amino acids. 
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Fig.6.8 Sequence Alignment of the Putative Protein (ORF 3) with a Hypothetical Protein from E.coli (Accession AE000392). 1: Putative 
Protein (ORF 3) from B.pseudomal/ei. 2: Hypothetical 12.5 k.Da Protein (Accession AE000392) from E.coli. * Asterisks denote identical amino 
acids; : denotes similar amino acids. 
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Fig.6.9 Multiple Sequence Alignment of Proteins with a High Homology to the Putative Pilin Gene Identified on a 5 kbp B.pseudomallei 
DNA Fragment. CLUST AL W Multiple Sequence Alignment (Thompson et al., 1994). 1: B.pseudomallei putative pilin gene. 2: 
Acinetobacter calcoaceticus (comf) (Accession AF027189). 3: P.aeruginosa (pilE) (Accession U02552). 4: Neisseria gonorrhoeae (pilE) 
(Accession Z69262). 5: Moraxella bovis (Prepilin) (Accession L32968). 6: Haemophilus injluenzae (Prepilin) (Accession U327 15). 
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6.7 PREDICTION OF THE BIOCHEMICAL NATURE OF THE 
PUTATIVE PILIN MOLECULE BY WEB-BASED PROTEIN ANALYSIS. 
The amino acid sequence of the putative pilin gene was entered into several Web-based 
protein analysis programs to analyse the biochemical nature of the sequence. 
6.7.1 Secondary Structure Prediction. 
Using the ProtParam tool at ExPASy on the interne!, the molecular weight of the protein was 
predicted to be 15,806 kDa with a theoretical pi of 5.81. A self-optimised method for protein 
secondary structure prediction (SOPM) (Geourjon and Deleage, 1994) was carried out by Pole 
Bio-lnformatique Lyonnais (NBTL) on the internet. By analysing the distribution and nature of 
the amino acids within a sequence the program can make a number of predictions about its 
secondary structure. Each prediction scheme utilises a different algorithm to calculate the 
probability that a given sequence of amino acids will be an a-helix, 13-sheet structure or a turn. 
The results of this can be seen in Fig.6.1 0, which is a consensus sequence of a number of 
different predictions. 
6.7.2 Physio-Chemical Profiles. 
The Network Protein Sequence @analysis (NPS@) program available at Pole Bio-
lnformatique Lyonnais (NBIL) calculates different physio-chemical profiles for the given 
protein. Amongst these are hydrophilicity and hydrophobicity plots, which relates to the water 
relationship of different portions of the molecule. Hydropathy plots are calculated by the 
evaluation of overlapping segments of a given amino acid sequence, with the average score of 
each segment being plotted at its mid-point (Doolittle, 1986). Such plots are useful in 
determining whether a portion of a sequence is likely to be on the outside, or conversely on the 
inside of a protein. It also has uses in determining the presence of certain features, such as 
membrane spanning domains. NPS@ also utilises the method of Hopp and Woods (1981) to 
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determine hydrophilicity and that of Kyte and Doolinle (1982) to determine hydrophobicity 
(Fig. 6.11). As well as a hydropathy plots both flexibility and antigenicity plots were carried 
out as part of the program. Although interesting, their relative value to in this initial 
characterisation of the protein product of the putative pilin gene is questionable. 
6.7.3 Transmembrane Helices Prediction. 
In addition to the other analyses carried out, a program exists on the intemet that calculates, 
based on the sequence of amino acids and their nature, the probability of transmembrane 
helices present in the protein (TMHMM 1.0). This is based on the method of Soonhammer el 
al. ( 1998). The computer output result for this can be seen in Fig.6.12. 
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Fig.6.10 Self-Optimised Method (SO PM) for Protein Secondary Structure Prediction of the Putative Pilin Gene Protein Product Carried 
Out by PBIL SOPM: Alpha helix (h): 36.67% 
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Fig.6.11 Physio-Chemical Profiles of the Putative Pilin Gene Amino Acid Sequence Carried Out By NPS@ at Pole Bio-Informatique 
Lyoonais (NBIL). Profiles (from top to bottom): Hydrophilicity (Hopp and Woods, 1981), Hydrophobicity (Kyte and Doolittle, 1982), Flexibility 
(Karplus and Schulz, 1985) and Antigenicity (Parker eL al., 1982). 
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Fig.6.12 Computer Output of a Transmembrane Helices Prediction Program (TMHMM 
1.0) (Soonhammer et al., 1998). 
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6.8 DISCUSSION. 
The putative peroxidase encoded by ORF I had a very high homology with lsfA of P.putida, 
96% homology at the amino acid level and at the nucleotide level there was 80% identity for 
the available sequence. LsfA is part of a locus (ssu) involved in the assimilation of sulphonate 
and sulphate ester-sulphate in P.putida. The ssu locus comprises seven genes of which lsfA is 
the first. All bacteria require sulphur during growth for the synthesis of protein and of a variety 
of essential enzyme eo-factors, however if not present in this form, bacteria must derive it 
from another form. Sulphonates play an important part in the soil sulphur cycle and Leisenger 
et al. (unpublished) have shown in P.putida and P.aeruginosa that aromatic sulphonates may 
be desulphonated by this novel system which is repressed when favoured sulphate sources are 
present. As B.pseudoma/lei is found in soil it would appear it too might have this novel 
system, although further work sequencing the DNA up-stream of the putative gene is needed to 
investigate whether B.pseudomallei possesses the other genes found in the ssu locus of 
P.putida. Although interesting, it was beyond the aims ofthe study to investigate this further. 
The two putative genes encoded by ORFs 2 and 3 have a high homology to two intergenic 
regions found in the EXUR-TDCC region of E.coli, which encode putative proteins with 
unknown function. It is unlikely that these were responsible for the immunopositivity observed 
and so further work on these putative genes was discontinued. 
However, a putative type IV pilin gene was identified, encoded by ORF 4. Type IV pili are 
adhesins expressed by a number of diverse gram-negative pathogens that cause a variety of 
disease in animals and humans. These include P.aeruginosa, Neisseria gonorrhoeae, 
N.meningitidis, Moraxella bovis, Dichelobacter nodosus, Eikenella corrodens and the more 
distantly related type IV producer Vibrio cholerae (Ottow, 1975; Paranchych and Frost, 1988; 
Shaw and Taylor, 1990; Rao and Progulske-Fox, 1993). The contribution of pili to virulence 
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lies primarily in their ability to promote attachment to various types of receptors during tissue 
colonisation, although now they have also been deemed responsible for a novel mode of 
flagella-independent surface translocation called "twitching motility" (Bradley, 1980) and can 
act as receptors for various bacteriophages (Bradley, 1972). All type IV pili use a similar 
secretion and assembly machinery, made up of at least a dozen polypeptides which are 
functionally and evolutionary related to components of the type 11 secretion pathway or GSP 
from gram-negative bacteria (Pugsley, 1993; Russel, 1998). 
Type IV pili are characterised by the occurrence of N-methylated amino acids (phenylalanine 
or methionine) as the first amino acid of the mature pilin structural subunit. An extensive 
region of amino acid homology is present at the N-terminal end, which is characteristically 
hydrophobic (Patrick and Larkin, 1995). Pilin genes are essentially synthesised as precursors 
with unique, short, basic, amino-terminal leader peptides. Leader sequences are removed by 
endoproteolytic cleavage between an invariant glycine residue and a phenylalanine prior to 
assembly of the pilin monomers into pili. The N-terminal segment is proposed to act as a 
signal that allows nascent molecules to be recognised for transfer to a specific location in the 
cell and serves as a structural element that preserves the integrity of the pilus filament (Russell 
and Darzins, 1994). 
The type IV pilin family can further be divided into two groups, type A and type B. Type A 
consists of pilins from P.aeruginosa, N.gonorrhoeae, N.rneningilidis, M.bovis and D. nodosus 
and Type B include the subunits of the toxin-coregulated pili (TCP) of V. cholera and subunits 
of the bundle-forming pili (BFP) of £.coli (Strom and Lory, 1993). Type 8 pili are 
synthesised with longer leader peptides than those of group A, between 13 and 25 amino acids. 
The putative gene in B.pseudornallei has a leader sequence of 12 amino acids, which is fairly 
long for type A. However, tyrosine residues have been demonstrated in all type A pili, at 
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positions 24 and 27 in the hydrophobic domain, which have not been identified in type B pili. 
The putative type IV pilin gene in B.pseudomallei possesses such tyrosine residues at positions 
24 and 27 (Fig. 6.9) and so is most likely, type A. The tyrosine residues have been shown to be 
at a dimer/dimer interface in both native pili and reassembled pilin filaments, only present in 
type A pili. 
Type IV pili are related through similarities in the primary amino acid sequences of the 
structural subunits, a conserved assembly machinery and a similar mechanism of 
transcriptional regulation (Strom and Lory, 1993). The middle of these sequences 1s 
considerably less homologous and contains variable domains that comprise the antigenic 
epitopes of pili (Strom and Lory, 1993). However, another conserved feature is a pair of 
cysteine residues that function to form a disulphide loop near the carboxy terminus (C-
terminus) of the sequence. Studies concerning pilin structure have found that the C-terminus is 
exposed at the surface of the filament, whereas the hydrophobic N-terminal domain forms the 
pilus inner core, and the two are interconnected by a a-helical region (Forest and Tainer, 
1997). A pair of cysteine residues are present at the C-terminus in the putative B.pseudomallei 
pilin sequence (Fig.6.9). 
lt has been estimated that as many as 20-40 chromosomal genes may be required for type IV 
pilus production in P.aeruginosa (Hobbs et al., 1993) and that the genes required for pilus 
biogenesis in general are not tightly clustered (Russell and Darzins, 1994). The putative pilin 
· gene has homology to pilE of P.aeruginosa, which was shown by Russell and Darzins (1994) 
to be required for pilus biogenesis, as pilE insertion mutants lacked pili and were twitching-
. 'I 
~ vt.'r · \ ,.Ji'' (\ ).ye' ~-,:f! motility deficient. 
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The N-tenninal domain of the B.pseudomallei putative pilin gene contains a relatively 
hydrophobic region (Fig.6.11 ), similar to other pilin genes, which has been shown in other 
studies to be important for membrane translocation; and for pi/A of P.aeruginosa has been 
shown to be important in maintaining the structural integrity of pilin subunit-subunit 
interactions (Russell and Darzins, 1994). 
The putative pilin gene identified in B.pseudmallei is a potential virulence gene that may have 
been responsible for the immunopositive nature of the clone, A.BPGTI. Therefore it was 
decided to continue work with the putative gene to attempt expression of a gene product to 
facilitate further characterisation. 
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CHAPTER 7 
CHARACTERISATION OF THE PUTATIVE PILIN 
GENE FROM B.pseudomallei. 
7.1INTRODUCTION. 
In gene cloning experiments it is necessary to prove that the cloned product is a true 
representative of that which occurs in the organism from which the cloned DNA originates. As 
although precautions are taken, there are opportunities throughout the isolation and cloning 
procedures for contamination to be introduced and for mutations to arise, especially if the 
product is toxic to the host cells. To assess the cloning fidelity, the basic procedure is to use 
the foreign DNA sequence as a hybridisation probe against the genomic DNA of the organism 
from which it was supposedly derived, and to demonstrate that the cloned sequence anneals to 
a homologous genetic DNA fragment through a Southern blot procedure (Southern, 1975). The 
detection of homologous DNA sequences through the method of Southern blotting has made a 
tremendous contribution to molecular biology as it is essential for understanding basic 
problems such as gene structure, gene expression and genome organisation (Meinkoth and 
Wahl, 1984). Probes used in these procedures, in general, can be purified cDNA, a cloned 
fragment of genomic DNA or even a PCR product but in practice the end result of 
hybridisation is clearer if DNA used as the probe is under 2000 bp in length and separated 
from any plasmid vector used for cloning (Darbre, 1999). 
Previous attempts at determining the protein product responsible for the immunopositivity of 
the A.BPGT I clone and its subclone pBPGT2 proved unsuccessful (Chapter 5). However, it 
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was discussed (5.8) that a possible fusion with [3-galactosidase in A.GTII may have been 
responsible for the immunopositive nature of the original clone and on subcloning the 
fragment such expression was lost. On sequencing the 5 kbp fragment in pBPGT2 a putative 
peroxidase gene was discovered (Chapter 6) at the beginning of the sequence and so it may 
have been possible that the part of the gene present was in-frame with the [3-galactosidase 
system. Therefore, the fusion protein created could be responsible for immunopositivity, not 
through encoding an immunopositive antigen, but through a reaction with the detection system 
itself. Immunological screening carried out in Chapter 4 used a peroxidase-conjugated 
secondary antibody and the developing solution therefore included hydrogen peroxide. It is 
feasible that the immunopositive clone produced a [3-galactosidase fusion with the putative 
peroxidase and this was what reacted with the hydrogen peroxide, perhaps therefore 
responsible for the unusual "halo" of reaction encircling the plaque. It was therefore necessary 
to investigate this further. 
Unknowingly at the time, subcloning the 5 kbp fragment further into pCD 1-5 disrupted the 
pilin gene sequence. The initial part of the sequence was contained in pCD3 with the 
remainder of the gene in pCD2. Therefore, to aid expression of this gene a smaller fragment 
containing just the putative pilin gene was subcloned into a plasmid vector. Often it is the case 
that genomic DNA fragments used to construct libraries, especially those from bacteriophage 
vectors are often much larger than the genetic sequence of interest. Consequently, not only will 
the cloned DNA fragment contain non-essential intergenic regions, it may also contain other 
functional gene sequences. Where the goal of cloning gene sequences from an organism is to 
isolate and characterise specific encoded protein molecules, these non-essential regions of 
DNA should ideally be removed from the initial recombinant molecule, which can be achieved 
by subcloning procedures (Singer and Berg, 1991 ). The aim of this was to ascertain whether 
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the putative pilin gene product was responsible for the immunogenicity of the clone or whether 
it was just fortuitously stumbled upon as frequently happens in such scientific research. 
7.2 ANALYSIS OF CLONING FIDELITY: SOUTHERN BLOT 
HYBRIDISATION OF EcoRI CLEAVED B.pseudoma/lei GENOMIC 
DNA. 
To determine the fidelity of the cloning procedure that generated the 5 kbp EcoRI fragment 
that conferred an immunopositive reaction to antisera (Chapter 4), a Southern blot was carried 
out. 
7.2.1 Source of DNA. 
The DNA used in the Southern blotting procedure was that of the B.pseudomallei isolate, 204 
(Table 2.1 ). B.pseudomallei 204 was chosen because it was the isolate used to create the 
genomic library in A.GTII. However, for use in the Southern blotting procedure the genomic 
DNA was purified with the RapidPrep™ Genomic DNA Isolation Kit (Pharmacia Biotech) 
(2.4.4.1 ). 
7.2.2 Creation and DIG-Labelling of the Probe. 
As the 5 kbp fragment had been sequenced it was possible to design PCR primers that could 
amplifY a particular region of the sequence. The PCR product could then be labelled with DIG 
and function as the probe in the Southern blot procedure to check for the presence of this 
particular sequence in the genomic DNA of B.pseudomallei. PCR primers were designed 
(2.8.1) specifically to the putative pilin gene sequence (Fig.6.5), using the DNasis computer 
program. The suggested primers given were checked with the use of Amplify software. 
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The following primers were deemed the most suitable and synthesised at Sigma Genosys: 
Forward primer (PiiF): 5' TCGAACA TGATCCGCAGCACATAG 3' 
Reverse primer (PiiR): 5' GAGAGGCTTCACCTTAATCGAGGT 3' 
These primers were designed to amplify within the 5 kbp target sequence (Appendix Ill) from 
bases 2161 to 2405, yielding a PCR product 244 bp in length. The PCR carried out was a 
standard reaction (2.8.3) with an annealing temperature of 60°C. DIG label (Boehringer 
Mannhein) was incorporated into the PCR product through the reaction (2. 7.1) and the 
concentration of the PCR product was checked by agarose gel electrophoresis alongside /... 
DNA standards. 
7.2.3 Southern Blotting Procedure. 
About 0.3 jlg ofpBPGT2 DNA and 0.5 jlg of B.pseudomal/ei 204 genomic DNA was digested 
with the restriction enzyme EcoRl (2.5.4) and analysed by agarose gel electrophoresis. The 
agarose gel was used in a Southern blot procedure (2.7.2) using the DIG-labelled probe 
prepared in 7.2.2. The results of which can be seen in Fig. 7.1. The 5 kbp insert of pBPGT2 
developed along with a 5 kbp EcoRl fragment in the B.pseudomal/ei 204 genomic DNA 
proving that the cloned fragment indeed originated from B.pseudomallei. 
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23,130 bp ..... 
4,361 bp ..... 
2,322 bp ..... 
1 2 3 
Fig. 7.1 Southern Blot of EcoRI-digested Recombinant Plasmid pBPGT2 and 
B.pseudomallei 204 Genomic DNA Using the DIG-Labelled Putative Pilin Gene PCR 
Product as the Probe to Check the Cloning Fidelity. LANE I: DIG-labelled J.Hindlll 
ladders (from top to bottom) 23, 130 bp, 9,416 bp, 6,557 bp, 4,361 bp, 2,322 bp, 2,027 bp, 564 
bp and 125 bp. LANE 2: pBPGT2/EcoR1. LANE 3: B.pseudomallei 204 genomic DNA/EcoRl . 
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7.3 INVESTIGATION OF THE PUTATIVE PEROXIDASE GENE TO 
DISCOUNT A ROLE IN THE IMMUNOPOSITIVE REACTION. 
it was considered possible that if somehow produced as a fusion protein with the 13-
galactosidase system in A.GT 11 or indeed from its own promoter, the portion of the putative 
peroxidase produced may have reacted with the detection system used in the screening 
process. 
7.3.1 Testing of A.BPGTl with the Detection Solution used in the Initial Screening 
Procedure (Chapter 4). 
A loopful of A.BPGTI was streaked out onto NZCYM media supplemented with 0.2% lactose 
and overlayed with 3 ml of soft NZCYM media also supplemented with 0.2% lactose and 
containing Y I 088 cells to gain single plaques. A negative control of A.GT 11-infected Y I 088 
cells was also streaked out. Plates were incubated at 37°C for 18 h. Areas of well-separated 
plaques were overlayed with nitrocellulose and carefully removed with forceps and placed into 
Blocking Solution for around I h. before placing the nitrocellulose into the developing 
solution. No positive reaction was observed and it was assumed that the immunopositive 
reaction had not been due to the putative peroxidase. 
7.4 SUB-CLONING OF A FRAGMENT OF B.pseudomallei DNA 
ENCODING A PUTATIVE PILIN GENE. 
A smaller fragment containing just the putative pilin gene was subcloned into pUC 18. This 
functioned to separate the putative pilin gene from the rest of the 5 kbp fragment, which may 
interfere with its expression in an E.coli system. Digesting the recombinant plasmid pBPGT2 
with San cuts the 5 kbp fragment (Appendix Ill) at positions 1907 and 2726 to generate an 819 
bp fragment containing just the putative gene which could then be isolated for subcloning. 
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Approximately 2 11g of pUC 18 DNA and 2 11g of p8PGT2 DNA were similarly digested with 
Sail. The products were checked on an agarose gel and a fragment of around 800 bp from the 
digest of p8PGT2 was excised from the gel. This fragment, containing the pilin gene was 
extracted and purified from the agarose slice using the 810-RAD Prep-A-Gene kit (2.4.6.2). 
The digested pUC 18 DNA was treated with alkaline-phosphatase (2.5.5) and purified using the 
810-RAD Prep-A-Gene kit. A standard ligation reaction was set up (2.5.6) with the Sail 
digested pUC 18 DNA and the purified Sail 800 bp fragment isolated from p8PGT2 and 
incubated for 18 h. at I5°C. A transformation using CaCh-treated DH5a cells was carried out 
(2.5.1) and the transformation mix plated out onto L8 media supplemented with ampicillin, X-
gal and IPTG for blue-white screening and incubated at 37°C for 18 h. White colonies obtained 
were cultured in I 0 ml L8 broths and incubated at 3 7°C with shaking for 18 h. After this time, 
5 successful cultures (pSAL 1-5) were subject to small-scale plasmid extractions (2.4.2.1) and 
the isolated plasmid DNA digested with Sail to release a fragment. Only one of these released 
an 800 bp fragment, pSAL2. The recombinant plasmid, pSAL2 was digested with Mlul, as the 
foreign fragment should contain this restriction site (cuts at position 2343), which is not 
present in pUC 18 hence the result should be to linearise pSAL2. The result of these digests can 
be seen in Fig.7.2. 
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Fig.7.2. Agarose Gel Electrophoresis of a Recombinant Plasmid (pSAL2) Containing a 
SaU-Generated Fragment from B.pseudomallei Encoding a Putative Pilin Gene. LANE I: 
1 kbp ladders. LANE 2: pSAL2/Sa/l. LANE 3: pSAL2/Mlul. LANE 4: pSAL2/SalUMZuL 
LANE 5: I kbp ladders. 
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7.5 ATTEMPTS TO DETECT THE MOLECULAR DETERMINANT OF 
THE PUTATIVE PILIN GENE ENCODED ON THE RECOMBINANT 
PLASMID pSAL2. 
Subcloning the fragment further (7.3) functioned to isolate the putative pilin gene away from 
any interfering sequences contained on the 5 kbp fragment as in the initial subclones created 
(pCD 1-5) the pilin gene was disrupted. As expression of the protein product may be low, the 
in vitro transcription and translation kit was applied to the recombinant clone, pSAL2 and to 
aid detection of the product, DNA from a DH5a host containing pUC 18 (the parent plasmid to 
pSAL2) was used as a comparative control. 
7.5.1/n vitro Transcription and Translation of the Recombinant Clone, pSAL2. 
Plasmid DNA from DH5a cells containing pSAL2 and DH5a cells containing pUC 18 was 
isolated using the Qiagen Plasmid Isolation Minikit (2.4.2.4) to gain high quality plasmid 
DNA. The DNA was then used in the in vitro transcription and translation system (as in 5.7) 
using the provided positive control. Products of the reaction were used in SOS-PAGE analysis 
and then subject to Western blotting. No product was isolated in the recombinant clone that 
differed to the negative control used. This was repeated, varying the reaction conditions but no 
product was visualised. 
7.6 ATTEMPTS TO CREATE A FUSION PROTEIN. 
As attempts to express the protein product of the putative pilin gene usmg the in vitro 
transcription and translation kit had failed, as well as many earlier attempts in Chapter 5, it 
was decided to try to produce the pilin gene protein product as a fusion. Problems associated 
with lack of, or poor expression may be overcome by making fusion proteins between genes, 
whereby the cloned gene is introduced into an expression vector at the 3' end of a carrier 
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sequence coding for the amino terminus of a highly expressed carrier protein. The carrier 
sequence provides the necessary signals for good expression and the expressed fusion protein 
contains a N-terminal region encoded by the carrier, which may be 13-galactosidase, MBP 
(maltose binding protein), glutathione-S-transferase or protein A fusions. In this case a fusion 
with 13-galactosidase was attempted. In E.coli the lacZ gene codes for the polypeptide 13-
galactosidase, which is I 021 amino acids long. However, when expression of a foreign gene is 
dependent on its fusion to an E.coli gene, it is important that the correct translational reading 
frame is maintained. Therefore for most gene fusions consideration and possible adjustments 
may need to be made at the gene junction. This method then results in the production of the 
hybrid protein carrying amino-terminal amino acids from 13-galactosidase. Subsequent 
purification of the recombinant protein from a crude cell lysate can be achieved by 
immunoprecipitation with antibodies directed against 13-galactosidase. 
7.6.1 pUC18. 
A fusion was attempted with 13-galactosidase in pUC 18 (Appendix 11) by cloning the gene in-
frame with the system. The strategy behind creating this fusion protein can be seen in Fig. 7.3. 
Approximately I J.lg of pUC 18 DNA was digested with Sail and Aval and the resulting 
plasmid DNA was treated with calf-intestinal alkaline phophatase (2.5.5). Approximately 2 J.lg 
ofpBPGT2 DNA was similarly digested with Sail and Aval, which functioned to cut the 5 kbp 
fragment (Appendix Ill) at positions 1901 and 2501 respectively to produce a 517 bp fragment 
containing the putative pilin gene. The products of the digest were run on an agarose gel and 
the desired band, which was approximately 517 bp was excised from the gel and purified using 
the BIO-RAD Prep-A-Gene kit (2.4.6.2). A standard ligation reaction was set up with the 
digested pUC 18 DNA and the B.pseudomallei DNA fragment (2.5.6) and the resulting ligation 
was used in a transformation with CaCh-treated DH5a cells (2.5.1) and plated out onto LB 
media supplemented with ampicillin, X-gal and IPTG for blue-white screening of 
recombinants. A very low transformation efficiency was observed and those white colonies 
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obtained were cultured in I 0 ml of LB broth at 37°C for 18 h. Small-scale plasmid extractions 
(2.4.2.1) were carried out on cultures, but none were found to contain inserts. This was 
repeated several times with the screening of every colony, including blue ones but none were 
found to contain inserts. 
7.6.2 Other Fusions. 
Alternative vectors were also used to attempt to create fusions with the putative pilin gene 
product and 13-galactosidase, which were pAX5+ and pEX I but again after numerous attempts, 
no recombinants were isolated. 
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The 5 kbp fragment was digested with restriction enzymes Aval and Sail to yield the 
following within the pilin gene: 
5' Aval 3' 
TAC GGT ACA TGC ccc GCG ITA AGC GGG~Cf CCG AAG TGG 
ATG CCA TGT ACG GGG CGC AAT TCG CCC TCG AGA GGC TTC ACC 
M p c T G R N s p s R G F T 
pUC18 was digested with Sail and Aval: 
3' Sail 5' 
cc!c ea~ GTA CCG AGC TCG 
GGG GC CAT GGC TCG AGC 
p G M A A A 
On ligation a fusion protein is created with the following sequence: 
5' 3' 
I I 
GCT CGA GCC ATG CCG AAG TGG 
AGC GCT CGG TAC GGC TTC ACC 
A A A M G p G F 1 
Fig 7.3. Cloning Strategy to Attempt to Produce a Fusion Protein of a Putative Pilin Gene 
Product from B.pseudomallei with the ~-galactosidase System in pUC18. The A and T 
bases highlighted in colour in the fusion protein represent mismatches, but these can often be 
repaired by the E.coli system. 
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7.7 PCR ANALYSIS TO DETECT THE PRESENCE OF THE PUTATIVE 
PILIN GENE IN ISOLATES OF B.pseudomallei and B.thailandensis. 
The putative pilin gene was cloned from the B.pseudoma/lei isolate 204 and so to test other 
isolates for the presence of the fragment, the PCR primers designed in 7.2.2 were used to test 
isolates of B.pseudomal/ei and B.thailandensis (Table 2.1 ). The PCR primers were specifically 
designed to the putative pilin gene sequence and so by using genomic DNA from a number of 
isolates and carrying out a PCR reaction using the primers, a PCR product of the correct size 
(244 bp) may indicate the presence of the fragment. The PCR reaction does not show whether 
the sequence is transcribed in the particular isolates, but it was used to observe any differences 
between the virulent B.pseudomallei and the avirulent B.thailandensis. 
Approximately 20 ng of genomic DNA was used in each PCR reaction with the same reaction 
conditions used in 7.2.2. The annealing temperature was dropped to 55°C as results tried at 
60°C were very faint and even at the lower temperature the reaction products were taint. This 
was tried a number of times but results could not be improved upon. Results can be seen in 
Fig.7.4. 
1t was observed that none of the B.thailandensis isolates tested produced a PCR product. 
However, not all of the B.pseudomallei isolates produced a PCR product but this does not 
necessarily mean that the sequence is not present. lt may have been that the genomic DNA 
used was of a poor quality and contaminants may have inhibited the reaction, or that the PCR 
itself was unreliable. To investigate this further, it was decided to carry out a Southern blot 
procedure, which has a higher stringency than a PCR reaction to confirm the results obtained. 
-- ~-
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 1516 17 18 1920 21 22 23 24 25 26 27 28 29 30 31 32 
500 bp 
lOO bp 
LANE ISOLATE LANE ISOLATE LANE ISOLATE 
1 1 kbpLadders 12 I kbpLadders 23 1 kbpLadders 
2 -ve control 13 22 24 212 
3 204 14 25 25 216 
4 E27 15 E25 26 217 
5 E82 16 33 27 392 
6 E255 17 46 28 E254 
7 E256 18 53 29 426 
8 E260 19 97 30 448 
9 E8 20 98 31 576 
10 19 21 102 32 I kbp_ Ladders 
11 l kbpLadders 22 1 kbpLadders 
Fig.7.4. Agarose Gel Electrophoresis of PCR Products Using Primers Designed to a Putative Pilin Gene Identified in the B.pseudomallei 
Isolate 204 on Isolates of B.pseudomallei and B.thailandensis. Of the isolates tested, those highlighted had a PCR product of approximately 250 
bp. 
7.8 SOUTHERN BLOTTING ANALYSIS OF ISOLATES OF 
B.pseudomallei AND B.thailandensis FOR THE PRESENCE OF THE 
PILIN GENE FRAGMENT. 
7.8.1 Source of DNA. 
The DNA used in the Southern blotting procedure was from isolates shown in Tables 2.1 and 
2.2. Genomic DNA from the following species was isolated using the Puregene® Genomic 
DNA Isolation Kit: B.vietnamensis (LMG 6998, LMG 6999, LMG 10926), B.plantarii (LMG 
10908), B.cocovenans (LMG 11626), B.vandii (LMG 10620) and from the University of 
Plymouth's culture collection, genomic DNA from strains of P.aeruginosa, P .jluorescens and 
E. coli DHSa. To a 0.5 ml of overnight culture in a MCC tube, 0.5 ml of Cell Suspension 
solution was added and the cells pelleted by centrifugation at 13,000 x g for 5 sec. The 
supernatant was removed and 300 j.ll of Cell Lysis solution added and the mixture incubated at 
80°C for 5 min. A 1.5 j.ll volume of RNase A solution was added, mixed and incubated at 37°C 
for I h. The samples were cooled to room temperature and I 00 Ill of Protein Preparation 
solution was added, vortexed and the preparation centrifuged at 13,000 x g for 3 min. The 
supernatant was transferred to a new MCC tube and precipitated with isopropanol. Finally, the 
pellet was resuspended in 50 Ill of DNA Hydration solution by incubating for I h. at 65°C. 
7.8.2 Southern Blotting Procedure. 
Approximately I j.lg of genomic DNA from B.pseudomallei, B.thailandensis and other 
bacterial species used was digested with EcoRI. Portions of the digests were run on agarose gel 
to check that the digests were successful and to give an indication of the concentration of 
DNA. A suitable volume of the digests were run on an agarose gel for use in the Southern 
blotting procedure (2.7.2). This was carried out using the DIG-labelled PCR product (7.2.2) as 
the probe. The results of the Southern blot can be seen in Fig.7.5. 
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LANE ISOLATE LAJ'ffi ISOLATE LANE ISOLATE LANE ISOLATE LANE ISOLATE LANE ISOLATE 
1 HindUl MARKERS 8 216 15 98 22 MARKERS 29 B. vietnamensis LMG 6999 36 DHSa. 
2 pBPGTI 9 448 16 102 23 MARKERS 30 B.plantarii 
3 204 10 22 17 212 24 £256 31 B.cocovenans 
4 £8 11 33 18 217 25 £255 32 B.vandii 
s 19 12 46 19 392 26 £260 33 B.cepacia I 
6 25 13 53 20 426 27 £38 34 P.aeroginosa 
7 £25 14 97 21 £82 28 MAL6 35 P .jluorescens 
Fig.7.6 Southern Blot Hybridisation of EcoRI cleaved B.pseudomallei, B.thailandensis and Closely Related Species' Genomic DNA to 
Detect for the Presence of a Putative Pilin Gene Fragment. 
The Southern blot revealed again that none of the B.thialandensis isolates tested appeared to 
contain the fragment containing the putative pilin gene. The other Burkholderia species used 
similarly did not develop a band on Southern blotting. However, all of the B.pseudomallei 
isolates tested developed a band of approximately 5 kbp and therefore posses the DNA 
tfagment containing the putative pilin gene. 
7.9 ATTEMPTS TO CREATE A MUTANT OF THE PUTATIVE PILIN 
GENE. 
Attempts were made to create a knock-out mutant of the putative pilin gene in the suicide 
vector, pCVD442. The vector was kindly donated by Dr.R.Titball, Porton Down, Salisbury 
and it was hoped that the mutant created could be tested at Porton Down to ascertain whether 
the putative pilin gene has a role in the virulence of B.pseudomallei. The strategy involves the 
introduction of a DNA insert into the gene under study to produce defective mutants. However 
the insertion of DNA in this case provides a new functional element that is resistance to the 
antibiotic, kanamycin. 
7.9.1 Propagation ofthe Plasmid. 
The plasmid pCVD442 can only replicate in strains that have the pir gene, usually supplied by 
a A. lysogen encoding the Pi protein, which is necessary for the replication of this plasmid. A 
suitable A. lysogen, SY326 was kindly supplied by Mr Derrick Pickard, Imperial College, 
London and the vector was transformed into this. 
7.9.2 Cloning a Kanamycin Cassette into pCVD442. 
It was decided that the most suitable antibiotic to use in such a study with B.pseudomallei was 
kanamycin, which was already the chosen antibiotic for use with mutants at Porton Down. The 
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kanamycin resistance gene from pGD 103 (Appendix 11) was removed with the restriction 
enzymes Clal and EcoRI, and attempts were made to clone this into the suicide vector 
pCVD442. However, the vector proved to be highly unstable and degraded very quickly once 
isolated from the organism it was transformed into. The plasmid was purified via CsCI/EtBr 
density ultracentrifugation and re-transformed into a number of hosts, but degradation 
continued to occur. 
7.10 DISCUSSION. 
Expression of the putative pilin gene from B.pseudomallei in an E.coli system proved 
unsuccessful even when attempts were made to incorporate the protein product as a fusion 
with 13-galactosidase. Synthesis of a functional protein depends upon successful transcription 
of the appropriate gene, efficient translation of the mRNA and, in many cases, post-
translational processing and compartmentalisation of the nascent polypeptide. A failure to 
perform any one of these processes can result in the failure of a given gene to be expressed. 
However the use of the in vitro transcription and translation kit should overcome these 
fundamental problems. One factor is that the pilin gene does indeed require post-translational 
modifications in the form of the cleavage of its signal sequence by a specific protein, which is 
highly unlikely to be present in the E.coli system. This may therefore have prohibited the 
expression of the protein. Similar problems were encountered by Russell and Darzins ( 1994) 
when attempting to express pilE from P. aeruginosa in E. coli as an orientation-dependent 
production of the estimated 15 kDa polypeptide could not be demonstrated. In this case the 
authors resorted to expressing pilE in a P. aeruginosa T7 expression system. 
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However, there is still the factor of the relative stability of foreign proteins in E.co/i. The 
putative gene was initially cloned, and presumed to be expressed if indeed it was responsible 
for making the clone immunogenic, into A.GT 11, with the use of a host deficient in the Ion 
protease. Such a host has a reduced complement of intracellular proteases, thus increasing the 
stability of foreign proteins. However, once the gene was cloned into the plasmid vector 
pUC 18 this did not apply, which could a reason for the lack of expression observed. 
The putative gene was placed under the control of an E. coli promoter in an attempt to produce 
a fusion protein. In the design of the fusion with the !3-galactosidase system in pUC 18 there 
were a couple of mismatched bases, which would function to decrease the efficiency of 
ligation and therefore many more clones needed to be screened in order to isolate one in which 
the E.coli system had repaired the mismatches. Hundreds of colonies were screened, 
irrespective of whether they were white or blue, as often recombinants can still appear a blue 
colour, without any success. As none of the transformants contained inserts, it could be that 
the mismatched bases were so rarely repaired by E.coli that the screening of hundreds more 
colonies was necessary in order to find one, or simply that the production of a fusion with the 
B.pseudomallei protein was deleterious to the cell and the fragment was therefore deleted. 
Alternative vectors were tried that contained no mismatches and that had a lower copy number 
than pUC 18. Numerous attempts at cloning the putative pilin gene in such vectors were carried 
out again with no success. The reasons for this could be that the fusion protein produced, even 
at a low level, is deleterious to the E.coli host or perhaps that to produce the fusion 
successfully, the first few amino acids of the foreign protein were needed. These were not 
incorporated into the fusion protein, as the transcriptional reading frame would have been 
disrupted. 
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The experiments used to determine the presence of the putative pilin gene sequence in other 
isolates of B.pseudomallei and in the avirulent species, B.thai/andensis, showed that the 
sequence was not present in any of the B.thailandesis isolates tested but Southern blotting 
confirmed its presence in all B.pseudomallei isolates tested. Thus indicating that the gene 
sequence is not present in the avirulent species, but present in the virulent B.pseudomallei 
species, suggesting therefore a potential role for the pilin gene in the virulence of 
B.pseudomallei. There is no information in current literature confirming whether members of 
the B.thailandensis species possess type IV pili, although type IV pili have been confirmed in 
B.pseudomallei isolates (Vorachit et al., 1995; Woods et al., 1999). Interestingly in the study 
by Vorachit et al. (1995) it was observed that some isolates did not produce pili and these 
adhered to surfaces as dispersed, individual cells rather than biofilms, which was the method 
of adherence for those possessing pili. It may well be the case therefore that the non-piliated 
isolates were actually avirulent B.thailandensis rather than B.pseudomal/ei. 
Unfortunately a mutant could not be constructed with the suicide vector, pCVD442 to 
elucidate the role of the putative gene in the virulence of B.pseudomallei. However, when the 
suicide vector was donated, it was stated that problems were often encountered when trying to 
clone with the vector (Petra Oyston, personal communication). 
Regrettably, a size and a probable function could not therefore be elucidated for the putative 
pilin gene. Also, very importantly, it could not be proven that it was this gene product 
responsible for the immunopositive nature of the original clone A.GTBPI. Other type IV pilin 
genes have allegedly been cloned by Woods et al. (1999) with homology to pi/B, pi/C and 
pi/D of P.aeruginosa and the putative gene cloned in this study has homology to pilE of 
P.aeruginosa, although it may have a different function in B.pseudomallei. 
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The pilE gene of P.aeruginosa has been studied in some detail, although a definitive function 
has yet to be assigned. Russell and Darzins (1994) managed to generate two chromosomal pilE 
insertion mutants, which were broadly resistant to pilus-specific phages and additionally 
unable to translocate across solid surfaces in a twitching motility assay. The mutants, although 
they produced unassembled pilin pools, failed to assemble pili. However, Russell and Darzins 
( 1994) have implicated pilE in P.aeruginosa as a pilot that guides pi/A subunits to and from 
the assembly platfonn during the alternating mechanisms of pilus polymerisation. It has also 
been suggested that pilE functions as a component of the pilus assembly apparatus by capping 
and uncapping the interactive surfaces of pilin subunits that have been translocated across the 
cytoplasmic membrane (Russell and Darzins, 1994). 
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CHAPTERS 
USE OF PCR TO SCREEN FOR THE PRESENCE OF AN ADP-
RIBOSYLA TING TOXIN IN B.pseudomallei. 
8.1 INTRODUCTION. 
Pathogenic bacteria have evolved mechanisms for evading the defence systems of their hosts 
and for destabilising the cell's functional system, of which perhaps the commonest and most 
effective way of achieving this is to produce toxins (Balfanz et al., 1996). In particular, ADP-
ribosylating toxins have been the focus of research for more than 30 years, providing 
invaluable insights into their structure and function, which may be the key to the prevention 
and treatment of diseases caused by such toxin-producing bacteria. It has been reported that 
B.pseudomallei possesses a toxin belonging to the ADP-ribosylating class of bacterial 
exotoxins, and more specifically to ADP-ribosylate elongation factor 2 (EF-2) (Mohamed et 
al., 1989: lsmail et al., 1991 ). Diphtheria toxin (DT) and P.aeruginosa Exotoxin A (ET A) also 
catalyse the ADPcribosylation of EF-2 (Van Ness et al., 1980) at a dipthamide residue in a 
stereochemically identical manner (Patrick and Larkin, 1995). EF-2 is a tRNA translocase 
responsible for the translocation of the growing polypeptide chain from the aminoacyl-tRNA 
to the peptidyl-tRNA position at the ribosome, the energy for which is created through the 
hydrolysis of GTP (Balfanz et al., 1996). The overall effect of the toxin therefore, is to inhibit 
protein synthesis, leading to inevitable cell death. Diphtheria toxin is synthesised as a protein 
with an approximate molecular weight of 62 kDa, which is enzymatically cleaved to produce 
two fragments, A and 8, with molecular weights of 21 and 40 kDa respectively 
(Pappenheimer, 1955; Gill and Din ius, 1971 ). The A fragment is responsible for the enzymatic 
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properties of the toxin and the B fragment is thought to be involved in attachment and entry of 
the toxin into the target cell. ETA is synthesised in the form of a proenzyme with an 
approximate molecular weight of 66 kDa, which has to undergo conformational change before 
it becomes toxic. lt is Domain Ill that contains the enzymatic activity of the molecule, that is, 
catalysing the transfer of ADP-ribose from NAD to EF-2 in eukaryotic cells. 
The resemblance in the mode of action of DT and ETA corresponds to similarities in the 
amino acid sequence of the toxins, especially in the region of the NAD+ binding site 
(Domenighini et al., 1991 ). However, their catalytic and receptor-binding domains are located 
at opposite ends of the molecules, with the catalytic domain being at the amino terminus in DT 
and at the carboxyl terminus in ET A (Aktories, 1992). Early studies on these toxins indicated 
that although the two primary amino-acid sequences showed little overall homology there is 
homology within the NAD+ binding site where, for example, Glu-148 of DT and Glu-553 of 
ET A are homologues within this site (Carroll and Collier, 1988). This strongly suggests that 
both these enzymatic domains originated from a common ancestral protein and that there is a 
common evolutionary origin of all ADP-ribosylating enzyme toxins (Patrick and Larkin, 
1995). 
PCR is a very powerful technique for the molecular biologist and has found many applications 
in its basic form. The technique can be applied in investigations to compare the sequence 
homology of conserved genes in different organisms. In the case of this project, although a 
toxin with ADP-ribosylating activity has been reported and purified in culture filtrates of 
B.pseudomal/ei, the gene encoding the toxin has yet to be cloned and sequenced. However, 
other ADP-ribosylating toxins of closely related organisms, such as P.aeruginosa ET A have 
been cloned and sequenced, and so it is possible to use the sequence information available. As 
'I I 
' 
the toxin in B.pseudomallei has been reported to have the same mode of action as ET A, PCR 
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primers were designed to the most conserved region of these toxins, the active site. Therefore 
by using the primers developed in a PCR reaction with B.pseudomallei genomic DNA, a 
corresponding product may be amplified if there is a high homology between the genes of the 
two toxins. Products of the PCR reaction can be cloned into plasmid vectors for DNA 
sequencing which may identify the PCR product amplified as part of a gene encoding the 
ADP-ribosylating toxin in B.pseudomal/ei. 
8.2 PRIMER DESIGN AND INITIAL EXPERIMENTATION. 
PCR primers were designed in consultation with Dr. M. L Gilpin, based on sequence analysis 
available for the ET A produced by P.aeruginosa (Gray et al., 1984). The primers were 
designed to regions around the active site of the gene (Fig.8.1 ). The following primers were 
synthesised by Sigma-Genosys: 
Forward primer (I F) 5' GGCGACGTCAGCTTCAGC 3' 
Forward primer (2F) 5' CGAAGCGATCCGCGAGCA 3' 
Forward primer (3F) 5' CCTGCTGGAGCGCAACTA 3' 
Reverse primer (I R) 5' GCTCGAGCGCGGCACAT A 3' 
Reverse primer (2R) 5' A TCGCGTCGAGGTCCTGG 3' 
Reverse primer (3R) 5' AATCACCACGGTGCGCTC 3' 
203 
2F 
la 
DOMAIN I 
TWO NON-CONTIGUOUS REGIONS 
INVOLVED IN CELL RECOGNITION 
DOMAINll 
ll MEMBRANE TRANSLOCATION 
lb 
2R DOMAIN Ill 
Ill ADP-RJBOSYLATION OF EF'2 
Fig.8.1 Primer Design to the Active Site of the ETA Gene in P.aeruginosa (Gray et al., 
1984). The figure represents the structure ofthe ETA gene of P.aeruginosa, which includes all 
three domains of the gene responsible for differing functions. The thick dark green line 
represents the coding region for the active site of the toxin and the blue lines indicate where 
the primers were designed. 
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Synthesised primers were resuspended to give an overall concentration of I 00 pmol/lll (2.8.2). 
A standard PCR reaction was used (2.8.3) with an annealing temperature of 60"C. Genomic 
DNA from B.pseudomallei isolates 204, 576, 4845 and E8 and B.thailandensis isolates 82, 27 
and 25 (Table 2.1) were used in the PCR reactions. In the initial experiments, different 
combinations of the forward and reverse primers were used. It was found that using the primer 
combination, 2F and I R yielded a PCR product with some of the isolates at around 500 bp 
(Fig.8.2), which was close to the expected product of 600 bp based on the primers 2F and I R 
annealing to the correct sequence in the P.aeruginosa ET A gene. lt was noted that products 
were only obtained with B.pseudomallei isolates and not with the avirulent B.thailandensis 
isolates used, with the exception of B.pseudomallei isolate 4845. Also that isolate 204 had an 
additional band amplified at around 900 bp. 
8.3 CLONING THE PCR PRODUCT INTO A PLASMID VECTOR. 
8.3.1 Isolation of PCR Products for Cloning. 
From the initial experiments it was decided to clone the PCR products amplified with 
B.pseudomallei isolates 576 and 204 for eventual sequence comparison. A PCR reaction was 
carried out with both isolates using the same reaction conditions and primers as in 8.2 and the 
products were run on an agarose gel. The PCR products obtained were of a very low 
concentration and so the reaction products gained were re-amplified usmg the same PCR 
reaction. The re-amplified products were visualised on an agarose gel and bands of 
approximately 500 bp were excised from the agarose gel and the DNA isolated by 
electroelution (2.4.6.1 ), and purified by using the 810-RAD Prep-A-Gene kit (2.4.6.2). The 
additional 900 bp PCR product observed in the initial experiment with B.pseudomal/ei 204 
DNA failed to be amplified again in a number of PCR reactions carried out. 
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1 2 3 4 5 6 7 8 9 
900 bp 
500 bp 
Fig.8.2 PCR Products Obtained in a Reaction Using Isolates of B.pseudomallei and 
B.thailandensis to Ascertain the Presence of an ADP-Ribosylating Toxin Sequence. 
LANE I: 4845. LANE 2: 576. LANE 3: 204. LANE 4: 82. LANE 5: 27. LANE 6: 25. LANE 
7: E8. LANE 8: -ve control. LANE 9: lOO bp ladders. 
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8.3.2 Cloning the PCR Products. 
The PCR products from both isolates 204 and 576 were cloned into pUC 18 using the 
SURECLONE™ Kit (Pharmacia) (2.5.7) and the ligation products were transformed using 
DH5a competent cells (2.5.3.2). Transformations were plated out onto LB media 
supplemented with ampicillin, X-gal and IPTG for blue-white screening, and incubated at 
37"C for 18 h. Afterwards, 10 white colonies from the 204 transformation (pAD 1-1 0) and I 0 
from the 576 transformation (pOP 1-1 0) were cultured in I 0 ml of LB broth supplemented with 
ampicillin and incubated at 37°C with shaking for 18 h. Next, small-scale plasmid extractions 
(2.4.2.1) were carried out on all cultures. Restriction enzyme EcoR1 and Pstl cleavage sites are 
located either side of the Smal site in pUC 18 (Appendix 11), which was the blunt-ended site 
used to clone fragments in the SURECLONE™ kit. Therefore, by digesting recombinant 
plasmid DNA with these enzymes it functions to release the foreign DNA insert. Therefore, 
the resulting plasmid DNA was digested with EcoRl and Pstl and the products of the digests 
were analysed by agarose gel electrophoresis. Bands of approximately 500 bp were identified 
in all of the plasmid digests. A recombinant plasmid from each of the isolates 204 and 576, 
pADI and pDPI respectively, were cultured in 500 ml of LB broth supplemented with 
ampicillin and the plasmid DNA extracted using the Wizard Maxiprep kits (2.4.2.3). 
Approximately 0.5 !lg of pAD I and pOP I DNA was digested with restriction enzymes Pstl 
and EcoRI and the results of the digest was visualised by agarose gel electrophoresis to check 
that the plasmids still contained an insert (Fig.8.3). Both pAD I and pOP I released a 500 bp 
insert and approximately 30 !lg the plasmid DNA from both isolates was sent to Dr. R. Titball, 
Porton Down for DNA sequencing. 
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12 kbp ..... 
2 kbp ..... 
I kbp ..... 
..... 
0.5 kbp 
l 2 3 4 5 6 7 
Fig.8.3. Agarose Gel Electrophoresis of Restriction Enzyme Digests of Recombinant 
Plasmids with EcoRI and Pstl to Release Cloned DNA Inserts. LANE l: I kbp ladders. 
LANE 2: pUCL8/EcoRI. LANE 3: Undigested pDPI. LANE 4: pDPI/EcoRI/Pstl. LANE 5: 
Undigested pAD I. LANE 6: pADI/EcoRl/Pstl. LANE 7: I kbp ladders. 
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8.4 SEQUENCE ANALYSIS OF pAD I and pDPl. 
8.4.1 The Complete Sequence of pAD I and pDPI. 
The sequence information received from Dr. R. Titball, Porton Down, showed that the two 
PCR products had identical nucleotide sequences, which can be seen in Fig.8.4. The total 
length of the sequence was 453 bp, including primer sequences. 
8.4.2 Sequence Analysis of the PCR Product. 
Firstly an alignment (BLAST 2 sequences program available at Genbank) was carried out 
between the nucleotide sequence of the PCR product and that of the ET A gene of 
P.aeruginosa. This showed that there was no significant homology at the nucleotide level 
between the two sequences. The sequence received was then translated into an amino acid 
sequence in all six possible reading frames, using the DNasis software. Again, no homology 
could be found at the amino acid level in any of the translations between the two sequences. 
Investigations into amino acid sequence homologies within the active sites of different ADP-
ribosylating toxins have been carried out (Rappuoli and Pizza, 1991) the results of which can 
be seen in Fig. 8.5. The amino acid translations of the sequence received was searched for any 
of the patterns in Fig.8.5 without success. 
Web-based BLAST-X searches were carried out for the ammo acid translations of the 
sequence, but little information could be derived from this. lt was decided that as the PCR 
reaction failed to amplify a product with any of the B.thailandensis isolates tested but gave a 
result for most of the B.pseudomallei isolates tested that the sequence could be of interest and 
to pursue it further by obtaining sequence information up and down-stream of the fragment. 
The fragment might encode a toxin slightly different to the other ADP-ribosylating toxins 
discovered, or perhaps it is part of a sequence encoding another putative virulence factor in 
B.pseudomallei. 
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2F 
1 GAGCTCGGTA CCCCGAAGCG ATCTGCGAGC ATCTCAATCA ACATTCGGGC 
51 CCGGGAATCG ACTATGCCGT ACGATGAAAT TCTGCCTATT GAAACGCTGG 
101 TTCGACCCAA AGTATCGGAC TTCCGCGAGC ATTACCTCGA AAAAGAGCGC 
151 CCGGTGAAAA TCGCGAGGGC GCTCGATGCG TGGCCGGCGA TGCAGAAGTG 
201 GTCGCTCGAC TATTTCGAGA ATCGTTTCGG CGACGAGACC ATCGGCGTCG 
251 AGAGCTTTCA GCCTGACGAG CGCGGGCCCG GCAACAACAG CCCGCAAGGT 
301 TACGTCAAGC ACTTGCGTTT CCAGGAGCTC AAGCTCAAGG AAACTGATCC 
351 GGATCTTGCG AACGAAGCCG GACCACATGT ACTACATGGC GTCGCATCCG 
401 TTTCGCAAGA GCTTTCCGAA CCTGCGCGCC GATCTCGCGC CGCATCYGTA 
lR 
451 TGTGCCGCGC TCGAGCGGG 
Fig.8.4 Nucleotide Sequence of the PCR Product from B.pseudomallei Isolates 204 and 
576 Using Primers Designed to the Active Site of ETA of P.aeruginosa. The sequence 
includes both primers sequences (in red) and sequences in green represent vector DNA. Y 
represents a pyrimidine base (C or T). 
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PAETA ~6 ~ V G y H G T F L E 464 A w R G F y (8) y G y 
DT 17 F s s y H G T K p G 49 D D w K G F y (10) y 
PT 31 N V L D H G R s 82 G H F G y y (7) F 
CT 40 N L y D H A R G T Q 79 G H s T y y y (8) F 
LT 40 N L y D H A R G T Q 79 G y s T y y y (8) F 
PAETA 545 p · ~ E G G R L D L G ~ p N DT 140 F A E G s s s V E y N N E 
PT 121 G A L A T y Q s E y L : ~~ : CT 119 I p y s Q I y G w y R 
LT 119 I p y s Q y G w y R V N F G 
Fig.8.5 Homologies Between the Active Sites of a Number of ADP-Ribosylating Toxins (Rappuoli and Pizza, 1991). P.aeruginosa ETA 
(PAETA), Diphtheria toxin (DT), Pertussis toxin (PT), Cholera toxin (CT) and E.coli heat-labile enterotoxin (LT) 
8.5 ISOLATION OF A LARGER FRAGMENT FROM B.pseudomal/ei 
CONTAINING THE PCR PRODUCT. 
It was decided to use the PCR product as a probe to isolate a larger fragment of 
B.pseudomal/ei DNA containing this DNA sequence, so that sequence information up and 
down-stream could be analysed. The probe was used to screen a B.pseudomallei 204 A.GEM 11 
genomic library constructed by Mr M. Mahfouz, University of Plymouth. This was used in 
preference to the A.GTII library created (4.4) as A.GEMII (Fig.8.6) is not an expression vector 
and so potentially toxic genes may be more stable within this system. 
8.5.1 DIG-Labelling of the PCR Product from B.pseudomallei 204 (pADl ). 
A DIG label was incorporated into the sequence through a PCR reaction. The PCR was set up 
as in 8.2 using primers 2F and I R and B.pseudomallei 204 as the template DNA, and 5 111 of 
DIG-UTP was incorporated into the reaction (2. 7 .I). The concentration of the DIG-labelled 
PCR product was checked by running an aliquot of the reaction products on an agarose gel. 
8.5.2 Probing a A. GEM 11 Gene Bank. 
A A.GEM 11 genomic library was constructed with 204 B.pseudomallei genomic DNA by Mr 
M. Mahfouz. This was achieved by partially digesting 204 B.pseudomal/ei genomic DNA with 
Sau3A and cloning fragments into A.GEM I I BamHl arms (Promega), using E. coli LE392 as 
the host. Plates were set up using the same method as in 4.4.2, to have around I 000 plaques 
per plate. 
Nitrocellulose filters were placed onto plates as in 4.5. Once removed, filters were washed 
firstly with distilled water for 2-3 min. followed by 20X SSC for 2-3 min. Washed filters were 
placed in-between 2 pieces of filter paper, kept in place with paper clips and baked in an oven 
at 80°C for 2h. in a vacuum (20 Hg/500 mmHg). Afterwards, filters were incubated with 
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Hybridisation Solution for 2 h. at a volume of 5 ml per 100 cm2 of membrane, at 68°C in a 
hybridisation oven. During this time, the probe created in 8.5.1 was denatured by heating to 
95°C for I 0 m in in a PCR machine and placed directly onto ice. The Hybridisation Solution 
was replaced with fresh Hybridisation Solution and the denatured probe was also added, at a 
concentration of approximately 120 ng and incubated for 18 h. at 68"C. Next, filters were 
washed twice with 50 ml of Wash Solution I at 20"C for 5 min., followed by twice with 60 ml 
of Wash Solution 11 for 15 min. at 68°C. Afterwards, filters were washed for I min. in 20 ml of 
Detection Buffer I. The antibody conjugate (anti-AP) was diluted I :5,000 in Detection Buffer I 
and the filters incubated for I h. with 25 ml of the diluted antibody conjugate at 20°C. 
Following incubation, filters were washed twice in I 00 ml of Detection Buffer I for 15 min. at 
20°C. and equilibrated for 5 min. in 30 ml of Detection Buffer Ill before adding the Colour 
Development Solution (NBT/X-phosphate system). Positive plaques appeared brown in colour 
after I h. and filters were washed in Detection Buffer IV to stop the colour reaction. Positive 
plaques were identified and picked (2.3.2.1) along with several negative controls. Positive 
phage were re-screened as before and seven positives in total were selected (A.BP 1-7). 
8.5.3 Isolation of Recombinant Phage DNA. 
High titre stocks of positive phage were made from confluent lysis plates (2.3.2.2) and the 
stock was titred (2.3.1) before extracting the recombinant phage DNA using Wizard® Lambda 
Preparations (Promega) (2.3.3.1 ). Resulting phage DNA was purified using the BIO-RAD 
Prep-A-Gene kit (2.4.6.2). 
8.5.4 Restriction Digests of Recombinant Phage DNA to Estimate the Insert Size. 
The A.GEM 11 genomic library was created using a Sau3A partial digest of 204 B.pseudomallei 
genomic DNA ligated into the BamHI site of A.GEM 11. Therefore, only foreign DNA 
fragments between 9 and 23 kbp were cloned. There are Sacl cleavage sites either side of the 
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BamHI site (Fig.8.6) hence digestion with Sacl releases the cloned DNA fragment, and the 
pattern of bands observed will reflect any internal sites. Approximately 0.3 Jlg of A.BPI-7 
DNA was digested with Sail and the results were analysed by agarose gel electrophoresis (Fig. 
8.7). Similarly, the recombinant phage DNA was digested with the restriction enzyme Xhol 
(Fig. 8.8), which also has cleavage sites either side of the Barn HI site. The restriction enzyme 
EcoRI (Fig 8.9) was also used, which has no cleavage sites on BamHI-digested A.GEM 11 DNA 
and so will only cut internally, therefore reflecting any EcoRI sites on the foreign DNA 
fragment. All digests were heated to 65°C for I 0 min. before running on an agarose gel. In 
most digests there appears two bands, one situated above the 12 kbp band at the top of the I 
kbp ladders, which represents the Left Arm of the vector (20 kbp) and one at 9 kbp which is 
the Right Arm of the vector. 
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Sacl Xlwl Bamm A vrii EcoRI Xbal EcoRI Avrll BamHI Xlwl Sacl 
I I I I I I I I I I I I 
LEFT ARM (20 kbp) CENTRAL STUFFER (14 kbp) RIGHT ARM (9 kbp) 
A.GEMll 
Fig.8.6 Tbe Bacteriophage Cloning Vector, A.GEMll . Restriction enzyme cleavage sites are shown for the insertion of foreign DNA 
fragments either side of the central stuffer region. 
LANE 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
1 2 3 4 5 6 7 8 9 10 11 
12 kbp ..... 
2 kbp ..... 
I kbp ..... 
500 bp ..... 
DNA/DIGEST 
I kbp Ladders 
Uncut A.BPI 
A.BPI/Sa/1 
A.BP21Sall 
A.BP3/Sa/I 
A.BP4/Sall 
A.BP5/Sall 
A.BP6/Sall 
A.BP7/Sall 
pUC18/Sall 
I kbp Ladders 
Number of Bands Relative Size of 
Bands (kbp) 
- -
- -
8 0.6, 0. 75, 1.1 , 1.5, 
2.0, 2.2, 6.0, 
• -
4 0.75, 2.0, 2.2, 6.0 
7 0.55, 0.7, 1.2, 1.3, 
2.2, 6.0 
• -
• -
7 0.5, 1.2, J .4, J .9, 
2.2, 4.0 
- -
- -
Total Size (kbp) 
-
-
14.15 
-
10.95 
11 .95 
-
-
11 .20 
-
-
Those marked with a star(*) indicate that a partial digest was obtained and so analysis of the 
fragments yielded cannot be carried out accurately. 
Fig.8.7 Agarose Gel Electrophoresis of Recombinaot A.GEMll Phage (A.BPl-7) Digested 
with San. 
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12 kbp ..... 
3kbp ..... 
lkbp ..... 
500 bp ..... 
LANE 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 2 3 4 5 6 7 8 9 10 
DNA/DIGEST Number of Bands Relative Size of Total Size (kbp) 
Bands (kbp) 
I kbp Ladders - -
-
Uncut pUCI8 
- - -
A.BPI!Xhol 5 0.8, 1.3, 1.9, 2.0, 13.7 
2.6, 5.0 
A.BP2/Xho1 3 2.3, 3.4, 4.0 9.9 
A.BP3/Xhol 6 0.6, 1.2, 1.8, 1.9, 13.8 
3.3, 5.0 
A.BP4/Xhol 6 0.8, 1.0, 1.2, 1.6, 8.6 
1.9, 2.1 
ABP5/Xhol 7 0.8, 1.0, 1.2, 1.4, 10.0 
1.6, 1.9, 2. 1 
A.BP6/Xhol • 
ABP7/Xhol 4 0.8, 1.0, 1.6, 2.1 5.5 
I kbp Ladders 
- - -
Those marked with a star (*) indicate that a partial digest was obtained and so analysis of the 
fragments yielded cannot be carried out accurately. 
Fig.8.8 Agarose Gel Electrophoresis of Recombinant Phage DNA (A.BPl-7) Digested with 
Xhol. 
2 17 
1 2 3 4 5 6 7 8 9 10 
12 kbp ~ 
3kbp ~ 
1.6 kbp ~ 
l kbp ~ 
500 bp ~ 
LANE DNA/DlGEST 
I I kbp ladders 
2 pUCI8/EcoRI 
3 A.BPI!EcoRJ 
4 A.BP21EcoRI 
5 A.BP3/EcoRI 
6 A.BP4/EcoRJ 
7 A.BP5/EcoRI 
8 A.BP6/EcoRl 
9 A.BP?/EcoRJ 
10 I kbp Ladders 
Number of Bands Relative Size of 
Bands (kbp) 
- -
-
-
I 8.0 
• -
• -
I 5.0 
• -
• -
3 2.3, 4.0, 5.0 
-
-
Total Size (kbp) 
-
-
8.0 
-
-
5.0 
-
-
11.3 
-
Those marked with a star (*) indicate that a partial digest was obtained and so analysis of the 
fragments yielded cannot be carried out accurately. 
Fig.8.9 Agarose Gel Electrophoresis of Recombinant Phage DNA (A.BPl-7) Digested with 
the Restriction Enzyme, EcoRI. 
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Analysis of the restriction enzyme digestion patterns visualised on the agarose gels (Figs.8.7, 
8.8 and 8.9) was carried out, looking for DNA bands common to a number of clones, 
indicating that these may represent the same DNA sequence. This was observed in the 
recombinants, A.BP4 and 5, which had very similar banding patterns when digested with Sall 
and Xhol indicating that the cloned sequences were very similar. This is because the 
recombinants were created from a Sau3A partial digest of B.pseudomallei genomic DNA, 
therefore the DNA fragments cloned should all carry the desired DNA sequence, but are all 
slightly different, depending on the Sau3A site cleaved. The other phage DNA restriction 
digest patterns were all different, with few bands in common. The EcoRI digest patterns were 
all slightly different with the added complication of partial digests. As there was so little phage 
DNA actually isolated it was decided to firstly clone the 8 kbp fragment created by digesting 
A.BP I with EcoRI and check that it contained the fragment through a Southern blotting 
procedure. In this way there would be sufficient DNA up and downstream of the PCR product 
to analyse. 
8.6 SUBCLONING AN 8 kbp EcoRI FRAGMENT FROM A A.GEMll 
RECOMBINANT CLONE INTO A PLASMID VECTOR. 
8.6.1 Attempts to Subclone into pUC18. 
Attempts were made to clone the fragment into the EcoRI site of pUC 18 but no recombinants 
could be isolated. Plates were incubated at room temperature with the addition of 0.2% 
glucose to suppress the lac promotor in case a toxic product, deleterious to the E.coli was 
being produced, but recombinants were still not isolated. 
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8.6.2 Subcloning into pGDl03. 
As attempts to clone the 8 kbp fragment into the high copy number vector, pUC I8 had failed, 
it was decided to clone the fragment into a lower copy number vector. The plasmid cloning 
vector, pGDI03 (Appendix 11) was derived from the low copy number plasmid, pLG339 and 
permits the propagation of cloned DNA fragments at low gene dosage levels. Hence this 
vector can be used to clone genes encoding products that are toxic to the host when cloned in a 
high copy number vector. The selectable phenotype in pGD I 03 is kanamycin resistance and, 
unlike its parent pLG339, it contains the lacZa region from pUC8 and so has the advantage of 
the selection of recombinants by virtue of their lac- phenotype in E. coli K 12 host strains not 
possessing the lacZa region. 
About 0.5 (.lg of A.BP I was digested with EcoRI and an aliquot of the digestion products was 
checked on an agarose gel. The products of the digest were then purified by the 810-RAD 
Prep-A-Gene kit (2.4.6.2) for use in a ligation reaction. Approximately 0.5 (.lg ofpGDI03 was 
digested with EcoRI, treated with alkaline phosphatase (2.5.5) and purified with the 810-RAD 
Prep-A-Gene kit. A ligation reaction was set up with pGD I 03 and the purified digest at a ratio 
of approximately I: I, incubated at I5°C for 18 h. and used in a transformation with CaCI2-
treated DH5a cells (2.5.1 ). Transformation mixes were plated out onto LB media 
supplemented with kanamycin and 0.2% (w/v) glucose. However, half of the transformation 
plates were kept at room temperature and the other half were incubated at 37°C to investigate 
whether temperature affected the number and stability of recombinants. Twenty colonies were 
picked from the room temperature plates (pBPR 1-20) and similarly, twenty from the plates 
incubated at 37°C (pBPTI-20). These were cultured in 10 ml LB broths supplemented with 
kanamycin and 0.2% (w/v) glucose. Cultures were incubated with shaking according to the 
temperature used previously on the transformation plates. Therefore subclones pBPR 1-20 were 
incubated at room temperature and subclones pBPTI-20 were incubated at 37°C. When small-
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scale plasmid extractions (2.4.2.1) were carried out, it was clear from the size ofthe plasmids 
isolated that none of those incubated at 37°C (subclones pBPT 1-20) contained an 8 kbp insert 
and when digested with £coR I were confirmed not to contain an insert. However, of the clones 
isolated at room temperature, when digested with EcoRI, one released an 8 kbp fragment 
(pBPR I) (Fig.8.1 0). A I L flask of pBPR I was cultured at room temperature to obtain enough 
DNA for sequencing, if the fragment was shown by a Southern blot to contain the desired 
DNA sequence. As pGD I 03 is a very low copy number vector, large volumes are required to 
obtain sufficient amounts of DNA for processes such as sequencing. A large-scale plasmid 
preparation was carried out on the culture (2.4.2.2) and the plasmid DNA was purified by 
CsCI-EtBr Density Ultracentrifugation (2.4.3.1). 
8.6.3 Southern Blot Analysis to Check pBPRI for the Presence of the Labelled Fragment. 
To check that the recombinant plasmid pBPR I contained the desired sequence (Fig.8.4) a 
Southern blot was carried out using the previously DIG-labelled PCR product as the probe 
(8.5.1 ). Approximately 0.5 )..lg of B.pseudomal/ei 204 genomic DNA was digested with EcoRl 
and 0.3 )..lg of pBPRJ was similarly digested with EcoRl. These were subject to agarose gel 
electrophoresis for use in a Southern blotting procedure (2.7.2). The results of the Southern 
blot can be seen in Fig.8. 11. The blot showed a strong positive reaction for the cloned 8 kbp 
EcoRJ fragment as well as a corresponding 8 kbp EcoRJ fragment from B.pseudomallei 204 
genomic DNA. Proving not only that the 8 kbp fragment contained the desired PCR product 
sequence, but that the 8 kbp fragment was derived from B.pseudomal/ei. 
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12 kbp .... 
3kbp .... 
1.6 kbp .... 
12345 67 8 91011 
Fig.8.10 Agarose Gel Electrophoresis of Recombinant Plasmids Digested with EcoRI. 
LANE I: I kbp ladders. LANE 2: pBPRI /EcoRI. LANE 3: pBPR2/EcoRJ. LANE 4: 
pBPR3/EcoRI. LANE 5: pBPR4/EcoRI. LANE 6: pBPR5/EcoRI . LANE 7: pBPR6/EcoRJ. 
LANE 8: pBPR7/EcoRl. LANE 9: pBPR8/EcoRI. LANE 10: pBPR9/EcoRl. LANE 11 : I kbp 
ladders. 
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9,416 bp ~ 
6,557 bp ~ 
4,361 bp ~ 
1 2 3 
• 
Fig.8.11 Southern Blot to Check for the Presence of a Specific DNA Fragment Contained 
in a Recombinant Plasmid. LANE I: A.Hindlll Markers (DIG-labelled). LANE 2: 
B.pseudomallei 204 genomic DNA/ EcoRI. LANE 3: pBPR I I EcoRI. 
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8.7 NUCLEOTIDE SEQUENCE ANALYSIS OF THE 8 kbp FRAGMENT. 
The recombinant plasmid pBPR I was DNA sequenced by MWG Biotech Ltd., which showed 
the cloned fragment to be 7. 7 kbp in length and can be found in Appendix Ill. 
8.7.1 Alignment of the PCR Product with the Full Length Sequence. 
The first analysis carried out was a BLAST program available at Genbank to align the PCR 
product sequence (Fig.8.4) used as the probe with the full length 7.7 kbp sequence to ascertain 
its relative position on the fragment, which can be seen in Fig.8.12. The PCR product was 
situated near the beginning of the sequence from 434 bp to 863 bp. 
8.7.2 Search of the Fragment for any Homologies with ADP-Ribosylating Toxins. 
The nucleotide sequence of the 7. 7 kbp fragment was searched, firstly at the nucleotide level, 
using the Web-based BLAST -N service for homology with the nucleotide sequence of the 
active site of ETA (Gray et al., 1984), which revealed no significant homology. Following this, 
using the DNasis computer software the 7. 7 kbp nucleotide sequence was translated into all six 
possible reading frames and searched for any of the conserved amino acid sequences common 
to the active sites of a number ADP-ribosylating toxins (Fig.8.5). This again yielded no 
observed homologies with the active sites of known ADP-ribosylating toxins. However, as the 
initial PCR only amplified a product in B.pseudornallei isolates, it was decided to search the 
translated sequences for homologies with any other virulence factors. 
8.7.3 Analysis of Web-based BLAST Searches of the 7.7 kbp Fragment for Homologies to 
Potential Virulence Factors. 
As in Chapter 6, the translated sequences were analysed for open reading frames, and each of 
these were subjected to a BLAST -X search to search the database for homologies with protein 
sequences of a known or putative function. Over the whole 7.7 kbp sequence four potential 
open reading frames with homology to known proteins were identified (Fig.8.12). 
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0 
ORFl 
... 
lR 2F 
1 
PCRPRIMERS 
2 
ORF WITH NO HOMOLOGY ORF2 
3 4 5 6 7 
(kbp) 
Fig.8.12 Map of the 7.7 kbp B.pseudomallei Fragment Showing the Locations of the PCR Primers and Putative OFRs (ORFl-4) with 
Homology to Proteins in the BLAST Database. The arrow in red denotes a large ORF, spanning over 2 kbp, which had no homology to any 
proteins in the Database. 
8.7.4 Protein Sequences Identified from BLAST Searches with Homology to the Putative 
ORFs Identified. 
The following tables (Tables 8.1-8.4) show the accession numbers and functions of those 
protein sequences with homology to the sequences encoded by the ORFs identified (Fig.8.12). 
Table 8.1 Web-Based BLAST Matches for ORF I. 
Accession Match Sequence Title Percentage Similarity 
Number 
AF047828 Syringomycin synthetase Pseudomonas syringae 44 
AF027770 fxbC Mycobacterium smegma/is 36 
AL035707 CDA peptide synthetase Ill Streptomyces coe/ico/or 48 
X98690 Pristinamycin I synthase 3 and 4 Streptomyces prislinaespiralis 37 
Z99120 Similar to antibiotic synthetase Bacillus subtilis 40 
Z99113 Polyketide synthase Bacillus subtilis 40 
U08223 Thioesterase Streptomyces fradiae 36 
U07359 Pyoverdine synthetase D Pseudomonas aeruginosa 37 
U95370 Thioesterase Bacillus /ichenoformis 35 
AL022076 pksl3 Mycobacterium tuberculosis 36 
AJ005061 LchA-TE protein Bacillus lichenoformis 36 
Yl2527 HMWPI protein Yersinia en/erocolitica 37 
AL021409 Thioesterase Streptomyces coelicolor 36 
AF074705 Pyochelin synthetase P.aeruginosa 38 
L42523 Fengycin synthetase Bacillus subtilis 38 
The putative ORF I has homology to a number of peptide synthetase genes most notably, 
those with an involvement in the acquisition of iron. For example, pyochelin synthetase 
(AF074705) and pyoverdine synthetase (U07359) from P.aeruginosa are involved with the 
synthesis of the siderophores, pyochelin and pyoverdine, respectively. A number of others are 
involved with the synthesis of antibiotics. Thus the B.pseudomallei putative peptide synthetase 
gene may therefore have a role in the virulence of the pathogen. 
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Table 8.2 Web-Based BLAST Matches for ORF 2. 
Accession Sequence Match Title Percentage 
Number Similarity 
0638223 opcP I Burkholderia cepacia 51 
L36817 ORF9 Ralstonia eutropha 49 
X58488 Outer Membrane Porin Protein Precursor Bordetella pertussis 49 
Ul6266 ompQ Protein Bordetella pertussis 37 
A38528 Outer Membrane Porin Protein 32 Precursor Comamonas acidovorans 41 
X65530 Major Outer Membrane Protein Precusor (Porin) Neisseria 41 
menin!lieidis 
X79464 Class 3 Outer Membrane Protein N.menin2itidis 41 
X65531 Class 3 Major Outer membrane Protein precursor (serotype 4) 40 
N.meninflitidis 
U07190 Class 3 Outer Membrane Porin N.meningitidis 40 
J03017 Major Outer Membrane Protein Precursor (Porin) N.gonorrhoeae 38 
AF051531 PorB Protein N.meningitidis 39 
AF060527 Porin Protein N.meningitidis 40 
The sequence encoded by ORF 2 has homology to a number of porin genes from a range of 
bacteria. 
Table 8.3 Web-Based BLAST Matches for ORF 3 
Accession Match Sequence Title Percentage 
Number Similarity 
Z99105 Similar to Transcriptional Regulator (AraC/Xyls) B.subtilis 50 
U79580 chpD P.aero2inosa 48 
AL031031 Putative Transcriptional Regulator Streptomyces coelicolor 38 
AFI28627 mtrA N.gonorrhoeae 49 
U35231 Probable Transcriptional Regulator /umQ Photobacterium leio!{natha 49 
AE000137 Putative AraC-type Regulatory Protein E. coli 42 
AF145724 AraC-Iike Transcriptional Regulator Homologue Streptomyces a/bus 52 
M96551 Putative AraC-like Transcriptional Regulator Streptomyces antibioticus 39 
U50452 AraC-Iike Regulator ybtA Yersinia pestis 41 
AJI32668 Yersiniabactin Transcriptional Regulator (ybtA) Y.enterocolitica 41 
U59485 altO Agrobacterium tume(aciens 41 
Z48959 AraC-Iike Protein Azorhizobium caulinodans 40 
090899 Rl!g!Jiatory Protein PchR Synechocystis sp. 36 
Z11519 Putative AraC-Iike Transcription Regulator Streptomyces lividans 38 
ORF 3 encodes a sequence that has homology to a number of transcriptional regulators 
belonging to the Xyls/AraC family of prokaryotic transcriptional regulators. 
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Table 8.4 Web-Based BLAST Matches for ORF 4. 
Accession Match Sequence Title Percentage 
Number Similarity 
Z99107 Similar to hypothetical proteins from Bacillus subtilis 39 
026185 Hypothetical 32.9 kDa protein in TETB-EXOA Intergenic Region Bacillus 35 
subtilis 
Zl9055 Hypothetical34.4 kDa protein in TRPA 3' region Buchnera aphidico/a 53 
AF027868 Hypothetical 33.0 kDa protein in PELB-PENP lntergenic Region Bacillus subtilis 45 
AJ248287 Hypothetical protein Pyrococcus abyssi 46 
AF056092 Unknown Yersinia enteroco/itica 51 
AF072874 Putative Membrane protein DcsA Mycobacterium smef!.matis 44 
AF013775 PagO Salmonella ryphimurium 52 
AB001488 HyjlOthetical 33.6 kDa protein in CSPC-NAP lntergenic Region Bacillus subtilis 45 
Xl3330 Hypothetical 32.2 kDa protein in DRSA-VSR Intergenic Region Escherichia coli 45 
AL031124 Putative integral membrane protein Streptomyces coelicolor 38 
AE000861 Hypothetical protein Methanobacterium thermoautotrophicum 40 
X73124 Hypothetical 31.3 kDa protein in PT A 3' Region Bacillus subtilis 36 
The sequence encoded by ORF 4 has homology to a number of hypothetical integral 
transmembrane proteins with an unknown function, although many of these are found in 
intergenic regions. 
A putative ORF was identified (Fig.8.12) which was over 2 kbp long but had no homology to 
protein sequences in the database. It may be possible that it encodes a novel protein that has 
not been found in any other bacterial species. 
8.8 DISCUSSION. 
The PCR primers designed to the active site ofthe ETA gene of P.aeruginosa failed to identifY 
a similar active site in B.pseudomallei. However, the primers used amplified a 453 bp product 
in the B.pseudomallei isolates tested but failed to amplifY a similar product in the avirulent 
B.thailandensis isolates. The exception to this was B.pseudomallei isolate 4845. This isolate 
was donated by Dr. R Titball, Porton Down and is possibly the oldest isolate in the collection 
(Table 2.1) and therefore has been subcultured frequently, and so it is possible that it may have 
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lost some of its virulence detenninants. However, it could be simply that the genomic DNA 
was of a poor quality and contaminated with complex carbohydrates, which was a common 
problem with genomic DNA preparations received. However, no products were amplified with 
the B.thailandensis isolates used, and so the sequence could be part of a gene or genes 
involved in virulence due to this association. Thus the sequence was used as a probe to isolate 
sequence infonnation up and down-stream for detailed sequence analysis. 
When using this sequence as a probe to isolate a larger sequence, a number of positive clones 
were identified in the A.GEM 11 library of B.pseudomal/ei 240 DNA. This genomic library was 
used in preference to the A.GTII library created in Chapter 4 because it is not an expression 
library. If indeed the probe isolated larger sequences encoding toxic products then the 
sequence would be more stable in the A.GEM 11 library. Attempts to extract the recombinant 
phage DNA from the positives yielded very little DNA, which hampered restriction enzyme 
analysis of the clones, as barely enough DNA was isolated to carry out the three digests 
(8.5.4). Moreover, the quality of some of the phage DNA isolated was not of a standard for 
efficient restriction digestion and so some could not even be analysed. The only recombinant 
phage from which sufficient DNA was extracted was A.BP I, which gave a single, 
approximately 8 kbp product on digestion with the restriction enzyme, EcoRI. Therefore it was 
decided to attempt to clone this fragment, as firstly, it was not necessary to isolate the 8 kbp 
EcoRI fragment before cloning, as it could be cloned directly from the purified digest, hence 
less DNA needed to be used and secondly, it was a large sized fragment and likely not only to 
contain the sequence, but sufficient DNA up and down-stream for sequence analysis. 
However, the only way the 8 kbp EcoRI DNA fragment could be successfully subcloned was 
by using a low copy number plasmid (pGDI03) and by keeping all incubation temperatures at 
room temperature. This indicated that the fragment might encode genes toxic to the E.coli host 
when in a high copy number vector, such as pUCI8 and if incubated at 37°C. In human 
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bacterial pathogens it is often the case that certain virulence genes are switched on at 37°C on 
entry to the human body. Therefore, keeping the subclone at room temperature may have 
functioned to suppress the expression of such genes. As the subclone was particularly difficult 
to clone it was decided to DNA sequence the fragment to determine if it did encode a toxin or 
indeed other putative virulence genes. 
Sequencing of the fragment revealed that here was no homology on the 7.7 kbp fragment with 
the sequence at the nucleotide or amino-acid level with the ETA gene of P.aeruginosa nor 
with any active sites from other ADP-ribosylating toxin genes. This does not discount the 
presence of an ADP-ribosylating toxin in B.pseudomallei for the active site may not possess 
the sequence encoded by the primers used or the primers may have failed to amplify the site. A 
PCR product of approximately 900 bp was amplified once with B.pseudomallei 204 DNA 
which may have been the active site, but the product could not be amplified again even after 
numerous attempts. However, the 7. 7 kbp sequence revealed putative open reading frames 
with homology to a number of interesting and genes from other bacteria some of which may 
have roles in virulence. 
The first ORF (ORF I) encoded a sequence with homology to a number of peptide synthetase 
involved in the biosynthesis of a number of important genes from a range of bacteria. These 
included iron acquisition genes such as pyoverdin and pyochelin in P.aeruginosa, and fxbC 
involved in exochelin biosynthesis in M.smegmatis (Yu et al., 1998). Also, the biosynthesis of 
a number of antibiotic genes in bacteria and the biosynthesis of syringomycin, a phytotoxin 
from P.syringae, which has a role in the virulence of the bacterium (Bender et al., 1999). 
Obviously more work is required characterising this putative gene in B.pseudomallei but it 
could be an important gene in the biosynthesis of a possible -virulence factor. 
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A putative ORF (ORF 2) was identified with homology to porins from different bacteria, 
including pathogenic species of Neisseria, in particular Nmeningitides and Ngonorrhoeae. 
The porin of Ngonorrhoeae is postulated to have a role in virulence by allowing the bacterium 
to survive inside phagocytes, through two activities. Firstly, when added to cultured epithelial 
cells it inserts into the membrane and collapses the membrane potential, probably by making 
pores, and secondly it is able to bind the eukaryotic calcium-binding protein calmodulin 
(Salyers and Whitt, 1994). More recently the porin has been shown to cause rapid calcium 
influx in target cells and to induce apoptosis by the activation of cysteine proteases (Muller et 
al., 1999) and also that the porin is itself able to arrest phagosome maturation within 
macrophages (Mosleh et al., 1998). B.pseudomallei has been shown to be able to survive 
within human phagocytes (Pruksachartvuthi et al., 1990; Jones et al., 1996) and, moreover, has 
been postulated by Harley et al. ( 1994) to escape, once phagocytosed, through damage to the 
vacuolar membrane. If indeed the putative porin of B.pseudomallei has a similar function to 
that of the species of Neisseria the porin may contribute to the intracellular survival of the 
pathogen. 
Another ORF (ORF 3) was shown to have homology to putative transcriptional regulators, 
belonging to the AraC/Xyls family of transcriptional regulators. Most proteins within this 
family are positive transcriptional regulators and have three main regulatory functions: 
I. Carbon metabolism, 
2. Stress response and, 
3. Pathogenesis (Gallegos et al., 1997). 
The putative gene m B.pseudomallei has homology to ybtA, which is the transcriptional 
regulator of the siderophore, yersiniabactin, receptor (psn) in Ypestis and Y.enteroco/ilica. 
Interestingly, this forms part of an inorganic iron transport system that functions at 37°C 
(Fetherston et al., 1996) and the sequence in B.pseudomallei could not be subcloned when 
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incubated at 37°C. A putative peptide synthetase (ORF I) also had homology to a number of 
genes involved in the biosynthesis of iron in other bacteria. Perhaps these genes are therefore 
part of an iron-regulated operon or perhaps are involved in iron acquisition themselves. 
Obviously characterisation of these putative genes is necessary and more sequence information 
would be required up and down-stream to investigate this. 
In addition to homology to ybtA of the Yersinia species, the putative transcriptional regulator 
also had homology to mtrA of N.gonorrhoeae. The mtr (multiple transferable resistance) gene 
complex in Neisseria gonorrhoeae encodes an energy-dependent effiux pump that serves to 
export structurally diverse antimicrobial, hydrophobic agents (HAs) (Rouquette et al., 1999) 
and mtrA is involved with the regulation of this. Again, ORF I had homology to genes 
responsible for the biosynthesis of antibiotic resistance factors in other bacteria. It is not 
known exactly what the functions are of these putative genes in B.pseudomallei but it is 
possible that they encode products with a possible function in antibiotic resistance, or iron 
acquisition or perhaps even another putative virulence factor, as a part of the sequence had no 
homology to proteins in the database. 
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CHAPTER9 
Sau3A UNDIGESTIBLE B.pseudomallei 4845 GENOMIC 
DNA FRAGMENTS. 
9.1INTRODUCTION. 
When creating gene banks the genomic DNA of the bacterium under study is digested with 
restriction enzymes in order to create fragments for cloning. Quite often this involves partially 
digesting the DNA with Sau3A in order to create fragments of a size suitable for cloning. The 
restriction endonuclease, Sau3A is a four-base cutter with the recognition sequence: -J..GA TC 
and therefore cuts DNA relatively frequently in comparison to six-base cutters such as EcoRI. 
It would be expected that any particular tetranucleotide sequence to occur about once every 44 
(256) nucleotide pairs in a long random DNA sequence assuming that all the bases are 
included equally. 
Sau3A also recognises a tetranucleotide sequence that is included within the hexanucleotide 
sequence recognised by the enzyme, BamHI. In this case, therefore, the cohesive termini 
produced by these enzymes means that fragments produced by Sau3A will cohere to those 
produced by BamHI. 
'I 
~}' 
{jJ',Ji( 
As Sau3A does digest DNA so~Iy often the digest is set up in a series of partial digests c~ 
with the enzyme. This then produces a random set of DNA fragments. A series of tubes are set 
up with a standard amount of genomic DNA but with varying amounts of enzyme produced by 
a doubling dilution series. These are then left at 37°C for 20 to 30 minutes after which time the 
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reactions are terminated via inactivation of the enzyme by placing the tubes at 65°C for I 0 
minutes. A sample of the digestion products are subjected to agarose gel electrophoresis and 
the enzyme concentration producing DNA fragments of an appropriate size for cloning can be 
determined. 
9.2 RESTRICTION DIGESTION OF B.pseudomallei GENOMIC DNA 
WITHSau3A. 
9.2.1 B.pseudoma/lei Isolate 4845. 
Serial digestions using the restriction enzyme Sau3A were carried out with 4845 
B.pseudomallei genomic DNA. A series of MCC tubes containing B.pseudomallei 4845 
genomic DNA were set up whereby the first tube contained double the amount of genomic 
DNA than the following tubes. Approximately 4 Jlg of 4845 DNA was contained in the first 
tube in a total of 39 Jll, including a 0.1 volume of Sau3A restriction enzyme buffer and the 
following tubes contained half this amount of DNA in a volume of 20 Jll, again including a 0.1 
volume of buffer. One ~-tl of Sau3A restriction enzyme was added to the first tube, mixed and 
20 Jll of this preparation transferred into the second tube, mixed and 20 Jll of this preparation 
transferred to the third tube, and so on for a total of 8 tubes. The MCC tubes were incubated at 
37°C for 20 min. before placing at 70°C for 15 min. to stop the digestion reaction. A 5 ~-tl 
sample of each tube was then subject to agarose gel electrophoresis (Fig.9.1 ). 
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12 kbp ..... 
3 kbp ..... 
2 kbp ..... 
1.6 kbp ..... 
l kbp ..... 
500 bp ..... 
12 3 4 56 7 8 9 
Fig.9.1 Agarose Gel Electrophoresis of a Serial Sau3A Digest of 4845 B.pseudomallei 
Genomic DNA. LANE 1: I kbp ladders. LANE 2: Tube 1. LANE 3: Tube 2. LANE 4: Tube 3. 
LANE 5: Tube 4. LANE 6: Tube 5. LANE 7: Tube 6. LANE 8: Tube 7. LANE 9: Tube 8. 
LANE 11 : 1 kbp ladders. 
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There appears to be two bands of the order of I 0 kbp in size that have not been digested by 
Sau3A. The restriction enzyme Sau3A theoretically cuts DNA every 256 bp and so over 10 
kbp it should have cut the fragment at least 39 times. No plasmids have been reported in any 
isolates of B.pseudoma/lei and so it is unlikely to be two plasmids. As this was observed with 
one isolate it was tried with other isolates of which there was a sufficient quantity of genomic 
DNA available. 
9.2.2 B.pseudomallei Isolates E8, 25, 204 and 576 and B.thailandensis 27 and 82. 
Approximately I J.lg of genomic DNA from all isolates was digested with I J.ll of Sau3A and 
incubated at 37°C for I h. the reaction was stopped by placing the tubes at 65°C for 10 min. 
Products of the digests were visualised by agarose gel electrophoresis (Fig. 9.2). Interestingly, 
genomic DNA from B.pseudomallei isolates E8 and 576 have completely digested but 25 has a 
band the same size as that of 4845, and 204 has a faint, smaller band than the others. 
B.thailandensis isolates 27 and 82 contain undigested DNA bands also. Isolate 27 has two, one 
si ightly smaller than the I 0 kbp band of 4845 and another at around 6 kbp, whereas 82 has 
three at approximately 5, 9 and I 0 kbp. lt was decided to investigate the undigested band of 
B.pseudomallei isolate 4845 as there was a surplus of genomic DNA available for this isolate 
and it would be necessary to digest high quantities of DNA in order to isolate useable amounts 
of the undigested fragments of DNA. 
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12 3 4 56 7 8 9 
12 kbp 
..... 
3 kbp ..... 
1.6 kbp ..... 
l kbp ..... 
Fig.9.2 Agarose Gel Electrophoresis of Sau3A Digested Genomic DNA from a Number of 
Isolates of B.pseudomallei and B.thailandensis. LANE 1: 1 kbp ladders. LANE 2: E8. LANE 
3: 25. LANE 4: E27 LANE 5: 82. LANE 6: 204. LANE 7: 576. LANE 8: 4845. LANE 9: I 
kbp ladders. 
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9.3 ISOLATION OF THE Sau3A UNDIGESTIBLE B.pseudomallei 4845 
GENOMIC DNA FRAGMENTS. 
Approximately 25 J.lg of B.pseudomal/ei 4845 genomic DNA was digested with an excess of 
Sau3A for I h. at 37°C. The products of digestion were subject to agarose gel electrophoresis 
and the I 0/12 kbp undigested bands were excised from the agarose gel and collected by 
electroelution (2.4.6.1) and purified using the BIO-RA D Prep-A-Gene Purification Kit 
(2.4.6.2). 
9.4 ATTEMPTS TO CLONE THE Sau3A UNDIGESTIBLE FRAGMENTS 
INTO PLASMID VECTORS. 
9.4.1 Attempts to Clone the Fragments into BamHI Sites of Plasmid Vectors. 
The nature of the termini of the Sau3A undigestible fragment was unknown and so firstly it 
was assumed that they possessed Sau3A termini. Several attempts were made to clone the 
fragments into pUC 18, pBR328 and pGD I 03 digested with BamHI. However, none of these 
yielded any results and so it was assumed that the fragments did not have Sau3A termini. / 
9.4.2 Cloning the Fragments Using the SURECLONE™ Kit 
As the nature of the termini were still unknown it was decided to perform a blunting and 
kinasing reaction on the fragments to be able to clone them into a blunt-ended site. The Sau3A 
undigestible fragments were used in the SURECLONE™ kit to attempt to clone into the Smal 
site of pUC18 (2.5.7). The product of ligation was transformed using DH5a competent cells 
(2.5.3.2) and two transformations were carried out, one incubated at room temperature and the 
other at 37°C. 1t was noted that the transformation put at 37°C, after the incubation time (90 
min.) the transformation mixture appeared clear, indicating that the bacterial cells had lysed. 
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The mixture was still plated out onto LB plates supplemented with ampicillin and 0.2% 
glucose to repress the lac promoter, so that if indeed the fragments encoded toxic products this 
would limit the expression of them, but no colonies grew on these plates. The transformation 
mixture kept at room temperature overnight was plated out onto the same media and left to 
incubate at room temperature. Eight colonies grew on these plates (pSAU 1-8) and so these 
were transferred to I 0 ml LB broths containing ampicillin and 0.2% glucose and incubated 
with shaking at room temperature. Small-scale plasmid extractions (2.4.2.1) were carried out 
on the cultures and the plasmid DNA was digested with EcoRl and Pstl to release any cloned 
fragment(s), the results of which can be seen in Fig.9.3. 
The results of this are somewhat ambiguous, as in some ofthe clones the size of the linearised 
pUC 18 appears to vary. Clones pSAU5-8 have what appears to be a smaller sized linearised 
pUCI8 DNA band than the control. The plasmid pSAUI has no insert, which is also the case 
with pSAU5-7. Only pSAU2, pSAU4 and pSAU8 have inserts, which all very in size and none 
of which have a single 10/12 kbp band. The recombinant, pSAU2 appears to have two inserts, 
which although add up to around 12 kbp are slightly strange in appearance as the upper band is 
not as bright as the two lower bands and should appear brighter as it contains more DNA. 
Due to the ambiguous nature of the clones in pUC 18, attempts were made to clone the 
fragment into the EcoRV site of the lower copy vector, pGDI03. However no recombinants 
were isolated. 
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12 kbp ..... 
3 kbp ..... 
2 kbp ..... 
1 kbp ..... 
1 2 3 4 5 6 7 8 9 10 11 
Fig.9.3 Agarose Gel Electrophoresis of Recombinant Plasmids Digested with the 
Restriction Enzymes EcoRI and Psti to Release any Cloned Fragments. LANE 1: I kbp 
ladders. LANE 2: pUC18/EcoRl. LANE 3: pSAU 1/EcoRl/Psti. LANE 4: pSAU2/EcoR11Psti. 
LANE 5: pSAU3/EcoR11Psti. LANE 6: pSAU4/EcoRl/Pstl. LANE 7: pSAU5/EcoRl/PstL 
LANE 8: pSAU6/EcoRl/Pstl. LANE 9: pSAU7/EcoRl!Psti. LANE 10: pSAU8/EcoRl/Pstl. 
LANE I 1 : I kbp ladders. 
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9.4.3 PCR Reactions Using pUC Derived Primers. 
Due to the ambiguous nature of the results of the digests with the recombinant plasmids, it was 
decided to use pUC-based primers in a PCR reaction to ascertain the size of the insert from 
clones pSAU2, 4 and 8 all of which appeared to have inserts. The pUC primers were designed 
to either side of the multiple cloning site by Dr. M. Kieman thus the PCR should amplify 
whatever DNA is between these. 
Forward primer 5' GTAAACGACGGCCAGT 3' 
Reverse primer 5' GTACCAGTATCGACAA 5' 
A PCR was carried out with an annealing temperature of 50°C and an extension time of 10 
min. for 35 cycles, with twice the normal amount of dNTPs as the inserts could possibly be 
several kbp in length. The results of which can be seen in Fig.9.4. Again the results were 
somewhat ambiguous but an insert could be visualised and what appeared to be a ladder of 
DNA up from the main band at approximately 700 bp. Different annealing temperatures and 
condition were attempted but yielded no differing products to the ones gained in Fig.9.4. Due 
to the interesting nature of these clones and the fact that probable deletional events had 
occurred it was decided to send them for DNA sequencing at Porton Down. 
9.4.4 Cultures of pSAU2, 4 and 8 Grown for Sequencing. 
One litre cultures of LB containing ampicillin and 0.2% glucose (w/v) ofpSAU2, 4 and 8 were 
set up and incubated with shaking at room temperature. The plasmids were extracted using the 
maxiprep plasmid preparation (2.4.2.2) and purified by CsCI!EtBr density ultracentrifugation 
(2.4.3.1 ). The plasmid DNA gained was analysed by restriction digestion with EcoRl and Pstl 
to check again the insert size. The recombinant plasmids pSAU4 and 8 still contained 
fragments of the same. However pSAU2 contained what appeared to be two fragments in the 
Fig.9.3, but after a large-scale plasmid preparation it now only contained the smaller fragment 
(Fig.9.5). 
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1 2 3 4 5 6 
12 kbp .... 
3kbp .... 
1 kbp .... 
500 bp .... 
Fig.9.4 Agarose Gel Electrophoresis of the PCR Products from Clones pSAU2, 4 and 8 
using pUC Derived Primers. LANE I: I kbp ladders. LANE 2: Negative control. LANE 3: 
pSAU2. LANE 4: pSAU4. LANE 5: pSAU8. LANE 6: l kbp ladders. 
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12 kbp .... 
3kbp .... 
1.6 kbp .... 
1 2 3 
Fig.9.5 Agarose Gel Electrophoresis of Recombinant Clone pSAU2 Isolated from a 1 
Litre Culture and Digested with Restriction Enzymes EcoRI and Pstl. LANE l: I kbp 
ladders. LANE 2: pUC1 8/EcoRI. LANE 3: pSAU2/EcoRIIPstl 
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9.5 TRANSFECTION PROCEDURE. 
In a previous experiment (9.4.2) it was observed that when the transformation mix was placed 
at 37°C it was noted that the preparation went clear and therefore the bacteria had appeared to 
lyse. This may have been due to toxic products encoded by the fragments, which had a 
detrimental effect on the host cells, but given the 90 min. incubation time such products may 
not have had time to be produced. However, lysis may have been because the I 0112 kbp 
fragments of DNA were bacteriophage in origin, hence causing the bacteria to lyse. To 
investigate this, a transfection procedure was attempted with the DNA fragments, which is 
based on the calcium shock method of Mandel and Higa ( 1970). Transfection in this case is the 
uptake of viral DNA (or RNA) by competent cells. A I 0 ml culture of E. coli C600 cells was 
incubated at 37°C for 18 h. in NZCYM broth. A 0.5 ml aliquot was removed and used to 
inoculate a 20 ml volume of NZCYM broth, which was incubated at 37°C for I 00 min. After 
which time, the cells were pelleted by centrifugation at 5,000 x g, for 10 min. at 4°C and 
resuspended in 20 ml of ice-cold 0.1 M MgCb. Cells were again pelleted as before and 
resuspended in I 0 ml of ice-cold 0.1 M MgCb. Finally cells were pelleted and resuspended as 
before but in I ml of ice-cold 0.1 M CaCb. Approximately 50 ng of the I 0112 kbp DNA 
fragments isolated was mixed with a 0.5 ml volume of the competent cells, heat shocked at 
42°C for 2 min., cooled and incubated on ice for 30 min. The preparation was added to 10 ml 
of molten NZCYM medium and overlayed onto NZCYM plates and incubated for 18 h. at 
37°C. However no plaques were observed on the plates. 
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9.6 ATTEMPTS TO USE A LONG TEMPLATE PCR SYSTEM TO 
ISOLATE LARGE QUANTITIES OF THE 10/12 kbp DNA FRAGMENTS. 
Problems are often encountered when trying to clone large fragments into plasmid vectors and 
as so little of the undigestible DNA from the Sau3A digest could be isolated, restriction 
analysis was not possible. It was therefore decided to try an experimental procedure by using 
the fragments in a ligation with pUC 18, but not transforming the resulting ligation products. In 
this way no selection pressure is put on the sequence by introducing it into a host organism. 
Instead, as there may be some successful ligations of the whole I 0/12 kbp fragments in the 
ligation mixture, by using commercial systems that allow the PCR amplification of such large 
fragments, large quantities of the fragments may be isolated for restriction mapping and 
subcloning. As PCR is highly sensitive it was hoped that it might be able to amplify the 
successfully ligated product in the reaction, even if the ligation was not highly efficient. The 
system used was the Boehringer Mannheim, Expand™ Long Template PCR System and is 
designed to amplify fragments up to 27 kbp from human genomic DNA and up to 40 kbp from 
A.DNA. A ligation was firstly set up using the SURECLONE™ kit as in 9.4.2 and incubated at 
I5°C for 18 h. The ligation products were precipitated with ethanol and resuspended in analar 
water. The following reaction was set up firstly as two mastermixes. 
Mastermix 1: Mastermix 2: 
Component Volume (J.d) Component 
dNTPs 3 Buffer I 
Forward Primer Enzyme 
Reverse Primer 2 Analar Water 
Template 4 
Analar Water To make a total of 25 1-11 
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Volume (!-11) 
5 
0.75 
To make a total of 25 1-11 
The forward and reverse primers used were the pUC primers used in 9.4.3. The two 
mastermixes were added, overlaid with 30 ~I of Mineral Oil and cycled through the following 
program: 
Function Temperature °C Time Number of Cycles 
Denaturation 94 2 min. I 
Denaturation 94 10 sec. 
Annealing 55 30 sec. 10 
Elongation 68 IOmin. 
Denaturation 94 10 sec. 
Annealing 55 30 sec. 20* 
Elongation 68 IOmin. 
·Prolonged Elongation 68 7 min. I 
* The elongation time was increased by 20 sec. for each cycle to increase the yield of the 
product. For example, cycle number I I had an additional 20 sec. and cycle number 12 had an 
additional 40 sec. and so on. This was carried out altering the annealing temperature and the 
elongation time, but no product was visualised on an agarose gel. 
9.7 NUCLEOTIDE SEQUENCE ANALYSIS OF CLONES pSAU2 and 
pSAU8. 
Both clones were partially sequenced by Dr.R.Titball, Porton Down, Salisbury. However the 
clones were very difficult to sequence and only a small amount of sequence information was 
derived from them. For pSAU2 only the first 308 bp could be sequenced in the forward 
direction and for pSAU8 only 181 bp could be sequenced in the forward direction and 209 bp 
in the reverse. The other clone pSAU4, which had a 5 kbp insert was in fact a contaminant. 
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9.7.1 Partial Nucleotide Sequence of pSAU2. 
GGGTCGGCGAGACGNTGACCATTNNGCATCAGATGNGAGAANAGACCACCTGTN 
GNGTTGNTTNATTGATGCNTGCCTGTNGGCNTGTGATCTGGTTACGNGCACGAGCT 
AACCGAGAGGACTGTAGAACCCATTCCGGGGTACCTGANTATGTCGTGAAGAANG 
GNGACNGCAGCATNGACNTGTCTCNGATNCAATCACAGTTGAAACGACAGTCGNG 
AGGGGTGGATGTAGTCATNGATGGATACAGGCAGGGTCGCCTTACCNTAGGCCTT 
TGTGCGCAGTTGCTTGGACGTTCGCCTGT AGAC (308 bp). 
N represents any nucleotide base. 
1 0.8.2 Nucleotide Sequence of pSA U8. 
10.8.2.1 Forward Sequence. 
CAGGNCGACTCTAGAGGATCCCCGTTTCAATAACAACCGACAGATTCCAATCGCC 
CAATACGAGGAATTAAAGCTGACTTCTGCACAGGGTATACAAGAGTGCTTCCAGT 
TCTCAAGAGGCCGGCGCTGCAGAGGCTTTCGTCGGCTCATTGATTCAACTCGGCC 
AATACGGAGCAAATAC (181 bp). 
10.8.2.2 Reverse Sequence. 
GATCGTGCGGCGCACGGGGCTCGCAAGCGCTTTGTGAATGGCGTCGGCATCAAAG 
GTCATGGGCGGCGCGGTGAAATCGCGAATCGTCGTTTGCCGAAGCTTAAATCGGC 
CGATGACGATATAAACAGCAACACTCTATTGACTAGGGGCGATGGTTGATGTCCA 
ACAA TT AAGTCTGTCGGGCGACGA T AAACTCTGTCGGACGGCAG (209 bp). 
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9.8 DISCUSSION. 
Most bacteria have defence systems to guard against invasion by foreign DNA, which involve 
the production of specific endonucleases. Bacteria protect their own DNA from the potentially 
lethal effect of their restriction enzymes by previously modifying it, usually by an appropriate 
DNA methylase. The methylation of certain bases at a limited number of sequences is carried 
out so that the enzymes no longer recognise them as sites. lt would appear that the undigestible 
I 0/12 kbp fragments from B.pseudomallei 4845 have been protected in some way against the 
restriction enzyme, Sau3A. 
It was found that the DNA fragments deleted when attempts were made to clone them into the 
plasmid vector pUC 18. The undesirable property of this vector, with regards to this 
experiment, is that it has a high copy number. Hence if the DNA encodes a toxic gene product 
it may be produced at a level that is deleterious to the host, and so it would be better to clone 
such a fragment into a lower copy number vector. Many attempts were made to clone the 
fragment into the lower copy number vector, pGD I 03, without any success. During attempts to 
clone the fragments into pUC 18, the procedure was carried out using a range of temperatures 
and it was found that lowering the incubation temperature to room temperature at every step 
permitted the cloning, albeit deletions of the original fragments. A similar finding was 
observed in Chapter 8 when subcloning a 7.7 kbp B.pseudomallei fragment into pGDI03, 
which could only be successfully subcloned at room temperature. It was discussed that as 
B.pseudomallei is a human pathogen, the expression of certain virulence genes may be 
triggered on entry to the human body, by the change in temperature to 37°C. Therefore, 
incubating B.pseudomallei clones encoding such thermoregulated genes at a lower temperature 
may function to repress the expression of virulence gene products that have a deleterious effect 
upon E.coli host cells. In the case of the Sau3A undigestible fragments even incubation at 
room temperature could not facilitate the cloning of the whole fragment and so only clones 
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containing deletions of the fragments were successful. It must also be considered that the 
fragments are of the order of I 0/12 kbp and large fragments such as these are not cloned as 
faithfully into plasmids as smaller fragments and that an increased metabolic load imposed 
upon the cell can instigate plasmid instability itself. 
When the recombinant clones pSAU 1-7 were initially isolated in Fig.9.3 there were some 
ambiguous findings. The recombinant plasmid pSAU2 appeared to contain a cloned fragment 
of around I 0 kbp when calculating the combined sizes of the two bands (7 kbp and 3 kbp) 
produced on digestion of the plasmid DNA with Pstl and EcoRl. However, after a large-scale 
plasmid DNA isolation procedure was carried out on a litre culture, there was only one, 3 kbp 
band cloned (Fig.9.4). It is likely that deletion events were occurring and on close examination 
of the agarose gel in Fig.9.3, the top band of around 7 kbp was not as bright as the bands 
beneath. The upper band should appear brighter than the bands beneath it because there would 
be more DNA fluorescing. What may have happened in this case is that there were two clones 
present in the preparation, and the one containing the 3 kbp band was present in higher 
numbers than the clone containing a 7 kbp band, and therefore the former was unwittingly 
picked for large-scale plasmid DNA isolation. Or perhaps the smaller sized clone was under 
less selection pressure and when cultured on a larger scale, the clone containing the 7 kbp 
fragment became present at a much smaller proportion or even selected out completely. 
Alternatively, the clone may have originally contained a I 0 kbp fragment and was undergoing 
a deletion event due to it's instability in the E.coli host, whereupon DNA was perhaps being 
looped out to leave just 3 kbp and what was observed on the agarose gel represented a culture 
containing recombinant plasmids at different stages in this process. Therefore, by the time a 
large culture was produced, all of the clones were deletions of the original I 0 kbp fragment. 
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Another ambiguous result in Fig.9.3 is that pSAU5-8 have what appears to be smaller sized 
linearised pUC 18 DNA bands than the control of 2. 7 kbp. When deletion events occur, a piece 
of DNA is looped out and with pSAU5-8 it is possible that this process has actually removed a 
part of the vector DNA, which could be why they appear smaller than the control. This might 
also have occurred in pSAU3, as the linearised plasmid, instead of being around 2.7 kbp, was 
around 4 kbp. However, in this case digesting with EcoRI and Pstl functioned to linearise the 
recombinant plasmid, as one of the sites was lost, due to a deletion but the other still existed. 
A myriad of attempts were tried to clone the full-length fragments all of which failed. 
Interestingly, it was discovered that a similar finding was observed with Francisella tularensis 
genomic DNA and the undigestible fragment also proved impossible to clone intact (R.Titball, 
personal communication). In one transformation procedure the bacterial cells appeared to lyse 
after incubation at 37°C (9.4.2), which indicated that the DNA might be phage-encoded. In 
many bacterial pathogens, virulence determinants are often encoded on a phage, for example, 
diphtheria toxin in Corynebacteria diptheriae is encoded on a lysogenic phage. It is possible 
that the undigestible DNA may be bacteriophage in origin and due to the difficulties 
encountered during attempts to clone the full-length fragments it is possible that the DNA 
encodes toxic products or perhaps other virulence-encoding genes. There exists pathogenicity 
islands (PAls) which have now been detected in a number of bacteria, which are large pieces 
of chromosomal DNA that carry virulence genes, which were most probably acquired by 
phage-mediated horizontal transfer (Buchrieser et al., 1998). In addition to this, in a study 
carried out on the lysogenic bacteriophage, MA VI from Mycoplasma arthritidis, which is 
associated with the arthritogenicity of the bacterium (Voelker and Dybvig, 1998), it was found 
that the MA VI genome contained no sites for the restriction enzymes, Sau3A and Mbol which 
both recognise the sequence GA TC. 
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Due to the interesting nature of these DNA fragments it was decided to sequence the clones, 
despite the fact that they contain deleted DNA, to ascertain any information regarding the 
nature of the fragment. Unfortunately the DNA proved very difficult to sequence and only a 
small amount of information could be derived, which was riddled with ambiguities. However, 
there appeared a Sau3A site in the sequence of pSAU2 and so the DNA may therefore be 
protected in some way, as opposed to containing no cleavage sites for Sau3A. This protection 
though, would not be through the host cells having GATC-specific modifications or GATe-
specific DNA methyltransferase activity, because, as with the Marthritidis genomic DNA, the 
rest of the B.pseudomallei genomic DNA is readily digestible with the enzyme. Then again, 
due to the ambiguities contained within the sequence and that a deletion event had occurred, it 
is possible that the Sau3A site does not actually exist. On the whole, it is possible that this 
DNA may be bacteriophage in origin and may encode virulence factors. 
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CHAPTERlO 
USE OF THE B.pseudomallei GENOME SEQUENCING 
PROJECT 
10.1 INTRODUCTION. 
At the International Congress for Melioidosis held in Bangkok, November 1997, it was 
announced that the Sanger Centre had been funded by Beowulf Genomics to sequence the 
genome of B.pseudomallei. Genome sequencing began early in the year 2000 in 
collaboration with Dr. R.Titball of the Defence Evaluation Research Agency, Porton Down 
and Dr. T. Pin of the Central Public Health Laboratory. The strain being sequenced 
K96243, was chosen as a typical example of the species and is a clinical isolate from a 
melioidosis patient in Thailand, supplied by Dr. S. Songsivilai of Mahidol University. 
The method in use by the Sanger Centre is a whole genome shotgun approach making use 
of several libraries. The results of the sequencing project are available on the intemet along 
a with a BLAST facility to search the sequenced data from the shotgun sequences for 
homologies at the nucleotide level. At the time of writing there were 58, 859 reads in the 
database giving a total of 26.574 Mb and a theoretical coverage of 98.3% of the genome. 
The sequences contained in the shotgun database, however, are unedited single reads from 
ABI sequencers and so contain errors as well as E. coli and vector contamination. Work has 
begun on assembling the shotgun sequences into contiguous fragments and this 
information is also available to search. 
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This facility is therefore an invaluable tool to search the genome for sequences from other 
bacterial species, which may indicate the presence of homologous sequences in 
B.pseudoma//ei. In this research project there are a number of lines of experimental work 
where the genome sequencing project could not only be applied, but serve as a very useful 
tool. Firstly, when testing isolates of B.pseudomal/ei and B.thai/andensis for activities 
(Chapter 3) it was discovered that the isolates of B.pseudomallei had hexosarninidase 
activity. However, on screening the A.GTll expression library for a clone with this activity, 
one could not be found. However, by searching the shotgun and assembled databases with 
sequence information encoding hexosaminidase genes in other bacteria, a corresponding 
gene in B.pseudomallei may be found. 
Similarly, PCR pnmers were designed to the active site of ET A in P.aeruginosa and 
isolates of B.pseudomal/ei and B.thilandensis were tested for the presence of a similar 
sequence (Chapter 8). The sequence information derived from the reaction products 
indicated no obvious homology with the active site of the toxin. It is possible to use the 
same sequence information as a probe to screen the databases to determine if there is a 
similar sequence, which was not amplified by the PCR primers designed. 
Additionally, two I 0/12 kbp Sau3A undigestible fragments were isolated in Chapter 9 but 
cloning of the full-length fragments proved impossible. Recombinants containing deletions 
of the original fragments were isolated but DNA sequencing proved difficult and only a 
small amount of sequence information was gleaned. However, it was possible to use this 
sequence information to search for its possible presence in the clinical isolate sequenced 
and to analyse any assembled sequence information containing the sequence in WEB-
based BLAST searches for homologies with any other sequences with known or putative 
functions in other bacteria. 
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10.2 PROBING THE SHOTGUN DATABASE FOR THE PRESENCE 
OF A HEXOSAMINIDASE GENE. 
A number of bacterial hexosaminidase gene sequences were deposited in the Genbank 
database and so several of hexosaminidase amino acid sequences were used to search the 
B.pseudomallei genome project databases to identify any shotgun or assembled sequences 
with homology (Table I 0.1 ). 
Table 10.1 Bacterial Hexosaminidase Amino Acid Sequences Used to Search the 
B.pseudoma/lei Genome Seguencing Project Databases for Homologous Sequences. 
Accession Organism Sequence Title Contig/Shotgun Similarity 
Number Reference (%) 
U24658 Vibrio parahaemolyticus Beta-hexosaminidase Contig 1720 52 
042078 Staphylococcus aureus N-acetyl-glucosaminidase NONE -
ALI62754 Neisseria meningitidis Putative hexosaminidase Burk258f03.plc 74 
AE004725 P.aeruginosa Beta-N-acetyi-D- Burk258f03.p I c 69 
glusosaminidase 
AE004155 V. cholera Beta-hexosaminidase Burk258f03.p le 60 
AE004294 V. cholera Beta-N-acetyl Contig 1720 64 
hexosaminidase 
L43594 Serratia marcesans N-acetyl-P-glucosaminidase Contig 1720 62 
AB022786 Enterobacter sp. N-acetyl-P-0- Contig 1720 61 
glucosaminidase 
From the preliminary searches carried out, two different hexosaminidase sequences were 
identified. One of these was contained on a shotgun sequence, Burk258fU3.plc and another 
on an assembled contiguous sequence, Contig. 1720. 
10.2.1 Identification of a Putative Hexosaminidase Gene Using tbe Shotgun Fragment 
Burk258tu3.pl c. 
The shotgun fragment Burk258fU3.plc, a 612 bp sequence, had a high homology to 
hexosaminidase sequences from a number of bacteria. This sequence was used to search 
the shotgun database for more information up and down-stream of the fragment (Table 
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10.2). The sequence was used on the assembled database but the sequence of this shotgun 
fragment has yet to be assembled. 
Table 10.2 Shotgun Sequences Identified Up and Down-Stream ofBurk258tu3.plc. 
FRAGMENT ISOLATED SEQUENCE FRAGMENT ISOLATED SEQUENCE 
UPSTREAM INFORMATION DOWNSTREAM INFORMATION 
(bp) (bp) 
Burk281 d I l.q I ea 331 Burk211 e06.q I ea 332 
Burkl70h l.qle 210 
A 1485 bp sequence was compiled from the shotgun fragments and used in a Web-based 
BLAST-X search. There exists an open reading frame with a high homology to a range of 
hexosaminidase genes (Table 10.3). The complete nucleotide sequence for the putative 
hexosaminidase gene can be seen in Fig.l 0.1. 
Table 10.3 Results of a Web-Based BLAST-X Search Using the Putative Hexosaminidase 
Sequence Compiled from the Shotgun Fragment Burk258tu3.plc. 
Accession Number Match Sequence Title Similarity (%) 
ALI62754 Putative hexosaminidase N.meningilidis 69 
AE002408 Glyeosyl hydrolase N.meningilidis 68 
AE004725 Beta-N-aeetyl-0-glueosaminidase P.aeruginosa 63 
U32777 Beta-hexosaminidase Haemophilus influenzae 61 
AE000211 Probable glucosidase E. coli 59 
AE004045 N-acetyl-beta-glueosaminidase Xy/ellafaslidiosa 59 
U52818 Beta-hexosaminidase V .fornisssii 59 
AE004155 Beta-hexosaminidase V. cholera 59 
AFI24757 Unknown Zymomonas mobilis 50 
A£001979 Glyeosyl hydrolase Dinococcus radiodurans 50 
AL359214 Putative sugar hydrolase Sireplomyces coelicolor 46 
APOOI509 Beta-hexosaminidase Bacillus halodurans 47 
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CACGTTCGTC GTCGCCGAGG CGCCGGACGA CGTCGCCGCC GCGCGCTCGG 
so START 
51 GCGCCGCTTC CTGATCCATT TTCCGCAAGG ~CGCTGATTC GATGAAACTG 
101 CCCCCCGGTC CGGTGATGCT CGACGTCGCC GGCACGACGC TCACGCGCGA 
151 CGACGCGCGC CGCCTCGCGC ATCCGCACAC GGGCGGCGTG ATCCTGTTCG 
201 CGCGCCACTT CGAGAGCCGC GCGCAACTCG TCGCGCTGAC CGAGGCGATC 
251 CGGGCGATCC GCGACGGCAT CCTGATCGCG GTCGATCACG AGGGCGGCCG 
301 CGTGCAGCGC TTTCGCACCG ACGGCTTCAC CGTGCTGCCG GCGATGCGCC 
351 GGCTCGGCGA GCTGTGGGAC AAGGACGTGC TGCACGCGAC GAAGGCGGCG 
401 ACCGCGCTCG GCTATGTGCT CGCTTCCGAG CTGCGCGCGT GCGGCATCGA 
451 CATGAGCTTC ACGCCCGTGC TCGATCTCGA TTACGGCCGC TCGAAGGTGA 
501 TCGGCGATCG CGCGTTCCAT CGCGATCCGC GCGTCGTCGC GTTGCTCGCG 
551 AAGAGCGTCA ACCACGGGCT CGCGCTCGCC GGGATGGCGA ACTGCGGCAA 
601 GCATTTTCCC GGCCACGGCT TCGCGCAGGC CGATTCGCAC GTCGCGCTGC 
651 CGACCGACGA TCGTCCGCTC GACGAGATCC TCGCGAACGA CGCGGCGCCG 
701 TACGACTGGC TCGGGCTGTC GTTGTCGGCC GTCATTCCGG CGCACGTGAT 
751 CTACACGCAA GTCGATTCGA AGCCGGCCGG CTTCTCGCGC GTGTGGTTGC 
801 AGGACGTGCT GCGCGGCCGG CTGCGCTTTG CGGGCGCCGT GTTCAGCGAC 
851 GATCTGTCGA TGGAGGCCGC GCGCGAGGGC GGCACGCTCG CGCAGTCGGC 
901 GCAGGCCGCG CTCGAGGCGG ACTGCGACAT GGTGCTCGTG TGCAACCAGC 
951 CGGATGCGGC GGAGCGGGTG CTCGACGAGC TGCGCACGAC GGCGTCGCGC 
1001 GAATCGTCAC GGCGGATCAA GCAAATGCGG CCGCGCGGCA AGGTGCTCGA 
1051 GTGGCGCAAG CTGATGCGCG AGCCGCGCTA TCTGAATGCG CAGGGTCTGT 
STOP 
1101 TGCGCAGCAC GTTCGCCTGA CGCGAAGCGA AAACGGCAGC CGAAGGCGGG 
1151 AGAGGGCGCA GCGAAGGCGC GATGAAGGCG AAACGTAGCC GACGCACGGG 
1201 GCGGCGCGGC GGCTCGTTCG CCGCGTCCGG GCGTCAGCCG ATCTT 
Fig.lO.l. Nucleotide Sequence of a Putative Hexosaminidase Gene from 
B.pseudomallei Compiled from the Shotgun Sequence, Burk258f03.plc. The sequence 
includes a putative SD sequence but no further sequence information was available up-
stream to facilitate the identification of putative -10 and -35 promoters. 
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1 0.2.2 Complete Amino Acid Sequence of a Putative Hexosaminidase Gene. 
The nucleotide sequence (Fig.1 0.1) when translated, encodes a 342 amino acid sequence 
and a predicted molecular weight of 37.5 k.Da. The hexosaminidase genes from other 
bacteria which had homology to the B.pseudomallei putative hexosaminidase were 
between 314 and 361 amino acids in length. 
MKLPPGPVMLDVAGTTLTRDDARRLAHPHTGGVILFARHFESRAQLVALTEA 
IRAIRDGILIA VDHEGGRVQRFRTDGFTVLPAMRRLGEL WDKDVLHATKAA T 
ALGYVLASELRACGIDMSFTPVLDLDYGRSKVIGDRAFHRDPRVVALLAKSV 
NHGLALAGMANCGKHFPGHGFAQADSHV ALPTDDRPLPEILANDAAPYDWL 
GLSLSA VIP AHVIYTQVDSKP AGFSRVWLQDVLRGRLRF AGA VFSDDLSMEAA 
REGGTLAQSAQAALEADCDMVLVCNQPDAAERVLDELRTT ASRESSRRIKQM 
RPRGKVLEWRKLMREPRYLNAQGLLRSTFA. 
1 0.2.3 Isolation of a Putative Hexosaminidase Gene on Contig. 1720. 
Another region of the genome, Contig. 1720 was identified as having homology to the 
hexosaminidase genes used to screen the database. Contig. 1720 was a 23,000 bp 
assembled fragment and the region with homology to the hexosaminidase genes was at the 
end of the sequence, starting at around 20,000 bp. The end 3,000 bp of the nucleotide 
sequence was used in a Web-based BLAST-X search to identify protein sequences in the 
database with homology to the translated nucleotide sequence (Table I 0.4). 
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Table 10.4 Results of a Web-Based BLAST Search using a Putative Hexosarninidase 
Sequence Located on an Assembled Fragment from the B.pseudomallei Genome 
Seguencing Database. Contig 1720. 
Accession Sequence Title Similarity 
Number (%) 
L43594 Chitobiase Precursor (N-acetyl-beta-glucosaminidase) Serratia marcesens 62 
AB022786 N-acetyl-beta-D-glucosaminidase Enterobacter sp. 61 
AE004294 Beta-N-acetylhexosaminidase Vibrio cholera 60 
J05004 N-acetyl-beta-glucosaminidase (Chitobiase) Vibrio harveyi 61 
AFI96349 Chitobiase Aeromonas hydrophila 59 
L04544 Beta-N-acetylhexosaminidase (Chitobiase) Vibrio vulnificus 49 
AB031320 Beta-N-acetylglucosaminidase Aeromonas sp. 45 
AB026053 Transglycosylative enzyme Altermonas sp. 42 
U24658 Beta-N-hexosaminidase Vibrio parahaemo/yticus 40 
AF063001 Beta-N-acetylhexosaminidase Streptomyces p/icatus 38 
AE003924 Beta-hexosaminidase precursor Xylella fastidiosa 43 
An open reading frame was identified in the sequence and the complete nucleotide 
sequence for the putative hexosarninidase gene can be found in Fig. I 0.2. 
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I CCTTGAAAGA CCCGATCGCA GCGACGTATT TCCACGGCGT CGTATCGCCG 
51 TTTTTTTGCC AAGGAACGCC CATGAACCGA ATCTCGCATT CCCTGTGCGC 
101 CGCGCTATTG GCCGCCGCGA CGCTGTTGCC CACGGCCTCG CGCGCGCAAC 
151 TGCCCGCGCG CCCCACGGCC GGCGCGGCCG CGCCCGCGAC GGCCGCGCCC 
201 GTGCGGCCCG CGTCCACGCC GGCCGAGCTC GCCGCGCGGC TCGCCAACGG 
251 CCTCGCGGTG CGCGTGGCCG TCGACAACAA TCACGCGGCA TCGGCCGGCG 
301 TGCCGTGCGC CGACCTCGGC GCGGACTGGG CGAGCTGCGC GACGGGCCGC 
351 CTGATCCTGC AGAATCGCGG CCACTCGCCC CTCACCGACG GCGGCTGGAA 
401 GCTCTATCTG CACAGCATCC GCCGGCTGCT CCGAATCGAC CGCCCCGGCT 
451 TCACGCTGCG CCATCTGACG GGCGATCTGT ACGAGCTGAC GCCGCAGCCC 
501 GGCACGGTAA GGCTCGCGCA GGGCGAGCGC ATCGAGCTGC CGTTCGTCGC 
551 CGAATACTGG CTGCGCCGCT ACAGCGACGT GATCCCGCGC CCGTACGTGG 
601 TCGTCGACGG CGCGGCGCCC GCGGTGCTGC GCTACGACGA TACCGACGAC 
651 GAGCTGCGCT ACGTCGAAAC GCTGCCCGCC GACGCGCAGA ACAACTCGCC 
701 CGGCAATGCG CCGCCCGCCG CCGCGCAGCC GGTGGCGAAC CGCGCGCTGC 
751 CGAGCGTGAA GCGGCAGCGC GCGCTGCCCG GCGCGCTCGA TCTGCGCGGC 
801 GTCGAGCTGA CGCTGCCGGA GCTGCCGTCC GCGCAGGTCG CGGCGCTGCG 
851 CGAACGCGCG GGCACGCTCG GCCTGGACGG CGCGCGCGTG CCGGTGTGGG 
901 GCGTCGTCGC GCCGCGCCGG CTGCCCGCCG ACATCGCGGT GCCGGGCGGC 
951 TACCGGCTCG CGATCGGCCC GCGCGGCGCG TTCATCGAGG GGGCCGATCG 
1001 CGCGGGCCTC TACTACGGCG TGCAGACGCT CTTCTCGCTC GTGCCGGCCG 
1051 GCGGCGCGAC GGTGCCCGCG ATGCTGATCG AAGACGCGCC GCGCTTCACG 
1101 CACCGCGGGA TGCACGTCGA TCTCGCGCGC AACTTCAAGC CGCCCGCCAC 
1151 GCTGCGCCGG CTGATCGACC AGATGAGCGC GTACAAGCTC AACCGGCTGC 
1201 ATCTGCACCT GTCCGACGAC GAGGGCTGGC GCATCGAGAT TCCCGGCCTG 
1251 CCCGAGCTGA CCGACGTCGG CGCGCGCCGC TGCCACGACC CGAGCGAGAC 
1301 GCGCTGCCTG CTGCCGCAGC TCGGCTCGGG GCCCGACGAT CGTTCGGGCG 
1351 GCGGCTACCT GACGCGCGAC GACTACGTCG CGCTGCTGCG CTACGCGGCC 
1401 GAGCGCTTCG TCGAAGTGAT CCCCGAGATC GACATGCCCG CGCACTCGCG 
1451 CGCGGCCGTC GTATCGATGG AGGCGCGCTA TCGCCGCCTG CACGCGGCGG 
1501 GCCGCGAGCG GGAAGCGAAC GCGTATCGGC TGCTCGATGC GCAGGACACG 
1551 TCGAACCTGC TGACCGTGCA GTTCTACGAC CGGCGCAGCG ATCTGAACCC 
1601 GTGCATGCCG GGCGCGCTGA ACTTCGCGTC GAAGGTGATC CGCGAGATCG 
1651 CGTCGATGCA CGCGGACGCG CAAGCGCCGC TGCGGATCTG GCACTTCGGC 
1701 GGCGACGAGG CGAAGAACAT CCTGCTCGGC GCGGGCTTCC AGCCGCTCGA 
1751 CGGCGCCGAT CCCGGCAAGG GCCGCGTCGA TCTCGCCGCG CAGGACAAGC 
1801 CGTGGGCGCG CTCGCCCGCC TGTACGGCGC TGCTTCGGCG CGGCGAGATC 
1851 AAATCGATCG ACGAATTGCC GACGCGCTTC GCGAAGCAGG TCAGCGCGAT 
1901 CGTGAACGCG AACGGAATCG GCACGATGGC CGCGTGGCAG GACGGCATCA 
1951 AGCACGCGAG CGGGCCGCGG GAGTTCAGCA CGCGGCACGT GATGGTGTCG 
2001 CTGTGGGACA CCATCTTCTG GGGCGCGTCC GACAGCGCGC GCGATCTGAG 
2051 CGCGAAGGGC TACCGGACCG TGCTCGCGCT GCCCGATTAC CTGTACTTCG 
2101 ATTTCCCGTA CACGCGCAAT CCGCGCGAGC GCGGCTATTA CTGGGGCTCG 
2151 CAGGCGACGG ACGAGTACAA GGTGTTCTCG CTCGCGCCGG AGAACCTGCC 
2201 GCAGAACGCC GAGGTGTTCG GCGATCGCGA CGGCAACCCG TTCGAGGTGA 
2251 CGAGCGCGGG CGCGGCGCCG AGCATCGAGG GCATCCAGGG GCAGGCGTGG 
2301 GGCGAGGTGA TGCGCAACGG GCAACTGCTC GAATACATGG TGTATCCTCG 
2351 CCTTCTCGCG CTCGCCGAGC GCGCGTGGCA CAAGGCCGAC TGGGAACTGC 
2401 CCTACGCGGC CGGCGTGCGC TACAAGCTCG GCGACACGCA TCACGTCGAC 
2451 ACGGCCGCGC TCGAGCGCGA CTGGGCGGGC TTCGCGACGG TGCTCAAGCA 
2501 GCGCGAACTG CCGAAGCTCG AGCGTGCGGG CATCGGGTAT CGCAAGCCCA 
2551 CGTTTACGCT GACGGGCGAA TGACGGGACG ATGATGGGCC GATCGCATCG 
Fig.10.2 Nucleotide Sequence of a Putative Hexosaminidase Gene Identified on 
Contig. 1720. The nucleotide sequence has been extended to include putative -35 and -I 0 
promoter sequences and a putative ribosome binding site. 
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10.2.4 Complete Amino Acid Sequence of a Putative Hexosaminidase in 
B.pseudomallei. 
The nucleotide sequence in Fig.! 0.2 encodes an 833 amino acid sequence, with a predicted 
molecular weight of 91 kDa. Most of the hexosaminidase amino acid sequences with 
homology to the putative B.pseudomallei hexosaminidase were between 858 and 885 
amino acids in length. 
MNruSHSLCAALLAAATLLPTASRAQLPARPTAGAAAPATAAPVRPASTPAEL 
AARLANGLA VRV AVDNNHAASAGVPCADLGADWASCATGRLILQNRGHSPL 
TDGGWKL YLHSIRRLLRIDRPGFTLRHL TGDL YEL TPQPGTVRLAQGERIELP 
FVAEYWLRRYSDVIPRPYVVVDGAAPAVLRYDDTDDELRYVETLPADARNNS 
PGNAPPAAAQPVANRALPSVKRQRALPGALDLRGVELTLPELPSAQVAALRE 
RAGTLGLDGARVPVWGVV APRRLPADIA VPGGYRLAIGPRGAFIEGADRAGL 
YYGVQTLFSL VP AGGATVP AMLIEDAPRFTHRGMHVDLARNFKPPATLRRLI 
DQMSA YKLNRLHLHLSDDEGWRIEIPGLPEL TDVGARRCHDPSETRCLLPQL 
GSGPDDRSGGGYL TRDDYVALLRY AAERFVEVIPEIDMPAHSRAA VVSMEAR 
YRRLHAAGREREANAYRLLDAQDTSNLLTVQFYDRRSDLNPCMPGALNFASK 
VIREIASMHADAQAPLRIWHFGGDEAKNILLGAGFQPLDGADPGKGRVDLAA 
QDKPW ARSPACT ALLRRGEIKSIDELPTRF AKQVSAIVNANGIGTMAA WQDGI 
KHASGPREFSTRHVMVSL WDTIFWGASDSARDLSAKGYRTVLALPDYLYFDF 
PYTRNPRERGYYWGSQATDEYKVFSLAPENLPQNAEVFGDRDGNPFEVTSAG 
AAPSIEGIQGQA WGEVMRNGQLLEYMVYPRLLALAERA WHKADWELPY AA 
GVRYKLGDTHHVDTAALERDWAGFATVLKQRELPKLERAGIGYRKPTFTLT 
GE. 
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10.3 ATTEMPTS TO PROBE THE SHOTGUN DATABASE FOR THE 
PRESENCE OF AN ADP-RIBOSYLATING TOXIN. 
The shotgun and assembled databases of the B.pseudomallei genome sequencing project 
were searched for any homologies with the ET A gene of P.aeruginosa (Gray et al., 1984). 
No significant homology was observed using the sequence of ET A, or the active site of the 
gene either at the amino acid or nucleotide level. Various conserved amino acid sequences 
belonging to ADP-ribosylating toxins (Chapter 8) were searched for and the sequences 
isolated were analysed for homology, but none could be found. 
10.4 SEARCHING THE SHOTGUN AND ASSEMBLED DATABASES 
FOR THE 10/12 kbp Sau3A UNDIGESTIBLE FRAGMENTS. 
The sequence information received for the recombinant clone, pSA2 (9.7.1) was used in a 
BLAST-search of the assembled B.pseudomallei genome sequencing project database for a 
homologous nucleotide sequence. An assembled fragment, Contig. 1748, contained a 
sequence with a high homology (80%) to that of pSA2. The assembled fragment, Contig. 
1748 was 38 kbp (APPENDIX Ill) in length and the homologous sequence to pSAU2 was 
located from 34,835 bp to 35, 143bp. The nucleotide sequence of Contig. 1748 was 
searched for any homology with the nucleotide sequence of the other recombinant clone, 
pSAU8, however no homology could be found. It is possible that the two clones pSAU2 
and pSAU8 represent the two undigestible Sau3A fragments. Therefore a similar search 
was carried out with the two sequences from the recombinant clone pSAU8, which 
comprised a small amount of information at the beginning of the cloned sequence and at 
the end (9.7.2). Shotgun sequences revealed had a lower homology than the previous 
sequence for pSAU2, at around 60% and when analysed using the assembled database, the 
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two sequences were not found on a contiguous DNA fragment. For this reason, it was 
decided to only pursue the pSAU2 sequence. Web-based BLAST-X searches were then 
carried out on the 38 kbp sequence to reveal any areas with homology to protein sequences 
deposited in the Genbank database, the results of which can be seen in Fig.l0.3. The 
sequence encoded 11 regions with homology to protein sequences deposited in the BLAST 
database (Table 10.5). However, the end 8 kbp of the fragment contained repeated DNA 
and the same proteins were identified in this region as those located at approximately 20-
25 kbp on the fragment. 
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Fig. 10.3 Map of the 38 kbp Fragment Showing the Locations of Sequences with Homology to Other Protein Sequences Deposited in the BLAST 
Data bases. 
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Table 10.5 Web-Based BLAST Results Showing Protein Sequences that have Homology to Regions on the 38 kbp Fragment. 
Sequence No. On Accession Number Sequence Title Similarity(%) 
Fra2ment 
I AP001512 Integrase/Recombinase Bacillus halodurans 39 
I 086934 Transposase A Staphylococcus aureus 45 
I X03216 Gene tnpA Staphylococcus aureus 45 
I AL445067 Site-specific integrase/recombinase Thermoplasma acidophilum 43 
I Z29084 Product similar to tnpA of S. aureus Clostridium butyricum 45 
I L29642 Methyltransferase Pseudomonas jluorescens 37 
I Z74024 Probable integrase/recombinase Mycobacterium tuberculosis 40 
2 U31759 Thermostable alkaline protease Thermoactinomyces sp. 42 
2 AP001512 Protease Bacillus halodurans 40 
2 064006 Serine protease Sy!7echocyst is sp. 37 
2 AL031541 Putative secreted serine protease Streptomyces coelicolor 37 
2 AL031231 Serine protease Streptomyces coelicolor 42 
3 AF224059 Putative variable cytadhesin protein Mycoplasma [l.allisepticum 36 
3 AB009049 Similarity to carbonic anhydrase gene Arabidopsis thaliana 38 
3 L22858 Hypothetical 24.1 kDa protein Autographa califomica polyhydrosis virus 52 
3 M34651 Probable nuclear antigen Pseudorabies vims 34 
4 AL445064 Hypothetical protein Thermoplasma acidophilum 49 
4 AB035945 Serine/threonine protein kinase Chlamydophila pneumoniae 49 
4 AL079038 Putative serine/threonine kinase Streptomyces coelicolor 42 
4 YI0256 Serine/threonine protein kinase Homo sapiens 44 
5 AL445064 Hypothetical protein Thermoplasma acidophilum 61 
6 AL445064 Hypothetical protein Thermoplasma acidophilum 46 
7 AE004565 Probable transcriptional regulator Pseudomonas aeruginosa 59 
7 AB016282 Immunity repressor protein Bacteriophage phi-1 05 61 
7 AF062070 Thermosensitive mutant immunity repressor Bacteriophage phi-1 05 59 
8 AB029393 Streptococcal hemagglutinin Streptococcus fl.Ondii 31 
8 U96166 srpA Streptococcus cristatus 33 
8 U30626 Cell surface flocculin with structure similar to serine/threonine rich GPI-anchored cell wall 37 
proteins Saccharomyces cerevisiae 
9 AF250878 Hypothetical protein Salmonella typhi 43 
Perhaps the most interesting putative gene found on the 38 kbp fragment was an open 
reading frame with homology to a range of proteases from other bacterial species. Protease 
activity has been published for B.pseudomallei and indeed from the activity experiments 
carried out in Chapter 3, strong protease activity was observed for both B.pseudomallei and 
B.thailandensis. However the gene(s) responsible for the proteolytic activity observed have 
yet to be cloned and sequenced. The putative protease gene is located from its start codon 
at 8755 bp to the stop codon at 7019 bp in the 38 kbp sequence and is complementary to 
the sequence in Appendix Ill. The nucleotide sequence can be seen in Fig. I 0.4. The 
nucleotide sequence encodes a gene product of 578 amino acids as follows and a 
theoretical molecular weight of 63 kDa: 
MADLNEMKLLIRLPNQHVLNFRSPTRRSAADLIGITGGKVEALFP 
DTSVQFVGGQNDWVVFQPDTVEDIHPWDRAHKQALSIVNSASGV 
GDVYVEPNiffiKRTLDSSDAGVRSSITPLSAQEDVTLAPPYPPTESL 
NPNYPPSEGASFSPA WHLQKAGFPRA WQTTKGEGIRIAHLDIGW 
WPNHYSAPLKVRKDLGYNFVEGNSNTVDPGVGPNKGHGTATLAL 
LAGNA VSLCGKAGQSEGDQVYRGFIGGAPSAEIVPVRIAGVDGSV 
VYLYGETMARGLA YAINPGDGRRCDVVSLSHGGLPMKSWAHAV 
NML YDAGVVVV AAAGDSYWAVLTDIA THFTVYPSAFYRVVTSTG 
VTFDDGPYKRDRLGVMQGCWGPDKVMKKA VGA YTPNVPWMC 
YNTKYGWDMNGAGTSASTPQMAAACALWLAKYGSVFPNDWRR 
V AACRAALGRSV ADAEKDFSEIGLGRLDVSAMIEQTLADEVKHLC 
DENRLQNIDPDDVSFPFLRLLFGLAPPGNGIEEMYEVEALQIFYQT 
TNERLFRAVEDYENERLQSNEDLSELRAQFLQEKGMSDALRGYL 
TSHA 
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1 CAGGCAATTT GAGGTCGATT GCATCTTCCG ATATCTAGCA TCTCGGAATT 
- -
51 AGATATATTG TTGCGCTTGA AGCTGTGACC AACAGCCTAC ATGATAGGCT 
101 GAAGCTATAC CTCGGGGAGT AGAGCATGGC TGACTTGAAT GAGATGAAGT 
----
151 TGTTAATCCG TTTGCCTAAT CAGCATGTTT TGAATTTCAG AAGCCCCACG 
201 AGAAGAAGTG CGGCGGACCT TATTGGTATC ACGGGCGGTA AGGTTGAGGC 
251 GCTTTTTCCT GATACGAGCG TTCAGTTTGT TGGTGGCCAA AATGATTGGG 
301 TCGTATTTCA ACCAGATACC GTAGAGGATA TTCATCCATG GGACCGCGCA 
351 CATAAGCAGG CGTTGTCTAT CGTAAACAGT GCGAGCGGTG TCGGTGATGT 
401 GTATGTTGAG CCCAATATTA TTCACAAGCG AACATTGGAC AGCTCAGATG 
451 CGGGAGTAAG AAGCTCAATA ACGCCTCTCA GCGCTCAGGA AGATGTCACA 
501 TTAGCGCCCC CCTATCCCCC CACCGAATCG CTCAACCCAA ATTACCCTCC 
551 GAGTGAAGGC GCGTCGTTTT CGCCTGCATG GCACTTGCAG AAGGCGGGTT 
601 TTCCTCGAGC ATGGCAGACT ACAAAGGGAG AAGGTATCCG CATCGCACAT 
651 CTGGATATCG GATGGTGGCC AAATCACTAT TCTGCACCTC TAAAAGTTAG 
701 AAAAGACCTG GGATACAACT TCGTCGAAGG AAATTCCAAT ACCGTTGACC 
751 CCGGAGTTGG GCCGAATAAA GGACATGGAA CAGCAACTCT CGCTCTGCTC 
801 GCTGGTAATG CCGTGAGCCT ATGCGGAAAA GCTGGCCAAA GTGAGGGCGA 
851 CCAGGTATAT CGCGGATTCA TTGGCGGCGC GCCAAGCGCG GAAATTGTCC 
901 CTGTGAGAAT . CGCTGGTGTG GACGGGTCCG TTGTTTATCT TTACGGTGAG 
951 ACTATGGCTC GTGGTCTTGC TTATGCGATT AATCCCGGCG ATGGGCGACG 
1001 TTGTGATGTG GTGAGTCTGA GTCACGGTGG TTTGCCAATG AAGTCATGGG 
1051 CGCACGCTGT GAACATGCTT TATGACGCTG GAGTAGTAGT GGTGGCGGCT 
1101 GCCGGCGATA GCTACTGGGC GGTGCTTACA GACATCGCAA CCCATTTCAC 
1151 GGTTTATCCG TCAGCGTTCT ACCGCGTTGT TACATCGACA GGCGTAACAT 
1201 TTGACGATGG CCCTTACAAG CGAGATAGAC TCGGGGTAAT GCAAGGCTGT 
1251 TGGGGGCCCG ATAAGGTGAT GAAGAAAGCG GTGGGAGCCT ATACGCCGAA 
1301 CGTTCCCTGG ATGTGCTACA ACACGAAGTA CGGTTGGGAC ATGAACGGTG 
1351 CCGGAACCTC CGCGAGTACA CCGCAGATGG CGGCTGCCTG CGCTCTATGG 
1401 CTGGCTAAGT ACGGCAGCGT ATTTCCAAAT GACTGGCGCA GAGTTGCGGC 
1451 GTGTCGAGCT GCGCTCGGTA GGTCGGTTGC GGACGCGGAG AAGGATTTCA 
1501 GCGAAATTGG CCTGGGGCGG CTAGATGTCA GCGCGATGAT AGAACAGACG 
1551 CTTGCGGATG AAGTTAAGCA TCTTTGTGAC GAAAATAGAC TCCAAAACAT 
1601 AGACCCAGAC GACGTTTCAT TTCCATTTCT TCGACTTCTA TTCGGGCTCG 
1651 CCCCTCCGGG AAATGGTATC GAGGAAATGT ACGAGGTAGA GGCTTTGCAG 
1701 ATTTTCTATC AAACCACCAA TGAACGCCTT TTTCGCGCGG TCGAAGATTA 
1751 TGAAAACGAG CGACTGCAAA GCAATGAGGA TTTGAGCGAG CTGCGAGCAC 
1801 AATTTCTACA GGAAAAGGGT ATGTCCGATG CGTTGCGTGG ATACCTGACC 
1851 TCTCATGCCT GA 
Fig.10.4 Tbe Complete Nucleotide Sequence of a Putative Protease Gene in 
B.pseudoma/lei. The sequence has been extended to include putative -35 and -10 
promoter sequences and a putative ribosome binding site. 
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10.5 DISCUSSION. 
The extracellular products from isolates of B.pseudomallei and B. thailandensis had been 
tested for hexosaminidase activity in Chapter 3, and it was revealed that all B.pseudomallei 
isolates had a positive activity with three different substrates, whereas the B.thailandensis 
isolates had no activity. However, construction and screening of genomic libraries in 
Chapter 4 yielded no clones with such activity. By searching the information available on 
the genome sequencing project with other bacterial hexosaminidase sequences available, 
two putative genes were identified. The first, isolated on a shotgun fragment was smaller, 
and yielded a 342 amino acid sequence with a predicted molecular weight of 37.5 kDa, 
with a high homology to beta-hexosaminidases from a range of other bacterial species. 
Beta-hexosaminidases catalyse the removal of beta-! ,4 linked N-acetylhexosaminidase 
residues from oligosaccarides and their conjugates. 
The second, isolated from an assembled fragment, Contig. 1720, yielded a putative 2,453 
bp gene with high homology to chitobiases (N-acetyl-beta-glucosaminidases) from a range 
of other bacterial species. The nucleotide sequence predicts a gene product of 833 amino 
acids and a predicted molecular mass of 91 kDa. Chitobiases break down chitobiose, a 
disaccharide sugar unit found in chitin. 
Both of these enzymes would possibly be extracellularly produced in B.pseudomallei and 
although the predicted sizes are given, they may well be processed to a smaller, active 
molecule. Both protein sequences were analysed by the Centre for Biological Sequence 
Analysis (CBS) on the intemet using the Signal PV 1.1 program (Neilsen et al., 1997) to 
predict whether there were likely signal peptide cleavage sites in the amino acid sequences. 
A likely signal peptide cleavage site could not be found for the smaller putative 
hexosaminidase (37.5 kDa) but one was identified in the larger, putative chitobiase 
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between amino acids 25 and 26 (Fig. I 0.2). Thus, the mature enzyme would be around 
88.5 kDa. 
In Chapter 3 extracellular products isolated from a representative group of B.pseudoma/lei 
and B.thailandensis isolates were subjected to SOS-PAGE and immunoblotting and the 
relative molecular weights of protein bands were calculated. These were analysed for 
proteins around 37.5 and 88.5 kDa. Results of immunoblotting yielded protein bands 
around 85.1 kDa but this was also found in one of the B. thai/andensis isolates and 
hexosaminidase activity was not found in this species (Chapter 3). However, a similar 
sized band such as this may not actually represent the same protein. In addition to this a 
protein band of 36.3 kDa was only found in B.pseudomal/ei isolate 576 but it must be 
remembered that the protein bands were overshadowed by the ladder of reaction to LPS 
and so it was difficult to analyse protein bands. However, SOS-PAGE analysis revealed 
protein bands of 87.1 and 38.9 kDa found only in B.pseudomal/ei isolates, which possibly 
represent the two putative proteins identified, but cloning and characterisation of the 
putative genes and their respective products would be necessary to prove this. 
The B.pseudomal/ei genome project was searched for homologies to ETA of P.aeruginosa 
both at the nucleotide and amino acid level but no obvious similarity was found. Sequences 
were also analysed for amino acid patterns found in the active sites of a number of AOP-
ribosylating toxins but again no obvious similarities were identified. This does not discount 
the presence of an AOP-ribosylating toxin in B.pseudomallei but perhaps implies that it is 
different from ETA of P.aeruginosa and perhaps those from other bacterial species. 
When the B.pseudoma/lei genome sequencing database was searched for the sequence 
information possessed on one of the Sau3A undigestible clones (pSAU2) (Chapter 9) the 
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sequence was present on an assembled fragment totalling 38 kbp (Contig. 1748). Previous 
attempts in Chapter 9 to clone the full-length I 0/12 kbp sequences had failed but clearly 
the process of cloning fragments in the genome sequencing project was successful, 
presumably because different vector systems and enzymes were used. 
Interestingly, the 38 kbp region of this fragment was found to contain no Sau3A cleavage 
sites (GATC). Additionally, the G+C content of this fragment was 56%, which is different 
from the rest of the genome, which is 69% (Redfearn et al., 1966). Such findings are 
consistent with Pathogenicity Islands (Pais), which have been found in a wide variety of 
bacterial species including E. coli, Salmonella, Helicobacter pylori, Dichelobacter nodosus 
and Vibrio cholera. Pais are large pieces of chromosomal DNA that carry virulence genes, 
which were most probably acquired by phage-mediated horizontal transfer (Buchrieser et 
al., 1998). A Pai can be defined according to the following criteria (Hacker et al., 1997): 
(i) Carriage of (often many) virulence genes. 
(ii) Presence in pathogenic strains, and absence or sporadic distribution in less-pathogenic 
strains of one species or related species. 
(iii) Different G+C content in comparison to DNA of host bacteria. 
(iv) Occupation of large chromosomal regions (often more than 30 kbp ). 
(v) Represent compact, distinct genetic units, often flanked by direct repeats. 
(vi) Association with tRNA genes and/or insertion sequence (IS) elements at their 
boundries. 
(vii) Presence of (often cryptic) "mobility" genes (IS elements, inte!:,rrases, transposases, 
origins of plasmid replication). 
(viii) Instability. 
One of the main features of Pais is the carriage of virulence genes and a putative gene 
encoding an alkaline protease was found within the sequence. Sexton and Jones (1994) 
believed that the extracellular protease they isolated belonged to the family of alkaline 
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proteases sensitive to metal chelators. The authors also found the protease capable of 
digesting transferrin and haemoglobin and so postulated its role in iron acquisition in the 
host. The putative protease gene product was calculated as having a theoretical molecular 
weight of 63 kDa. However, as with the putative hexosaminidases, it is likely that the 
protease contains a signal peptide cleavage site and so the sequence was subjected to 
analysis by the same program as the hexosaminidase sequences. A possible peptide 
cleavage site was recognised between amino acid 29 and 30 (RSA-AD). Thus giving the 
mature protease a size of 59.5 kDa. Conflicting reports exist in literature regarding the size 
of the protease whereby Sexton and Jones (1994) confirmed the presence of a 36 kDa 
protease and Percheron et al. (1995) a 42 kDa protease. Despite this, a 59.5 kDa protein 
band was searched for in the SOS-PAGE gels and immunoblotting in Chapter 3. Microtitre 
plate tests carried out on B.pseudomallei and B.thailandensis ECPs revealed that 
proteolytic activity was common to both species. A protein band of 60.3 kDa was found in 
B.pseudomallei isolates and a B.thailandensis isolate on SOS-PAGE gels. On 
immunoblotting a protein band of this size was not found, only ones at 57.5 and 63.1 kDa, 
which were, incidentally, found in both species. 
As the protease may be produced in both species its role in virulence is questionable and 
recent published literature suggests that the expression of a high proteolytic activity is 
neither sufficient nor necessary for virulence when bacteria are injected via the 
intraperitoneal route (Gauthier et al., 2000). However, a pathogenic role for the protease 
cannot be excluded, and it has been suggested that its role in the physiopathology of 
melioidosis is probably dependent on the route of entry of the bacteria into the organism 
(Gauthier et al., 2000). 
In addition to the putative protease another region encoded homology to a Streptococcal 
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haemagglutinin from Streptococcus gondii, which was present in two copies along with a 
putative transcriptional regulator. It has been postulated that the haemagglutinating 
adhesins of bovine group B streptococcal isolates are directly involved in the adherence 
mechanisms of these organisms (Wibawan et al., 1993) and so if it has a similar function in 
B.pseudomal/ei is another extracellularly produced protein with a putative role in 
virulence. 
The 38 kbp fragment also contained a putative integrase/recombinase gene at the beginning 
of the sequence, which are often associated with Pais at their boundaries. In addition to this 
the I 0/12 kbp fragment isolated from B.pseudomal/ei 4845 was unstable and only deletions 
of the fragment could be cloned. All of the discussed factors fulfil much of the criteria for 
the fragment being a Pais, although its presence in non-pathogenic strains has yet to be 
tested. In addition to this, it is also possible that the fragment is bacteriophage in origin due 
to lack of Sau3A sites as was found in the genome of the lysogenic phage, MA VI of 
Mycoplasma arthritidis, discussed in Chapter 9. Not only this, but a number of the regions 
identified on the fragment had homology to various phage genes (Table I 0.5). It is possible 
therefore that the 38 kbp fragment may be a Pais, bacteriophage in origin and encodes a 
number of excreted virulence genes in B.pseudomallei. 
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CHAPTER 11 
GENERAL DISCUSSION 
Following each experimental chapter within this thesis there are individual discussions, 
which focus on the tindings of that particular practical investigation. The purpose of this 
final chapter is to tie together all the information in a general discussion. 
This research project was concerned with the molecular characterisation of the pathogen, 
B.pseudomal/ei, of which there is a paucity of knowledge in published literature. As stated 
in the aims of this thesis the main aim was to apply the techniques of molecular biology, in 
particular those of gene cloning, to isolate and characterise extracellular virulence factors 
from the pathogen. With respect to this initial aim, although no firm information regarding 
the nature of extracellular virulence factors nor the pathogenic processes of the bacterium 
has been gained through this research, previously uncharacterised genes and biochemical 
activities of B.pseudomallei, which may have a role in the pathogenic processes of the 
bacterium have been discovered and are available for future study. In addition to this, 
fundamental differences between B.pseudomallei and the avirulent species, B.thailandensis 
have been elucidated, which was another aim of the research project. 
As previously stated in the aims, the order in which experimental work appears within the 
thesis is not representative of the chronological order in which the investigations were 
carried out. Thus some of the investigative work may appear illogical to the reader. 
However, the initial part of this thesis deals with the initial characterisation of extracellular 
products from B.pseudomallei and B.thailandensis followed by the construction and 
screening of B.pseudomallei genomic libraries. 
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When culturing facilities became available, at the end stages of the research project, a 
direct comparison of the ECPs isolated from B.pseudoma/lei and B.thailandensis isolates 
was carried out through SOS-PAGE profiles and immunoblotting with convalescent human 
antisera. As there was little opportunity to experiment with culture media, coupled with a 
lack of published literature regarding the evaluation of different media with respect to the 
isolation of extracellular products, it may have been the case that the full range of ECPs 
were not produced, or produced at a very low level. Indeed, the concentration of ECPs 
derived from the cultures was very low, which prohibited an extensive comparison 
between all of the isolates used. Future studies may benefit from a better-defmed media for 
use in isolating ECPs, as the isolates in this study were cultured simply in LB media. This 
may be achieved by simply assaying isolates on a range of media to test for enhanced 
expression of certain activities. 
However, a representative group consisting of both species, and including B.pseudomallei 
isolates from clinical and environmental sources could be compared and it became evident 
that the two species did exhibit different extracellular protein profiles on SOS-PAGE and 
immunoblotting. Isolates of B.thailandesis invariably contained fewer ECPs than those of 
B.pseudomal/ei. However, the two species did share a number of common bands, although 
obviously it cannot be concluded that similar sized bands represent the same protein. 
ECP protein profiles gained by SOS-PAGE and immunoblotting also revealed differences 
between isolates of B.pseudomallei. Not all strains of a virulent bacterial species are 
equally pathogenic and considering the wide range of clinical features and outcomes 
associated with infection with B.pseudomallei it is likely that the isolates of 
B.pseudomallei differ with respect to the virulence products they produce, which includes 
ECPs. Certain protein bands present in clinical isolates were not found in those isolated 
from the environment and may be indicative of virulence products elicited on infection. It 
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was not known what were the functions of the proteins identified, although suggested 
functions based on the relative sizes compared to those in published literature was 
discussed in Chapter 3. 
The results of the immunoblotting using convalescent human antisera were overshadowed 
in most isolates by the reaction to what was considered to be LPS, producing a ladder of 
bands. The exceptions to this were B.pseudoma/lei isolates 576 and 217. It has been 
reported that 5% of B.pseudomallei isolates possess an atypical LPS pattern (Dr. T. Pitt, 
personal communication), which includes B.pseudomallei 576, and on immunoblotting 
with the human sera there was no evidence of the ladder of LPS reaction. It was not known 
if B.pseudomallei 217 was included in the 5% of isolates with atypical LPS patterns but as 
there was no reaction of LPS with the sera it is possible that it is. The convalescent human 
antisera probably contained antibodies raised to the typical LPS pattern, found in 95% of 
B.pseudomallei isolates and so did not react with LPS from those isolates with an atypical 
pattern. If this was indeed the case, in order to analyse the other protein profiles, which 
were overshadowed by the LPS reaction, the study may have benefited from using human 
sera from an infection with an isolate of B.pseudoma/lei that has an atypical LPS pattern, 
such as B.pseudomal/ei 576. In this case antibodies would be raised to the atypical LPS 
pattern, which would possibly not react with LPS from isolates with the typical pattern 
therefore making the bands visible. Experiments were carried out testing isolates of both 
species for a number of activities with the aim of identifying novel targets for future gene 
cloning studies. Some of the activities identified had been previously reported for the 
bacterium, but not confirmed in the newly identified species, B.thailandensis. Protease and 
lipase activities, already identified in B.pseudomallei (Ashdown and Koehler, 1990), were 
shown to be similarly possessed by B.thailandensis isolates. This was also the case with 
phospholipase C activity, previously identified by Korbsrisate et al. (1999). 
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Of those tested, only a hexosaminidase activity, previously unreported, was found in 
isolates of B.pseudomallei and not in B.thailandensis, which represented therefore an ideal 
target for future cloning work as it might have a role in the pathogenicity of 
B.pseudomallei. Furthermore, the ECPs from the B.pseudomallei isolates tested yielded a 
positive reaction with three different substrates all testing for hexosaminidase activity: 
MU-d iacetyl-chi tobioside, MU-N-acetyl-galactosaminidine and MU-N-acetyl-
glucosaminidine, and it was postulated that B.pseudomallei may possess three separate 
enzymes, or a single hexosaminidase enzyme responsible for the activities observed. 
However, as this was carried out at the end of the research project there was little 
opportunity to investigate this. Although the B.pseudoma/lei genomic library, constructed 
in A.GTII was tested with one of the substrates, MU-N-acetyl-glucosaminidine, no 
recombinants were identified exhibiting this activity. However, it must be remembered that 
genomic library construction and screening was carried out well in advance of the 
experiments testing the ECPs for various activities, due to the lack of culturing facilities. 
The logical pattern would have been to test the ECPs first and from the results of this to 
identify activities such as the hexosaminidase activity to screen the genomic library with. 
In this case all three hexosaminidase substrates with which the positive reaction was 
observed would have been used. The logical next step if a clone exhibiting the desired 
activity was not isolated on screening the genomic library would have been to develop 
PCR primers based on other hexosaminidase gene sequences deposited in the Genbank 
database in the hope that these would amplify a similar sequence in B.pseudomallei that 
could then be cloned and sequenced. 
Towards the end stages of the research project, the B.pseudoma/lei genome sequencing 
project became available on the intemet to search sequence information that had been 
determined in the form of shotgun sequences and assembly of these sequences into larger, 
contiguous DNA sequences. It was a relatively quick and straightforward process to use 
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hexosaminidase sequences already deposited in the database to search the genome 
sequencing project for homologous sequences. This process yielded the isolation of two 
putative hexosaminidase genes, which, if their gene products are produced in 
B.pseudomal/ei may have been responsible for the activities previously observed in the 
ECPs isolated. Of the two putative hexosaminidase genes, one had homology to beta-
hexosaminidases from a range of bacterial species and the other had homology to 
chitobiases (N-acetyl-beta-glucosaminidases) of which a putative signal peptide cleavage 
site was recognised in the latter. The next step would possibly be to develop PCR primers 
to both sequences in order to amplify the sequences from B.pseudomal/ei isolates for 
cloning and characterisation of the putative genes and their respective gene products with 
the ultimate aim of determining a role of the enzymes in the virulence of B.pseudomal/ei 
through mutational studies. 
An anomalous result in testing the ECPs was the positive reaction of only B.pseudomal/ei 
isolate 576 in the panel of isolates used, to the chromogenic substrate for phosphatase 
activity, 5-bromo-4-chloro-3-indolyl phosphate. It was postulated that as this isolate has a 
different LPS pattern than the others in the panel of isolates tested, that this in some way 
enabled other components, in addition to ECPs, to be isolated during the ECP isolation and 
concentration procedure, such as the phosphatase not normally extracellularly produced by 
B.pseudomallei. Testing of other isolates with atypical LPS patterns may reveal the same 
result. 
One of the major virulence factors identified in B.pseudomallei is the presence of a 
thermolabile toxin (Nigg et al., 1955), which has been postulated to possess ADP-
ribosylating activity (lsmail et al., 1991 ). However, no simple, precise and highly sensitive 
test exists for the exotoxin (1smai1 et al., 1987). Again, as culturing facilities only became 
available at the end of the research project there was little opportunity to investigate or 
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design an assay for use to test the ECPs of B.pseudomallei and B.thailandensis for the 
presence of the toxin. Attempts were made throughout the research project to acquire 
antisera raised to the exotoxin, as well as other specific extracellular products of 
B.pseudomal/ei but these were unsuccessful. 
The application of recombinant DNA techniques to B.pseudoma/lei, through cloning 
fragments of the organism's genome in E.co/i host/vector systems, to facilitate the 
construction of representative genomic libraries was the very fust experimental procedure 
carried out. It was hoped that by subsequent screening of the genomic libraries for antigens 
or specific activities of B.pseudomallei, that the corresponding gene sequences which may 
be of importance in the pathogenicity of the bacterium would be isolated. However, at this 
time there existed no Category 3 culturing facilities at the University of Plymouth and the 
research project was dependent upon donated sources of genomic DNA. As the genomic 
DNA used to construct genomic libraries was donated there was no control over the 
genomic DNA isolation procedures, or any subsequent purification steps that were carried 
out prior to receipt of the DNA. This indeed proved to hamper the construction of various 
genomic libraries. The genomic DNA received often appeared to be contaminated with 
what was postulated to be complex carbohydrate material. When the Containment Level 3 
unit became available at the University of Plymouth and it was possible to culture the 
organism, it was noticeable that growth of both B.pseudoma/lei and B.thai/andensis was 
accompanied with the mass production of such material and complete separation of 
bacterial cells with this material proved difficult. It was therefore likely that a cell lysis 
procedure, followed by repeated phenol-chloroforms, the process used by the donators of 
the genomic DNA, would not have eliminated this carbohydrate material and so restriction 
enzyme digestion and Iigation procedures would be seriously hampered as a result. This 
was observed in the numerous attempts to construct both plasmid and cosmid genomic 
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libraries with the eventual outcome of just one successful genomic library in the 
bacteriophage vector, A.GT11. 
Screening of the B.pseudomal/ei genomic library in A.GT 11 with various substrates yielded 
very little in the way of results. There was little published work on the application of gene 
cloning to B.pseudomallei and so it was assumed that considering such a large number of 
genes from a wide range of bacterial taxa have been successfully cloned and expressed in 
E.coli systems that it would be possible to do the same with B.pseudomal/ei. As screening 
procedures yielded only two immunopositive clones with antiserum raised to 
B.pseudomallei 576 formalised cells, it could be the case that the E. coli expression system 
differs somewhat to that of B.pseudomal/ei, hence the relative success of expressing genes 
is limited due to such incompatibilities. Additionally, incompatibilities may also exist 
between a product encoded by B.pseudomallei and the metabolic activities of the E. coli 
cell or indeed deficiencies in the gene library screening procedure may exist. The genomic 
library in A.GT11 was shown to be composed of 99% recombinants and so it was unlikely 
that problems existed from the library being composed of a high proportion of vector-only 
ligations. 
lncompatibilities at the level of gene expression can be the result of a number of attributes 
of the cloned gene, including promoter strength (Deuschle et al., 1986), the structure of the 
ribosome-binding site (De Boer et al., 1983) and the choice of codons for amino acid 
incorporation (Kurland, 1987). As very few genes, particularly those involved in virulence 
of B.pseudomal/ei have been cloned and sequenced there was little information to 
compare. Although the phosphatidylcholine-hydrolysing phospholipase C (PC-PLC) gene 
was successfully cloned in an E.coli host/vector system and expressed even without IPTG 
induction, indicating that the promoter was recognised by the E.coli RNA polymerase 
(Korbsrisate et al., 1999). 
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lncompatibilities between the B.pseudomallei product and the metabolic activities of the 
cell may be due to the fact that the E. coli host may not possess certain factors for any post-
translational modification of B.pseudomallei proteins. Or cloned products may be 
inactivated or degraded by enzymes in E.coli or conversely, it could be that the 
B.pseudomallei components may be lethal to E.co/i host. This is especially relevant 
because the genomic library was constructed in A.GTll, which is an expression vector and 
so the expression of any clones that are encoding toxic products may have been lethal to 
E. coli. 
Any of the reasons discussed may have been why only two clones were identified from all 
of the screening procedures carried out. However, problems may also have arisen from 
inadequacies in the screening procedures themselves. The antiserum used to screen the 
bacteriophage genomic libraries was donated from an outside source and so again there 
was no control over its preparation or purity. It was already evident that extracellular 
carbohydrate material was a possible source of contamination in the genomic DNA 
preparations that had been received and considering that the antisera was raised to whole 
and formalised cells, it was likely that most of the immune response would be to this 
material. This became even more likely when immunoblots were carried out on ECPs in 
Chapter 3, as a ladder of what was most likely LPS material was the overwhelming 
response. Thus, screening the B.pseudomallei genomic library with the donated antisera 
would have not have yielded many positive results. 
Alternative cloning systems or techniques perhaps need to be considered, for example 
utilising a more closely related species, such as P.aeruginosa may aid expression of 
B,pseudomallei proteins, although care would have to be taken considering that 
B.pseudomallei is a Category 3 pathogen, and altering the host from E.coli may increase 
the containment level at which cloning experiments must be carried out. Transposon 
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mutagenesis is also a powerful tool to study bacterial pathogens and has been used 
successfully by DeShazer and Woods (1999) to identify a 12 kbp locus with a high degree 
of homology to the general secretory, or type 11 secretion pathway proteins and the authors 
have claimed to have cloned a number of putative virulence genes using this system. 
Future studies may also be improved by more selective methods of screening perhaps 
using monoclonal antibodies raised to certain molecules of interest produced by 
B.pseudomallei. 
Two immunopositive plaques were identified, which developed 'halos' of positive reaction 
encircling the plaques. It was not known what this unusual reaction indicated, but it was 
postulated that it could be indicative of an insoluble product, or one that was being 
degraded or the very low level of production of the immunopositive product. However, 
only one of the clones retained its immunopositivity after isolation and re-screening, and so 
the stable immunopositive A.GTII clone (A.BPGT I) was used for further analysis. 
Numerous attempts were made to detect a protein product being expressed by the 
immunopositive clone (A.BPGTI ), responsible for the activity observed, through SOS-
PAGE and Western blotting, none of which were successful. Analysis continued by 
attempts to subclone the immunopositive-conferring sequence of DNA contained in the 
recombinant clone (A.BPGTI ). The size of the cloned insert was determined and the 5 kbp 
EcoRI fragment was successfully subcloned into the plasmid vector pUCI8. However, 
attempts to determine whether the bacterial subclones were producing an immunopositive 
antigen, by carrying out a colony blot, was inconclusive. The recombinant colonies did 
develop quicker then the negative control, but not as a 'halo' of positive reaction and after 
a few minutes no difference could be observed between the negative control and the 
recombinants. Acetone powders were used to pre-adsorb any anti-E.co/i antibodies that 
may have been present in the antiserum, used as the primary antibody. However, it may 
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have been the case that this was not sufficient in the colony blots to prevent the high E. coli 
background reaction. 
A restriction endonuclease cleavage map was constructed using the recombinant plasmid 
pBPGT2 in order to further analyse the cloned DNA. Further subclones of the original 5 
kbp fragment were created (pCD 1-5) in an attempt to isolate the immunopositive-encoding 
sequence away from other potentially interfering sequences encoded on the 5 kbp 
fragment. However, attempts to express the immunoreactive product using a commercial in 
vitro transcription and translation kit on the subclones pCD 1-5 and pBPGT2 were 
unsuccessful. 
Unfortunately, a protein product responsible for the immunopositivity of the original clone 
could not be determined. It is not clear exactly what the 'halo' of immunopositive product 
indicated or indeed what exactly was responsible for it's production and so explanations 
can only be postulated. The immunopositive 'halo' of reaction, as previously discussed, 
may have been indicative of degradation or insolubility of the product, and if any of these 
were the case then a product may not have been visualised by SOS-PAGE or Western 
blotting of the original phage lysate. Moreover, a second immunopositive clone was 
identified, which possessed the same 'halo' of reaction but failed to retain its 
immunopositivity, which may indicate degradation of the product, or perhaps an instability 
of the cloned fragment encoding the immunopositive antigen. If the immunopositive 
antigen was initially being produced at a very low level, it too may not have been 
visualised on an SOS-PAGE gel or perhaps on Western blotting. It was hoped that the in 
vitro transcription and translation kit would overcome problems such as a low level of 
expression. However, it is possible that subcloning the fragment into a plasmid vector 
resulted in a deletion of nucleotide(s) and thus a loss of the correct reading frame for the 
immunopositive-encoding sequence, and therefore a product was not detectable with the 
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use of the in vitro transcription and translation kit. Alternatively, when the kit was used on 
pBPGT2 there may have been other, interfering sequences contained on the 5 kbp fragment 
that prevented the successful transcription and translation of the immunopositive product, 
and in further subcloning the fragment in order to alleviate such a problem, the sequence 
was unwittingly disrupted. 
Sequence analysis of the 5 kbp EcoRI fragment revealed four ORFs with homology to 
protein sequences deposited in the BLAST database. One of these was of great interest as it 
had homology to type IV pilin genes from a range of bacterial pathogens. Multiple 
sequence alignments revealed that the N-terminus of the putative pilin protein contained 
significant homology to type IV pilin genes over the first 40 amino acids. This included, 
most notably, pilE of the closely related species P.aeruginosa, which is postulated to have 
a role in pilus biogenesis (Russell and Darzins, 1994). Pilus biogenesis includes the 
concerted synthesis of major and minor subunits, various post-translational modifications 
and assembly into a functional organelle (Strom and Lory, 1993). Other type IV pilin genes 
have allegedly been cloned by Woods et al. ( 1999) in B.pseudoma!lei that have homology 
to pi!B, pi!C and pi!D of P.aeruginosa, but none with homology to pi/E. 
There are three major conserved features of type IV pilin genes all of which were 
identified in the putative pilin gene sequence of B.pseudomallei. Firstly, they are 
synthesised as precursors with unique, short, basic amino-terminal leader peptides, which 
are removed by endoproteolytic cleavage between an invariant glycine residue and a 
phenylalanine (Strom and Lory, 1993). The prepilin leader peptidase cleavage site is 
conserved in all members of the type IV pilin fan1ily, (Giy-Phe(Met)-Thr-Leu-IIe(Leu)-
Giu-) (Strom and Lory, 1993). However, many similarities exist between the biogenesis of 
type IV pili and the assembly systems required for the export of extracellular proteins or 
the import of DNA in a large range of gram-negative bacteria of which one of the 
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characteristics is the possession of multiple genes with prepilin-like signal sequences 
(Bally et al., 1992). However the putative pilin gene sequence in B.pseudomallei contained 
tyrosine residues (Try-24 and Tyr-27), which are thought to be involved in pilin subunit-
subunit interactions (Watts et al., 1983) not found in genes required for the export of 
extracellular proteins. The final conserved feature is that the carboxy terminus contains a 
characteristic pair of cysteines, forming a disulphide loop. 
Reports have stated that genes required for pilus biogenesis are not always tightly clustered 
(Russell and Darzins, 1994), which may be why no other pilin genes were identified on the 
5 kbp fragment. In addition to this, pilE of P.aeruginosa was mapped away from any other 
pilin genes 5 kbp downstream from piN another gene involved in the biogenesis of pili 
(Aim and Mattick, 1996). Perhaps sequencing up and down-stream of the 5 kbp EcoRI 
fragment may facilitate the isolation of other genes involved with the biogenesis of pili in 
B.pseudomal/ei. 
Numerous attempts at expressing the protein product of the putative pilin gene were 
unsuccessful. Therefore it could not be determined whether the immunopositive reaction 
was due to the pilin gene product, or whether this interesting gene has fortuitously been 
stumbled upon. As previously discussed, very little exists in published literature 
concerning the cloning and expression of B.pseudomallei genes in E.coli host/vector 
systems and based on the relative difficulty encountered during the research project on the 
expression of any B.pseudomallei products it may be that incompatibilities do exist. 
Putative -10 and -35 promoter sequences were identified for the pilin gene sequence, but 
these did differ from the consensus E.coli promoter sequences and so perhaps expression 
failed as the promoter sequences were not recognised by the E.co/i system. However, 
attempts to place the gene under the control of an E.coli promoter to produce a fusion 
protein with the J3-galactosidase system in E. coli were also unsuccessful. 
283 
---------------
Again it is not known why expression of the putative gene product failed but the sequence 
does require post-translational modifications, which are probably not present in the E.coli 
system and this may therefore have prohibited the expression of the protein. Additionally, 
the product may have been unstable or deleterious to the E.co/i host. Similar problems 
were also encountered when trying to express the pilE gene product of P.aeruginosa in an 
E.co/i system (Russell and Darzins, 1994). In this case the authors resorted to expressing 
pilE in a P.aeruginosa T7 expression system. This may be the step required to express the 
putative pilin gene product from B.pseudomal/ei in any future work carried out, as 
expression of the product is invaluable for its further characterisation. 
Attempts were made to further characterise putative pilin gene product through Web-based 
protein analysis programs to analyse the biochemical nature of the sequence. The 
information generated on the prediction of secondary structure, different physio-chemical 
profiles, a prediction on transmembrane helices and a table of codon usage of this putative 
gene and the others identified in the sequence are displayed in the thesis, but are included 
mainly for reference purposes. Although the hydropathy prediction proved that the N-
terminal domain of the B.pseudomallei putative pilin gene contains a relatively 
hydrophobic region similar to other pilin genes, which has been shown in other studies to 
be important for membrane translocation. However, in future studies of the putative pilin 
gene when hopefully it has been characterised further and a mode of action has been 
elucidated for the gene product, such secondary information may prove be valuable. 
Southern blot hybridisations using the putative pilin gene sequence as a DNA probe 
revealed the cloned 5 kbp EcoRI-generated fragment of DNA was homologous to a 
sequence found in the genome of B.pseudomallei 204, therefore establishing the fidelity of 
the cloning procedure. The presence of the gene sequence in other B.pseudomallei isolates 
and its absence in the B.thailandensis isolates tested was confirmed through Southern 
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blotting analysis. This indicates a possible role of the gene in virulence and the possibility 
of the absence of pili in the B.thailandensis species, which has yet to be established. Other 
species of the genus Burkholderia were also tested for the presence of the sequence, but a 
homologous fragment was not hybridised in any of the other species tested. 
Mutational analysis of the putative pilin gene could not be carried out due to the instability 
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of the donated suicide vector, pCVD442. Mutational analysis may have alluded to the role 
of the gene product, if indeed it possesses one, in the biogenesis of pili in B.pseudomallei. 
Russell and Darzins (1994) constructed a gene-replacement mutant of pilE in P.aeruginosa 
and carried out expression studies with the T7 RNA polymerase promoter system to show 
that the gene was required in pilus biogenesis because the mutants were pilus- and 
twitching-motility deficient. A similar study of the putative pilin gene of B.pseudomallei 
could possibly establish a role in pilus biogenesis and virulence. 
One of the mms of the research project was to use sequences encoding extracellular 
virulence factors available from other bacterial pathogens to construct PCR primers to test 
for the presence of homologous sequences in B.pseudomallei and B.thialandensis. It was 
decided that the target of such a procedure was the toxin of B.pseudomallei, which has yet 
to be cloned and sequenced. As previously discussed, the toxin is postulated to be of the 
ADP-ribosylating class of exotoxin with the same mode of action as ET A of the closely 
related species, P.aeruginosa (Jsmail et al., 1991). This made the proposed ADP-
ribosylating toxin of B.pseudomallei an ideal target because the ET A gene of P.aeruginosa 
had been cloned and sequenced (Gray et al., 1984) and so PCR primers could be designed 
to test for the presence of a similar toxin in B.pseudomallei. 
PCR primers were designed to the most conserved region of ADP-ribosylating toxins, the 
active site of ET A. The primers amplified a 453 bp product in the B.pseudomallei isolates 
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tested but failed to amplify a product in the B.thailandensis isolates. The PCR productS 
from B.pseudomal/ei isolates 204 and 576 were cloned into pUC18 and DNA sequenced. 
These two isolates were chosen for comparative purposes, both are clinical isolates but 
have different LPS patterns. Both sequences were identical but no obvious homology was 
observed with the ET A active site either at the nucleotide or amino acid level nor with 
published consensus sequences for active sites of ADP-ribosylating toxins (Rappuoli and 
Pizza, 1991 ). Despite this finding, the sequence was used as a DNA probe to isolate a 
larger fragment to analyse sequence information up and down-stream. It was hoped that as 
the PCR product was only amplified in B.pseudomallei isolates it might encode other 
putative genes with a role in virulence or a toxin that did not possess obvious sequence 
similarity over the 453 bp sequence isolated. 
The 453 bp PCR product was DIG-labelled and used to screen a B.pseudoma/lei genomic 
library constructed in the bacteriophage, A. GEM 11, chosen in preference to the A.GTII 
genomic library as A.GEMII is not an expression vector and so may facilitate the isolation 
of clones encoding toxic products to the E. coli host. Screening yielded six stable positive 
clones (A.BPI-6). Restriction endonuclease analysis was carried out on the clones and a 7.7 
kbp EcoRI fragment was isolated from one of the clones for further analysis. The first 
stage of analysis was to subclone the fragment into a plasmid vector. Difficulties were 
experienced with this procedure and attempts to subclone the fragment into the high-copy 
number vector, pUC 18 were unsuccessful and so a lower copy number vector, pOD I 03 
was used. However, subcloning of the 7.7 kbp fragment could only be achieved by keeping 
all incubation temperatures at room temperature. It was then proven by Southern blotting 
analysis that the cloned 7.7 kbp sequence contained the sequence of the PCR product 
before DNA sequencing. 
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Subsequent DNA sequencmg of the 7.7 kbp £coR! fragment revealed agam that the 
sequence had no obvious homology either at the nucleotide or amino acid level with ET A, 
or indeed the consensus amino acid sequences for active sites of ADP-ribosylating toxins. 
This finding in itself did not discount the presence of an ADP-ribosylating toxin in 
B.pseudomallei for the active site may not possess the sequence encoded by the primers 
used, or the primers may have failed to amplifY the active site. The B.pseudomallei 
genome sequencing project facilitated the opportunity to search the information available 
for homologies with ET A at the nucleotide and amino acid level as well as DT toxin, 
which has the same mode of action. Both BLAST-N and BLAST-X searches of the 
database yielded again no obvious similarity. 
However, the presence of a toxin with ADP-ribosylating activity cannot be discounted in 
B.pseudomallei. The ADP-ribosylating toxin in B.pseudomallei may have a completely 
different active site and possess unique biochemical properties to such toxins. Indeed ExoS 
of P.aeruginosa, in relation to members of the family of ADP-ribosylating toxins possesses 
several unique biochemical properties. Firstly, while most bacterial ADP-ribosylating 
toxins target specific host proteins, ExoS has been shown to ADP-ribosylate several host 
proteins in vitro, including vimentin (Cobum et al., 1989) although the in vivo target 
protein(s) of ExoS is undefined. Secondly, ExoS possesses an absolute requirement for a 
eukaryotic protein termed F AS (for factor activating exoenzyme S) to catalyse the ADP-
ribosylation reaction (Cobum et al., 1991 ). Thirdly, while most bacterial ADP-
ribosyltransferases possess a recognised A:B structure-function organisation (Kruger and 
Barbieri, 1995) the A:B organisation of ExoS is not apparent. Thus, the toxin of 
B.pseudomallei may too differ from other members of the family of ADP-ribosylating 
toxins. 
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The identification of the toxin in culture supematants of B.pseudomallei would be of huge 
value in future studies as the N-tenninal sequence of a purified protein can be determined, 
and so by using the amino acid sequence derived, a specific oligonucleotide may be 
synthesised for gene library screening by DNA hybridisation. The ETA gene of 
P.aeruginosa was cloned in this manner (Gray et al., 1984), by purifying ETA and 
subjecting it to N-terminal amino acid sequencing. As previously discussed attempts were 
made to obtain a monoclonal antibody to the exotoxin but these were unsuccessful. This 
may have been of value as immunoblotting using the ECPs isolated from culture 
supematants of B.pseudomal/ei with the monoclonal antibody to the exotoxin may have 
facilitated its isolation. 
However, the PCR product was only amplified in B.pseudomallei isolates and difficulties 
were encountered with subcloning it into the high copy number vector, pUC 18, which may 
be indicative of the fragment encoding products toxic to the E. coli host. Sequence analysis 
carried out on the 7.7 kbp fragment, despite it not having homology to known ADP-
ribosylating toxins, showed the 7.7 kbp sequence to encode other putative genes that could 
possibly have a role in virulence. Although it must be remembered that although such 
BLAST searches may give clues to the characteristics of a protein, there is no substitution 
for actual biochemical and molecular biological experimentation. Indeed, information 
derived from BLAST searches in this case functions as a useful starting point for further 
characterisation of putative genes and their gene products. 
The sequence was shown to encoded an ORF with homology to porins from different 
bacterial species, most notably porins from N.meningitidis and N.gonorrhoea, which 
function to aid intracellular survival in these bacteria. Other interesting homologies 
included an ORF with homology to peptide synthetase genes involved in the biosynthesis 
of a number of important genes such as those involved in iron acquisition and antibiotic 
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resistance. Additionally, another ORF was shown to have homology to genes from the 
AraC/Xyls family of transcriptional regulators, some of which regulated genes with a 
putative role in virulence. In addition to these there was an ORF of over 2 kbp which had 
no homology to any proteins deposited in the Genbank database and so may encode a 
novel protein, perhaps with an important role in B.pseudomallei pathogenicity. This 
fragment may prove to be an important operon containing genes involved with iron 
acquisition, antibiotic resistance or intracellular survival but much more work is required 
to characterise the putative genes identified and their respective gene products. 
Whilst carrying out a Sau3A restriction digest of B.pseudomallei 4845 for the purposes of 
creating a genomic library, it was noted that there existed two bands of around 10112 kbp 
in size that were resistant to the endonuclease action. Sau3A digests were then carried out 
on a number of other B.pseudomallei and B.thailandensis isolates, with similar results. 
Although the Sau3A resistant DNA fragments varied in size, and number with isolates 
there existed such bands in B.thailandensis. 
This finding occurred at the beginning of the research project when there was no facility to 
isolate genomic DNA and work was dependent on the donation of genomic DNA from 
outside sources. Moreover at the time there was only sufficient genomic DNA of 
B.pseudomallei isolate 4845 to continue work with the Sau3A undigestible bands. It was 
not known at the time exactly what this finding indicated although there was published 
information on MA V I a lysogenic bacteriophage from Mycoplasma arthritidis, where it 
was found that the MA V I genome contained no sites for the restriction enzymes, Sau3A 
and Mbo! which both recognise the sequence GA TC (V oelker and Dybvig, 1998). It was 
postulated that these fragments were therefore bacteriophage in origin and as virulence 
determinants are often encoded on a phage in bacterial pathogens the fragments may 
encode such genes in B.pseudomallei. This theory was somewhat strengthened when in a 
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transformation procedure the bacterial cells appeared to lyse after incubation at 3 7°C, 
which indicated that the DNA might be phage-encoded, although a transfection procedure 
using the DNA fragments yielded nothing. Additionally, despite numerous attempts, the 
full-length fragments could not be cloned and only clones containing deletions of the 
original fragments were isolated, pSAU2 and pSAU8. DNA sequencing proved difficult 
and only a small amount of sequence information was derived from the two clones. 
However, using the small amount of sequence information from one of the clones, pSA U2, 
to search the B.pseudomallei genome sequencing project for any homologies with the 
sequence facilitated the isolation of a 38 kbp assembled fragment containing homology to 
the sequence from pSAU2. The sequence information from the clone pSAU8 was similarly 
used to search the genome sequencing project database but shotgun sequences were 
identified with only around 60% homology to the forward and reverse sequences of 
pSAU8 and moreover they were found not to be contained on the 38 kbp fragment. It may 
have been that the two clones pSAU2 and pSAU8 contained DNA from the two separate 
fragments, which may have different sequences. However, the homologous sequence to 
pSAU2 was located from 34,835 bp to 35,143 bp and it is possible that the sequence 
encoded by pSAU8 is not actually contained on this assembled fragment, as the two 
sequences may be as much as 12 kbp apart. Despite this the two shotgun sequences with 
homology to the forward and reverse sequences of pSAU8 were found not to be contained 
on the same assembled fragment. It may be the case that the isolate used in the genome 
sequencing project possesses only one of these fragments or that the deletion event that 
occurred in pSAU8 resulted in non-contiguous DNA fragments lying next to each other. 
However analysis of the 38 kbp fragment continued. 
Sequence analysis of the 38 kbp fragment was carried out in the form of BLAST searches 
to identify any regions containing homology to proteins with known or putative functions 
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deposited in the Genbank database. The 38 kbp fragment appeared to fulfil some of the 
criteria defined by Hacker et al. (1997) to indicate that it could be a Pathogenicity island 
(Pai), which have been found in a wide variety of bacterial species. Firstly, such fragments 
are often associated with the carriage of virulence genes, and the fragment was shown to 
encode a region with homology to serine proteases. Sexton and Jones (1994) believed the 
protease they isolated from B.pseudomallei to belong to the family of alkaline proteases, 
sensitive to metal chelators. An ORF containing a putative gene sequence for the putative 
serine protease was identified along with putative -10 and -35 promoter sequences and a 
putative SO region. The nucleotide sequence encoded a putative product with a theoretical 
molecular weight of 63 kDa. However, a putative signal peptide cleavage site was 
recognised and the mature protease is estimated to be 59.5 kDa. This conflicts with the size 
of the protease isolated by Sexton and Jones (1994) (36 kDa) and Percheron el al. (1995) 
(42 kDa), although these two published reports also disagree with the size of the protease. 
The role of the protease in the virulence of B.pseudomallei has not been fully established. 
Although the expression of a high proteolytic activity by any B.pseudomallei strain was 
shown to be neither sufficient nor necessary for virulence when bacteria were injected via 
the intraperitoneal route (Gauthier et al., 2000) a pathogenic role for the protease cannot be 
excluded. Moreover, microbial pathogenesis is usually complex and multifactorial. 
Bacterial pathogens often have a number of biochemical mechanisms which may act 
individually or in concert to produce infection and disease, thus the elimination of one of 
the components may or may not render the organism avirulent. ln addition to the putative 
protease another region encoded homology to a Streptococcal haemagglutinin from 
Streptococcus gondii which is postulated to have a role in virulence. 
The 38 kbp fragment was of a different G+C content to the rest of the genome, and was 
calculated to be 56%, which is very different from the genome value of 69% (Redfearn et 
al., 1966). Pais often occupy large chromosomal regions, often more than 30 kbp and the 
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size of fragment identified in B.pseudomallei was 38 kbp. In addition to this, portions of 
the fragment contained repeated DNA. At around 15 kbp two regions encoded homology 
to the same hypothetical protein from Thermoplasma acidophilum and the end 8 kbp of the 
fragment was a repeated DNA region from immediately upstream of this, encoding 
homology to the Streptococcal haemagglutinin and a transcriptional regulator. There was 
also the presence of a region with homology to integrase genes at the beginning of the 
sequence which are often associated with Pais at their boundaries. 
Much more work is needed to ascertain whether this 38 kbp fragment is a putative Pai. It 
needs to be established whether this fragment or, perhaps part(s) of this fragment is present 
in other isolates of B.pseudomallei and, importantly in B.thailandensis. Pais found in other 
pathogens are characterised by their absence, or sporadic distribution in less pathogenic 
strains of one species or related species (Hacker et al., 1997). Pathogenic Yersinia spp. can 
be subdivided into highly pathogenic (high-pathogenic) and low-pathogenicity strains by 
the presence of a 'high-pathogenicity island' (HP I) (Camiel et al., 1996). Initial 
experiments carried out showed the presence of Sau3A undigestible fragments in a number 
of B.pseudomallei and B.thailandensis isolates. It is possible that a region of the 38 kbp 
fragment is present in B.thailandensis isolates but excludes several genes essential for 
virulence. B.pseudomallei infections range greatly in their severity and outcome, which 
possibly reflects the possession of different virulence genes and perhaps even more so with 
B.thailandensis isolates, which do not cause illness. Therefore investigations to analyse the 
presence of the 38 kbp fragment or parts of it in different isolates could possibly highlight 
specific genes found only in highly pathogenic isolates. 
In addition to this, the assembly of shotgun fragments was in its infancy at the time of 
writing and so the fragment may actually be much larger, as Pais can encompass 
chromosomal DNA segments of up to 200 kbp (Hacker et al., 1997) and possibly encode 
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other secreted virulence products. In addition to this a number of Pais have been integrated 
into, or close to tRNA genes (Bium et al., 1994) and it would be useful to search up and 
down-stream of the 38 kbp fragment, to analyse for the presence of such genes or other 
insertion elements. 
A common theme when trying to clone both the 7.7 kbp fragment and the Sau3A 
undigestible fragments was that the incubation temperature was a very important factor in 
determining the relative success of the cloning procedure. Bacteria are, in general, 
conservative in their gene expression and will only express genes that they require in a 
particular environment (Harb and Abu Kwaik, 1999). Intracellular pathogens, such as 
B.pseudomallei should therefore possess genes that are only expressed in the intracellular 
environment. Being a human pathogen, the virulence genes of B.pseudomallei expressed in 
the intracellular environment of a host cell may be thermoregulated. All the fragments that 
could not be cloned at 37°C do possibly encode putative virulence genes and so perhaps 
these genes are thermoregulated in B.pseudomallei. Moreover, if the 38 kbp fragment is a 
pathogenicity island, it may resemble other such Pais, for example that of S.typhimurium 
that have been shown to be induced during intracellular infection of macrophages 
(Groisman and Ochman, 1996). More work is obviously needed to characterise these genes 
and to apply techniques such as ~-galactosidase gene fusions, which has been successfully 
carried out with /acZ-listeriolysin (lisA) gene fusions and lacZ fusions to other virulence 
genes of L. monocytogenes to show that these genes are thermoregulated and therefore 
triggered by thermal cues, such as entry to the host (Leimeister-Wachter et al., 1992). 
The ability to sequence entire microbial genomes has generated vast amounts of 
information that leads to the understanding of gene structure and function, evolution, 
microbial diversity and pathology. B.pseudomallei is a medically important bacterium in 
the tropics and it is hoped that genome sequence information may offer new insights for 
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understanding disease-pathogenesis and host-microbial interactions, and for the 
development of new drugs and vaccine strategies. 
It is clear from the information gathered in this research project that the molecular 
characterisation of this bacterium although a major task in itself will eventually provide 
invaluable insights into how the bacterium causes disease and the weapons with which it 
uses to do so. When a fuller understanding of the pathogenic processes utilised by this 
pathogen have been established through recombinant DNA techniques, new drugs and 
hopefully a vaccine can be developed. 
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APPENDIX I 
Formulation and preparation of reagents, solutions and growth media. 
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BACTERIOLOGICAL MEDIA. 
LURIA BERT ANI (LB) MEDIUM. 
per litre of ddH20: 
Tryptone I 0 g 
Yeast extract 5 g 
NaCI 10 g 
The pH adjusted to between 7.2-7.4 and sterilised by autoclaving 15 min. at 15 lb/in2. 
LB agar made as above, with the addition of 1.5% (w/v) Agar No.2. 
ANTIBIOTIC STOCK SOLUTIONS. 
Ampicillin (sodium salt) 
Chloramphenicol 
Kanamycin 
Tetracycline 
50 mg/ml in ddH 20 
25 mg/ml in ethanol 
25 mg/ml in ddH20 
10 mg/ml in 50% (v/v) ddH20/ethanol 
All antibiotic stock solutions were filter sterilised (0.22 J.!m) and used at 1000 times less 
concentrated as a working standard. 
BACTERIOPHAGE METHODS. 
SMBUFFER. 
Per litre of ddH20: 
NaCI 
MgS04.7H20 
I M TRIS (pH 7.5) 
2% Gelatin solution 
5.8 g 
2g 
50 ml 
5 ml 
Made up in 100 ml batches and sterilised by autoclaving for 15 min. at 15 lb/in2. 
NZCYM MEDIUM. 
Per litre of ddH20: 
NZ Amine 10 g 
NaCI 5 g 
Yeast Extract 5 g 
Casamino Acids I g 
MgS04 2 g 
The pH adjusted to 7.0 with 5 M NaOH and sterilised by autoclaving for 15 min. at 15 lb/in2. 
NZCYM agar made up as above, with the addition of 1.5% (w/v) Agar No. 2. 
NZCYM soft agar for overlays was made up as above with the addition of 0.75% (w/v) Agar 
No.2 
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M9 SALTS (XlO). 
Per litre of ddH20: 
Na2HP04 60 g 
KH2P04 30 g 
NaCI 5 g 
NH4CI 10 g 
Made up in I 00 ml batches and sterilised by autoclaving for 15 min. at 15 lb/in2• 
PHAGE PROPAGATION MEDIA. 
Per litre of ddH20: 
M9 Salts (xI 0) 
20% glucose 
I M MgCb 
I M CaCb 
Casamino acids 
I 00 ml 
20 ml 
5 ml 
0.1 ml 
10 g 
DNA ANALYSIS METHODS. 
CHROMOSOMAL DNA ISOLATION . 
B.pseudomallei 
Solution A: Sucrose (75% w/v) in 0.15 M Tris-HCI (pH8.0) 
Solution 8: Lysozyme (15 mg/ml) in 0.05 M Tris-HCI (pH 8.0) 
Solution C: Na2EDT A (0.5 M) (pH 8.0) 
Solution D: Triton X lOO (8% v/v) in 0.2 M Tris-HCI (pH 8.0) 
PLASMID DNA ISOLATION FROM E.coli. 
All solutions made in ddH20. 
B & D SOLUTION I. 
Glucose 
TRIS/HCI 
EDTA (sodium salt) 
50 mM 
25 mM 
IOmM 
The pH adjusted to 8.0, made up in I 00 ml volumes and sterilised by autoclaving for 15 min. 
at 15 lb/in-. 
Prior to use only in the maxi prep method add 5 mg/ml lysozyme to sterilised solution. 
B & D SOLUTION 11. 
ddHzO 
NaOH (5 M) 
Sodium dodecyl sulphate (I 0% solution) 
B & D SOLUTION Ill. 
Sodium acetate 3 M 
4.3 ml 
0.2 ml 
0.5 ml 
The pH adjusted to 4.8 with glacial acetic acid, stored at 4°C. 
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RNase SOLUTION. 
Ribonuclease A (pancreatic RNase) I mM in a 50 mM TRIS buffer (pH 8.0). Before use, this 
solution is incubated at 95°C for 15 min. to remove any contaminating deoxyribonuclease. 
TE BUFFER. 
TRIS 10 mM 
EDT A (sodium salt) I mM 
Made into I 00 ml volumes, sterilised by autoclaving for 15 min. at 15 lb/in2. 
AGAROSE GEL ELECTROPHORESIS OF DNA. 
TBE BUFFER (XJO). 
TRIS 0.9M 
0.9 M 
0.025 M 
Boric acid 
EDTA (sodium salt) 
pH is adjusted to 8.5, sterilised by autoclaving for 15 min. at 15lb/in2• This X I 0 stock is 
diluted as required. 
FICOLL LOADING BUFFER. 
Per 10 ml ddH20: 
Bromophenol blue 
Ficoll 400 
0.025 g 
1.5 g 
ETHIDIUM BROMIDE SOLUTION. 
Ethidium bromide 10 mg/ml in ddH20 
Stored at 4°C in a dark bottle. 
DNA MANIPULATION METHODS. 
TRANSFORMATION OF E.coli K12 STRAINS. 
RFl MEDIUM. 
Per litre ddH20: 
RbCI 
MnCI2AH20 
Potassium acetate (I M, pH 7.5) 
CaCI2.2H20 
Glycerol 
12 g 
9.9 g 
30ml 
1.5 g 
ISO g 
The pH adjusted to 5.8 with 0.2 M acetic acid and filter sterilised (0.22 11m). 
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RF2MEDIUM. 
Per litre ddH20: 
MOPS (0.5 M, pH 6.8) 
RbCI 
CaCb.2H20 
Glycerol 
20 ml 
1.2 g 
11 g 
ISOml 
BLUE/WIDTE SCREENING. 
IPTG. 
lsopropyi-13-D-thiogalactopyranoside. Prepared as a stock solution of 24 mg/ml in Distilled 
water. 
X-gal. 
5-bromo-4-chloro-3-indolyi-13-D-galactoside. Perpared as a 20 mg/ml solution in 
dimethyl formam id e. 
PROTEIN ANALYSIS METHODS. 
SOS-PAGE. 
MAIN GEL. 
Acrylamide (40%) (SIGMA) 
Main gel buffer 
ddH20 
APS (10 mg/ml) 
TEMED 
STACKING GEL. 
Acrylamide (40%) (SIGMA) 
Stacking gel buffer 
ddH20 
APS (10 mg/ml) 
TEMED 
SOS-PAGE SOLUTIONS. 
All solutions made in ddH20. 
MAIN GEL BUFFER. 
TRIS 0.75 M 
SOS 0.2% (w/v) 
The pH adjusted to 8.8 with HCI. 
STACKING GEL BUFFER. 
TRIS 0.25 M 
SOS 0.2% (w/v) 
The pH adjusted to 6.8 with HCI. 
3.2ml 
5.2 ml 
1.72 ml 
380 J.ll 
30 J.l) 
0.7 ml 
2.0ml 
1.3 ml 
100 J.ll 
16 J.ll 
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AMMONIUM PERSULPHATE (APS). 
10 mg/ml solution made immediately prior to use. 
SDS SOLUTION. 
I 0% (w/v) solution. 
ELECTROPHORESIS BUFFER. 
Per litre of ddH20: 
TRIS 3.025 g 
Glycine 14.4 g 
SOS l g 
The pH adjusted to 8.3 using 5 M NaOH. 
SDS-PAGE LOADING BUFFER. 
TRIS 1.51 g 
Glycerol 20 ml 
Components dissolved in 35 ml of ddH20 and pH adjusted to 6.75 followed by addition of: 
SDS 4.0 g 
Bromophenol blue 0.002 g 
Diluted to 90 ml with addition of ddH20 and stored at ambient temperature for no more than 
12 weeks. Prior to use addition of 2-13-Mercaptoethanol to a final concentration of I 0% (v/v). 
STAINING OF POLYACRYLAMIDE GELS. 
COOMASSIE BLUE STAINING SOLUTION. 
Per litre volume: 
Methanol 
Glacial Acetic Acid 
ddH20 
Coomassie brilliant blue-R 
400ml 
70ml 
530 ml 
1.25 g 
DESTAINING SOLUTION. 
Per litre volume: 
Methanol 
Glacial Acetic Acid 
ddH20 
400ml 
70ml 
530ml 
IMMUNOBLOTTING (WESTERN BLOTTING). 
TRANSFER BUFFER. 
Per 2 litre volume: 
TRJS 6.1 g 
Glycine 28.8 g 
Methanol 400 ml 
ddH20 1600 ml 
The pH adjusted to 8.3. 
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IMMUNOST AINING. 
PBS. 
I tablet PBS (Oxoid, Basingstoke) dissolved in I 00 ml of ddH20. Sterilised by autoclaving for 
I 5 min. at I Slb/in2• 
BLOCKING SOLUTION. 
I% (w/v) casein in PBS. Sterilised by autoclaving for I 5 min. at I Slb/in2• 
DAB/NICKEL CHLORIDE DEVELOPMENT SOLUTION. 
PBS IOOml 
DAB SO mg 
NiCI2 300 ml 
Solution made fresh immediately prior to use in blot development and the chromogenic 
reaction initiated by addition of I 00 J.ll H20 2 solution. 
SOLUTIONS FOR SOUTHERN BLOTTING/PROBING A.GEMll 
GENOMIC LIBRARY. 
DEPURINATION SOLUTION. 
HCI 0.2 M 
DENATURATION SOLUTION. 
NaCI 1.5 M 
NaOH 0.5 M 
Solutions made separately and sterilised by autoclaving for I 5 min. at 15lb/in2 and added 
together prior to use. 
NEUTRALISATION SOLUTION. 
TRIS I M 
NaCI 1.5 M 
The pH adjusted to 8.0 with HCI sterilised by autoclaving for 15 min. at 15lb/in2 
SSC (X20). 
Per litre of ddH20: 
NaCI 175.32 g 
Na citrate 88.24 g 
Sterilised by autoclaving tor 15 min. at 15lb/in2. 
TRANSFER BUFFER. 
Per litre of solution: 
SSC (X20) 500 ml 
ddH20 500 ml 
Made prior to use. 
301 
HYBRIDISATION SOLUTION. 
Per 100 ml ofSSC (X5) solution: 
Blocking reagent (Boehringer Mannheim) 
N-laurylsarcosine, Na-salt . 
SOS 
0.5% (w/v) 
0.1% (w/v) 
0.02% (w/v) 
Solution made prior to use and heated to 65°C for 30 min. to dissolve blocking reagent. 
WASH BUFFER I. 
Per litre of solution: 
SSC (X20) I 00 ml 
SOS (10%) 10 ml 
ddH20 890 ml 
Sterilised by autoclaving for 15 min. at 15lb/in2 
WASH BUFFER ll. 
Per litre of solution: 
SSC (X20) 5 ml 
SOS (10%) 10 ml 
ddH20 985 ml 
Sterilised by autoclaving for 15 min. at 15lb/in2 
DETECTION BUFFER I. 
TRIS IOOmM 
NaCI IOOmM 
The pH adjusted to 7.5 with HCI and sterilised by autoclaving for 15 min. at 15lb/in2• 
DETECTION BUFFER 11. 
Blocking reagent (Boehringer Mannheim) 0.5% (w/v) 
Dissolved in Detection Buffer I, solution made prior to use and heated to 65°C for 30 min. to 
dissolve blocking reagent. 
DETECTION BUFFER Ill. 
TRIS 0.1 M 
NaCI 
MgCb 
0.1 M 
SO mM 
The pH adjusted to 9.5 with HCI and sterilised by autoclaving for 15 min. at 15lb/in2• 
DETECTION BUFFER IV. 
TRIS 
EDTA 
IOmM 
I mM 
The pH adjusted to 8.0 with HCI and sterilised by autoclaving for 15 min. at 15lb/in2 
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COLOUR DEVELOPMENT SOLUTION. 
Per I 00 ml of solution the following are added prior to use: 
Detection Buffer Ill I 00 ml 
NBT 0.033 g 
X-phosphate 0.0165 g 
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APPENDIX 11 
Plasmid Restriction Maps. 
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S5p I (2501) 
pUC18 
2686 bp 
Xmn I (2294) AlwN I (1217) 
• Sue not umque CfrtO 1 (1n9) 
The plasmid cloning vector, pUC18 (Yanisch-Perron et al., 1985). 
305 
·~. Hind Ill 
pGDJ03 
5.6 kbp. 
Aduse-Opoku et al. (1989) 
The plasmid cloning vector, pGD103 (Aduse-Opoku et al., 1989). 
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Hind Ill 
~~=-Jstl 
--Hindiii Sall 
BamHI 
Avai / Smal 
EcoRI 
APPENDIX Ill 
SOS-PAGE gels, Nucleotide Sequencing Data. 
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SDS-PAGE Gels of ECPs Isolated from Isolates of B.pseudomallei, B.thailandensis and other species of 
Burkholderia (Chapter 3). 
GEL LANE No. 
1 2 3 4 5 6 7 8 9 10 
1 MARKERS 19 22 33 25 46 53 97 98 MARKERS 
2 MARKERS 102 112 212 216 217 392 204 426 MARKERS 
3 MARKERS 448 576 441398 Hainan I Hainan 2 Zhan I E8 MARKERS E25 
4 E27 E82 Jie187 Hainan 706 Hainan 106 Hainan 93 Hainan 55 Hainan 4 MARKERS -
5 MARKERS LMG 6998 LMG 11626 LMG 6999 LMG 10908 E260 E256 £255 E254 MARKERS 
6 MARKERS B.cepacia J B. cepacia 11 B.cepacia B.cepacia B.cepacia IUb B.cepacia lllc B. cepacia fV MARKERS LMG 10620 
Illaepi Ilia non-epi 
SOS-PAGE Gell SOS-PAGE Gel2 SOS-PAGE Gel3 
2 3 4 56 7 8 9 10 2 3 4 5 6 7 8 9 10 2 3 4 5 6 7 8 9 10 
SOS-PAGE Gel4 SOS-PAGE GelS SOS-PAGE Gel6 
2 34 56 78 9 2 3 4 5 6 7 8 9 10 2 3 4 5 6 7 8 9 10 
The complete 5 kbp nucleotide sequence of the immunopositive clone pBPGT2 
(Chanter 6). 
1 AAGCTTGCAT GCCTGCAGGT CGACTCTAGA GGATCCCCGG GTACCGAGCT 
51 CGAATTCTCC CTTGAGCTTC GCGGTCAAGC CGAGCTCCGT CGTGCAGACG 
101 GGCGTGTAGT CGGCCGGATG CGAGAACAGG ACGCCCCAAC TATTGCCGAG 
151 CCATTCGTGA AATTTGATGC GGCCGAGGCT CGAATCCTGC TCGAAATCCG 
201 GCGCGATGTC GCCAAGACGT AGACTCATGT TACAGCTCCT TGAACTTGCA 
251 TGGGTTGGGT GCCCGGACGC ATCGCGCTAC CGGACAAGTT TTTAGCTTAA 
301 GCGATCCTGC GGCCGGCGCG AACGATTATT CCGTCAGATA TTCATGCCTT 
351 TTTATCATTC TTGCCGGGTG CGATTTGACA ATCCTGGAAA CTTTTTCGTT 
401 CCGCATCGGC TCTCTATTGT CACGGCAAGT CGTTTACCAT GCTGTTCAAG 
451 CGCGATCTTG CGCCACCTGC GCGCCGTGCC CGCGCGCCCG CGGCCAGGCA 
501 CGGGTTTCGC TACGATATCC GTAGCACAAC CCGCTTCGGC AAGAAGGGAG 
551 TCGCAATGTC TGAAGTCAAC AAGGAGAAAC TGATGTCGGA TATCAAAACT 
601 GTTCTCGCGG ACGCGGAAGA TCTGCTGAAG CAGGCCGCGA GCAGCACGGG 
651 CGACCGTGCG ACCGAGCTGC GCGAGAAGGC GCTCGCACGC CTGAAACAGG 
701 CGAAGGAGAA GGCGACCGAT GTCCAGGTGG TCGTGGTCGA AAAAGGCAAG 
751 AAGGCGGCGC GCGCCACCGA CGACTACGTG CACGAGCATC CGTGGACGTC 
801 GATCGGCATC GCGGCCGGCG TCGGCGTATT GATCGGCCTG CTGATCAACC 
851 GCAAGTAACG CGGCACGCCC CCGCGAGAGA CAGCCCCCGG CTCGCCGCCG 
901 CGTGACGGCC GGGGCCCTGC GCTCCGGCCC GCCGCGCCCA GTTGCGACGC 
951 CGGCCGTTCT CCGCGCGCAA GGCCCTCTTT CATGACGACA GAAACCTCAT 
1001 CGCACCAGTC CGGGCACGGA CCGCTGCGCC GCCTGCTCGG CTCGGTGCTC 
1051 GCGCTCCTGC AGACCCGGCT CGAACTCGTC GGCATCGAAC TCGCCGAGGA 
1101 GAAGGAACGC CTGATGGGCG TACTCTTTGT CGGGCTCGCC GCGATGATGC 
1151 TCGCGACGAT GGCGCTCATC AGCCTGACGG TGCTCATTGC GATCGCGTTC 
1201 TGGGATACGT ACCGCTGGCA ATCGCTCGCC GTCGTCACCG CGCTCTACGC 
1251 GCTCGGCGCA CTCGCCTGCT GGCTGAAGGC GCGCTCGGGA CTGCGCGACG 
1301 CGCCCAGCGT GTTCGAGGCG ACGCTGAACG AACTCGAAAA GGACCGCGAG 
1351 CTGTTCCGCG GCAAGCCGTG AACGCGCGGC TGCACTCCTT CCCTTCCCGC 
1401 CCATCTCACG CCGACGCGCC ATGAGTTACT CCGCTCCGGA ACAACGATTC 
1451 CACACCGCTT CGCAGAGGCG GCACATGAGC GCGGCCCAGT ACCGCGCGCT 
1501 GCGCAAGGAA CTGCTGATCC TGCGCTCGGA TGTCGAGCGC CTCGGAACTC 
1551 GCGCAGGCCG GCGCCGAGCT GCGCCAATCC ATCACCCATT TCAAATGGCT 
1601 GAAGCTCCTC GTGCCCGGGG TGTCGGGTGG GTCGCTCGGC AAATCGGCGA 
1651 GGAACGTGAA CGCGACGCTC GGCATGCTCG TCAGCCAATA TCCGCTATTG 
1701 AGCTCGCTGG CGTCGGTCGT GCTCGCCAAG CCCGTGCGCG CACTGCTGCG 
1751 CGCAAGCCGC GCCCCGCGCT CAAATGGGGC GCTGTCGGCT TCGCGCTCTG 
1801 GGAGGGCTAC CAGATCTGGA AACAGGCGAA CACGACGACG CATCCGACGC 
1851 CGGAGCGCGG CAACGCACGC GCCCGTAGCG ACACGCCCAG GACGCCCATG 
1901 GCGCCCGTCG ACCGAGCCGG CGCGCCGACC GCGCCGGCCG GCTGCCGGCG 
1951 CCGGGGAGAT CGACACGCCC GGCGCTGCGC AGCTAGCCTG TTCGCCAGCA 
2001 GGCATCGCCC TCCGCCGCAC CGCCATCGAG CGCGACGCCT CCGGCCACGC 
2051 GATTCTCGCG CGTGCCGTCC GCATGCAGCA CGTAGACGCC CGATCTGTCG 
2101 TCCCGCATTG CACCATCGGC GGCGGGACGC GCCTCCAGTG CGTATCCGCC 
2151 GCGCGCGTCG TCGAACATGA TCCGCAGCAC ATAGACGAGC TTGCCGGATT 
2201 CGGGCGCCCT GTTCACCCCT TCCGGCAACG CGGTGGGCGG CGCGTCGCCG 
2251 AACGCGTCCA CGTATTGCGC GCCGCGATAG AGCGCGGCAA CCGCGGTCAA 
2301 TCGGTTCACC CGTTCGACAT AACTGCGATA CGACGGCACG GCAAACGCCG 
2351 CGAGCACCGC CACGATCGCG ATCGCGACGA CCACCTCGAT TAAGGTGAAG 
2401 CCTCTCGAGG GCGAATTGCG CCCCGTACAT GGCATCGCTC ATGCCTCCCG 
2451 TTGCCTATGC CGGCCGTCCC ACGACCCGAC GCCACCGCCC CTCGACGCGC 
2501 CCGCCGTCGA GCGCAACCTG CAATTGCAGC CACTCGGCCG TATCGTTCGA 
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2551 TGCGCCCACG CCGCGCGCGG TTACGAGGAA GGCGCGCACG TCGGGGCGCG 
2601 CCGGCAGCCT CCATGCTTCG ATCAAGCAAC TCGGCGCCTG CGCCGCGCCC 
2651 GGCCATCCGG CGTACGGCCT GAACGCACCG ATGCCGTCGA ACGCGCCCGG 
2701 TTCGCGCCAG CCGCCCGGCT CGCGCGTCGA CGTCGTACCG TCGCCCGCCG 
2751 ACGGGTGTGG CGCCCTCCCG CTCTCCAGCG CGATCACGCA TGCTTCGAGC 
2801 CCGCATCCGC CGCACGAAAT GCAATGGATC GGCTGCGACG CTCGTCATAC 
2851 GCCGGACCTC CGTCTTCGCG ATCTCGAACC AAGCGAACGA CATCACGATG 
2901 AGCGAAGCCG TTACGGCAAG TACGCCCGGC AGCGCGACGC CCCGCGAACC 
2951 GCGCATCCGC GCTCCGCCGT CGCGGCGCGT CGCACGGCGT CGGGCGCGCC 
3001 CGGAACATCG GCAGTCGCTC CACATCCACC CCGACCATGA CGCGCATCAT 
3051 GTGCCGGCTC GGTTACGGAC CGCCACATAG CGCCGCCACG CCAGTCTCGC 
3101 GCGGGTGTCG GGTGCGCTCG CCACTCGAAA TTCGCAGTCG ACATACCGCG 
3151 CCGGGCGCCC CGTGCGCCTG CCTCGCACTT GCACGCAGAC GGAAACGACC 
3201 GCCACATTGG CCCAGTCGTC GACAGACAAG GCCGACGCGT CGGCCCATCG 
3251 TGCAGCACCA TATAGTCGAT AGCGCAAACT CAAGCGTTCG ACGCCTTCGA 
3301 CAAGCGGCTG CGCGATGCCG GGTCTGCCGC TGCCTTCGCA GTACAGTTCC 
3351 GGTTCGCCCG TCGACCTGAC GCGCGCGTAA AAGCGGTTGA CGATCAGCGG 
3401 CTGCGTATCG GCCGCGCCGA CGCCCTGGCC GAGGCAGTCC GTCGGCTGCC 
3451 CGCTCGCCGT CGGCCATGTG GAGACGCCGT CTCCGACATA GCGGACGACG 
3501 AGGCCGTCGG AGCGGCTCGC GAGCGGATCG CATGCGGTCT GACCGTCCGC 
3551 GCCGACCGGA CGTCCCGCCG CACAGCCGAA CAGCCCCGGC ACCGCGCGGG 
3601 CATCGTATGC ATCGAGCGGC ACGAAGCCCG CCATCTGGAT CTGCTGCGAG 
3651 ATCAGCGCGA GCGCCGCCTG CGCCGCGTCC CGCAAGCGCG CGGCATCCAC 
3701 CGCCGCTGAA TAAGCAGCCC GCTGCACGCG ATAGAGCGAC ATGGCGGCAA 
3751 GCAAAATCAG CAAGCCGAGC GCCATCGCGA TCATCACCTC GACCAGCGTA 
3801 TGCGCGCGCC AACGGGTCGT GCGCATCATC GGCGCTGCGT CGATGCATAC 
3851 GCGAGCGTCA CGCACGACTT GGCGGCATCG CGCGCAGCAG CGGCATCGCC 
3901 GTCGCAACGC AAAGCGCTTG CAGCCAATCC CGCGGACCGT TCCCATTCGA 
3951 CCCGTACGTT CGAAATATCC GCACCCGCGT TCGTCGCGAC GAGCTTGCCG 
4001 TGGCGCAATC CGGACATCGA CGCGTCCCAG TCGACGCCCG ACGGCCCACC 
4051 GGCTCGCGCC ATCTCCGCCC ACGAATCGGC GACGAGCACC GCCGGCTCGC 
4101 ATGCCGCGGT GTCGCGCTCG CTGCGTATCG CCGCGAGCAA CGCCGCCACC 
4151 ACACCGAGCG ACGCAACCGC GAGCAGCGCG CACGCGATCG CCGCCTCGAG 
4201 CAACGTGCTC CCACGCATCG AGCGGCAACA TGTCATGTCG ACCGTCCGCA 
4251 ACCGCCCTCG GCGAATCGCA CGCGACCACC CGCCGCGATG CGCAGGCAGC 
4301 GGCGCCAGCG TTCCCCGCGC CATGCGCCCG ATGCGTCTGC CGGCGCAAAC 
4351 TCGAAACTTC GGAAGCCGCC GATCACCTGG CCCGCGGGCG GCGTGAACAC 
4401 GACATCGACA GTCGTGCCCG TCACGGCCAC TCGGGCATCG GCGCAATGCG 
4451 CCGCAACAGG GCGTACCGCG TTCGCCATCC GCGGCGGCGA CGGCCCAGCC 
4501 GCACGACCAA TCGGCCGCCC CGCCACCGCA TGGCCGCCCC GCCGCAATGC 
4551 ATTTCGCGGT CGCATCGCTG CGGCACAGCA CCACGCGCGC GCCGAGCCTG 
4 601 ACCGCTTCGC CGCGCGCATA GGCGAGCAAT GCGCCGAACA CGCGCGCCCG 
4 651 CGCGTCCACT CGATCGCGCA TTCGAGCGCC GGCGAGCGTC GGCGCGGTCA 
4701 GCATCGCGGC AAGCGCCACG AGCATCAGCG CAGCCATCAC TTCGACGAGC 
4751 ACGAAGCCCG CCGTTGCCCA CCTGTCCAGC TCCGCTCGCA TCGCGCTCTC 
4801 CTTGAATCCG ATGCGCCGAC TCTACGCGTG CAGGCAAGCG CCGACCATCC 
4851 GCCGAATGGC CGAGTCGCGC GCCGCGACCG GGCACACGAC AATCGCCCAG 
4901 GCGAGCACGC ACACCGCGTG TTACGCGGGA GAAACGAATG GAACGGAAAA 
4951 CGAAACGGGA AACGGAATGG CAAGCTCAAC GCTTGCGAGG CGTCTTCGCG 
5001 GGCGCCGCGC GGCGGAATC 
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The com[!lete nucleotide seguence of the 7.7 kb[! EcoRI B.l!.seudoma/lei fragment 
(Cha[!ter 8). 
1 AAGCTTGGCT GCAGGTCGAC GGATCCCCGG GAATTCGGGC ACCAGGCGAA 
51 ACAGCTGCGG ATACGTGATG AAGAACGTGC TGATGGAAAT CGAGACATCC 
101 ATCGAGATCA CGCAGTCCCC CAGTTGCGCG GAATGTGCAG CGTCTCGCCC 
151 GGCTCGATGA TCGCCTGGTA CGGCGTGCAG TGCCGGTAGT TCGGATAGCG 
201 CTCGAGATCC GGCTTCTCCA AATCCACCGG ACTGAACGTC TCGCGCTCGA 
251 ACTGGCCGAT ATAGAGGTTC TTGCTGGCCT GATCCGGCGG GAACAGATAC 
301 ACCATCTTCC GGCCCACGAT CTGCGTGAGG AAATTCGGCA TCGGATCGGT 
351 GTGGATCGGC GTATGCGTGC CGGCCGGCCC GATCCACAGG TACGAATCCA 
401 TGTGCGCACC CGGGATGTGC TCGATATGCC CCTGCACATA CGGATGCGGC 
451 GCGAGATCGG CGCGCAGGTT CGGAAAGCTC TTGCGAAACG GATGCGACGC 
501 CATGTAGTAC ATGTGGTCCG GCTTCGTTCG CAGGATCCGG ATCAGTTCCT 
551 TGAGCTTGAG CTCCTGGAAA CGCAAGTGCT TGACGTAACC TTGCGGGCTG 
601 TTGTTGCCGG GCCCGCGCTC GTCAGGCTGA AAGCTCTCGA CGCCGATGGT 
651 CTCGTCGCCG AAACGATTCT CGAAATAGTC GAGCGACCAT TTCTGCATCG 
701 CCGGCCACGC ATCGAGCGCC CTCGCGATTT TCACCGGGCG CTCTTTTTCG 
751 AGGTAATGCT CGCGGAAGTC CGATACTTTG GGTCGAACCA GCGTTTCAAT 
801 AGGCAGAATT TCATCGTACG GCATAGTCGA TTCCCGGGCC CGAATGTTGA 
851 TTGAGATGCT CGCGGACGCT GGCAGGCACC ATGTCCGTCC AGAGTTGCTC 
901 GATGCGTTGC AGACACTGTT GCTTCGTCGC AGGTTCGCCG ACCGTTTCCC 
951 AACCGGCGGG AAGGCTTCGC CGTCCATCCA GACCGAATAC TGGCCCTCAT 
1001 TATTTCGCAC TACGAGTACA ATTCGTCGTC CATAGCTGGT TCCCAGGGAA 
1051 AGCAAGGTGA TGTGCCGGGT TTTTGCCGTG GCGGCGCGCA GGTGAAATCG 
1101 CGCAAGACCA TCGGCTGGAA AGACGCGCCG GATGTACCGC CTCGGCATCG 
1151 CTCGGATGCA GGCTCGCGAC TACGCCCAAC GCAGTGAATG CATCAGAGAA 
1201 TTGAGTATTT CTTCTGCGGG AATTGTCCTT TGAACTAACC TGATATTCGG 
1251 TTATTGGGTA TGTATTTGTC AACGAACTCT CATCTTCAAG GCACGATTAG 
1301 AATTAGCCAT AACCTCTCGC CTGTCAAGCT ATTTTGCGGC AAGGTACGCC 
1351 GCTTTATTTC AAACAACAAT GCCTCCCTGA TAAAGATTAC AGGCGAAAAA 
1401 GCTTTATTTC AAACAACAAT GCCTCCCTGA TAAAGATTAC AGGCGAAAAA 
1451 TGCCCCGCGC GCGGGGGGGC GATGCCCTGT GACTGGCCGG CCGCTGCGAG 
1501 GATTCGATGG GCGCTCGCTC GCCGCCCTTC ATCCGCAGCC GCTCGAAACG 
1551 GATCCAGGCA CATGAATCCA AACAATATTT TTCCCGGCTC AAGCGGCAAG 
1601 GAAAGCGAGC CGATTGAACT CGGAATGCTT GCGGCTGACC ATTAATTAAG 
1651 CGCGCACATT ATAGAAAATA TATTAATCAT CCATATTCGT GAGGCACGGA 
1701 AATTTTTACC GTCGATGCGT TTTTGCAAAG AAGCCTTGCC GACCCCAAAC 
1751 GAGTGCGCAA ATCTCATAAA CTTCCCCGGA TCATCCCGCC AGTCATTTTC 
1801 ATGAAATAAT TTCGGTGGAG AGAATAGATC AATCGATTAT TTTCAGTCAG 
1851 CCTGATCATT GCACCGAAGG CAACTAATTG CGCGTTCGAA ATACGGCGGC 
1901 GGCGCTTGGC ACCCGGTGCC GTCCGATCGC AACATGGAAT GCGCGCTACG 
1951 CGACATCGAA CCCCGGGAGA CCTGACCGCC ATGCATGTTT CGACCGATAC 
2001 GTCCGCCGAA GCCCATTCAC CGGCGCCGAA TGCTCGCGAC ACCGACTCAC 
2051 GCGCAGACTC ACTCGATATG TCAGACAGTG ACGCACTGCG CCGGATTGCC 
2101 GAAGCCGTCG ACGGCGGTGC GGCGAACATC GAGCGAATCG TTCCGCTCGC 
2151 CCGTGCGCGC GAGCGTATGC CGACGCGGCC TCGGCTCGAG CGGTGCGGCG 
2201 GCGGGCGAGT GACGGCGGCG CACATCACGC TCGACTCGCG TGCGCGTCTC 
2251 GATGCGTTGC TGCACGCATT GCAACGCGCG ATCGACCAGA ACGCGGACCT 
2301 GCGAACGTGC ATTTTGGGGG CGTGCCTGCG GCGGCCGATG CAAGTCACGC 
2351 TTCGCGAGGT TCGCCTGCGA GTGCACGCCG CGACGCTCGA CCCCGACCTC 
2401 GATCCCGCCG CGCAGTTGGC CGCGCTGAGC ACCGGGCCCG GCATGCGCAT 
2451 CGACATGCAA CGCCCGCCGT GGGTGCTCGC GTGCATCGCG CGCATTCCGG 
2501 GCAGCGGGCA ATGGCTGCTG CGGCTCGTGG CAGCCCCGAT CGCGGCCGGA 
2551 TTCGACGCGC TCGACGCGCT GCTTCGCGAG GCGGTGATTC ACGGCGACCG 
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2601 GGAGCCCGGG CCGACGCCGT TTCACTGGAC TGTGGAAACG GCTGTTGAAT 
2651 CGTGCGGAGG CGAACCTGCG TCGTTGCCGA CCGCGGGCGC GGTTTGGCCG 
2701 TCGAACGACG TATCACGCGC TTGCGATCCG GATGCCGCGT CGTGCGTCGA 
2751 GGCGCGCATC GCCGCGATCG CGTCCGATCT GCCGGGCGTC GTGCATGGCG 
2801 GACCACGAGA CGATTTGCGC GCGCTCGGAC GAACGCCGTT GCAGGCGCTT 
2851 CGACTCGCGC GCCGTATCCG CGACGAGCTG GGCGTGACCG TACCGGTCGA 
2901 GTCGATCCTC GCGAGTCCGA CCATCGTCGA GCTTGCCGGA TACGTCGAGC 
2951 AATTGCGCTC GCGGGACGTC CGCGACGGCG CTGCGCCCGT GTCGATCGGC 
3001 GAAACACCGG CGGACGCGGA TGCTCGGGCG CAGGCGCAGG CGGATACGGA 
3051 TACGGCGCAC ACCGATTGCC TGATCGTCAT TCAAGCAGGA GGCGCCGAAC 
3101 AAGCGCCGGT GTTCTGCATC CCGGGCGCGG GGGGCAGCGT CGCGTCGTTC 
3151 GTTGCGCTTG CGAGCATGCT GCGCGCCGAC ATACCGGTAT ACGGCTTGCA 
3201 GCCTCGCGGG CTGGACGGCC TGGGGCCGCC GGACCGGTCC GTCGAAGCGG 
3251 CTGCGCGCCG GTACGCGCGG GCCATTCTGG ATGCCGCCCC GCCCGGGCCG 
3301 CCGCGCATCG TCGGCCACTC GTTCGGCGGC TGGATCGCGC TCGAGACAGC 
3351 GCGGCTGCTG GACGGCATGG GAACGCGCTG CGCCCCGCTC GTCCTGCTCG 
3401 ATTCGAATCC ACCGCCCGCG TCGCAGGCCT GGCGCGCGCC TTCCGAGGCA 
3451 GACATGCTGC GCACGCTCGT CGGCCTGCTC GAGCAGGCGC CGGGCGGCGC 
3501 CCCATCCGGG ATCGGCGACG AAGAAATCGC CCGTTGCGCG CGACGCCCGC 
3551 AGGATCGCGC GGATGCGCTC GTCCACGCCT GCATGGTGAG GACCGAAATG 
3601 CTGCCGCCGC GCGCGCCGGT CGAAGCGGTG GCATGGTGAG GACCGCCCTG 
3651 CGAAGCCCAT TCGAGCACCC GCTACGCGCC GGGCGGCCGA TACGCGGGCG 
3701 ACGCAACGGT GATCGTCGCC AACGGCGATC GCGACGCGGG CGAGATGGTG 
3751 CCGGCGTTCG GATGGGCCGC GCTGATCGAG CGAGTCGAGG TGGCCGTGAC 
3801 GCCGGGCAAT CACATGAGCA TGCTCGCGGC GCCGTATGTT CGTCACGTCG 
3851 CGCTGACGAT GAAGGCGGTA TGGCGCATGA TCTGAATCAG CGCGGCGGCC 
3901 GCCGCCGCGC TGCGATGGCC GTTCGTTGCG CCCCGTGCGC CGACCGATGA 
3951 AGCCGGCCGG GCGCCGGCAC GGCGGCGATC GGTCGTGGCG CGGCCGGCCG 
4001 CGTCGCGCTT CCGGCCGAGC TGTCTTCGCG GCGAAACCTC GCGCGCTTCC 
4051 GATCGATCGC GCCGCGCAAC GGCCAACGCC TGCGCATCCG GCGCGCATGC 
4101 TTCGCGGCCC GACACGAGGC GTTCATGAAC AGCGCCGCCG GTATCGTTTG 
4151 CAAGCCGGTT GGAGCCGACG GCGCGCCTCC CCCGCCGTGG ATCGAACGCC 
4201 CCATCGCGAA ACGGCAGCCG GCATCGGGCC GGTCATTCCA ACGCCGCCGT 
4251 CGGAGCGCCG CGCCGAGCCG GCCGGCCGCC CTCGCCTGCC GCGCGCCGTC 
4301 TAGAACCGAT GCCGCAGCCC CAGCGCGACA ACGACCTGAT TGCCGTTCGC 
4351 GGACGGCGTC AGCGTCCAGA TCGTCGCGTT GAACGCCGGA ATGCCGTTGC 
4401 CGCCGCTCAC GCGCTGATAG ACGGCCGCGA GATACGCGTC CGTGCGGATC 
4451 GAGAACGCGT AATCGGCTTG CGCGACCATG TGATTCCACT TCGGACGGGT 
4501 TTCGCCCGAG CGCGCGTCGA AGCGGCCCAT CGTGTACGTG TACGCCGCCG 
4551 CGAGGCTCAA CCTCGGCGTG ACGACGTAGC GCCCGTCGAG CGTGAAATTG 
4601 TCGAAGACGA GCGAATTGCC GTCGAGCTTC GCGATGCTGC CGCCCTGGAG 
4651 CACGCCGCTC ACGCGGTCGG TGGCCGAATG GGACCACGCG GCGCCGATCG 
4701 AATGCGGCCC GAACGCATAG CGGCCCGCGA CGGCCCAGAT CTGCTGGCTG 
4751 CCGCCCGTGA TCGTCGCCGA GCCGTCCGTC GTGCTCAGCG CGCCGTTCGC 
4801 GTTCGCGGCG TTCGGATTCC GATTGATTCT CAGATAGCCG GCGCCGAGTT 
4851 TCAGCGGGCC GTTCGCATAG GACAGGCCCG CGCTCCACGC CGCGTTGTTG 
4901 CCGAACGGGC CCGCCGTGTT CGAGAAGCCG TACATTGCGC CGAGGGTCCA 
4951 TCCGCGGTAT GTCGGGCTCG TGTACTTGAC CGCGTTGTTG ATGCGGATGT 
5001 TGCGGTTCGA GTCGTCGTTG TCGTACGGGT GAACGGCGAG GTTGCCGCCC 
5051 CAGCCGGTCC CCGACGCGCC GAGCGGCGTG ACGAAATCCA GGATGAGGTC 
5101 GTACTGGCGG CCGAGCGTGA GCGCGCCCCC TTCCTTCGAT TTCAGTCCGA 
5151 TCCATGCCTG CCGGCCGAAC ATGTCGACGC CCTTTTGCGA TAGCGCGCCG 
5201 CTCGCCCCCG AGAAGCCGTT CTCGAGCGCG AAGATCGCCG ACACGCCGTC 
5251 GCCGAGGTCT TCGCGGCCGC GCAATCCCCA GCGTGACGCA TTGAGCGCGC 
5301 CGCTCGTCAC GGCCCAGCCG GGGCTTCCCG GCGAGCCGGC TCCGTGGGTG 
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5351 CGCTGGTTGT TCGCGTAGGT GATCGACGTA TCGATCAGGC CGTACAGCAC 
5401 GACGCTGCTT TGCGCGTGAG CCGTGCTCGC GCCGAAGCCG GCGGCGCATG 
5451 CCGCGGCGGC GGCGCCGGCG AGGCGCGCGA GCCGGCGGTT GCCGGGAAGC 
5501 TGCCGGGCCG CGCGAGCCGA CATCCCGGAG CGGAGGGTCT TGTGTCGTTG 
5551 GTTATCCATA TTAATTGTTA TGTTGGCGGG CGCGATTGGC GGTGCGTGCC 
5601 CGGGCGCCGA TTGGCGGACG GAGCGCCATT ATTGGAGACG ACGCGCGTGT 
5651 CGATTAACCC TCGGGTTCGG AAAGGTCCTC TGCGAAATCG CGATCAATCG 
5701 AATCCAATCG CGTTCAAGCA CATTGCGCGC GAATGCGATC GAGCGCGCGC 
5751 CGGGCGTTCG GGCGCGAGCG CGCCGCGGGT CGCGCGCCGC AAACCCGGGC 
5801 GGACCGGACC CGCGCCGCTT CCGGCGCATA ATGGCGTCTC GGCCGGCCAG 
5851 CGGCCGTTCG AGGAGCGCGC ATGCACCGTG TCACCCATTA CCGCCGCGCC 
5901 GACGACGGCA TCGAAGCGAT CAGTCTCGAT ACCGATCGTG CGTTTCCGCG 
5951 TCACGCGCAT GACGAGTTCG GCGTCGGCGT GATCGTCAGC GGCGCGCATC 
6001 GTTCGTGGAG CGGATGCGGA ACAGTCGATG CGCGCGCCGG CGACACGATC 
6051 ATGGTCAATC CGGGCGAAGT CCATGACGGC CTGCCGCTCG GCGCACGCAC 
6101 GGCGCGCAGC TGGCGCATGC TCTATCTCAC ACCCGCGCTC GTGGCGGGCT 
6151 TCGCCGCCGA AGAAGGATGC GGCGGCGTCG AGCTCGCGCA TCCGGCCGTC 
6201 CGCGACGCGC GACTCGCGGC CGCCGTCGAG CGGCTGTTCG CGCGTGTCGT 
6251 GGCGGGCGCG CAAACGCCTG CGGCGTCCAT CGCGTGCGAC GAGGCGCTCG 
6301 CCCTGCTCGT CGCCGCGCTG CTCGCGCGGC ATGCGAGCGG GCGCGCGCCG 
6351 CGCCGGGAGC GCGCCCGCGA TCCGGATCGT GCGCGAGCGG CTCGACGCGT 
6401 CGCCGGCCGA TGCCGTGTCG CTCGCCGAGC TCGCGAGTCT GGCGGGCGTC 
6451 AGCCGTTTTC AACTGCTGCG CGGTTTCGCG CGCGAGCTCG GCATCACGCC 
6501 GCATGCCTAT CTGATTCAGT CGCGCGCACG CTTCGCCCGT GCGTTGCTTG 
6551 CGCGCGGCCT GTCGATCGCG CAAGCCGCGG CCGAGGCGGG TTTCGCCGAC 
6601 CAGAGCCATC TGACGCGCGC GTTCGTTCGC CAGTTCGGCA TCACGCCGGG 
6651 ACGCTTCGCG TCACGCTGAA CGCGTGCTCG CTGCCGCCGC GCGAGCTCGG 
6701 GCCGTGCGCG TCGCATGTCC GCAATAGTCC GAGATGGTCC TCGCCATCGC 
6751 CCGCTCCCCC CGCTTCCCGA TCGCCGCCGC GCCGTTGCAA TTTTGTTCAA 
6801 GACGCGCTCC GCCCGCGAGG CGACGATGCG GGCATGAAAA CGAAACTCAT 
6851 CGGTTATCTG TCTCTCGCCG CGGCGATGAT GGGCGTCGGC AGCACGGTCG 
6901 TCGCGAGCCG CATCGCGGGC GATGGCCTGC CGCCCTTCAC GGCCGCCGCG 
6951 CTGCGCTTTC TGATCGCTTC GCCGCTGCTG TACGCGCTGA TGCGCGCGCA 
7001 GCGGCTGCGC TGGCCGCGCC TCGCGCCGCG CGAGCTCGGG CTGCTCGTCG 
7051 TGCAGGCGGC GTGCGGCGGC GTCGGCTATA CGGTGCTGCT GATCGTCGGC 
7101 ACGCGCCTGT CGTCGCCCGT CGACGCGGGC GTGATGCTCG GCACGCTGCC 
7151 GGCGATGTCG ACGCTGATCG CGGCCGTCGT GCTGCGCGAG CGGCAGACGC 
7201 CGCGCGACTG GGGCGCGGCC GCGCTCGCGA CGGCCGGCGT GCTGCTCGTC 
7251 ACGCTCACGC CGGGCCGCAC GACGATGTCG ACGCGGGCGC TCGCGGGCGA 
7301 CGCGCTCGTG CTCGCGGCGG TCGCGTGCGA GGCTGTCTTC ATTTTGCTGA 
7351 ACCGCCGGCT TGCCGTGCCG CTCGCGCCGC TCACCCAGTC GAGCGCGATG 
7401 TCGGCGGCCG GCTGCGTGCT CGCGCTCGCG CCGGCGGCGT TCGAATGGCG 
7451 CGCGGCGACG GCCGCCGCGT GGCAACCCGC CGCGCTCGCG GCGATCGCGT 
7501 ACTACGCGCT CGTGCCGACC GTGCTCGGCT ATCTGTGCTG GTACGCCGGT 
7551 TCCGCGCGCA CGAGCGGCAC CGAGGCGGCG TTGTTCACGG CCGTGGCGCC 
7601 GGCCTCGGCG GTGCTGTTCG CGGCGGCCGC GTTCGGCGAG CCGCTCGACC 
7651 GAACCCGGCT CGCCGGCATC GCGATGGTGG TGGCGGGGGT GCTGGTGGGC 
7701 GCGATCCGGC GCGCTGCGGC GCGCATCGTC CACGCGAAGC CGCTGCGGCG 
7751 AATTC 
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The Nucleotide Sequence of the 38 kbo Sequence Containing the Cloned pSA2 
Sequence (Chapter 10). 
1 CCGCGTTCGCGGCGGAAATGCAGGAAAAGCAGGTGGACTGGCAGCTTCATCTCTTCGGCG 
61 GCGTCGGCCATGCCTACACGAATCCCGACGCCGACGGGTGGAACAAGCCCGGCTACGGCT 
121 ACAGCCGCGCCGCGGACCAGCGGGCATGGACGATGATGCTCGCGCTGTTCGACGAAGTGT 
181 TCGGCGGCGCAGCCGCCGTCGGCAAGGCGTGAATGTCGGCGCGTTGAAGCGCGGTCGAAT 
241 TCGCGCCCTCCGTCTGAACGACGGAGAAAAGAAAAACCCCGCGCAAGGGCGGGGTTGATT 
301 TCTGCATGCCGCGGTTGCGCGACTCAGAACGGAAGTGGGCATCGATGAGAGCGGAAGAAG 
361 GGGAGGAAGATTTGGGCTCGAAGCCTTGTCCCTTGGGTTGAGGGGAGCTTCCTGCATCAA 
421 CGCACGAACCTGTAGCTGCCCCCGCTCCGTATCTCAGTGGTGCCGTTATCACTTCGCGCA 
481 CAACGTCCCTTCCGAAGAAGGAAGGCCCCCGTTAGGGGGCCAAAATCAGGCTGGCGCGCA 
541 CGCAAAGCTCTTGCGGACAAATTCAGAGAAAACGTCGCTGATAGCGTTACCGGCCTTCCT 
601 GTAGCAGTGTGCGCACCGGCACCACGACCGTCTCTGCACCGATTGCGTCCAGGCATTCGA 
661 ACAAGAACGCTGCCTGGAACGAACCTCGCGACATCTTCAGTTTGATTGTGGTTTCGGTCT 
721 CAGCACCGGGCCGTCGTTCATTCAATCGCTCCGCCAGCACCTTGTACGTTATTCCTCTTT 
781 GAGCCAGCTCCGAACGAAGCAATGCGGCAGCCGCCCGACGATAGCGGTCCTTGTTAGGAC 
841 TACTTGCATCAGCCATTTGTGTCCTGTAGAGTTAGGTATCGCCCGACGATACCTTTGAGT 
901 CGCAATGTGAAACGTCTGAATAGGAGAATGATGTCAACAACCGACTTGGAAGCACGTAGC 
961 GTCCGCCGCATGAGTATAGCAACCAGCCTCGAACGCGTCGGCGCCGGGACAACGCCTCCG 
1021 CTTCGTAAGCGTAGGCGAGCCAAGTCACGCCCGCGCTATCGCCAGTGCCGCGTAATCAGT 
1081 CGGGGGGTCGTACTAGACTCTTGGGGGAAGCCAGGCATGCACCCCGCTTTCAGCGCGCGA 
1141 ATTGATAAGCCAATTCGACGGACAAAATCGATTATCAATTAATTGATAATCACGAGCATC 
1201 ACATCTCTTTTCAATTGACACACACAAATAATGCCACCGACTTTACCTCGACCTCTTGAA 
1261 AAATTATATTTCCGTGATACGATGCGCTGGTTTGACATGAAGCACATCATCAACGAAAGA 
1321 GGAAATCAACAAACATGGAAGGATAGGCCAACACCACATTCGCGGGGATATCCCGTTAGC 
1381 GCCCCAAAAAAACAAGGGCGCTAACGGGATTCCCCGAGAGCGCCCTTGCGCCGACAGTCC 
1441 ATAAGACACGCCGGACCTCAGAAACCGCAGTGTCCTATGAAACTCCCTCGGTGTCAAGGA 
1501 TGGAATCGTTCGTCCATCGATTTTGTGATGGACGAACGATTAATATCGTCCGTAGCAAAA 
1561 CACCGAAATGAGCGAAACCGATAATCCCGGCAACAATCTCCCGGCAACTGATATCCAGCA 
1621 GCAGCCCGGCACACCGCCCCCGCCAATGCCGCAGGGATATCACGTTAAGATTCTAACGCT 
1681 CCAGCGAGGCATTAATCGCGGGGAGCGCATCTCCATATTGCTAGATGGTTCTCGTGAACC 
1741 GGTGACTCTCGCAAATGAGCACATGCTTTGCGGGAAGCGATTACTCCTCTCACCCAACAC 
1801 TTATTTCAATCACCTTTCACACATCGCCCTGATATACAAGTGGGCGGATGAGCACAACAT 
1861 ATCGGTAGCCCAGAGGTTGCTTGGGGGCATCGGTTTTGCCAATTATGAGGTGAGCTCAAT 
1921 CTTCGCAACAGTCCGAAAGCGTCAACGGCAAGCCAAGCCCGGCACGATGATTGTCGGCAA 
1981 AACGGAGCAAAGAGCGCGCATGGTCCGAATAAAGAACTTCGTGATTAGCGGGATGGAAAC 
2041 CGCCACGGCAAATCTCGACCCACGAACCGACACGGAAAAGCTGAACGCGCTTGAATATCG 
2101 CGTGGAAACGACACGAACACTGTTTGAGCAAACAACGCCGAGCAAGGAACGCTCGCCATC 
2161 GAAGAAAGGACTCACGGCAGAGTCGGTGCAATTGCTGGCAGATACACTTTCTCCAGGGAG 
2221 CGCGAATAATCCCTGGAGAAAGCCGCTAGTCCAGCATCGCAATTTCATACTCGTCATGCT 
2281 CTATTTGGTCACCGGCTGTCGCCGAGGTGACTTGGCCAAGGTAAAACTATCCGACATCGT 
2341 GCATGAACAAACACCCTACATCCGCTTTGACGCACACGTCAGTGACCCTAACGACAGACG 
2401 GCCTGCTGAGCCGAGGCTGAAAACGCTGTCTCGCGAGTACCCCATTCATACGACGGTTGC 
2461 CGATGCCGTTAGCCGGTACATCGCCCAACATCGGGTGGAAATCCCGAACGCGGCCGACAG 
2521 CGAGTACCTATTCCTCGAAACCAGCGAAGGGCGTGAACTCGCTATGCGGACGGTCAATGC 
2581 CATCTTCGAGACGTTACAAAGCGTCATTCCTGACCTCACGCCGCACATTTTGCGGCACAC 
2641 GAAAACCGAAAGCCTGCTCCGAGACGCAGAAGCGATGGGGCTGACGGAAACACAAGTTCT 
2701 CGAGACCGTCATGTATCTCAACGGCTGGCGAACAGACAACCGGGCAACATACACGGCCCG 
2761 CAAACGTGAGGAAGTCGCACGCCGCGTTGCCACCGCCCGACAAGAGGAGTTCTTCGTCAA 
2821 ATGATGGACTACCAGAAGAACTTTCTCGACGTCTATGGCAATCCGGTCATCGTTGAGCCT 
2881 CACCGATGGACCATTGCTACATCGCGTGGAATCGAGGGGCTGCCTTGGAAGGGAATTGAC 
2941 AATGCCGGCGAGGGTTTCTCGTCCCTCTGTCGTGCGTACGTCCAAAACTTCCTGCTCCGC 
3001 AAATCCCCCATCGAGGCACTCAACGTGCATCGCGAGCTATGCAGTTTCGCTCGGTTCTAT 
3061 AAGACCACACCCGGAGCTTCTATGCTCGCAGCTGTATTGGGATACCTCGCACAGTTGACA 
3121 TCGAAGGGCAGCCGCTGGCGATGGTCACGAATTCGTGCCTTCTATCGCTTTTTTGCTGAA 
3181 CAGCGGCATCCGGAGTTCGACCGGAGGGCTCTCGTGGATATCAATCGAATAGTAGTTGGT 
3241 GGCAATCCCAAGGGAGTAGCCGTCCGAACCGGCGACCCAGTCTCCGGGCCGATGAGTCGC 
3301 GAGGAAGCAACCGTGTGGAGAGATGCCATCCTTGATGACGACGACGATAGCTATTCGTCA 
3361 ATCAGGGAGCGCGCCATTGCGACCCTAGTCACGGTACTAGGACTACGGCCGACAAGCATC 
3421 GTCCATCTGATGGAGTGCGATTTCGTTCAAAACGTGACAATCGATGGCACGCCGGTCGCG 
3481 TTTGCTCTTGATATACCGCGCGCCAAGAAAAGGGCTGCGCCTAGGACACATCGCCGACGC 
3541 ATTCCCATTCATCCCCAGCTAGCCGCCACGGTTCAGAGGTTGATTGAGCTCAACCGCAAG 
3601 CTGCATCCTGAGCCGCAGTCGGCCGACGTGCGACCAATAATCTACGCCACGAAGCCCAAT 
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3661 TCCACCTTCGGCACACTGGGTTGGAAGGAAAGCTCCGACGGGGTGTCTGCCATTCTGAAC 
3721 CGGGCGGTCAACCGCTATGGCGTCGTATCGCCCAGAACCCAGCAGGCGCTGATAGTTTTC 
3781 CCAACACGTCTCCGGCGCAGCGCGGCGACAGCGCTAGCGAGAGAGGGTTATTCGGCCGAG 
3841 CACATTGCATCTTTCCTCGACCAAGAAAGCTTGCAAAACGTCACCGTGTACACCGACGCT 
3901 GCTCGGGGCACTATCGAACACTTGGATGTGTCTCTTGCAGATGCCTATGCGCCGTTTATC 
3961 GACGCATTCACGGGCGCTATGCCCAAACCTTCATCGAAACGGAGAAGGAGAAAAACGGTC 
4021 TCGTACGTGACGGACGACGGCCGTCTTCTTACGCTCGGCGAGTGCGGTCAGGAGCGGGTG 
4081 CCTTGCCGGCGTCATGCTCCCTATTCGTGTTACCGCTGCGAGCTTTTCGGGCCGTTCAGT 
4141 GATTCAGAGCATGTCGCTCTGCAGAGCGACATGCTCGCTCGCCGCGCGCGCCTCGGAAAA 
4201 TCCGGCTCGCTAGCAGAGCGACGAATGGCCGCTCTTATTGACCGCACCATTTTCGGTGTT 
4261 TCGCACGTGAAGCTGTTGATTGAGGAAATGAAGAGTGAGCAAGAGTTCAGTTGAGCGGAC 
4321 GGACGTGGCTCTAGCAGCCCTCCAACACGTGGCTACCGTGCGACCGGTAGCGAGCGTCGT 
4381 ACGAATCGACCCGCGAACAGACAGCTGCATTGTGGCTCGACGTTCGCTGATTGAGTTGTA 
4441 TAAGACCTCACAGCCGTTTGGCGAAATCAACTGGCTCTCGAGTTGCTGGGACATAACCGA 
4501 CGCTTTGCGAGACAAAATTAAGGGATACACGGCGCGAAAGCGTGCACTCGTTCACTTTAC 
4561 CCGTCACCGTGAAGTCGGGCAGCGCATAGGACTGCCATTTCCCGAGGAGGACGACCTCGC 
4621 CAGCGTAATCAAAGCATTCGCGTGCCGCCAACATGTCCTCAATGGCGTGACCGCCGCGAG 
4681 GCATATGGTCTACATCCGCGCGTGGCGGTACATAGTTGGCGCAATGCGCGGGACTGACAT 
4741 CGCACAGGTCACCCCCGCAACATTCAATTCCGCCGCACTAGCCGCAACTAGGGAAAAGTC 
4801 ATCGAGCGCATATACGGTCCACGGTGCCCTTGAGGCAATTGCGGATATGCTCGACGAACT 
4861 GCGCCTTACCAAAGTACCACTCCGCTGGAGGTGGGTGAAGAAAAAGCGGGGAAAGGGGTA 
4921 CGGTGGAAGTAAGCAGATACGACTGGGACAAGCACCTGACACCGACCGGCGCGCATCCGA 
4981 TGACGTCGTCTACGCTGTCGCGCAGTTGTATCGCATCGTTCCTAAGACCAAGTGGGCAGA 
5041 CCGAATCTGTGTGCTGCTGGCGACGATTCTCGTCTGTACGGGTCTCCGCCTCGGGCAAGT 
5101 GCTCTGCTTGAGAGCTGAAATGCCCGCTTTCGATGAGGCAACCGGTGAGCACTTCATTCG 
5161 GCTCGTCGCATTTAAGCGAACGGACGCGACGCGAAAAACGCTGCTCTCCGAAACCGTAGG 
5221 CCTTCTGAATGATGTCTTCCGGGAGCTGTTGGAAATTACAGAGCCGGTTCGTGAGGTCGC 
5281 TCGTTGGCTCGATAAAAACCCGGGGAGAGTCAACCTGCCCAAGCCGGATAACTCCGACGG 
5341 AACTGTGACGGCTGCGAGATTGCGAACCTGGTTCGGACTCTCCACTGGCGCCTTTAAGCG 
5401 TCGTCTCCAGACATGGGGCTTCGCAGGAGCCGCGATACCGCTGCACGAACTCAACGAACG 
5461 CCTACTTCGGGATAGATTCGACAAGCCAGTTGTTCCCGGCACGAGAGGCGAACAACTGCT 
5521 GCTCAAAGACTGCCTTTCAATATCATTCGTTTCGGCAATGAAGCAAACGACGGCTGCCCT 
5581 GAAACATGCTGTTCGCCCCATCGGCGAGCAACACGTGTCGGACCGGTTACGCGGTCGTCA 
5641 GTTGGGAGACGGCCGCTCACGAGCGACCATCTTCGACCGCTATTCTTTGACAGATAGCCA 
5701 AGGTAACCCCCTGAGCACATATACCCATGGCTTTCGCCATAAGCTCAACGACGCTCTGGA 
5761 TAAGGGCGGTGCACCGGACGTCATTCAGGCACAGTGGTTCGGGCGTGCGAATCCGCGCGA 
5821 CAACAAGGCATATCAGTATCGCACTCATGCAGAAATGCGAGAGCGAGCGCGCGACATGCT 
5881 CATCAAGGGCCAACTCAATGGGCGATTTGCAACGTTGCTTAGCCAGGTCACGCCGGAGTG 
5941 CCGAAAGGAGGCTGCTGAGTCCATGGTGCAAGTCGCGCATCCTATATCCGGGGGCTACTG 
6001 CTTGCAGAATTTCGCACAAGTCGACTGCGAGCACTGTGGTCAGTGTCTCGATGAGTGCAT 
6061 GTCTTTTCACTGGGTACCGGGCGAAACCGACCGACAAGACGAAGTCATCGCCATCCGAGA 
6121 CACCATTTCGCGAAAGCTGAATGTCATGCTCGACAAGATGTCCCCTACCGAAAGACAGAA 
6181 CGACGAGTCGTTCTCACGACTACGTCATCAGCAAAACTTCGTGAACCAAATCCTGAAATC 
6241 TATGGAGGAGAGCAAGGTTGGTGAACCGAACAAAACCTAAGAAGGGTGCAAGAGCTAGAG 
6301 CCGTACCCAAGATGGGGCCTCGCGACACCGAACGCGTAATGAAGGAGCTTCTTGCTTTCG 
6361 AGCAAGGAAAGCGAGCTACCATCACGTTGACTTGGAAACATCTCGCTCGGGTAGCCGGCT 
6421 TTACCGACCGGTCTTTGCGTTCGAAGCCCAAGCTTCGCGCACGGTTCGATGAGGTAAGAG 
6481 ATGCCCTGCTGGGGAAGGGACGTATTCGCCGCTCCACCGGCATGGTTCACGAAGACCTTC 
6541 AGAAAGCGAATTCTCGGCTTCGACAACAGCTCAAGATGTACGAGAAACTCGAAAACGAAT 
6601 GGCTTGAAAGATGGATTCGCATCGCCGCGTCACTCAAAGCACACGGGATGAGCATCGACC 
6661 AGTTCGATGTCGACCTTGAGCTGAGGAGTGAGCGGCGCTCAGGCTGATTCTCGCGCACAT 
6721 CAAGACAGGACGCAAAAAGCATGGGGGGGCAAAGCATCACGCAGCGGCAAGCGATGTAAT 
6781 TCCATCGATGACCGTTTAGCGGAAAAGAAGCGTTACGGCGGCCGTGAAATTAATTGACGA 
6841 ATTCCAACCAAAAAAAAGATGAATTGACGTGATTATCACTTCGCGGCCGTCGGCTACCAC 
6901 GACCGTCTTTTTCCATTTCACCTCGACGATTATAGGTGCCCCACACGTGGGCTGGCCTCA 
6961 CCAACGAAGACAAATGGCATGGCGAGCAAAAAAGGCACGTCACGCCGAGGCGGTTCTGTC 
7021 AGGCATGAGAGGTCAGGTATCCACGCAACGCATCGGACATACCCTTTTCCTGTAGAAATT 
7081 GTGCTCGCAGCTCGCTCAAATCCTCATTGCTTTGCAGTCGCTCGTTTTCATAATCTTCGA 
7141 CCGCGCGAAAAAGGCGTTCATTGGTGGTTTGATAGAAAATCTGCAAAGCCTCTACCTCGT 
7201 ACATTTCCTCGATACCATTTCCCGGAGGGGCGAGCCCGAATAGAAGTCGAAGAAATGGAA 
7261 ATGAAACGTCGTCTGGGTCTATGTTTTGGAGTCTATTTTCGTCACAAAGATGCTTAACTT 
7321 CATCCGCAAGCGTCTGTTCTATCATCGCGCTGACATCTAGCCGCCCCAGGCCAATTTCGC 
7381 TGAAATCCTTCTCCGCGTCCGCAACCGACCTACCGAGCGCAGCTCGACACGCCGCAACTC 
7441 TGCGCCAGTCATTTGGAAATACGCTGCCGTACTTAGCCAGCCATAGAGCGCAGGCAGCCG 
7501 CCATCTGCGGTGTACTCGCGGAGGTTCCGGCACCGTTCATGTCCCAACCGTACTTCGTGT 
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7561 
7621 
7681 
7741 
7801 
7861 
7921 
7981 
8041 
8101 
8161 
8221 
8281 
8341 
8401 
8461 
8521 
8581 
8641 
8701 
8761 
8821 
8881 
8941 
9001 
9061 
9121 
9181 
9241 
9301 
9361 
9421 
9481 
9541 
9601 
9661 
9721 
9781 
9841 
9901 
9961 
10021 
10081 
10141 
10201 
10261 
10321 
10381 
10441 
10501 
10561 
10621 
10681 
10741 
10801 
10861 
10921 
10981 
11041 
11101 
11161 
11221 
11281 
11341 
11401 
TGTAGCACATCCAGGGAACGTTCGGCGTATAGGCTCCCACCGCTTTCTTCATCACCTTAT 
CGGGCCCCCAACAGCCTTGCATTACCCCGAGTCTATCTCGCTTGTAAGGGCCATCGTCAA 
ATGTTACGCCTGTCGATGTAACAACGCGGTAGAACGCTGACGGATAAACCGTGAAATGGG 
TTGCGATGTCTGTAAGCACCGCCCAGTAGCTATCGCCGGCAGCCGCCACCACTACTACTC 
CAGCGTCATAAAGCATGTTCACAGCGTGCGCCCATGACTTCATTGGCAAACCACCGTGAC 
TCAGACTCACCACATCACAACGTCGCCCATCGCCGGGATTAATCGCATAAGCAAGACCAC 
GAGCCATAGTCTCACCGTAAAGATAAACAACGGACCCGTCCACACCAGCGATTCTCACAG 
GGACAATTTCCGCGCTTGGCGCGCCGCCAATGAATCCGCGATATACCTGGTCGCCCTCAC 
TTTGGCCAGCTTTTCCGCATAGGCTCACGGCATTACCAGCGAGCAGAGCGAGAGTTGCTG 
TTCCATGTCCTTTATTCGGCCCAACTCCGGGGTCAACGGTATTGGAATTTCCTTCGACGA 
AGTTGTATCCCAGGTCTTTTCTAACTTTTAGAGGTGCAGAATAGTGATTTGGCCACCATC 
CGATATCCAGATGTGCGATGCGGATACCTTCTCCCTTTGTAGTCTGCCATGCTCGAGGAA 
AACCCGCCTTCTGCAAGTGCCATGCAGGCGAAAACGACGCGCCTTCACTCGGAGGGTAAT 
TTGGGTTGAGCGATTCGGTGGGGGGATAGGGGGGCGCTAATGTGACATCTTCCTGAGCGC 
TGAGAGGCGTTATTGAGCTTCTTACTCCCGCATCTGAGCTGTCCAATGTTCGCTTGTGAA 
TAATATTGGGCTCAACATACACATCACCGACACCGCTCGCACTGTTTACGATAGACAACG 
CCTGCTTATGTGCGCGGTCCCATGGATGAATATCCTCTACGGTATCTGGTTGAAATACGA 
CCCAATCATTTTGGCCACCAACAAACTGAACGCTCGTATCAGGAAAAAGCGCCTCAACCT 
TACCGCCCGTGATACCAATAAGGTCCGCCGCACTTCTTCTCGTGGGGCTTCTGAAATTCA 
AAACATGCTGATTAGGCAAACGGATTAACAACTTCATCTCATTCAAGTCAGCCATGCTCT 
ACTCCCCGAGGTATAGCTTCAGCCTATCATGTAGGCTGTTGGTCACAGCTTCAAGCGCAA 
CAATATATCTAATTCCGAGATGCTAGATATCGGAAGATGCAATCGACCTCAAATTGCCTG 
CCAACTCAAGTGCGTTGCACCCGGTCGAGCGAATGCTGTACCACGACGGCGCTCTGTCGT 
CAGCTTGTCATTGCCGCAGTGTAAGTACACCTCATTACAGATAGGACATTGTCGAGAACA 
TTTCAAGTCGTTGTTGGCGTAGAAGCGGGTGCCGGCTCAGCCTCACCTGGGACCAGCCGT 
ACAGTACTGACGCGCACAACATGGCTCCTCGAAGGGCATGATTTGGGCCGCGCCGATTGC 
CGGAGCGATGCTCATTGCGGCGTTCGCCAAAGCTCTTTGATGTCGATGCGGATTGAGGGG 
CAAACAGTATCCGTGACCGCTGCATCCGGTTCTGCAGGCTGAGGAGGCGAGCGACAAGCG 
TTACTGGATAGGGAGCACGCACCCTGCACCTTTTCAATGAATTGTAGCCAACGTGCCTTC 
CGCGTGTTTATATCCCTCGATGCGCATTGCCGAATCTATCCGCCTCGGTTCAATGCCCGA 
AGAACCGGGTCGCACACGCAGAGAGACTTTCCACTCCGCCAAATGACGAGAATGCGTGCG 
CCCCTAAGTCGTCCACCTCGCTGGGCTCATAACTGGTTGCATGTCCCAGACGTGCAGCGA 
GCGCGAATACGAGGTACGGGCCTTCCTCGCTACTCGACACCCTGATTCGGCTGGTCGTAG 
CGCTTCTAGTATACGGATATGGAGGCGTGCCTTGTCCTCTCAGTTCTACTTCCGTCACGG 
GTCTGGGCTTGCCCAGAGCGGGGTCATGAATGAGTTGCGCTGCGGCAACCGAAATTTCAG 
CGGGAGATTCGTTTTCATCGGCCACGAGAGCGTAGACCTTATGGTTGTCTCTCAAGCGAA 
CAATCGCGCCGGCATTCAAATATCCGGTCGGCCCGTTCTTGCCTGTAAGGCTTGACGGCA 
TCACCAAAAAGGGGAGTCTGTCAGAATCTGCGTATTGAACCCCGTGCCCATCGGGCATGC 
TCACTGGGTGGGCGGTCACCGAGTTGAAGAAGCCCGGAGCCGGGTCACCCTCTTTCTGCA 
CGGGTAGCGGACCGATACCGAGGCCAGTGCCCCAGACAGGCTTGTCTCCAACCTTCCTCG 
CGCTGTTGGCGGCAAAGCCATAGACGCAGAACGCCGGGGACTTCACAGGGTCCCACTGGA 
CAGCCTGCGCCTGGCGAACTGCAGCCGTGCAGGCGGTGTCGTCGCGAACGCATCTGCCGC 
CCCGGTAGATGTCGAGCCCATCACAAAGGCTGGAACTACCGATATTCTCTGGGTGATAGG 
CAGTGGATGCACCGTCAGTGTCGGTGCTCAGGCTGCCGGCCCATACGACGAAGCCACCTG 
GGAAGGTAGCAAACCTGTTTCCCTTCGGCTGTTTCCCTGGAAGATGAATCTCGGTAAAAG 
TGGGACAGGCCCTTTCAGCAAGGGCTGTCCCGGAACCCGACATGAAGCCTCCTACGAGGA 
GCACAGCAATCGCAGAACGTACGTGGAAAGTCACAATGCCTCCGACGCAAGTATAGAGAG 
TAAAAGTGTCGACGCGCTGAGTGGCTAGCGACGCATTCGCCGCTCAACTAACATAGTCCA 
CCATAACCTCCAGAAAACCAACTTGCGACTTAGGCAGCGGCGCAAGATGTACCGGAAACT 
CGAAAGCGAACGGCTCGCGTGACGGTTTGCATCGCGTCGTCGCTCAAAACCTATGCGATG 
AGCATTGCCAATTCGCTGTCCCGCCGGTATTCAGGCGCGAGCGACTTCCATATGGGGCAG 
CGGCTACGGGTGCGGACATGCGATATATTGATGCAGTCATCATCGACGGAAAAAACTATG 
TCCCGCCTCGGTATCGAACACGACCACGGCCTCGTCTATGAGGGCACCGACCATCCAAGC 
CACCTCACTGTCCCTGCGCCAATAATTTCACAGTGCGTACTCATTGAGTCCCCGTCTAAC 
CTCGACGATTTGCCTAGCGGGATGCTGAGTGACCCGTTTCGATGGATTTTTCGCGAGGAC 
TCGTTCGACCCGGTGTCGCGCGTTCGGCGAGGTCGCCTTTTCCAGCCGTTTGAAAGAGCC 
AATCGCGTATCGTATTTCGTTGAAGCACATCCCAACTTGCTATCGGATAGTCGCCGGAGG 
ACCGAAGACGGTCGGGTCCAGAAGGAATTGAATGTGTTCATTCACTGCACCGAACTGTTG 
CGACGTGCCAATCGAGGGGAGGGGCTCCAACTGGCGATAGGCAACGCGCAGGCGCACTCA 
CTATGGCGAATCCTGCAAACAGAGCAGACGGTGAGTCAGGATGTTTTGGTGACGCTTCGA 
GCAGAGTCTGCGTTTGGTGTCCTTCCCGCTCTCAACATTGACCAAGCTCCGGACGAAACG 
CGCAAGTCGGTGTCGGATGCCTACGAGCGCGTCATGCAAGTGGCATATAGGGACTCGCCA 
ACATCGGTCGTCGACCAATGCCGTAACCTGTGTGCCGTCGTCAGCGCGCGGTGGCTGTAC 
AAGTTGACAGGAAACAGAGCAATGCTCGAAGAAGACCTTGGCGATTGCATTACAGCGGTC 
AAGAAGCACTTCGGCGAGAAGGAGCAACGGCTCATTCGCGCGTCCCTCGAAACGGTTAAT 
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CTCCTCCATCCGAGGGGAAAAGATAACGAACGCGAACGCTACAAACTTCGCGAGGTATCA 
AAGGAGGACGCCGAACTTGCCTTGCACGCAACGGGCTTCTTGCTGAGAGAGCTCGGATGG 
GGATGCTGAGACTCTCCCATTTTGGTGATTGGCGGTACATCGGTCGTAGACTTTGCCGGC 
GCCTTGCAGATGGTAGCGCTGATGTACCGTTGTCTATGGCGAAGGCAACGGCCGAATTTC 
CGAGCGAGCTAGTGCAGCACTAGCATCACTAGGGCGAGGAGGAACAGCCCCCCTGCCACA 
TAGACCCAGCCCGGGACGGCCTGTCTACCCGACTTGGAGTTGAAAGGCGCTTGCTGATAC 
GTCGGTGTTGTGGTTGCCGCAGGAGACGCTGCTGCCGGTGGTTCGCGATGCCCCCGTTCG 
ACCGGCTGCGGAATTGGGCGCGGCGCCGACATCGGTTGTGGAACAACGGGTCGTGGCGCT 
GGGGTCGACGACGGTGGATTCTGCGTTATTTTGGTCGGTGGCGACGGACGTGGATTGCGC 
GCTGCCATGGCTACCGTAGGCGCCTGCTGTTGTGCCTTCATCTTCATTTGCGCTAAACGC 
TGCGCGTTCGCAGCTGTCGCACCGGTCGAGATGTTAGTCTGTACTGGTGATGGTCGTTGA 
GCCTTCGGCTCTTGCGGCGCGGGCTGGTTGGCGCTCATCCCAGCAAGCAATTTCCGATTG 
TCAGTCGAGGAGACACGAGGGCTCGGACTATCCTTCATTGCATCCGGACGCTCGGAATCC 
ATGCGATACCGTGCCTCATGCTCGTCGATGGTGTGAATCTGTCCCGGAGCAGAAACGACG 
AGCTGGACGTATACGCGTCCGTCTCGCTCTCTCCTCCTTCGAATTTGGCCCTTCACGCTC 
AACCACCGCCCCTTCCATGAGCTTTGCGGCTTGATTTTCATCTTGCGTAGGACGTCATCC 
CAAATCGTAAGCCGCACGCTGTTTCCTGGTCGCCAATCGCCGAAATTGATGAAGGCATAC 
GGACGGTTGTTACCATCTTTCGTCTTCTTGTTCGCAACGTCCACGACCATACCCACCAAT 
TCGACCACCTCGTCCAGTTCATCGAGAGCCGCAGCAAAATTCGACGCATCGACGACGGGA 
TGGGAGGGGAGATAGCGTCCGCGCGCGAATTTGGCGCCCAATTCCGGAGCAAGATATCTC 
GGTCCCGTAGGGATACCCTGACCCAAAATGAAGTCAGCCAGGGAAGGCACGCGGTCGGCG 
CCAGCAAGGCATATGGTCGCGAAGCTCGCGACGTCCCGTGCGAGCTCACCAATCCGCGAC 
AGCGACGCGAACACACGAGAACTCTGCGGCGAGGCAAAATCATTTGCCCGGAATACAAAT 
GCGTCTGCGTCGCTGTTTGTATGGCCCCATAGCTCGGCTGCAGCGCTAATCGCTCGGAGT 
GCGATGTCGAGCGAAATAAACGCAAATCTATCCAGCTTCGCGTTGAACAGCGTATGGTCT 
CGTCCCGGGTGCTGGAAGTTTCGGTGACCTATCTCAGCGCTATGCATGCCCGCAAGCGCC 
GGAACAAACATGCCGTCGTAATCGATAAGCCTTACTGACGCACCGTCCGGTGAAACCATC 
AAGTTGCCGGGTTGGATGTCGCCGTGGGCTATACCTTGACTCTCGAGATATTGTGCGAGC 
CGACGAAGCGCTTCGATTAGCCTAGCCAGCCTCGTCCGGTCGTCGTAGTACTGTTCAACG 
AATTCGCCTAGAGTGACGCCGCTCGCCCACTCCATCTTCACGATAGGGTAGGCAGTGCCA 
TCCACCCATATCCCGTTCCTCGCGAAGTTGAACCGCACGAAGTACGGCGACCTCAACGTC 
TCAAGATGGCGCGCGACGGCGGTGTAACGGTCTTCGAGGTCCTTCGATTCTTTGTGGAAG 
CACCGAAGAGCGACTTTCCGATTTTGCGCCAGTGTGAACGTATAGGTGAGTGCAAAGCCT 
CCGCACATGACGAGCGGAAGTCCGAAGCCATCTCTTGCAACGGAGCCTTGTGCAAGCTCA 
GCGTCCCCACGAAATGCCGTCTTGGGAAATTGCAGTACCTCTTGGTACCGTTCCAGAGCC 
GGGTACGTCATTTCGCCTGGGGTCGGCTACGCACTGCAAGGACGAGTAGTGAGGTATCGT 
CGATACGCAGGACTCCTTCGCGTCTTTCGGACAGAACAAGCTCGGTGAACGCAGCATCCG 
TATTCACCGACAGCAGCCTTTCCAGGCGCGAGCCTGCGGGATTTTCCGACAATAGCCACT 
GGCCCAATGCGTCCGTCATGAGAAGGACAACGCTGCCTTCGCTGAGGTGCCAGACCGTAC 
CGGAATCGTTGTTAAACGACGCCGCACTCACGAACTCATTCGCTTCGGCGCGCGTAGAGA 
GCAGCCGTGGACGCTGGTCGAACTCGGCGGCGGTCGTGTACGGGTGCGACTGAACGACTT 
TTGCGGCCTCCACGTGTACCGCGACGCTATCGCCCACGGAGACAATCTCGAGGTTCCCTA 
AATGTTCTTGCCATTGGCAGCCCAGTAGGGTTGAGAAACTGCCACGGTCGAAAGCCATCT 
GTTCGGACCAGCCGAGACTGTTGTAGTCCCAGGTGCGGTCATAGCTTTGCCTTGCGGCGT 
TGACCCATTCAGGGCTCACGGCGGGAAGCTCGACGAATCGAGAAGCGAGCAGGTGTGCCC 
AGGCACGTGAATCGAACGATTCCGAAGCGCCGTCTGCAACGGCGAAGACGCCACGACCCT 
CGTCGATGCAAACTGCGTCCTCGTTCCGCTCAGGCTCGTCGGTGACCTTTGCCACAGTCG 
ACTGAAACGCTAGAACCAGCCGCATAAATTATCGGAGCTGCGACGGGCGGGTGCCGATGT 
CGAAGAAGTTCACGATTTGTTCAGCCTCGGCGTTGAACATGAAACCTCGGCTCTCGAACG 
AAGCCGCAATGCCCTTCTCCTGGGCAACGCGCACCAGATGCTCTGGAAGCTGGCTCGACA 
TACGGAAAAGCAGCTTGGCGTACTGGTCTGCAAGGGCGTTCTCTGATGCCGGAAATTGCA 
CTGGTTGTCCCGCTTGAGAGCTTACGTGCAGGTTCAGCAATAGTACGTTGCCATCGTCCG 
TCTGAAACTGGCGCAGCGTATCGGCAAGCTCTTCCGGGTCCCCGTCAGTTGAATCACCAT 
CGGTAACGTGTAGAACCGTTGGCGGATAGCTCCTGGGATGCGCGTCACACCATCCAGCGA 
GCGCTTCGGCCGCCGCCATGATTGCCGCTCTCATAGGCGTACCACCATCGGCCTTGGGCT 
CGAACCACACGGGAAACTTCGTCAACTGCTCGACGAGTCCGCCGGCACCATCATCCACCT 
TTCGTTTTCGTTCTTCGATACGGAGCGGATTGGCCTCGACCACCGAAATTGGCTGCAAGG 
TCGTCTGCGAGAGTACACCGTGAAAGCCGTTCGTTACCGAGTCCCCACCATACCCGAGAA 
CCCCAACATTGAAATAATCTCGAACACCGTCTGACTTCCTGCAGCGAACGATAAGGTTGG 
CCAGAGTCCGATTCAAGACGTCGGCAACGAACTGCGCTTTTGTGCGTTCGCTTCCCGCCA 
TCCTGTCCTCCATCGACCGTGACTGGTCAACAAGAAACAGCAATGCGGTAGGGTCACTGC 
GCTGAATGGCAGCCTGGTAAGCCATATTGCTCTCCGTGTGGGGGTACCGTTGCCTAATCT 
TATTTAACCGCAAACATACCAGCAGCCATCATGATATGCCAGCGACGGCCGCTATTGCTG 
GAGGTTGCCTGGCACTGCAGTACAGAAACTACAGCGCATTTCTCTCGGTCCTTGCGTAGA 
TATGCCATATGCATGGTGATGGCGATTGAAAACGATTTTCCTTCGAGTTCACCTCAAAGG 
318 
15361 
15421 
15481 
15541 
15601 
15661 
15721 
15781 
15841 
15901 
15961 
16021 
16081 
16141 
16201 
16261 
16321 
16381 
16441 
16501 
16561 
16621 
16681 
16741 
16801 
16861 
16921 
16981 
17041 
17101 
17161 
17221 
17281 
17341 
17401 
17461 
17521 
17581 
17641 
17701 
17761 
17821 
17881 
17941 
18001 
18061 
18121 
18181 
18241 
18301 
18361 
18421 
18481 
18541 
18601 
18661 
18721 
18781 
18841 
18901 
18961 
19021 
19081 
19141 
19201 
GCATACGGTCGCGGAACGGAAGTCGTGTGTCGGCTCCCCGGACGAACCGCTCAAGCTGCG 
GCCATCGAAAGCAAAATGTCAGGTTTGTGCAGGGCTGATACCGTTTCGGCTTCGCTCCCC 
GGCGCTACTATCCCGCCAACGAGTTTTAGGTGGAGTCGTGCCCGGGCAGGGAAACCGTCG 
TTCCATGCCAATGAAAATGCTTGTTTGAAATCTGCTCGAAAGCCTCTATGCCCGATATTT 
TCGACTCGTAATCGTTGATGCCACGCCCGGCCACCAATACAATCGCGCTAACAACTCAAA 
AATTTTCGCACTTCGGGGGCACCATGAACTTGTGGACGCACATCGCCACGTTTCTGGCCG 
GCTTAGCGACTGGCTGGACGCTAAAGGTCGTGATTTCCAATCGTTCGAACCGTTCGCACC 
GCGCTACCTTTGTTTCACAGAAGGGCAACATGGCAGGCGGCGATATCGTCGGCGGCGACA 
AGAGCACCCGCGAGTAGTATTCGTGTTCACGAACCAAAGCAATAACGAGGTCAATGGCGG 
AGACCTCGTTGCCGGCGACAAGGTCGATAACAGCACGACTACAGTCATCCACGTCACGTC 
GAATGGCTCGGCCAGCGAAGAGTTGTCAAAGCTCTACGAGAAGTTAAAGACTGACGGCAT 
CGGTGACCCGTCGGGCGGAAAATTTTCCGAGAAGCTCGAGCACTACATGTCGTCGGCGAC 
TGATGGGGACGTGCGAGGGCTGGAGAAAAAGTTGTGCGAAAGCGGAAGACAAGACATCTT 
GCATGCCGCTCTCAGCCTCAAAGAGCGCGCCGCCAAGTCCATCATGAAGCATCAGACGTC 
GAGAACGGCGCAGCGAATCTTCACCATTGTCCTCACCGAGCTGCACGCGCGATTCACTCT 
CACTGTCACGCCGGTTATCCAGCAGGGTCTCGACCGCGTCGCAGTCGACCAGTGCATCAA 
TACGATTATTCAAGGGACTCAAAACGTGTTGGGCGAGAACGTTCTTGAGTTGGATGCCAT 
TGACCTGCTCGCGTTGCTCTATTACCTGGGCGGCAACTGCCATATCCGGTGGGATAAATG 
CTGATATACCACCCTGCCTATGACGCCTATCACTGTGTGTTCCGGATGCTGCTCATTGCC 
GAGCGAGTCTCTGGCATCGAGGTGGAGAAAGCGCGAATCTTGGACTTCTATCTGGTTTTC 
CCGGGCATGGTGAAGAAGATACGTTTGCCGGACACACTCAAAGTACTCCGGGCCCATGCA 
AAAGGCGCTGGTAACGTGTACCGCGACCCTGTCAGCAGTACATCCACATTCATGGAGATG 
CGGCATATACAGGAAGCTGCACTCAAGTCAATCGCCGCGTCTGGCTTGATTGACCTCGAG 
AGATTCTCGGCCGGATATGTTGTGCGCTCTCAAGCGCCGGTTCCGCCTTCGCTCGCGGCA 
AAGCTGGACGAATTTGTGGCCGCAAACTCGCCTATGGCCGAGAGTATCCTTAACGGCCTC 
TCACAGATTCCACTGCTTGGGAGCAACGGGCTGAAGCATCGTTCCGAACTCATGGAGTAC 
CGGTATGACTATGCTTGACCCGACGCTGCGCGTAAGCCGACTCGTCGTTTTCCAGGGCGG 
TCACGTCGCATTCGACTGCTCGTTCCACAGCGGAGTCAATGTCATTCGCGGCCGGAATAG 
CTCTGGCAAGACAACCATCATGGACCTTCTCGCGTTTTCGCTGGGCGCAGAAAATATCCG 
ATGGAAGCCAGAGGCACTGCGTTGCACCAATACGTTCGTTGAGGTACAGCTTAACGGCGC 
CGTCGCGTGTCTTCGTCGTGAGATTGATACGGCACTTCAACGCCCAATGTCGATATTTTG 
GGGCGCACTCGACGCATCACTGAAGGCCGGCCCGCAACAGTGGGAGCTGTATCCCTTCAA 
GCGAAGCGCGCATCGCATCAGCTTCTCTCAAGCATTGTTCGATGCACTTGACATGCCGCA 
AGCGCAAGGTGACGGAGCATCGAACCTAACGATGCATCAGCTTTTGCGCGTCCTCTATGC 
AGACCAACCATCGGTACACAGCCCCATCTTCCGCCTCGACAACTTTGATAGTCCTCTGAC 
GCGCGACATGGTCGGCGGGTACCTCAGCGGCGTATATGACGACCGGCTTTATTCAGCGCA 
ACTGCGACTTCGCGAACTTGACGGGCAGATTGCGAAGCAGGAGACGGAGCTCCGAGGCAT 
CTTTCACGTACTTGGACGTTCTGGTCAAACCCCGGACCTTCAGTTTCTGACCGATAAAAT 
TTCCGAACTGGAAGCGGCTCGCAGAGCGCTTTCCGATACGCTGACAAAACTGAAGCAGGA 
CCGAACGCTGCCTCGCAAAGATGCGAACAAGGCGCGCGCCTCCGCCGACACTTTGCGTAG 
CACTCTGAACGCTGCGCGCCAGGCCGAATTCGCAGCCAAGGACCGTCTGGCGGCGCTCGA 
ACTCGACATCGAAGATTCTCGCCTGTTCGTCGGCGAACTCAAGTCCAGACTGCAGAGCCT 
GGGCGAATCGAAAGAAACCCGGACTTATTTTAGTAATTTGCAGTTCCAGTTTTGCCCGAG 
CTGCCTCGCCGAGCTTCCAAAAGCAACGGCGGACTCCCACGTTTGTCATCTTTGTACCGG 
CTCGCTCGGTGACGGCCGGGCAGACACGCAGCTTCTCCGGATGAAAAACGAACTGAACAT 
CCAACTTAAAGAATCGACGACTCTCATCGAAACTCGTCTGAAGGATGCCGAAAAGCTTCG 
TGTCGAAGTCCCCCACCTTTCACAACGAGTTAGAAAGCTGGAGCAGGACTATGCTGCGGC 
AGCTACGTCGTGGTCTAGCGAACTCGAGATTGCCCTTGAGGAACACGCACGCAAGCTCGG 
TGCAGTAGACGAAGAAATACGTCAAGCGTACGAGCAACAAAAGCTCGCTACCGTCATCAC 
GGACCTGCAAAAACGCCGTGACGCGCTAACCGCCGAAGGCAAGCGGCTGCAAGAGAGCAT 
CATACGTTTGGAGCAACAGCAAGCCGAGCGGAAGGTCGAAGTCGCGAATACGATTACCGC 
TGCAATGGTTAGGCTTCTCAAGCTCGACCTGCCCCTGACGCCTGAATTCATCGATGCGCA 
GGTAGCGAACTTCGACTTCGTGGCAAACGAAGTCTACGTTAACGGCTCCAAAAATTTTTC 
TGAGAGCTCGGCTGTAGTGTTGCGCCATATCTTCCACCTCTCACTGCTTACGGCAAGCGT 
GCAGAAGCCGTTCATGCGCGTACCGCGCTTCATGATGCTTGACGGAATCGACGACGGTGG 
CATGGAAAAGGAACGCAGCCACCGCCTGCAAGAAATCATCGTTGAGGAATGCGCGAGCTA 
CGATGTCGACTATCAGCTCATCTTCGCGACTTCCGACATAAACCCGAAGTTCGAAGAGAC 
TGACTTGGTGGTGGGCAGATTCTTTACACCCCAGGCTCGCTCGCTGGACGTGCGAGAAGC 
CTAGCCTGGCAAATACCATCGCGATTGAAGTCGGCATCTTTAGCGCACAGCAAAACCGAG 
AGGCATCGTGTCAGTCATCAAGCAGCAGTATAAAAGCCTAGCCCCAAAGGGCGAGTGTCT 
GTCGGACATCGTTGTTCTCGCGCAGGCCTGGAAGAAATCGCATACCTTCATTCGAAGACA 
CAATTGGTACGCCGATGTTCTCGAGCTCGATTGTTCGACTGTCGACCTCGAGGAGCGCCT 
CAATCAATGGGCAGACGAAGTCGCGCAGCCGGAGTTTTCGACCGCTGAGTTGTTGCTCGT 
GCCTGCCCCGAAGAACGCGCGATGGGAGTTCAAGGCGGCGCCAGACCTACGAGCCGTTCC 
CGACATTCTCGACGTCAACTTGGACGATTTCGGTTCCGAACCATCGTTTGGGGACTGGGT 
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GCCAATCGAAAATGGCGATGCTCCATCTCAGAATTCATCGGACGCCGGTCAAAAGCTACG 
CCCTCTAGCTCATGTCGCGATACGAGACCAGACGCTCGCGACTGCCGTGATGATGTGTCT 
CGCTGAGGCCATCGAATCCCACCAAGGGGACACCACCGAAGGTGATTTGACGAAGCTACG 
CAAATTGGGGGTCGTTAGCTATGGCAACCGCCTGCAGTGTCGATGGGTTGAGAAGGGCGA 
TGGCACAAAACGCGCGCACTTTTCGTGGGGTAACAGCCGTACCTACAGACAATATTTCGA 
GGACTACCGCGCGTTTCTTTCGCGACCGCGAAGGGTCTGCGCGGAGCTTTCACCGCAAAC 
CGCGACGAGAAAGGAACTATTCGTCGTGTCACTCGACATCAAGTCGTTCTTTGACTGTGT 
CGATAGCAAGGCATTGGTACATGAACTTTACCGACTTCAGACAACCTATCAGAAACATGA 
GGGCCTGTCCGAGAACGACTCCACAGACGTGCCGTTCTGGGAATTGGCATCGCTCATTCT 
TAGTTGGCGGTGGCGGGAAAGCGACCATCAATCTGCACCGCTAATTCGCGGCCAGGACTT 
TGAGCACCTTGCAGTAGGTCTCCCGCAAGGACTCGTCGCATCTGGCTTCTTCGCCAACGC 
TTACCTCGTCGGCTTCGACACCGAGATGTGGAGAGTATGTGAAGAGCAGCAGCAACTGCC 
AGAAGATATCCGCATACTCGACTATTGCCGCTATGTCGATGACCTTCGTATCGTGGTCGA 
GGCGCCGCTTGCAATGGGTGCCGCTGGGAGCGAGAGGACGCTGCAACGAGTCCAACAGTT 
TGTGTCGGAGATGTTGGCGAATCACTGCCTGCGTCTACAGGCAAACGTGTCACTGACGCT 
TTCCCTGCAAAAAAGCAGCATCACACCATACCGGTCGATTTCGGCGCAGAGCAATGTCTC 
ATCGCTGATGGAAGCATTGAACGCAGACCTAAGTGGAACGTTCGACCTTGAATCTTTGGT 
ACAGACAGCCGGAGGCCTCGAAGGCCTTTTGTGGATGTCTGAGCAAATAGAAGACGCTCC 
CCCATCAAGCCGCTCACGACTGGCGCTCGCCAATGTAGCCGTTCCCAACACCGATGTACG 
GGACGATACTGTCAAGCGATTCGTAGCAAGCAGGCTCGCTCAGGTAATGCGTCACAGGTT 
GGCGATGACGGATACCGAATCTCCGGCGGACACTGACGTGGCTGTCTCCGACGCCGTGAG 
CGCCGGAGCAGCGCTCTCTCACGAATTCGAACAAACCGCTCGAAAGCTCATAAAGTGCTG 
GGCCGAGAATCCTTCACTAGCACTGCTGCTGAGGTGCGGGCTAGACCTCTTTCCTCACCC 
GAGGCTGCTTTCCCCAGTTACCGAGGCCCTAATATCCAAACTACCAGGAGCCCAAAACGC 
CTTCGACAGCGAGCAGATAAAACAGGTGCGCACGGCCGAGTACGTCGCTGCTGATATTTT 
GCGCGCGGGTGCCACAGAGACTGGGTATCGCGATAGGGACGAGTACCCGGAGTTCGTCGA 
CATCGAAGGTTACCGGGAGAGCCTCGGTGCATTTGCGCGATGGATACTCCTTGAGTACAA 
GCATGCGCCCTGGTATCTGCTTCAACAGGTCCGTCTCTACCTTGCGTCCATTGGAGATTT 
CTCAAACATTCGGTCTGTGAACGGAAGCATGGAGGAATCGTACGCCTTACTCCATCGCGC 
CTCGCTATATCAGCCAGTACGCTCGGGCGAGTTGTTGCGCCTTCTGCCGTTTGCGCTCGT 
CGCCCAGCAGCTCAATCCCAATCCGCGCAGATTCGGCGTTTGGCTCGCCGAATGCCTTCG 
TCGGACGCGGAGCGAGGGCGAACAGGCCAAAGCCGTTACAACCGTCGCACTCAACCGACC 
GGATTTGATGCTCGAAGCTTTGAGGTCGAAGACTATTAAAGCCAACGGGTGGGTAAAGCA 
TGTGCCAACGCCGCTCGCCGAAGTCGACCGGAAGCTGCTGAAGAGGGGAAAGACGACCGA 
CGGCACGAGAACCCTGATTCGTTGCATGCTCGACAACGACAACCTGTTCGCACAAGAGAA 
CGGCTTGCTGGTCCTTGCCCAAGCGCTTCTGCGCAGCCCGGACATCCAAAAGCGCCTATC 
TGACGGCTTGGACGCCAGTCAAATTACTCTCCGGTGCGAGGAATGGGAGCAGATTCATTC 
CATTCCAACGGCCACGGACTTCATGAAGGTCGAACTTGCGCCCCCTCCAGGCACGCAGAA 
TCCATTGTATGAAACGCCACTTTGGGTGGCAGAGGACAAGGCTTGGCTCTACGGCCTCGG 
ACGTATACTTCGCGCCGCGTTGACTGGCGAGTTTGATTTTACTAGCCGGCGCTATCTTGT 
GACGGAAGAGGTCGGTCGATACTTCGGTCTTCGAAGTACTTGGTATAAGCGTAGGTTCGG 
TATGCTGAATTCTGGCACTGGCTTGCTTCACGAACCAACGCCCATCTCCCCCTGGCTTTC 
TGGACTGTTGTCCACGTTGCTTCAGTGGCCCGGGGTCGAGTTCAGGGCGAACGACGCCGC 
TGCAGCGGGTGACGCTAACACCCCGGAAGAACTGCTGGCCCTAATCGAGAAACGAGCGGC 
AGAACAGCGCGCATTGTACGGTTCGCGCAGCCGCACGCCAATGTACGTCATACCGGCATC 
AGGGGATGATGCACCATTGAATGAAAGACCATTGCGCGTTGCGATTGTGCAACCGCTTCG 
ACCAAGGCGTGACGATTTCGATGCAAAGGACCCTACGCATTGGACAAAGGGAATGCTTGC 
CGAGCATCGAAGGCACCTTGCTGCCGTATGCCGACTCGCTGAACAGCAGCTACGAACGTG 
GGCGTCGGCCCACAGCAAAGTCGACACGGACAAGGGGCCGCTGGTCGACATAGTGTTGTT 
CCCCGAACTCTCAGTGCATCCAGAGCACGTCGGCTTGCTTCGTCGGCTGTCGGACAAACT 
GAAAGCGAACGTTTTTTCCGGTCTAACCTTCGTTCATTCTGACAAGGTCGGAGGTCCGAT 
AAATCAGGGACTTTGGTTGATTCGCAGCGAAACTGCCGAACATGGTCGAAGCATCCAGTA 
CGTTTGGCAAGGCAAGCTTCATCCAATGAAGCTTGAACGAGCCATGGGCATTAAGCCGTA 
CCGGCCACACGTGACACTTGTTGAATTGCCAATCGGCACGAAGTCGCCGACCCGGATAGC 
AGCGGCGATTTGCTACGATGCGACGGACCTCGATTTGGTTGCAGACCTCCGAACCAAGTC 
CGATGTCTTTCTCGTTGCAGCACTCAACCAGGACGTTCAGACATTCGACAATATGGTCGC 
TGCTCTGCATTTCCACATGTACCAGCCCGTCATATTGGCGAACTCCGGTGAGTTCGGCGG 
CTCGACCGCTCAAGTCCCGTTGCCGAAGCACGAACGCCTCGTGGCGCATGTACATGGCAG 
CAATCAAATAGCGGTCAGCGTGTTCGAAGTCGACCCCGCACCGTTCAAGTCCACTGCAAC 
ACCGAAAGCCACGAAGGAACTGAAGGCACCTCCCGCCGGCTACAAGGGGCGACCCTGTTA 
GAGGCAACACATGAGTGCAAACCAGACTATCGTAATCGATTGCCCGCAATGCGCCGTTCG 
CGTTAAGTCCGAAGCCTCCTGCTGGGTCGGTGATGCGCAAGAACAAGCATATTTCCTAGC 
GGAATGTCCGTCCTGTCGCCAGGCATTGTTCGGCTCATCTTCCCTCATTCGCGACGAGCG 
GGGTGACTGGGAGTGGGACACAGCGGAACGGCTTTGGCCTGCGCCAATGATAGCGGACTT 
GGGTCCGTCGGTCCCGCCTGCGGCGCGGCGAGACGTGAGCGCCGCGCAAAAGTGCTTTAG 
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TCACGGCATCTATCCCGCCGCTGCGGTTATGTGCGGCCGTGCTTTAGAGCGACTCGTCGC 
GGAAAAGACGGGGAAACCACAGTCCCTTGCTAGGGGCCTTGCCGAATTGAGAGCGCAAGG 
TGTCATCGACGAACGGCTTCACGCGTGGGCAGATGCCTTACGTGTCGAGCGCAATATCGG 
CGCTCATGCGTCCAACACGGAAACGACGAAAGACGATGCCGAAGACATCATCGACTTTAC 
AGTCGCGATATTCGACTACGTCTACACTCTTGCGGAGCGATATCAAAAGTATCTCAAACG 
AAAAGAGGCTGGGGGATAGCCGCCCTCGGTACGAGGAAGACGCCATGCGAGCACCAGATT 
GATAGGCTCCATTTCGCAAAGGTCGGCGAGTCGTAGGTTGAAGCTCTCCGAGCGCCCTAA 
GTAATTTCTGATTTGATAGAGTGATGAAGATAAAGATTCATTGGACCACCGCATTGACCC 
TTCGAGCTGACCCACAGCTCATATATAGCCCGTCTGTACTTGAAAGCGTGGACGACGTGC 
CGGGGGTCTATGTATTCGCGCGGAAGTACGGCAGTCGCGTTACCCCGCTGTATGTGGGGA 
AAGCTCTAAACCTAAAAGGGAGAATCAAGCAACAGTTAAACAACTTGCGACTGATGCGCC 
AAATCCAGGACTGGGAAAAAAACGGCGCTCGGGTCCTTTTGCTTGGGTATCTGAAGGTTC 
ACGGTTCGCAAGACGTAGGAACGGCGTTGGACGTCATCGAGCGCGCACTGATTGAACATG 
GGCTTGCCGAGGGACATCCACTCGTCAACGTACAAGGTACTCGTACTCCGTTCCACACAC 
TAAGCTTCACGGGCAATAGAATGTCCGAACAGGTTGCGCCACGTCAGATGTTCGTTAAAG 
CATGAAAGCGAGCTCCCCACGAGCCTCAAACTCGTGGGGCCTGTCGGGGATGGCCTTGGC 
CTGAGATGCGTCCGCTTCCGTGCCTTGATTTTTCGCTCAAACCAGCGGTCGATGTGGTCA 
GCTTGCACCGCTCGAACGGTTTCGCCGCCTGGCTGGCGGGCATCTTTCAAGCAGTTTACT 
AGTCCAGACCTTCATCTGCTCAAGCAGGAACAGTCGGTCGTCTCCGGCGAGCGGCTCTAG 
AAGACGCACGATATCGTGCGCGACCTGCTGCGCGTCGCCCGAACTCCCTTCCAACAGGTC 
CATCCACGAGCACTAGAGTACCGCACAGAGCCGCTCGAGTGTCGCAACACCCGGCATCAC 
CGCCCCTCGCTCGAACCTAGAGACCGTCTCGGCATCGACGTCGATTTGCTCTGCGACGGC 
GGCTTGCGTCAGCCCGCGCTGCTTCCGAACCGATGCGATGTTCCGGCCAATGACCGACGC 
GAGGCTTGTAGGCATTACTCAACTCAACCTGTGGAGAGACACATAAAAATGTTGAGTTGC 
CGGCGGCGGTTTGGTAAGGTTCCAATCTGTAGACTAACAACAGATTAGTCCCATTCATCC 
ACGAAAGCATGCTGTCGTCCCACGAACGACGCACCGGTGATATGCCACCGCGAGCCCGTC 
TCGGGCACGTGCTGAAAACAAAGGAAGCTGGCTCCTGCCAGCGGACCGGCGATATTTCGC 
CCATGCATCGGCGTCCGTGACCGAGCTCCGGACCGCGAGCGGCCGGGCGTCGGTCGAAAT 
TTGAAAGACGGGGAAAACGTGAAGAAATCGGGGATTGTCGCGGCTTCTGTGCTCGCCGCA 
GCTTTGCTAGCCATCGCCTCGCCGGCGACATACGCATGGACCGACATTGTCTCGGGCCCG 
TACGTCGAGACCGCGCCACATTATCTTTCGCACACGTTCTATGTGTCCGGCGTTTGGCCA 
ACCAAGGGGAAAGCATCGGCCCAAGCACATATGGAGTGCGTACAGGACAACAGCTTCGAG 
GACCGCTTTCGCGGTAGCTGCCAATCAATCGCAACGTTCGACGGCCCGGCTGTCATTGCT 
CTTGTGTCCGCTCAGAATCACTACTGGTCAGCATATGCAGACCCTGACACGAACACCGCA 
GTGCGAAAGGCAATGGCACTTTGTCATAAGGACAAAGCGGAGGAGTGCCAGCTGACCAAT 
ATCTACTGGGATTTCGGGCACAACTTCCTCGATGCCCCGGAGAGCTTCAAGCAGCTCTAC 
ATGAAACTTCACGACGGCGAATACTGGCGGCCGCTGAAGGGCTACTGGGTTCCCTGAGTC 
GCTTGCCTGAAACCGCCCGAGGCGCTGCCATGTAGCGCCTCCGTTACGGTATGTGCCCGC 
CATCGTCTTCGAGGACGTCCCGACTGAGGCGAGCGCACATTCAACGCTAGGTGTGAGCAC 
GCATCGCCAGTCATCACCGCGCGTCCTGTCTATGGCATACGAGCACGCCGCAGTCGGGTG 
CGCCCCCCCATTCTTAAGGCACCGCTGAGCGGCGTGTTAGCGCTCGGCGGGAAAGACTCA 
CGACCATACTTGGGACAACTCAACGTGAAACATCGGCAAATTGCAGCGACGACCGCTTGC 
ATCTCTCTCGCGATTCTGACAACCGGCTGCGCGACGGTTACTGGCGGGACCACGCAAAAC 
GTATCGGTGAAAACACAAAAGGACGCAGCAGACGTTGCAGGAGCGGACTGCGTCCTGTCG 
AACTCAAGGGGTAGCTGGACGGTGACCACGCCCGGGAAGGTCAGCGTCCATCGGGCACAG 
GACGACTTGAATGTCCGATGCTCGAAAGATGGCGAACGCGACATCACCACGGCCGTGAAG 
TCGAGGACACGCACTGGAACGATAGTTGGAAATGTCGTCCTGTTAGGAGTAGGCGCCTTG 
GTCCTGGATGGGGTCGACAAGGCGAATGGCTCGGCCTACGCCTATCCGGAAGCCATCACC 
GTGTCGTTTGTAAATGGCAATGAGTCGCAGGGAATCCCCGGTGACGCAAGTACCGGCTCT 
ATCAACGGCGCGCCAGCTCAAGCGGCAGCGACGCCGGCGACAAACACCGCGTCGAGTCTG 
ACCAGGTAACTTATTTTCTTGCGGAGCTCGCGCATAGTTCTGCACTCGCTGCCGTCATAG 
GAGCGGATGACTGCGCCGTTGATGTTCGGCGCCGTCATCGAGACGTCGACGCTCTTGATA 
GGCGAGCGTCAACGATGCAGAGGCAGTCTTTCTCGGTTGCCGTACAGAACGGCGATTACA 
TGACGTCGGTCCACTCGACCGATTCGAACGTGCGACATTGGCGTGCTCCGTAGCACACGC 
TGTTGACGCCGAGTTCGTATGCAGCATCGAACATACAACGCCCGCACAGGGCTGCCATCG 
CCGTTTCCTTGCCGGATTCGACCGCATTCGACGCCTGAATCAAGGTCTGCAGCGGGACCT 
CGTGAGTTCCTTCAGGCAAATTGTCGTCATGGGGCACATCGAGGAAGGGACCGTCGGCCT 
TGCGCCGTTTGGCATGGGCGCGGTCAATGACACGGCGCCCCCAGCCATCAGGCTCAGTAT 
CGGCAATGGCACCCGCAAAGGTAGAAGTCTCCTTGCTTCCCGTGCGGTATTGAAAGTCGG 
TGCTCAGGGGGAGGTCCGGAGACAGTGCGAAGCAATCTGGATTACTGAGCCAGGCGGGGG 
AGTACCGGAATGCCGAGACCTCTTTTTGCCCCTGTCTGGAAAATTGCAGTTCGCCCACTT 
CCAGTCCCGTGTCGCCCAGATAGACGAGCAGCGTCCGCGTTGTGCTGGTTTTTGCTTTTT 
TTGTCGTCGCCATTACAGGGCTCCACTGTCCGGGTTGGCTTTGCGTCCCCGGATGCGTTT 
GGGCACCGCCTTGTTCATGAGCGCCAGGCCGAGCGCATCATTGGTGGTGTTCAGGGCCTT 
GTTGAGCTCGGGGAGGAGATTCAGGATGTTCAGGACCCGAATCACAGCGCCCCACGACAC 
321 
27061 
27121 
27181 
272q1 
27301 
27361 
27421 
27481 
27541 
27601 
27661 
27721 
27781 
27841 
27901 
27961 
28021 
28081 
28141 
28201 
28261 
28321 
28381 
28441 
28501 
28561 
28621 
28681 
28741 
28801 
28861 
28921 
28981 
29041 
29101 
29161 
29221 
29281 
29341 
29401 
29461 
29521 
29581 
29641 
29701 
29761 
29821 
29881 
29941 
30001 
30061 
30121 
30181 
30241 
30301 
30361 
30421 
30481 
30541 
30601 
30661 
30721 
30781 
30841 
30901 
TCCGGGGTCGCCCTGTTCCAGCCGGTAGAGCGTCTTTTTTGAGATGCCCGCCCGCTCCGC 
CATGGATGACGTAGAAAGCCCCCGGCGTCGGCGGGCCAGCGCAAGGTCATCTCCGGCAGC 
AACCAGCGCACGCTCGACCGGCAAGGGCATCGGATTTTCGGTGAAGCGGCCGGAAGGTTT 
GGGTGTCGCCGCTATTTTTGGTTTATCGGTCATATCTGAACCCTTAATGCGTTAATACGT 
CATATTTGACCACTATACAGCTTTTCTCAGGTGGGCGTCAGCGCGCTGATGAAAACGGTC 
AAATATGGGTCATAATGTCATTTAATAGGTCATATTTGACTCTTCATCGTGGAGTCAGGC 
GCAAGAAGAGTCCAGAGGCTCCCTGTTGAGAAACGCCCACCCAACCGGGAGCGCGACATC 
CTGTTCCTGTCGAGGGTGGCCGACCTCGAGTGCTGCCACGCGCTTTCAGGGAACGCCCGT 
GACCAGCGTTTCAACGTCGCGGCGAGTCGTGCGCGTGACCGCATGTATCTGGTCAGGCCG 
GTAACGGCCGAGTAGCTCTCTCCGAGAAGGACATCCGGATGACGCTGCTGGAGCACTTCA 
GCGGGCCTGCAGTTGAGAATGAGGTGGACCAGGCAGGACTCATCAAACTCTGCGAGTCGG 
GTTTCGAGCGCGAGTTCTTCGGCATGCTGGTCGAGCGCGGGTTATCGCGTCATCCCGCAG 
GTGAAGAGCGGCGCTATCGTCTGGACCTGGTCGTGGAAGGGGCAAACGACGCTCGACTAG 
CCTCGAGTGCGATGGCGACGCCCTCCACGGCCCCGACTGGTGGGCCCGTGACATGTCCCG 
TCAGCGAATTCTTGAGCGCGCAGGCTGGACCTTCTGGCGATGCTTCGCGTCGACGTGGTG 
TCTGCGCAAGGAGGAAGTCTTTGAGGAACTGATTGAGTGACTCACGAGCATGGGCGTCGA 
GCCCCTAGGTCGCGAACTAATAAAAAAGACCCATAAATTTCTCGACTTAGCGGTCCTAGA 
TTCTTAGGTTATGCGTCTACCTACAATCGAGTGGAGCCTGACGCAGTCAGCCCAATCGGC 
ACTAGTGTTGTTGGATACTAGGTACGTATCTCGTTCGATAGGCGACAGGCTATTCCAGAA 
AGGGCTCCAAAACTGACGCCACCAGTACGCAACATCGCCTTGCAGCGCGCCCAACCCCAG 
CGGGTCCAGGTGTGGGAACACGGTCCAAGGCGGAGGTGGTGAGAACCTACCTTCTGCGAT 
ATGGTGAAACACCTCTGCATCGTCTGAAACGAGCGATACGACGACGCCAGCGAACTTCGG 
CGCTCGACTCAGGTGGATATGGAAATGCGCGCCTCCGGCGACCTTGCTGTAGGCAGCTCC 
GCCCGCTGGCTCATATCCACGCGTCGCCACCTGTACGAGCAGCGCAGCATCCGATTCGCG 
AACCTGAAACTGAGCAAAAAATGCCCTGATTCCCGCTTCGGCAAGGTCCTGCACGACGGG 
ATATGCAACGTCGGGCTGACGCAGCGACCGGCTCGCTGAGTCACCATAAGTTTTACGCAG 
AGCCTTCGTGTCAAGGCCAAGCAATCGCTCGAAGGTATTGCTCCGCTCGATTCGGATTCG 
GCGCTCCATAAGCGCATTTTTCAAGCTGAACATGTGGCGAAGATTAAAGTGGGTCGAATT 
TGTTGTTGAGCCAGTCCGCGCCAAAGTACCCAACTGCACCGAACAAAAGCCCGCCAATCG 
CTCCCGTGATAATAGCCCCAGGGCCGGTCTCAACACCGATGCTCGCGCCCAGCGCTGCCC 
CAATCCGCGCCCCCGCCGTGGCCCCGCTCCAGCCGCCCATCTGTCTTACGGCTTCCCTTC 
GAATCGGACGGATGCTCTTTGTTTGCACCGATTGCTCGGCCGCCACGTCGAGGTCGTACG 
CGGTGAACACGATTCCGAAAATTTGCACGACGCGCGCGTACTTCGTGAATCCGAGCGCAG 
TCCGTAGCGACCTTTCGTTGAAGATGGCCGATGCCGGAACCTTGGGACTCTGAACAAGCA 
CCTCCTTGTCGATGTCCTTTACATACCCAGCAATTTTTGACACCCGCTTGGCCAGGTGCG 
GATTCTCGGCTTTGTATTGCTCAAGAGCCGTCAAGATTTCGTCGGTCTGCACCAGCTTCG 
CGCCCGCGCGCTTCGCTTTCGCGATATCGATGACGATGCTGCGGCCTTCGAAGCGAGGTG 
AGCCACCGGGGAACAACTCGCTCGTCGAGACGTAAGACGACATATTGTTGCCCATCACGT 
GTTCAGCGACGCTCGTTCCGGCTTCGAAACTTTTGGGAGATAGTCCGTACTTCTCTGGAT 
GCAACTCCTGCAGCTGCTGGAGCGGAGAAAGCCCCATGTCCCGCAGGAACACGTTGTCCG 
GTGCCGCGTAAATTTTGCGAACGAGAAATCCGTCTTTCCCTGGCTCGTCGACAATCGCGA 
AGAAGAAGGCGCGTGCCGGCATGAGGTGTCCGGTCACATCGTGGCGCGAACCTTCCTTGT 
CGTTGGTCGGTGTCTGGTAGTGATAGGCGGGCATTATTTTTTCCACTTTTCCAAAGCTGC 
GACGCCGACTGCAATCGACAAGGTTTCGATGCTGGCCGTCGAAACTCGCGGGCACAGGCC 
ATCCTCGTCCGTCAAACCCTGGTATTCGTTACCAGACTGGTCCCGGATGTGATACGGAAC 
GTTCGCGAGAGGTTCACCATGCTCATCGAGGATTCGGACTTGCTCGTCAAAGGCATGCAT 
GGCTTGGTCGCTCAGTGGGCTACCGTCGGCTGCGTACCCCATCTGTGCGAGTTGATGTCC 
CTCGAAGGTCATGAACATATCGTTCTTCGAGGCAATCATCCGAGGGGGAGGGTCGCACTT 
ACAGACGCACAAGTCGTTCTCCAAAGCCACCTGCTTGCCGTCGAAAGTCATCGGCCAGGA 
CGGACCCGCGCCAACAATGTGGCCATCCGATTTGCAAGTAGGGCAGTGGACAAGCGCGCC 
ATGATAGGCGAGAGGCGTTCCATTATTGAAGCCCGCAGCCACTCCCTCTTGCACAATGCC 
ACCCGCCGTCGTTCTATCCCCTAACACGAGCATATTGCGTTTCATGCGATACCTCTATCT 
AACCATTGCCCGATTCGACGGCCGCTCCTAACGCGCCTCTCGTGCAAATCTCGACTGATT 
TCCACTTCCCGCCAGTTGGCGTCAAGCATCCGGTTATACATTCGCGGGAAAACCGGAAAT 
CATAGATTAGAACGCAACGAGAGCACAGTGCCGCAGGCAAAATCAGACGAAGTCGCCGTC 
TCTTTTATGCACTGCGCGTCACATATAAAGACAGGTCAGTTTTGAGCTAGAGAGCATGCC 
ACCGAAATCTATAGGCAACGGGCGGAATCGCCGGTTGCCGCAGGTTACGCGAAGCAACAT 
GAGACGTGGTCCATGCCCGCGACGAATCTTCTGGCTCCGGGGTGAATGTAGTCCTATCGG 
TGCCAGACTCATTGGCCGCATAAAATCGAAATTTGCCATTTACACGGCCAATTGTTTTAA 
ATCAATGACATAGCGCCACCGCCAACGGGGCAGTCGCTCCGTCCCAGCGCAGGCGCGGCC 
CGATTCGTCACAACGTGATATTATGTTATATCATCGACTTTGATATAAGCCGTCCGAATC 
GGCCGGGGGAGCCGACTGTCTTGCGGGCCTGCATGGCGAAAGTTCGATAGTTGACGGGCT 
CGAATCTGAAGCGGCCACTGCTTCGGCACAACGCTGGCGCGTAACGCCGCAGGGCTTCTT 
CGGCGCTCACCTGGCAATGTGTTTTCGGACGTCGTCACCCATGCTGACGATGTCGTCCGG 
GACATCAAACTTCCTCTTTGCAATACCGATGCGCTTTTCTTCGCGGCTTAGTCGAGCCTC 
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AGCAGACGCCTTTGCCCGAGATTTTCCGAGCTCAACGGCGTCCCGCACGTTCATCTCGAG 
TGCCCCCCGGTCTTTTTCTGGAGACGCCAGTTCGGCGAGAGCGCCATCCCGGCCTATGAG 
CCATAAGGCCGTCGCATACAGGCCGATACCCACACCCGGTTCGCCAGCTTCTATACGCAT 
CAGAGTCGGTACACTAACCCCGAGCCGGGCCGCCCAGGAAACGAGCGACTCTTTTCTGCG 
TAGACGAGCCACAGCCAGGTCTGCGCCCAAACGCTCGAGAGCCGCAACGGTGGCTGGAGG 
CATTTGCCAAATCGCGACGGGGGTTTTCGGCGTAAATTCTATTTACGTACGAGACTGTAT 
TCCGTGCAAATCTTCTTTACGATTTGCGTTTCCGCTCATCGGCTAGGCAACGTAGTCACT 
CTGTTTCGTTGCCTCTTCATCGCTTCCCGACGTCGCTCGTACAGCTCGTCGCGCAACAGC 
TGCTTGAACCTGTAGCCGATTTCGAACGGGGACATCGTCCGAAGCGCAACGTACTCTCGC 
GGCGTCATCGCATCAAGGACCTGCATAAGACCATGGTCCATAGCATCAGCAAGCATCCGC 
TCGAGCGTGTACCGCCCGCCAATGGTTGACTCGGCGCGTTGTCCCTTGGTTCGCATCCTT 
CCCCCTCAATACCAGGCTTTTTGCTCTCAATCATGCGGTGCCGCCAACCACTGCTGACTA 
TGAGAATCGTTCATGTAGTCTGCGCCGCAGAAGGTCGACGACAGCAGGGTCACCCAACCC 
ACATTCGGACTGACAATGGACAAGCCGCTCTCTGCTGCTCTCGAATCCGTCGCTGCGGTC 
ATCAATCGCAAGCCATTCTAGGCCCTCACATCCTTGTCGGCGAACGTAGTCGAGGACCTG 
TGCGCCTCTCGATAGCATTGGCCAAAATTGCTCGTCGAATTCGCAACCCTGATACGTTGC 
GCCGATTACCCGTGCGCGCAACGATGCCGACGGCAGCTGGGAACGGGTGTAGTCAAGCCC 
GAATCGATAGGCCCAATCGGACGAAAGCACAACCGGCACGTCTGGATGCGAGTTCAATGC 
GTCGTCCAGCGTGGGCACGAACTCAAACAGTTCGATGCGCCCGGGCGCGCTGCTCAGGAT 
GCGGCGGCCCGCAACATACGAGTTGCCTCGGTGCAGGACCCCGTCAATGTCGAGAAAGAG 
AATTCGCCGCTCGCTCATCGTCACTATCGGTTGCCACGCTACTTGGCGCCGGCCCGCAAT 
CTGCAGGCTCGGCGCTAGCACAGACATCACCAGCTACCACACTGAGCCATCCGACAGAGC 
GGGCAGCACCGCCGTTGCCTTCGAAATGCGCCAGTAGCTCGCGGTTTCTCGAGGTAACCA 
ATTTGGGCATTCAAATGGTTCGCTGCCTGCTATGTGCGAGATAGGTCTGTAAACGCCGCA 
CCCACGGGTTGCCAGCAGTTGCTCTCATGATGTCGTCGGTAGAGACGGGGTGCGTAGCGG 
CCTCGGCGGCCTTCTCAAGAAGCACTCGCAACCGGTCAGCCGCACCAGCGTCAAAACCGA 
ACTGCGAGTCGACGTTCACACGCCTCGCCGCCGTCACCTCGCTGAACTCGAAATCCGTCG 
ATGTGACCACGATGTACTCGACCGACCGGGAGGACAAAAAACCCAATATCGCTTCCTCTT 
TCGTGCCGCCGAGGATTCTCACTGCGTTCACGATGCGCTGCGCGAACGGCACGCACTCTT 
GGCCCAGGAACTCGATGTCGTAGAGCAGTGGCCAGTCGTTTGCAATGACAACAAGGGCGC 
CAGGGTATGGCTCGATTGTCTCCGCGAACAGGCGAGCGTCCGATTCGAGCGAACGGGTCG 
CTGCAGGCTCGTTTTCGCGAGTCGTTATGGACGGATGTCGGTCAACCGCGCCCAGGACGC 
CGCTGATGCTGAAGAAAATCAAAACCATGTATGTCCCATTTCGGAAGGAAGCTACCGGTG 
CGTGCCCGGGGTTTTCAATTTGCGTCGGCCGCTCGCCTCGCCGAGACGACGGGCTTATCA 
ATAGCGCGCACCTCCCTCGGTCCATTGCTCCGCTGGAGGGTCAATCGAACTGTGCGAAAA 
GTGTCCGCGACGGAGGCTCTCGCTCCGTCGGCTCGAGTCGAATTGTAGCTTTGTATGCGT 
ATTCTTTTCAAGCGTACACATACGGAGTGGTAGAAAATTTTTCGACTGCAAGGGATGCTG 
TGCGGCTATGCCGAAGCTCCATGAAGCGGTCGCCAACGGGCTGTCCGAACGACTTAGAAC 
GATTCGAAAACGTGCCGGCCTCTCGCAAGACGAACTCGCTGCGAGGGCGTCGCTGGCTCG 
CACGAACCTCGCGAGCGTCGAACAAGGACGGCGGGCAAACCTCCGACTCTCGACCCTTTC 
CCGTCTAGCTGATGTACTGGGCGTGGATGTGCTCGACTTCTTCTGTGACCGGCCTGTCGG 
CGAACAGGAACCAGCCGGGGAAGACGCCCCGGCTCGGGTAATAGCGAATGTGAAACGGCT 
GCGCAGTGAGGCAGGGCTCAGTCAAGAAGCACTCTCGGTCAAAGCCCATCGATTTCGGAC 
GTACGTCGGCCGGTTGGAGAACGAAGCGGCCAGCCCAATGGTGGTCGATTTGCAGGACCT 
GGCTGACGCCCTTGGCATCTCGATTCCGGCACTCCTCGAGCCTAGCCAGCACAAAGCCAA 
ATAAGGAATGAGCGGAACGCGGCCAAGGGCCTAGCCGTCAACGTTCGGCAGTGCCTCTTG 
CTTCTCGAAAAGGATTGGGCGACAGAGGCAATAGAGCGAACGCAAACTATGCTTGGTCGG 
CGCCGTTTTTCCCTCCGCAACTTCCTTCGCGCGAAACAGCGACGCCGCGATAAATTCCGA 
TAGCTCGTCCGCTCTTTGGCGCAGTGCGGCGGTAAGGGTTGGATGCCATGGGGCAGCCTC 
GTAAACTTCCTCTACCGTGTGCTGTAGCGCTTCGCGCATCGCCTCGTCCGCCACTGAACG 
GAATGCCGGATGCCGGTAAATTGCTGAGGCGAGTCGCTCGACAACGCATGCCAATGCACC 
GAACTGAACGTCCAGCAAGTGAAGCGAACGGAACACACCGCACACTACGCGAACAGCAGA 
GTCGAACCATGTGTTCGAACTTGCAATCACTTCGGCCCACGCGTCGAGGACAATACTCGA 
ATAACCGGCTTGCGACAGCATCCATAGGAAGTCATAAGACGCGATGGAGATGTAGGTGCG 
GTTTGAGAGAAGCGACAGCATCAAATACTGACGGTGCTCCGCAAGTGGGAGCTGTCCCGT 
CTGCGTCGCGTGTGCAATAACAGCCTGTGGCGACACGGATGAGACCTCGAATCCGCTAAG 
CGCTAACGCACGCAGGCGCGCGTCAATCGACACGAGTTCCGCTCGCTTTTCAAGGCAAAG 
AGCGATGGCATCGTAGGATTCGTCGTCCAAGACACCCTTGAATTCTAGAAAATTGTTAGG 
CACCTCCGCCGGGCCATACGCGGGCGCGACTTCGCAGTAGCGCTGAACCGACTCGATAAT 
TGACGTCAGCATCGCCACTCTTTGCTGCCGGTCTTCGGGACCGTACCGAACTATCGCAAG 
CTCCCCGTCTATTTCCCTCGCTCGACCTATCGAGCGTTCATCTTTTGCCTCGTCCAAGGC 
GATAAGCAGCAAATCATAGGCACGCTGCGAAACAACAGGATGCGGCAACAAGCCCAGAAC 
TGACAGAGCCTTAAATAAGCCCAACTCGACCAGCGTGATGCAATCCAGCACGCACGATGA 
ACTTGAGCCGGGTGGATTCGACCGCTCAGGCCCACCAGTGACACGTCCCTCGGCAACAAC 
CAATGGCGGCTGGCTCGGCCCCCAGGACAAGATAATGTCCACTGGCGAACGTCCAAGCAA 
323 
34861 
34921 
34981 
35041 
35101 
35161 
35221 
35281 
35341 
35401 
35461 
35521 
35581 
35641 
35701 
35761 
35821 
35881 
35941 
36001 
36061 
36121 
36181 
36241 
36301 
36361 
36421 
36481 
36541 
36601 
36661 
36721 
36781 
36841 
36901 
36961 
37021 
37081 
37141 
37201 
37261 
37321 
37381 
37441 
37501 
37561 
37621 
37681 
37741 
37801 
37861 
37921 
37981 
38041 
38101 
38161 
38221 
38281 
CTGCGCACAAAGGCCTACTGTAAGGCGCCCCTGCCTGTAGCCATCGATGACTACGTCCGC 
TGCCCCCGACCATCGTTTCAACTGTGAGTGAATCCGGGACATGTCGATGCCCCCGTCATC 
GTTCTTGAAAGAGATGGTCCGAAATCCCGGAATGGGTTCTACGGAGTTTTCGGTTAGCTC 
GTGCGCGTAACCAAGCAGGTATCTCAAGGCAGGCATCAATGAAGCAACGCGATAGGTGGT 
CTCTTCTCCCAGCTGATGCCGAATGGTCACCACGTCGCCAACGCCCTTGCCCATGAAGTT 
CGCGGCGAAACCAGAGTCGTGAGGGAAGTAATTCTGTGCCTGCGGAAGGTTACCGACGTC 
TGCTGGGTCGACGACAATGGTGAACGGCGACCCGTCTTCTCGCAGCAAGGTCGCCGCAAC 
ACCCGCAGAGACAGCTGTAGGTGCAGCGCCCCATGGAATGTCGTCGGCGGTAAGCAGGGC 
GGTGATGAAGCCAGCGGCTGCGTTCGCATTGTCGAGGTTGCATCTGAACAATCGATACAA 
CCGGCGCATACCGAGGTCACGGTCGCCGTATTGAATTTCAGCCAACGCTACCCTGCGGAT 
AACCTTTGGGTCACCGCTTAGCTCCAGCGGGGCCTCGCCAAACGCACGCCGAATTTCTCC 
CGGCCTAAGGGTTTGAAGAGCCACCCTATACCAAAACTCCCAGGCTCGCGCATCCGTAGG 
GCAACGGTCCCTTTGTCGCAGCGCCAGCGGCTTTAACCGGTGCCAGTCATTCGCCTGCTG 
AGCTGCGAGGATAGCCATGCCGACGAAGGCGTCGTCCTCGAACCAATCTGGTGGAGCGCT 
ATCCACGATGGAGCGTGCCTTCGCGCGGTAACCACCCTTCGCATACGCCTCCAGTAGGCG 
TGTTTGCAACCCACGACTGAGATTGGCATTCGGAACCGAGGTCAGCAGCGATATCGCCGC 
CTTGTAGTTCCCAAGTGCAGTAAGCGTATCGGCCGCCTGAATCTTCACGGGCTGAGCCGA 
GGCCGTCGTCACCAAAGCAGCAATCTTCCCGCCTAACATCGCAGCTTTCTCTTGCTGCCC 
AACCGCCAGATAAATGCGGGCCGCCGCGTTCAGCAAAATAGGGGCGGTCTCAACCTTGAA 
ATCATGCTTATCAAGCAAATCAGTGGCTGATGAACTGTCGCCGCTGTTTCGAAGCGCAAT 
CCACATCAGCGCCTGAGCAGTTTTCGCCGCGTCGCTGTCAGTGGCCACAGCGTTCGATTC 
CGCGATGTCCCGTACCAACTCGGGCATTCCGAGAATAGCGGCAGACTCGCCGACCATCAT 
CTGCGCCGAGATATGCATATCTTTCAGGTGTGGTGCGCCGACCTCAACAACCTTCTTCAG 
GTCTCCCAGTTCGTGGTACGCGTATACACGCGGAGCCGCGAGCTTCAACGCAGACTCGCC 
AAATACGCCCGCTTCCTCGCAAATCTTCAAGCAAGCCAAGGCGTCGCCGAGCAGTAGCCT 
TCCGACCGCAAGGTTAGCCGCTGCATCCGAAACTAGTGGGCCGATTTCCTTGCGCCAGAG 
TCTTTCATCGCGTGGTTCAAAACATTCGCATACGGCTTGCAATGTACGTGCGACCTCTGG 
GGGCAGGAGCCCCATAGAAGCCAAAAACGGGTCCTTACTGGCGAAATCTGTGGCGATAAA 
TAGAACGTTGGTCCACGTGTAGAAGCCTGCACCATCCGCATGTAAAGCACGGTCAGCATA 
TGTGAGGGACAACGCTCGGTTCCCCGCATCATGAAAGCTAATTGCCATCATCTGCAACGC 
ATCAGCGTTGCCTTCGAACTTCCTTGGCAAATCAGCTTCAGCAAGAAACTGCTTTAGTGC 
GATTTTCGTATTGGCCCAAGCAAGCCATACGTGAGCAGAATCGGGAAAACGGGAGCGCGC 
TCTCTCAGCGATGTCAAACGCGTCATCAAGATGGTCAGAAAGCAAAAGGCCACGCACCTT 
TCCGGACGCAACTCGGTCATCGTCCGGGTAGGTCTCATATGCCGTATCAAACTTTTGCAC 
TGCGCCACTGACATCTCCCGCGTGCCAATCCACGATTCCTGAGAGGAGATACCATCTCGC 
TTTCTGCCGCTCGTTCAATGACGAGAACTCATCAAAAATCACCGATAGCAGCGCACTTGC 
ACCGCTATAGCTCATTTCCTTAATGAACTCGGCCACCTTGTCCAGCTGTCTCGATACCGT 
ATTATTCTCGTTTGTTACGAGCGACGACACAAAGGCATGGCCACCCACCTGTGTCATCAG 
CGAATCGAGCTTCGACGATAGCGCGCTTACGAGCTCATTGGTTTCAACTACCGTCGAATG 
AGTCTTCTCCGACGATGTTCTAATGTCATCATAGACACCGCCTGGAGAGTTAGGGCTGTA 
CTTCTTCTGAAGAATGGCATGACGCTTTATGTGATTACAAATGTCGTCCCAAAACTCGAT 
GCTTACCTTGAACTTTCCAGACTCAGCCCGAGCGTCAGTCAAATCCTGGGCATACTTGAC 
GAGCTTCGAATCACTCGCGGCCGTCGTCGCTACAATTAACTCGCCGATACTCCAGCCAGC 
CTTGTCGGCCGCAACCACTTCATCAGCTATAACTTTTTCAGTGACCTTCGTTTCGTAGTA 
ACGCTTGCACTGAATTCCTTTACGCTTACCAACGCGAGGCTCAACAAAAATGTCTACACC 
GCCCTGACTTTGTCCGGTTCGACCGTTGCGCTTCGGGGTGGGGTCTTCAAAGACTACTGA 
GTAGATTTCGGCGCAGTAATCTTCGAAGTCCTCGGCATGCTTGGGCTTGACGATTTCTAA 
AGTGAACGTACGCATGTAGATGCTTCTTCGCTCTTCCGAAACCAAAGGATATACATCATC 
GAATCCGACGTTCCGGTATCGGCGTATGCATAGTCGTCGGCTTGAACATTGTGCCCGAAA 
ACACCCAAAGGAAAATGCGTCCGCCGACGCAGTGAAGGTACTCGACCTGGCTCATCGGCC 
GTCATTCGATGTATGAACAGCTTCGCGACAGAACGATGCCGCTCCGAACCGAGAGGAAGA 
TGCATCGGCTCCTTCTACAAAGCGAAGCCTGCGGTTTCCCGAATTTTTCCCTTTTTGCTC 
AAGCTGTTAGGTGACCCAACGTGCCGCCCATCTTCCTGTTTCACAGCACCACGCCGTGGC 
ACAAAAAAGGGCGCCCCGAGAGGACGCCCTAAAGTCACCTTTTTCCGATATCCATCAAGG 
AGTTAGAGTGAGAATCTTCCTTCCTCTTGTTGGTATGCTCCCTAGAACGGAATATCGTCG 
TCCATCTCATCGAACCCGCCGCCCGCCGGGGCGCTCGGTCGGTTCGCGCCGACGACGACA 
CCGCTGCTCGCACCCACACCGACGACACCCGACACGCGGACGACACCGTCGTCGAGCTCC 
ATGTTCCGGGCGACG 
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